1	ORIGINAL	JJ	O	original	amod	3	SENT_1	[p1l185t84r375b123],
2	RESEARCH	NN	O	research	nn	3	SENT_1	[p1l394t84r583b123],
3	ARTICLE	NN	O	article	_	0	SENT_1	[p1l601t84r752b123],
4	°	CD	NUMBER	°	dep	3	SENT_1	[p1l1569t81r1975b125],
5	"	``	O	"	punct	4	SENT_1	[p1l1569t81r1975b125],
6	”	CD	NUMBER	”	num	7	SENT_1	[p1l1569t81r1975b125],
7	P	NN	O	p	dep	4	SENT_1	[p1l1569t81r1975b125],
8	“	CD	PERCENT	“	num	9	SENT_1	[p1l1569t81r1975b125],
9	%	NN	PERCENT	%	dep	3	SENT_1	[p1l1569t81r1975b125],
10	§	CD	NUMBER	§	dep	9	SENT_1	[p1l1569t81r1975b125],
11	?	.	O	?	_	0	SENT_1	[p1l1569t81r1975b125],

1	§	NN	O	§	_	0	SENT_2	[p1l1569t81r1975b125],
2	.	.	O	.	_	0	SENT_2	[p1l1569t81r1975b125],

1	:3	CD	NUMBER	:3	num	2	SENT_3	[p1l1569t81r1975b125],
2	Z	NN	O	z	_	0	SENT_3	[p1l1569t81r1975b125],
3	§	CD	NUMBER	§	num	4	SENT_3	[p1l1569t81r1975b125],
4	zE	NN	O	ze	dep	2	SENT_3	[p1l1569t81r1975b125],
5	?	.	O	?	_	0	SENT_3	[p1l1569t81r1975b125],

1	83S	NN	O	83	_	0	SENT_4	[p1l1569t81r1975b125],
2	;	:	O	;	_	0	SENT_4	[p1l1569t81r1975b125],
3	$	$	PERCENT	$	amod	10	SENT_4	[p1l1569t81r1975b125],
4	%	JJ	PERCENT	%	dep	3	SENT_4	[p1l1569t81r1975b125],
5	é3l32374233	NN	O	é3l32374233	nn	10	SENT_4	[p1l1569t81r1975b125],
6	©	CD	NUMBER	©	num	10	SENT_4	[p1l1455t157r1469b172],
7	2007	CD	DATE	2007	num	10	SENT_4	[p1l1477t156r1521b172],
8	Adis	NNP	O	Adis	nn	10	SENT_4	[p1l1529t156r1570b172],
9	Dcztci	NNP	O	Dcztci	nn	10	SENT_4	[p1l1578t156r1627b172],
10	Information	NNP	O	Information	dep	1	SENT_4	[p1l1636t156r1748b172],
11	BV	NN	O	bv	dep	10	SENT_4	[p1l1757t156r1786b172],
12	.	.	O	.	_	0	SENT_4	[p1l1757t156r1786b172],

1	All	DT	O	all	det	2	SENT_5	[p1l1795t156r1817b172],
2	rights	NNS	O	rights	nsubj	3	SENT_5	[p1l1825t156r1876b176],
3	reserved	VBN	O	reserve	_	0	SENT_5	[p1l1884t156r1974b172],
4	.	.	O	.	_	0	SENT_5	[p1l1884t156r1974b172],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_6	[p1l187t251r924b319],
2	and	CC	O	and	_	0	SENT_6	[p1l958t251r1110b319],
3	Tolerability	NN	O	tolerability	conj_and	1	SENT_6	[p1l1142t251r1638b342],
4	of	IN	O	of	_	0	SENT_6	[p1l187t361r270b429],
5	Duloxetine	NNP	O	Duloxetine	prep_of	1	SENT_6	[p1l301t361r763b429],
6	following	VBG	O	follow	dep	1	SENT_6	[p1l797t361r1205b452],
7	Oral	NNP	O	Oral	nn	8	SENT_6	[p1l1238t361r1419b429],
8	Administration	NNP	O	Administration	pobj	6	SENT_6	[p1l186t471r829b539],
9	to	TO	O	to	_	0	SENT_6	[p1l860t479r936b539],
10	Healthy	JJ	O	healthy	amod	12	SENT_6	[p1l970t471r1302b562],
11	Chinese	JJ	MISC	chinese	amod	12	SENT_6	[p1l188t581r522b649],
12	Subjects	NNS	O	subject	prep_to	8	SENT_6	[p1l558t581r905b672],

1	Si	NNP	O	Si	nn	9	SENT_7	[p1l186t727r222b760],
2	Tianmei	NNP	O	Tianmei	nn	9	SENT_7	[p1l238t723r413b766],
3	}	NNP	O	}	nn	9	SENT_7	[p1l238t723r413b766],
4	Mary	NNP	PERSON	Mary	nn	9	SENT_7	[p1l424t727r528b772],
5	Pat	NNP	PERSON	Pat	nn	9	SENT_7	[p1l543t727r605b760],
6	Knadleigz	NNP	PERSON	Knadleigz	nn	9	SENT_7	[p1l620t723r794b766],
7	Ming	NNP	PERSON	Ming	nn	9	SENT_7	[p1l803t726r908b772],
8	T.	NNP	PERSON	T.	nn	9	SENT_7	[p1l924t727r957b760],
9	Lim	NNP	PERSON	Lim	_	0	SENT_7	[p1l976t723r1075b766],
10	,3	CD	NUMBER	,3	num	13	SENT_7	[p1l976t723r1075b766],
11	Kwee	NNP	O	Kwee	nn	13	SENT_7	[p1l1085t727r1183b760],
12	Poo	NNP	O	Poo	nn	13	SENT_7	[p1l1198t727r1265b760],
13	Ye0	NN	O	ye0	dep	9	SENT_7	[p1l1282t723r1375b766],
14	,3	CD	NUMBER	,3	num	13	SENT_7	[p1l1282t723r1375b766],
15	Leyan	NNP	PERSON	Leyan	nn	16	SENT_7	[p1l1385t727r1495b772],
16	Teng	NNP	PERSON	Teng	dep	13	SENT_7	[p1l1513t723r1630b772],
17	,3	CD	NUMBER	,3	num	19	SENT_7	[p1l1513t723r1630b772],
18	Shu	NNP	PERSON	Shu	nn	19	SENT_7	[p1l186t781r256b815],
19	Liang	NNP	PERSON	Liang	dep	9	SENT_7	[p1l272t778r504b827],
20	,1	CD	NUMBER	,1	num	19	SENT_7	[p1l272t778r504b827],
21	Alzzn	NNP	O	Alzzn	nn	23	SENT_7	[p1l272t778r504b827],
22	X.	NNP	O	X.	nn	23	SENT_7	[p1l520t782r560b815],
23	Pan	NNP	O	Pan	dep	19	SENT_7	[p1l578t778r666b815],
24	?	.	O	?	_	0	SENT_7	[p1l578t778r666b815],

1	’	NN	O	’	_	0	SENT_8	[p1l578t778r666b815],
2	and	CC	O	and	_	0	SENT_8	[p1l691t781r766b815],
3	Evelyn	NNP	PERSON	Evelyn	nn	5	SENT_8	[p1l783t781r909b827],
4	D.	NNP	PERSON	D.	nn	5	SENT_8	[p1l926t782r968b815],
5	L0b02	NN	PERSON	l0b02	conj_and	1	SENT_8	[p1l987t778r1088b815],

1	1	CD	NUMBER	1	num	4	SENT_9	[p1l186t866r200b892],
2	Peking	NNP	ORGANIZATION	Peking	nn	4	SENT_9	[p1l241t865r355b903],
3	University	NNP	ORGANIZATION	University	nn	4	SENT_9	[p1l367t866r542b903],
4	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_9	[p1l554t866r691b893],
5	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l704t865r737b893],
6	Mental	NNP	ORGANIZATION	Mental	nn	7	SENT_9	[p1l748t865r864b893],
7	Health	NNP	ORGANIZATION	Health	prep_of	4	SENT_9	[p1l876t865r997b898],
8	,	,	O	,	_	0	SENT_9	[p1l876t865r997b898],
9	Beijing	NNP	LOCATION	Beijing	conj_and	7	SENT_9	[p1l1010t866r1132b903],
10	,	,	O	,	_	0	SENT_9	[p1l1010t866r1132b903],
11	China	NNP	LOCATION	China	nn	14	SENT_9	[p1l1145t865r1243b893],
12	2	CD	NUMBER	2	num	14	SENT_9	[p1l184t914r202b941],
13	Drug	NNP	O	Drug	nn	14	SENT_9	[p1l241t914r327b951],
14	Disposition	NNP	O	Disposition	conj_and	7	SENT_9	[p1l339t914r538b951],
15	,	,	O	,	_	0	SENT_9	[p1l339t914r538b951],
16	Eli	NNP	ORGANIZATION	Eli	nn	17	SENT_9	[p1l551t913r595b941],
17	Lilly	NNP	ORGANIZATION	Lilly	prep_of	4	SENT_9	[p1l607t913r683b951],
18	and	CC	ORGANIZATION	and	_	0	SENT_9	[p1l695t913r757b941],
19	Company	NNP	ORGANIZATION	Company	nn	25	SENT_9	[p1l770t914r941b951],
20	,	,	O	,	_	0	SENT_9	[p1l770t914r941b951],
21	Indianapolis	NNP	LOCATION	Indianapolis	appos	25	SENT_9	[p1l954t913r1170b951],
22	,	,	O	,	_	0	SENT_9	[p1l954t913r1170b951],
23	Indiana	NNP	LOCATION	Indiana	appos	25	SENT_9	[p1l1183t913r1319b946],
24	,	,	O	,	_	0	SENT_9	[p1l1183t913r1319b946],
25	USA	NNP	LOCATION	USA	prep_of	4	SENT_9	[p1l1331t914r1408b941],
26	3	CD	NUMBER	3	num	25	SENT_9	[p1l185t962r201b989],
27	Lilly-NUS	NNP	O	Lilly-NUS	nn	28	SENT_9	[p1l241t960r409b999],
28	Centre	NNP	O	Centre	dep	4	SENT_9	[p1l421t961r531b989],
29	for	IN	O	for	_	0	SENT_9	[p1l544t960r590b989],
30	Clinical	JJ	O	clinical	amod	31	SENT_9	[p1l603t960r729b989],
31	Pharmacology	NN	O	pharmacology	prep_for	28	SENT_9	[p1l741t960r989b999],
32	,	,	O	,	_	0	SENT_9	[p1l741t960r989b999],
33	National	NNP	ORGANIZATION	National	nn	34	SENT_9	[p1l1002t960r1146b989],
34	University	NNP	ORGANIZATION	University	appos	31	SENT_9	[p1l1158t961r1333b999],
35	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l1346t960r1378b989],
36	Singapore	NNP	ORGANIZATION	Singapore	nn	38	SENT_9	[p1l1390t961r1565b999],
37	,	,	O	,	_	0	SENT_9	[p1l1390t961r1565b999],
38	Singapore	NNP	LOCATION	Singapore	prep_of	34	SENT_9	[p1l1578t961r1744b999],

1	AbS	NN	O	ab	nsubj	16	SENT_10	[p1l184t1111r387b1149],
2	'	POS	O	'	_	0	SENT_10	[p1l184t1111r387b1149],
3	l'	NN	O	l'	dep	1	SENT_10	[p1l184t1111r387b1149],
4	I	PRP	O	I	rcmod	3	SENT_10	[p1l184t1111r387b1149],
5	'	''	O	'	_	0	SENT_10	[p1l184t1111r387b1149],
6	GC	NN	O	gc	dobj	4	SENT_10	[p1l184t1111r387b1149],
7	'	''	O	'	_	0	SENT_10	[p1l184t1111r387b1149],
8	l'	JJ	O	l'	amod	9	SENT_10	[p1l184t1111r387b1149],
9	Objectives	NNS	O	objective	dep	6	SENT_10	[p1l631t1118r818b1155],
10	:	:	O	:	_	0	SENT_10	[p1l631t1118r818b1155],
11	The	DT	O	the	det	12	SENT_10	[p1l830t1119r890b1147],
12	objectives	NNS	O	objective	dep	6	SENT_10	[p1l900t1119r1058b1155],
13	of	IN	O	of	_	0	SENT_10	[p1l1069t1119r1103b1147],
14	the	DT	O	the	det	15	SENT_10	[p1l1110t1119r1157b1147],
15	study	NN	O	study	prep_of	4	SENT_10	[p1l1168t1119r1251b1155],
16	were	VBD	O	be	_	0	SENT_10	[p1l1261t1128r1336b1147],
17	to	TO	O	to	aux	18	SENT_10	[p1l1346t1123r1375b1147],
18	characterise	VB	O	characterise	xcomp	16	SENT_10	[p1l1385t1119r1572b1147],
19	the	DT	O	the	det	20	SENT_10	[p1l1582t1119r1629b1147],
20	pharmacokinetics	NNS	O	pharmacokinetic	dobj	18	SENT_10	[p1l1638t1119r1916b1155],
21	and	CC	O	and	_	0	SENT_10	[p1l631t1168r687b1196],
22	assess	VB	O	assess	xcomp	16	SENT_10	[p1l701t1177r795b1196],
23	the	DT	O	the	det	24	SENT_10	[p1l810t1168r857b1196],
24	tolerability	NN	O	tolerability	dobj	22	SENT_10	[p1l871t1168r1044b1204],
25	of	IN	O	of	_	0	SENT_10	[p1l1058t1168r1093b1196],
26	duloxetine	NN	O	duloxetine	prep_of	24	SENT_10	[p1l1104t1168r1270b1196],
27	in	IN	O	in	_	0	SENT_10	[p1l1284t1168r1313b1196],
28	healthy	JJ	O	healthy	amod	30	SENT_10	[p1l1327t1168r1443b1204],
29	Chinese	JJ	MISC	chinese	amod	30	SENT_10	[p1l1457t1168r1583b1196],
30	subjects	NNS	O	subject	prep_in	22	SENT_10	[p1l1599t1168r1723b1204],
31	after	IN	O	after	_	0	SENT_10	[p1l1738t1168r1810b1196],
32	single	JJ	O	single	amod	37	SENT_10	[p1l1824t1168r1916b1204],
33	and	CC	O	and	_	0	SENT_10	[p1l631t1217r687b1245],
34	multiple	JJ	O	multiple	conj_and	32	SENT_10	[p1l700t1217r830b1253],
35	oral	JJ	O	oral	amod	37	SENT_10	[p1l844t1217r903b1245],
36	60mg	JJ	O	60mg	amod	37	SENT_10	[p1l917t1217r1005b1253],
37	dosing	NN	O	dosing	prep_after	22	SENT_10	[p1l1019t1217r1131b1253],
38	.	.	O	.	_	0	SENT_10	[p1l1019t1217r1131b1253],

1	Methods	NNS	O	method	_	0	SENT_11	[p1l630t1266r787b1294],
2	:	:	O	:	_	0	SENT_11	[p1l630t1266r787b1294],
3	This	DT	O	this	nsubj	15	SENT_11	[p1l812t1266r881b1294],
4	was	VBD	O	be	cop	15	SENT_11	[p1l904t1275r964b1294],
5	a	DT	O	a	det	15	SENT_11	[p1l988t1275r1004b1294],
6	single-centre	JJ	O	single-centre	amod	15	SENT_11	[p1l1027t1266r1238b1302],
7	,	,	O	,	_	0	SENT_11	[p1l1027t1266r1238b1302],
8	double-blind	JJ	O	double-blind	amod	15	SENT_11	[p1l1262t1266r1471b1299],
9	,	,	O	,	_	0	SENT_11	[p1l1262t1266r1471b1299],
10	randomised	JJ	O	randomised	amod	15	SENT_11	[p1l1495t1266r1687b1299],
11	,	,	O	,	_	0	SENT_11	[p1l1495t1266r1687b1299],
12	placebocontrolled	JJ	O	placebocontrolled	amod	15	SENT_11	[p1l1711t1266r1916b1302, p1l630t1315r741b1348],
13	,	,	O	,	_	0	SENT_11	[p1l1711t1266r1916b1302, p1l630t1315r741b1348],
14	single-period	JJ	O	single-period	amod	15	SENT_11	[p1l763t1315r970b1351],
15	study	NN	O	study	dep	1	SENT_11	[p1l990t1315r1073b1351],
16	in	IN	O	in	_	0	SENT_11	[p1l1093t1315r1122b1342],
17	healthy	JJ	O	healthy	amod	20	SENT_11	[p1l1141t1315r1257b1351],
18	native	JJ	O	native	amod	20	SENT_11	[p1l1276t1315r1371b1343],
19	Chinese	JJ	MISC	chinese	amod	20	SENT_11	[p1l1391t1315r1517b1343],
20	subjects	NNS	O	subject	prep_in	15	SENT_11	[p1l1538t1315r1671b1351],
21	.	.	O	.	_	0	SENT_11	[p1l1538t1315r1671b1351],

1	A	DT	O	a	det	2	SENT_12	[p1l1692t1315r1720b1342],
2	total	NN	O	total	nsubj	9	SENT_12	[p1l1739t1315r1808b1343],
3	of	IN	O	of	_	0	SENT_12	[p1l1828t1315r1862b1343],
4	32	CD	NUMBER	32	num	5	SENT_12	[p1l1879t1315r1916b1343],
5	subjects	NNS	O	subject	prep_of	2	SENT_12	[p1l632t1364r765b1400],
6	,	,	O	,	_	0	SENT_12	[p1l632t1364r765b1400],
7	19	CD	NUMBER	19	num	8	SENT_12	[p1l793t1364r826b1392],
8	men	NNS	O	man	appos	5	SENT_12	[p1l849t1373r916b1392],
9	(	VBP	O	(	ccomp	21	SENT_12	[p1l939t1364r989b1398],
10	14	CD	NUMBER	14	dobj	9	SENT_12	[p1l939t1364r989b1398],
11	on	IN	O	on	_	0	SENT_12	[p1l1012t1373r1050b1392],
12	duloxetine	NN	O	duloxetine	prep_on	9	SENT_12	[p1l1073t1364r1247b1397],
13	,	,	O	,	_	0	SENT_12	[p1l1073t1364r1247b1397],
14	5	CD	NUMBER	5	nsubj	21	SENT_12	[p1l1271t1364r1287b1392],
15	on	IN	O	on	_	0	SENT_12	[p1l1311t1373r1349b1392],
16	placebo	NN	O	placebo	nn	17	SENT_12	[p1l1371t1364r1505b1400],
17	)	NN	O	)	prep_on	14	SENT_12	[p1l1371t1364r1505b1400],
18	and	CC	O	and	_	0	SENT_12	[p1l1529t1364r1585b1392],
19	13	CD	NUMBER	13	num	20	SENT_12	[p1l1611t1364r1643b1392],
20	women	NNS	O	woman	prep_on	14	SENT_12	[p1l1667t1373r1782b1392],
21	(	VBP	O	(	_	0	SENT_12	[p1l1806t1364r1856b1399],
22	10	CD	NUMBER	10	nsubj	39	SENT_12	[p1l1806t1364r1856b1399],
23	on	IN	O	on	_	0	SENT_12	[p1l1879t1373r1916b1392],
24	duloxetine	NN	O	duloxetine	prep_on	22	SENT_12	[p1l631t1413r805b1446],
25	,	,	O	,	_	0	SENT_12	[p1l631t1413r805b1446],
26	3	CD	NUMBER	3	appos	22	SENT_12	[p1l818t1413r834b1441],
27	on	IN	O	on	_	0	SENT_12	[p1l847t1422r885b1441],
28	placebo	NN	O	placebo	nn	29	SENT_12	[p1l895t1413r1030b1449],
29	)	NN	O	)	prep_on	26	SENT_12	[p1l895t1413r1030b1449],
30	between	IN	O	between	_	0	SENT_12	[p1l1041t1413r1172b1441],
31	the	DT	O	the	det	32	SENT_12	[p1l1183t1413r1230b1441],
32	ages	NNS	O	age	prep_between	29	SENT_12	[p1l1242t1422r1310b1449],
33	of	IN	O	of	_	0	SENT_12	[p1l1322t1413r1356b1441],
34	20	CD	NUMBER	20	nn	37	SENT_12	[p1l1364t1413r1402b1441],
35	and	CC	O	and	_	0	SENT_12	[p1l1414t1413r1470b1441],
36	39	CD	DURATION	39	conj_and	34	SENT_12	[p1l1481t1413r1518b1441],
37	years	NNS	NUMBER	year	prep_of	32	SENT_12	[p1l1529t1422r1620b1449],
38	,	,	O	,	_	0	SENT_12	[p1l1529t1422r1620b1449],
39	participated	VBD	O	participate	ccomp	21	SENT_12	[p1l1632t1413r1818b1449],
40	in	IN	O	in	_	0	SENT_12	[p1l1829t1413r1858b1441],
41	the	DT	O	the	det	42	SENT_12	[p1l1869t1413r1916b1441],
42	study	NN	O	study	prep_in	39	SENT_12	[p1l632t1462r723b1498],
43	.	.	O	.	_	0	SENT_12	[p1l632t1462r723b1498],

1	Duloxetine	NNP	O	Duloxetine	nn	5	SENT_13	[p1l734t1462r909b1490],
2	60mg	JJ	O	60mg	amod	5	SENT_13	[p1l919t1462r1007b1498],
3	(	CD	NUMBER	(	num	5	SENT_13	[p1l1017t1462r1253b1496],
4	enteric-coated	JJ	O	enteric-coated	amod	5	SENT_13	[p1l1017t1462r1253b1496],
5	pellets	NNS	O	pellet	nsubjpass	11	SENT_13	[p1l1261t1462r1363b1498],
6	in	IN	O	in	_	0	SENT_13	[p1l1373t1462r1402b1490],
7	a	DT	O	a	det	9	SENT_13	[p1l1412t1471r1429b1490],
8	capsule	NN	O	capsule	nn	9	SENT_13	[p1l1438t1462r1567b1498],
9	)	NN	O	)	prep_in	11	SENT_13	[p1l1438t1462r1567b1498],
10	was	VBD	O	be	auxpass	11	SENT_13	[p1l1577t1471r1637b1490],
11	given	VBN	O	give	_	0	SENT_13	[p1l1647t1462r1733b1498],
12	orally	RB	O	orally	advmod	11	SENT_13	[p1l1743t1462r1834b1498],
13	once	RB	DATE	once	advmod	11	SENT_13	[p1l1843t1471r1916b1490],
14	on	IN	O	on	_	0	SENT_13	[p1l631t1520r669b1539],
15	day	NN	DURATION	day	prep_on	13	SENT_13	[p1l681t1511r736b1547],
16	l	NN	O	l	tmod	13	SENT_13	[p1l753t1511r764b1539],
17	and	CC	O	and	_	0	SENT_13	[p1l780t1511r836b1539],
18	once	RB	DATE	once	advmod	19	SENT_13	[p1l848t1520r921b1539],
19	daily	JJ	SET	daily	advmod	11	SENT_13	[p1l933t1511r1011b1547],
20	on	IN	O	on	_	0	SENT_13	[p1l1023t1520r1061b1539],
21	days	NNS	DATE	day	prep_on	19	SENT_13	[p1l1074t1511r1144b1547],
22	4	CD	DATE	4	num	21	SENT_13	[p1l1157t1511r1175b1539],
23	to	TO	DATE	to	dep	21	SENT_13	[p1l1188t1515r1217b1539],
24	9	CD	DATE	9	num	21	SENT_13	[p1l1230t1511r1256b1539],
25	.	.	O	.	_	0	SENT_13	[p1l1230t1511r1256b1539],

1	Sequential	JJ	O	sequential	amod	3	SENT_14	[p1l1271t1511r1435b1547],
2	blood	NN	O	blood	nn	3	SENT_14	[p1l1447t1511r1537b1539],
3	samples	NNS	O	sample	nsubjpass	5	SENT_14	[p1l1550t1511r1674b1547],
4	were	VBD	O	be	auxpass	5	SENT_14	[p1l1687t1520r1763b1539],
5	collected	VBN	O	collect	_	0	SENT_14	[p1l1775t1511r1917b1539],
6	over	IN	O	over	_	0	SENT_14	[p1l631t1569r700b1588],
7	72	CD	DURATION	72	num	8	SENT_14	[p1l712t1560r749b1588],
8	hours	NNS	NUMBER	hour	prep_over	5	SENT_14	[p1l761t1560r847b1588],
9	after	IN	O	after	_	0	SENT_14	[p1l861t1560r932b1588],
10	the	DT	O	the	det	11	SENT_14	[p1l943t1560r990b1588],
11	dose	NN	O	dose	prep_after	5	SENT_14	[p1l1002t1560r1073b1588],
12	on	IN	O	on	_	0	SENT_14	[p1l1086t1569r1124b1588],
13	days	NNS	DURATION	day	prep_on	11	SENT_14	[p1l1136t1560r1206b1596],
14	1	CD	NUMBER	1	num	13	SENT_14	[p1l1223t1560r1234b1588],
15	and	CC	O	and	_	0	SENT_14	[p1l1250t1560r1305b1588],
16	9	CD	NUMBER	9	prep_on	11	SENT_14	[p1l1317t1560r1344b1593],
17	,	,	O	,	_	0	SENT_14	[p1l1317t1560r1344b1593],
18	and	CC	O	and	_	0	SENT_14	[p1l1358t1560r1413b1588],
19	a	DT	O	a	det	21	SENT_14	[p1l1425t1569r1442b1588],
20	predose	NN	O	predose	nn	21	SENT_14	[p1l1452t1560r1575b1596],
21	sample	NN	O	sample	nsubjpass	23	SENT_14	[p1l1588t1560r1697b1596],
22	was	VBD	O	be	auxpass	23	SENT_14	[p1l1709t1569r1769b1588],
23	obtained	VBN	O	obtain	conj_and	5	SENT_14	[p1l1782t1560r1917b1588],
24	on	IN	O	on	_	0	SENT_14	[p1l631t1618r669b1637],
25	days	NNS	DURATION	day	prep_on	23	SENT_14	[p1l687t1609r758b1645],
26	7	CD	NUMBER	7	num	25	SENT_14	[p1l777t1610r794b1637],
27	and	CC	O	and	_	0	SENT_14	[p1l815t1609r870b1637],
28	8	CD	NUMBER	8	prep_on	23	SENT_14	[p1l890t1609r915b1637],
29	.	.	O	.	_	0	SENT_14	[p1l890t1609r915b1637],

1	Duloxetine	NN	O	duloxetine	nn	2	SENT_15	[p1l935t1609r1110b1637],
2	concentrations	NNS	O	concentration	nsubjpass	6	SENT_15	[p1l1129t1609r1357b1637],
3	in	IN	O	in	_	0	SENT_15	[p1l1377t1609r1406b1637],
4	plasma	NN	O	plasma	prep_in	2	SENT_15	[p1l1424t1609r1536b1645],
5	were	VBD	O	be	auxpass	6	SENT_15	[p1l1554t1618r1630b1637],
6	determined	VBN	O	determine	_	0	SENT_15	[p1l1648t1609r1826b1637],
7	by	IN	O	by	_	0	SENT_15	[p1l1843t1609r1882b1645],
8	a	DT	O	a	agent	6	SENT_15	[p1l1901t1618r1917b1637],
9	validated	VBN	O	validate	partmod	8	SENT_15	[p1l630t1658r775b1686],
10	liquid	NN	O	liquid	nn	11	SENT_15	[p1l787t1658r879b1694],
11	chromatography-tandem	NN	O	chromatography-tandem	dobj	9	SENT_15	[p1l891t1658r1280b1694],
12	mass	NN	O	mass	nn	14	SENT_15	[p1l1292t1667r1369b1686],
13	spectrometry	NN	O	spectrometry	nn	14	SENT_15	[p1l1384t1662r1588b1694],
14	method	NN	O	method	dep	11	SENT_15	[p1l1601t1658r1727b1686],
15	.	.	O	.	_	0	SENT_15	[p1l1601t1658r1727b1686],

1	The	DT	O	the	det	3	SENT_16	[p1l1741t1658r1801b1686],
2	tolerability	NN	O	tolerability	nn	3	SENT_16	[p1l1815t1658r1916b1686, p1l630t1707r712b1743],
3	evaluation	NN	O	evaluation	nsubj	4	SENT_16	[p1l734t1707r898b1735],
4	included	VBD	O	include	_	0	SENT_16	[p1l919t1707r1054b1735],
5	a	DT	O	a	det	7	SENT_16	[p1l1076t1716r1092b1735],
6	physical	JJ	O	physical	amod	7	SENT_16	[p1l1112t1707r1243b1743],
7	examination	NN	O	examination	dobj	4	SENT_16	[p1l1265t1707r1467b1740],
8	,	,	O	,	_	0	SENT_16	[p1l1265t1707r1467b1740],
9	vital	JJ	O	vital	amod	10	SENT_16	[p1l1490t1707r1559b1735],
10	signs	NNS	O	sign	dobj	4	SENT_16	[p1l1581t1707r1669b1743],
11	,	,	O	,	_	0	SENT_16	[p1l1581t1707r1669b1743],
12	adverse	JJ	O	adverse	amod	14	SENT_16	[p1l1692t1707r1811b1735],
13	event	NN	O	event	nn	14	SENT_16	[p1l1832t1711r1917b1735],
14	monitoring	NN	O	monitoring	dobj	4	SENT_16	[p1l631t1756r805b1792],
15	and	CC	O	and	_	0	SENT_16	[p1l819t1756r875b1784],
16	clinical	JJ	O	clinical	amod	18	SENT_16	[p1l888t1756r1002b1784],
17	laboratory	NN	O	laboratory	nn	18	SENT_16	[p1l1016t1756r1177b1792],
18	evaluations	NNS	O	evaluation	conj_and	7	SENT_16	[p1l1191t1756r1377b1784],
19	.	.	O	.	_	0	SENT_16	[p1l1191t1756r1377b1784],

1	Results	NNS	O	result	_	0	SENT_17	[p1l631t1805r763b1833],
2	:	:	O	:	_	0	SENT_17	[p1l631t1805r763b1833],
3	Duloxetine	NNP	O	Duloxetine	nn	4	SENT_17	[p1l777t1805r952b1833],
4	disposition	NN	O	disposition	nsubjpass	9	SENT_17	[p1l965t1805r1137b1841],
5	on	IN	O	on	_	0	SENT_17	[p1l1149t1814r1188b1833],
6	oral	JJ	O	oral	amod	7	SENT_17	[p1l1200t1805r1260b1833],
7	administration	NN	O	administration	prep_on	4	SENT_17	[p1l1273t1805r1500b1833],
8	is	VBZ	O	be	auxpass	9	SENT_17	[p1l1512t1805r1536b1833],
9	characterised	VBN	O	characterise	dep	1	SENT_17	[p1l1549t1805r1757b1833],
10	by	IN	O	by	_	0	SENT_17	[p1l1768t1805r1807b1841],
11	a	DT	O	a	det	14	SENT_17	[p1l1820t1814r1836b1833],
12	onecompartment	JJ	O	onecompartment	amod	14	SENT_17	[p1l1848t1814r1916b1833, p1l631t1858r839b1890],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_17	[p1l847t1854r1110b1890],
14	model	NN	O	model	agent	9	SENT_17	[p1l1121t1854r1226b1882],
15	.	.	O	.	_	0	SENT_17	[p1l1121t1854r1226b1882],

1	Duloxetine	NNP	O	Duloxetine	nsubjpass	4	SENT_18	[p1l1238t1854r1413b1882],
2	is	VBZ	O	be	auxpass	4	SENT_18	[p1l1423t1854r1447b1882],
3	well	RB	O	well	advmod	4	SENT_18	[p1l1458t1854r1524b1882],
4	absorbed	VBN	O	absorb	_	0	SENT_18	[p1l1535t1854r1685b1887],
5	,	,	O	,	_	0	SENT_18	[p1l1535t1854r1685b1887],
6	with	IN	O	with	_	0	SENT_18	[p1l1696t1854r1765b1882],
7	a	DT	O	a	det	9	SENT_18	[p1l1776t1863r1792b1882],
8	median	JJ	O	median	amod	9	SENT_18	[p1l1801t1854r1917b1882],
9	time	NN	O	time	prep_with	4	SENT_18	[p1l630t1903r699b1931],
10	of	IN	O	of	_	0	SENT_18	[p1l716t1903r750b1931],
11	maximum	NN	O	maximum	nn	13	SENT_18	[p1l763t1903r923b1931],
12	plasma	NN	O	plasma	nn	13	SENT_18	[p1l938t1903r1050b1939],
13	concentration	NN	O	concentration	prep_of	9	SENT_18	[p1l1066t1903r1280b1931],
14	at	IN	O	at	_	0	SENT_18	[p1l1296t1907r1324b1931],
15	6	CD	NUMBER	6	nn	18	SENT_18	[p1l1340t1903r1357b1931],
16	and	CC	O	and	_	0	SENT_18	[p1l1374t1903r1430b1931],
17	4	CD	DURATION	4	nn	18	SENT_18	[p1l1445t1903r1464b1930],
18	hours	NNS	NUMBER	hour	prep_at	13	SENT_18	[p1l1480t1903r1566b1931],
19	following	VBG	O	follow	_	0	SENT_18	[p1l1583t1903r1735b1939],
20	single	JJ	O	single	amod	23	SENT_18	[p1l1753t1903r1845b1939],
21	and	CC	O	and	_	0	SENT_18	[p1l1861t1903r1917b1931],
22	multiple	JJ	O	multiple	conj_and	20	SENT_18	[p1l630t1952r761b1988],
23	dosing	NN	O	dosing	prep_following	18	SENT_18	[p1l776t1952r889b1988],
24	,	,	O	,	_	0	SENT_18	[p1l776t1952r889b1988],
25	respectively	RB	O	respectively	advmod	4	SENT_18	[p1l904t1952r1103b1988],
26	.	.	O	.	_	0	SENT_18	[p1l904t1952r1103b1988],

1	At	IN	O	at	_	0	SENT_19	[p1l1119t1952r1158b1980],
2	steady	JJ	O	steady	amod	3	SENT_19	[p1l1174t1952r1272b1988],
3	state	NN	O	state	prep_at	32	SENT_19	[p1l1288t1956r1367b1985],
4	,	,	O	,	_	0	SENT_19	[p1l1288t1956r1367b1985],
5	the	DT	O	the	det	6	SENT_19	[p1l1383t1952r1430b1980],
6	mean	NN	O	mean	npadvmod	7	SENT_19	[p1l1445t1961r1529b1980],
7	apparent	JJ	O	apparent	amod	12	SENT_19	[p1l1544t1956r1679b1988],
8	oral	JJ	O	oral	amod	12	SENT_19	[p1l1694t1952r1754b1980],
9	clearance	NN	O	clearance	nn	12	SENT_19	[p1l1769t1952r1916b1980],
10	(	CD	NUMBER	(	num	12	SENT_19	[p1l632t2001r772b2035],
11	CLSS/F	NN	O	clss/f	nn	12	SENT_19	[p1l632t2001r772b2035],
12	)	NN	O	)	nsubj	32	SENT_19	[p1l632t2001r772b2035],
13	,	,	O	,	_	0	SENT_19	[p1l632t2001r772b2035],
14	mean	VB	O	mean	dep	32	SENT_19	[p1l785t2010r870b2029],
15	apparent	JJ	O	apparent	amod	16	SENT_19	[p1l882t2006r1017b2037],
16	volume	NN	O	volume	dobj	14	SENT_19	[p1l1028t2001r1146b2029],
17	of	IN	O	of	_	0	SENT_19	[p1l1158t2001r1192b2029],
18	distribution	NN	O	distribution	nn	21	SENT_19	[p1l1201t2001r1382b2029],
19	(	CD	NUMBER	(	num	21	SENT_19	[p1l1395t2001r1504b2035],
20	Vss/F	NN	O	vss/f	nn	21	SENT_19	[p1l1395t2001r1504b2035],
21	)	NN	O	)	prep_of	16	SENT_19	[p1l1395t2001r1504b2035],
22	and	CC	O	and	_	0	SENT_19	[p1l1518t2001r1574b2029],
23	mean	JJ	O	mean	amod	29	SENT_19	[p1l1585t2010r1669b2029],
24	terminal	JJ	O	terminal	amod	29	SENT_19	[p1l1681t2001r1811b2029],
25	elimination	NN	O	elimination	nn	29	SENT_19	[p1l1824t2001r1916b2029, p1l630t2050r728b2078],
26	half-life	NN	O	half-life	nn	29	SENT_19	[p1l741t2050r868b2078],
27	(	CD	NUMBER	(	num	29	SENT_19	[p1l883t2050r941b2084],
28	ti/2	NN	O	ti/2	nn	29	SENT_19	[p1l883t2050r941b2084],
29	)	NN	O	)	conj_and	16	SENT_19	[p1l883t2050r941b2084],
30	were	VBD	O	be	cop	32	SENT_19	[p1l956t2059r1032b2078],
31	86.8	CD	NUMBER	86.8	num	32	SENT_19	[p1l1047t2050r1112b2078],
32	L/h	NN	O	l/h	_	0	SENT_19	[p1l1126t2050r1189b2083],
33	,	,	O	,	_	0	SENT_19	[p1l1126t2050r1189b2083],
34	1570L	NN	O	1570l	conj_and	32	SENT_19	[p1l1208t2050r1306b2078],
35	and	CC	O	and	_	0	SENT_19	[p1l1320t2050r1376b2078],
36	11	CD	DURATION	11	num	37	SENT_19	[p1l1393t2050r1424b2078],
37	hours	NNS	NUMBER	hour	conj_and	32	SENT_19	[p1l1441t2050r1536b2083],
38	,	,	O	,	_	0	SENT_19	[p1l1441t2050r1536b2083],
39	respectively	RB	O	respectively	advmod	32	SENT_19	[p1l1551t2050r1749b2086],
40	.	.	O	.	_	0	SENT_19	[p1l1551t2050r1749b2086],

1	CL/F	NN	O	cl/f	nsubj	11	SENT_20	[p1l1765t2050r1848b2078],
2	and	CC	O	and	_	0	SENT_20	[p1l1861t2050r1917b2078],
3	Vss/F	NN	O	vss/f	conj_and	1	SENT_20	[p1l630t2099r716b2131],
4	on	IN	O	on	_	0	SENT_20	[p1l734t2108r771b2127],
5	single	JJ	O	single	amod	6	SENT_20	[p1l790t2099r882b2135],
6	dosing	NN	O	dosing	prep_on	1	SENT_20	[p1l901t2099r1004b2135],
7	were	VBD	O	be	cop	11	SENT_20	[p1l1023t2108r1098b2127],
8	not	RB	O	not	neg	11	SENT_20	[p1l1116t2103r1166b2127],
9	statistically	RB	O	statistically	advmod	11	SENT_20	[p1l1184t2099r1362b2135],
10	significantly	RB	O	significantly	advmod	11	SENT_20	[p1l1381t2099r1576b2135],
11	different	JJ	O	different	_	0	SENT_20	[p1l1594t2099r1730b2127],
12	(	NN	O	(	nn	13	SENT_20	[p1l1748t2100r1778b2135],
13	p	NN	O	p	dep	16	SENT_20	[p1l1748t2100r1778b2135],
14	>	JJR	O	>	dep	16	SENT_20	[p1l1797t2106r1817b2127],
15	0.05	CD	NUMBER	0.05	num	16	SENT_20	[p1l1835t2099r1915b2133],
16	)	NN	O	)	dep	11	SENT_20	[p1l1835t2099r1915b2133],
17	compared	VBN	O	compare	_	0	SENT_20	[p1l631t2148r786b2184],
18	with	IN	O	with	prepc_compared_with	16	SENT_20	[p1l797t2148r866b2176],
19	multiple	JJ	O	multiple	amod	20	SENT_20	[p1l878t2148r1009b2184],
20	dosing	NN	O	dosing	pobj	16	SENT_20	[p1l1021t2148r1133b2184],
21	.	.	O	.	_	0	SENT_20	[p1l1021t2148r1133b2184],

1	The	DT	O	the	det	3	SENT_21	[p1l1146t2148r1207b2176],
2	linearity	NN	O	linearity	nn	3	SENT_21	[p1l1218t2148r1349b2184],
3	index	NN	O	index	nsubj	32	SENT_21	[p1l1361t2148r1456b2181],
4	,	,	O	,	_	0	SENT_21	[p1l1361t2148r1456b2181],
5	calculated	VBN	O	calculate	partmod	3	SENT_21	[p1l1470t2148r1629b2176],
6	as	IN	O	as	_	0	SENT_21	[p1l1641t2157r1671b2176],
7	the	DT	O	the	det	8	SENT_21	[p1l1684t2148r1731b2176],
8	ratio	NN	O	ratio	prep_as	5	SENT_21	[p1l1742t2148r1814b2176],
9	of	IN	O	of	_	0	SENT_21	[p1l1826t2148r1860b2176],
10	the	DT	O	the	det	11	SENT_21	[p1l1869t2148r1916b2176],
11	area	NN	O	area	prep_of	8	SENT_21	[p1l631t2206r696b2225],
12	under	IN	O	under	_	0	SENT_21	[p1l706t2197r796b2225],
13	the	DT	O	the	det	19	SENT_21	[p1l805t2197r853b2225],
14	plasma	NN	O	plasma	nn	19	SENT_21	[p1l863t2197r975b2233],
15	concentration-time	NN	O	concentration-time	nn	19	SENT_21	[p1l986t2197r1283b2225],
16	curve	NN	O	curve	nn	19	SENT_21	[p1l1294t2206r1380b2225],
17	(	CD	NUMBER	(	num	19	SENT_21	[p1l1393t2197r1499b2231],
18	AUC	NN	O	auc	nn	19	SENT_21	[p1l1393t2197r1499b2231],
19	)	NN	O	)	prep_under	5	SENT_21	[p1l1393t2197r1499b2231],
20	during	IN	O	during	_	0	SENT_21	[p1l1511t2197r1613b2233],
21	the	DT	O	the	det	24	SENT_21	[p1l1624t2197r1671b2225],
22	dosing	NN	O	dosing	nn	24	SENT_21	[p1l1682t2197r1786b2233],
23	interval	NN	O	interval	nn	24	SENT_21	[p1l1797t2197r1916b2225],
24	T	NN	O	t	prep_during	19	SENT_21	[p1l630t2253r647b2274],
25	at	IN	O	at	_	0	SENT_21	[p1l664t2250r691b2274],
26	steady	JJ	O	steady	amod	27	SENT_21	[p1l709t2246r807b2282],
27	state	NN	O	state	prep_at	5	SENT_21	[p1l826t2250r896b2274],
28	(	CD	NUMBER	(	num	30	SENT_21	[p1l914t2246r1067b2282],
29	AUC	NN	O	auc	nn	30	SENT_21	[p1l914t2246r1067b2282],
30	¢	NN	O	¢	dep	27	SENT_21	[p1l914t2246r1067b2282],
31	,	,	O	,	_	0	SENT_21	[p1l914t2246r1067b2282],
32	ss	VBP	O	ss	_	0	SENT_21	[p1l914t2246r1067b2282],
33	)	CD	NUMBER	)	dobj	32	SENT_21	[p1l914t2246r1067b2282],
34	to	TO	O	to	_	0	SENT_21	[p1l1084t2250r1114b2274],
35	the	DT	O	the	det	36	SENT_21	[p1l1131t2246r1178b2274],
36	AUC	NN	O	auc	prep_to	32	SENT_21	[p1l1195t2246r1276b2274],
37	from	IN	O	from	_	0	SENT_21	[p1l1294t2246r1370b2274],
38	time	NN	O	time	prep_from	36	SENT_21	[p1l1387t2246r1456b2274],
39	zero	CD	NUMBER	zero	num	38	SENT_21	[p1l1473t2255r1539b2274],
40	to	TO	O	to	_	0	SENT_21	[p1l1556t2250r1586b2274],
41	infinity	NN	O	infinity	prep_to	32	SENT_21	[p1l1603t2246r1718b2282],
42	after	IN	O	after	_	0	SENT_21	[p1l1736t2246r1807b2274],
43	single	JJ	O	single	prep_after	41	SENT_21	[p1l1824t2246r1916b2282],

1	768	CD	NUMBER	768	num	2	SENT_22	[p1l185t2301r233b2325],
2	Tianmei	NNP	O	Tianmei	_	0	SENT_22	[p1l1790t2300r1899b2325],
3	et	FW	O	et	nn	4	SENT_22	[p1l1910t2303r1933b2325],
4	al.	FW	O	al.	dep	2	SENT_22	[p1l1943t2300r1973b2325],
5	.	.	O	.	_	0	SENT_22	[p1l1943t2300r1973b2325],

1	dosing	NN	O	dosing	_	0	SENT_23	[p1l631t2432r734b2468],
2	(	CD	NUMBER	(	num	3	SENT_23	[p1l747t2432r948b2470],
3	AUC	NN	O	auc	dep	1	SENT_23	[p1l747t2432r948b2470],
4	.	.	O	.	_	0	SENT_23	[p1l747t2432r948b2470],

1	x.	NN	O	x.	nsubj	9	SENT_24	[p1l747t2432r948b2470],
2	,	,	O	,	_	0	SENT_24	[p1l747t2432r948b2470],
3	sjng1e	NN	O	sjng1e	nn	5	SENT_24	[p1l747t2432r948b2470],
4	dose	NN	O	dose	nn	5	SENT_24	[p1l957t2432r1026b2466],
5	)	NN	O	)	appos	1	SENT_24	[p1l957t2432r1026b2466],
6	was	VBD	O	be	cop	9	SENT_24	[p1l1038t2441r1097b2460],
7	1.15	CD	NUMBER	1.15	number	8	SENT_24	[p1l1113t2432r1176b2460],
8	(	CD	NUMBER	(	num	9	SENT_24	[p1l1190t2432r1371b2466],
9	coefficient	NN	O	coefficient	_	0	SENT_24	[p1l1190t2432r1371b2466],
10	of	IN	O	of	_	0	SENT_24	[p1l1381t2432r1416b2460],
11	variation	NN	O	variation	prep_of	9	SENT_24	[p1l1424t2432r1564b2460],
12	35.7	CD	PERCENT	35.7	num	13	SENT_24	[p1l1576t2432r1697b2466],
13	%	NN	PERCENT	%	dep	11	SENT_24	[p1l1576t2432r1697b2466],
14	)	CD	NUMBER	)	dep	13	SENT_24	[p1l1576t2432r1697b2466],
15	.	.	O	.	_	0	SENT_24	[p1l1576t2432r1697b2466],

1	The	DT	O	the	det	2	SENT_25	[p1l1710t2432r1770b2460],
2	accumulation	NN	O	accumulation	nsubjpass	7	SENT_25	[p1l1782t2441r1916b2460, p1l630t2481r720b2509],
3	in	IN	O	in	_	0	SENT_25	[p1l741t2481r771b2508],
4	duloxetine	NN	O	duloxetine	nn	5	SENT_25	[p1l793t2481r958b2509],
5	exposure	NN	O	exposure	prep_in	2	SENT_25	[p1l980t2490r1121b2517],
6	was	VBD	O	be	auxpass	7	SENT_25	[p1l1143t2490r1203b2509],
7	estimated	VBN	O	estimate	_	0	SENT_25	[p1l1226t2481r1376b2509],
8	to	TO	O	to	aux	11	SENT_25	[p1l1397t2485r1427b2509],
9	be	VB	O	be	cop	11	SENT_25	[p1l1448t2481r1485b2509],
10	50	CD	PERCENT	50	num	11	SENT_25	[p1l1507t2481r1576b2509],
11	%	NN	PERCENT	%	xcomp	7	SENT_25	[p1l1507t2481r1576b2509],
12	on	IN	O	on	_	0	SENT_25	[p1l1600t2490r1638b2509],
13	multiple	JJ	O	multiple	amod	14	SENT_25	[p1l1660t2481r1790b2517],
14	dosing	NN	O	dosing	prep_on	11	SENT_25	[p1l1813t2481r1916b2517],
15	compared	VBN	O	compare	_	0	SENT_25	[p1l631t2529r786b2565],
16	with	IN	O	with	prepc_compared_with	11	SENT_25	[p1l805t2529r874b2557],
17	single	JJ	O	single	amod	18	SENT_25	[p1l895t2529r987b2565],
18	dosing	NN	O	dosing	pobj	11	SENT_25	[p1l1007t2529r1119b2565],
19	,	,	O	,	_	0	SENT_25	[p1l1007t2529r1119b2565],
20	consistent	JJ	O	consistent	amod	18	SENT_25	[p1l1140t2529r1298b2557],
21	with	IN	O	with	_	0	SENT_25	[p1l1317t2529r1386b2557],
22	the	DT	O	the	det	26	SENT_25	[p1l1405t2529r1453b2557],
23	ti/2	NN	O	ti/2	nn	26	SENT_25	[p1l1472t2533r1507b2561],
24	and	CC	O	and	_	0	SENT_25	[p1l1527t2529r1583b2557],
25	dosing	NN	O	dosing	nn	26	SENT_25	[p1l1602t2529r1706b2565],
26	interval	NN	O	interval	prep_with	20	SENT_25	[p1l1726t2529r1845b2557],
27	(	CD	NUMBER	(	number	28	SENT_25	[p1l1866t2529r1916b2563],
28	24	CD	DURATION	24	num	29	SENT_25	[p1l1866t2529r1916b2563],
29	hours	NNS	NUMBER	hour	dep	30	SENT_25	[p1l630t2578r738b2612],
30	)	RB	O	)	amod	26	SENT_25	[p1l630t2578r738b2612],
31	.	.	O	.	_	0	SENT_25	[p1l630t2578r738b2612],

1	The	DT	O	the	det	3	SENT_26	[p1l754t2578r814b2606],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_26	[p1l828t2578r1090b2614],
3	parameters	NNS	O	parameter	nsubj	13	SENT_26	[p1l1104t2582r1277b2614],
4	of	IN	O	of	_	0	SENT_26	[p1l1292t2578r1326b2606],
5	duloxetine	NN	O	duloxetine	prep_of	3	SENT_26	[p1l1337t2578r1503b2606],
6	in	IN	O	in	_	0	SENT_26	[p1l1517t2578r1547b2605],
7	Chinese	JJ	MISC	chinese	amod	8	SENT_26	[p1l1561t2578r1687b2606],
8	subjects	NNS	O	subject	prep_in	5	SENT_26	[p1l1702t2578r1826b2614],
9	were	VBD	O	be	cop	13	SENT_26	[p1l1841t2587r1916b2606],
10	not	RB	O	not	neg	13	SENT_26	[p1l630t2631r680b2655],
11	statistically	RB	O	statistically	advmod	13	SENT_26	[p1l696t2627r873b2663],
12	significantly	RB	O	significantly	advmod	13	SENT_26	[p1l889t2627r1084b2663],
13	different	JJ	O	different	_	0	SENT_26	[p1l1100t2627r1235b2655],
14	from	IN	O	from	_	0	SENT_26	[p1l1249t2627r1325b2655],
15	those	DT	O	those	prep_from	13	SENT_26	[p1l1339t2627r1421b2655],
16	reported	VBN	O	report	partmod	15	SENT_26	[p1l1435t2627r1567b2663],
17	previously	RB	DATE	previously	advmod	16	SENT_26	[p1l1581t2627r1747b2663],
18	in	IN	O	in	_	0	SENT_26	[p1l1762t2627r1791b2654],
19	Caucasian	JJ	LOCATION	caucasian	amod	22	SENT_26	[p1l1806t2627r1916b2655, p1l632t2676r693b2704],
20	and	CC	O	and	_	0	SENT_26	[p1l708t2676r764b2704],
21	Japanese	JJ	MISC	japanese	conj_and	19	SENT_26	[p1l778t2677r917b2712],
22	subjects	NNS	O	subject	prep_in	16	SENT_26	[p1l933t2676r1066b2712],
23	.	.	O	.	_	0	SENT_26	[p1l933t2676r1066b2712],

1	There	EX	O	there	expl	2	SENT_27	[p1l1083t2676r1174b2704],
2	were	VBD	O	be	ccomp	17	SENT_27	[p1l1188t2685r1264b2704],
3	no	DT	O	no	det	7	SENT_27	[p1l1279t2685r1317b2704],
4	clinically	RB	O	clinically	advmod	5	SENT_27	[p1l1332t2676r1477b2712],
5	significant	JJ	O	significant	amod	7	SENT_27	[p1l1493t2676r1659b2712],
6	adverse	JJ	O	adverse	amod	7	SENT_27	[p1l1673t2676r1792b2704],
7	events	NNS	O	event	nsubj	2	SENT_27	[p1l1807t2680r1915b2709],
8	,	,	O	,	_	0	SENT_27	[p1l1807t2680r1915b2709],
9	abnormal	JJ	O	abnormal	amod	12	SENT_27	[p1l631t2725r779b2753],
10	safety	NN	O	safety	nn	12	SENT_27	[p1l793t2725r885b2761],
11	laboratory	NN	O	laboratory	nn	12	SENT_27	[p1l898t2725r1059b2761],
12	data	NNS	O	datum	nsubj	17	SENT_27	[p1l1073t2725r1138b2753],
13	or	CC	O	or	_	0	SENT_27	[p1l1151t2734r1183b2753],
14	vital	JJ	O	vital	amod	16	SENT_27	[p1l1195t2725r1264b2753],
15	sign	NN	O	sign	nn	16	SENT_27	[p1l1279t2725r1343b2761],
16	changes	NNS	O	change	conj_or	12	SENT_27	[p1l1356t2725r1481b2761],
17	reported	VBD	O	report	_	0	SENT_27	[p1l1494t2725r1634b2761],
18	.	.	O	.	_	0	SENT_27	[p1l1494t2725r1634b2761],

1	Conclusion	NN	O	conclusion	_	0	SENT_28	[p1l632t2773r829b2801],
2	:	:	O	:	_	0	SENT_28	[p1l632t2773r829b2801],
3	Duloxetine	NNP	O	Duloxetine	nn	4	SENT_28	[p1l848t2773r1023b2801],
4	pharmacokinetics	NNS	O	pharmacokinetic	dep	1	SENT_28	[p1l1039t2773r1316b2809],
5	in	IN	O	in	_	0	SENT_28	[p1l1334t2773r1363b2801],
6	healthy	JJ	O	healthy	amod	8	SENT_28	[p1l1379t2773r1495b2809],
7	Chinese	JJ	MISC	chinese	amod	8	SENT_28	[p1l1512t2773r1638b2801],
8	subjects	NNS	O	subject	prep_in	4	SENT_28	[p1l1656t2773r1780b2809],
9	given	VBN	O	give	dep	4	SENT_28	[p1l1797t2773r1884b2809],
10	a	DT	O	a	det	13	SENT_28	[p1l1901t2782r1918b2801],
11	60mg	JJ	O	60mg	amod	13	SENT_28	[p1l631t2822r719b2858],
12	once-daily	JJ	O	once-daily	amod	13	SENT_28	[p1l738t2822r903b2858],
13	dosing	NN	O	dosing	iobj	9	SENT_28	[p1l922t2822r1026b2858],
14	regimen	NNS	O	regimen	dobj	9	SENT_28	[p1l1045t2822r1173b2858],
15	were	VBD	O	be	auxpass	17	SENT_28	[p1l1192t2831r1267b2850],
16	well	RB	O	well	advmod	17	SENT_28	[p1l1286t2822r1353b2850],
17	characterised	VBN	O	characterise	rcmod	14	SENT_28	[p1l1372t2822r1579b2850],
18	and	CC	O	and	_	0	SENT_28	[p1l1598t2822r1654b2850],
19	consistent	JJ	O	consistent	dep	4	SENT_28	[p1l1672t2822r1830b2850],
20	with	IN	O	with	_	0	SENT_28	[p1l1848t2822r1917b2850],
21	known	JJ	O	known	amod	23	SENT_28	[p1l630t2871r737b2899],
22	duloxetine	NN	O	duloxetine	nn	23	SENT_28	[p1l749t2871r915b2899],
23	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	19	SENT_28	[p1l927t2871r1204b2907],
24	in	IN	O	in	_	0	SENT_28	[p1l1218t2871r1247b2899],
25	healthy	JJ	O	healthy	amod	26	SENT_28	[p1l1259t2871r1374b2907],
26	Caucasian	JJ	MISC	caucasian	prep_in	23	SENT_28	[p1l1387t2871r1548b2899],
27	and	CC	O	and	_	0	SENT_28	[p1l1561t2871r1617b2899],
28	Japanese	JJ	MISC	japanese	amod	29	SENT_28	[p1l1628t2872r1768b2907],
29	subjects	NNS	O	subject	prep_in	23	SENT_28	[p1l1782t2871r1915b2907],
30	.	.	O	.	_	0	SENT_28	[p1l1782t2871r1915b2907],

1	Both	DT	O	both	preconj	3	SENT_29	[p1l630t2920r706b2948],
2	single	JJ	O	single	amod	3	SENT_29	[p1l719t2920r811b2956],
3	dosing	NN	O	dosing	nsubjpass	13	SENT_29	[p1l823t2920r927b2956],
4	and	CC	O	and	_	0	SENT_29	[p1l939t2920r995b2948],
5	multiple	JJ	O	multiple	amod	7	SENT_29	[p1l1006t2920r1136b2956],
6	once-daily	JJ	O	once-daily	amod	7	SENT_29	[p1l1149t2920r1314b2956],
7	dosing	NN	O	dosing	nsubjpass	13	SENT_29	[p1l1326t2920r1429b2956],
8	of	IN	O	of	_	0	SENT_29	[p1l1442t2920r1476b2948],
9	duloxetine	NN	O	duloxetine	prep_of	3	SENT_29	[p1l1485t2920r1650b2948],
10	60mg	JJ	O	60mg	amod	9	SENT_29	[p1l1663t2920r1751b2956],
11	were	VBD	O	be	auxpass	13	SENT_29	[p1l1763t2929r1838b2948],
12	well	RB	O	well	advmod	13	SENT_29	[p1l1850t2920r1916b2948],
13	tolerated	VBN	O	tolerate	_	0	SENT_29	[p1l630t2969r768b2997],
14	by	IN	O	by	_	0	SENT_29	[p1l780t2969r819b3005],
15	healthy	JJ	O	healthy	amod	17	SENT_29	[p1l832t2969r947b3005],
16	Chinese	JJ	MISC	chinese	amod	17	SENT_29	[p1l961t2969r1087b2997],
17	subjects	NNS	O	subject	agent	13	SENT_29	[p1l1101t2969r1226b3005],
18	in	IN	O	in	_	0	SENT_29	[p1l1240t2969r1269b2997],
19	this	DT	O	this	det	20	SENT_29	[p1l1282t2969r1337b2997],
20	study	NN	O	study	prep_in	17	SENT_29	[p1l1353t2969r1444b3005],
21	.	.	O	.	_	0	SENT_29	[p1l1353t2969r1444b3005],

1	Background	NN	O	background	_	0	SENT_30	[p1l137t3234r737b3333],

1	Duloxetine	NNP	O	Duloxetine	nsubj	6	SENT_31	[p1l132t3483r586b3555],
2	is	VBZ	O	be	cop	6	SENT_31	[p1l616t3483r679b3555],
3	a	DT	O	a	det	6	SENT_31	[p1l713t3506r756b3555],
4	potent	JJ	O	potent	amod	6	SENT_31	[p1l782t3494r1040b3576],
5	dual	JJ	O	dual	amod	6	SENT_31	[p1l1069t3483r1242b3555],
6	inhibitor	NN	O	inhibitor	_	0	SENT_31	[p1l1272t3483r1625b3555],
7	of	IN	O	of	_	0	SENT_31	[p1l1654t3483r1742b3555],
8	serotonin	NN	O	serotonin	nn	11	SENT_31	[p1l1769t3483r2146b3555],
9	and	CC	O	and	_	0	SENT_31	[p1l11t3611r155b3682],
10	norepinephrine	NN	O	norepinephrine	nn	11	SENT_31	[p1l204t3611r824b3703],
11	reuptake	NN	O	reuptake	prep_of	6	SENT_31	[p1l873t3601r1377b3703],
12	.	.	O	.	_	0	SENT_31	[p1l873t3601r1377b3703],

1	“’	NN	O	“’	nsubj	8	SENT_32	[p1l873t3601r1377b3703],
2	2	CD	NUMBER	2	number	3	SENT_32	[p1l873t3601r1377b3703],
3	]	CD	NUMBER	]	dep	1	SENT_32	[p1l873t3601r1377b3703],
4	Duloxetine	NNP	O	Duloxetine	dep	1	SENT_32	[p1l1431t3611r1885b3682],
5	is	VBZ	O	be	cop	8	SENT_32	[p1l1936t3611r1999b3682],
6	an	DT	O	a	det	8	SENT_32	[p1l2053t3634r2146b3682],
7	effective	JJ	O	effective	amod	8	SENT_32	[p2l9t30r365b101],
8	treatment	NN	O	treatment	_	0	SENT_32	[p2l399t41r787b101],
9	for	IN	O	for	_	0	SENT_32	[p2l819t30r938b101],
10	major	JJ	O	major	amod	12	SENT_32	[p2l970t30r1209b122],
11	depressive	JJ	O	depressive	amod	12	SENT_32	[p2l1242t30r1672b122],
12	disorder	NN	O	disorder	prep_for	8	SENT_32	[p2l1707t20r2142b115],
13	,	,	O	,	_	0	SENT_32	[p2l1707t20r2142b115],
14	[	CD	NUMBER	[	number	15	SENT_32	[p2l1707t20r2142b115],
15	3	CD	NUMBER	3	num	20	SENT_32	[p2l1707t20r2142b115],
16	]	NN	O	]	nn	20	SENT_32	[p2l1707t20r2142b115],
17	stress	NN	O	stress	nn	20	SENT_32	[p2l12t169r232b229],
18	urinary	JJ	O	urinary	amod	20	SENT_32	[p2l286t158r580b250],
19	incontinence	NN	O	incontinence	nn	20	SENT_32	[p2l633t148r1231b229],
20	[	NN	O	[	appos	12	SENT_32	[p2l633t148r1231b229],
21	4	CD	NUMBER	4	num	22	SENT_32	[p2l633t148r1231b229],
22	]	NN	O	]	dep	12	SENT_32	[p2l633t148r1231b229],
23	diabetic	JJ	O	diabetic	amod	28	SENT_32	[p2l1289t158r1609b229],
24	neuropathic	JJ	O	neuropathic	amod	28	SENT_32	[p2l1663t158r2144b250],
25	pain	NN	O	pain	nn	28	SENT_32	[p2l7t276r258b378],
26	[	NN	O	[	nn	28	SENT_32	[p2l7t276r258b378],
27	5	CD	NUMBER	5	num	28	SENT_32	[p2l7t276r258b378],
28	]	NN	O	]	dep	22	SENT_32	[p2l7t276r258b378],
29	and	CC	O	and	_	0	SENT_32	[p2l318t286r462b357],
30	generalised	JJ	O	generalised	amod	32	SENT_32	[p2l516t286r982b378],
31	anxiety	NN	O	anxiety	nn	32	SENT_32	[p2l1036t286r1333b378],
32	disorder	NN	O	disorder	conj_and	28	SENT_32	[p2l1389t276r1823b371],
33	,	,	O	,	_	0	SENT_32	[p2l1389t276r1823b371],
34	[	CD	NUMBER	[	number	35	SENT_32	[p2l1389t276r1823b371],
35	6	CD	NUMBER	6	num	36	SENT_32	[p2l1389t276r1823b371],
36	]	NN	O	]	appos	12	SENT_32	[p2l1389t276r1823b371],
37	and	CC	O	and	_	0	SENT_32	[p2l1883t286r2027b357],
38	is	VBZ	O	be	aux	41	SENT_32	[p2l2080t286r2143b357],
39	currently	RB	DATE	currently	advmod	41	SENT_32	[p2l9t415r376b508],
40	being	VBG	O	be	auxpass	41	SENT_32	[p2l432t415r658b508],
41	investigated	VBN	O	investigate	conj_and	8	SENT_32	[p2l716t415r1211b508],
42	for	IN	O	for	_	0	SENT_32	[p2l1268t415r1386b487],
43	the	DT	O	the	det	44	SENT_32	[p2l1441t415r1563b487],
44	treatment	NN	O	treatment	prep_for	41	SENT_32	[p2l1620t426r2008b487],
45	of	IN	O	of	_	0	SENT_32	[p2l2064t415r2152b487],
46	fibromyalgia	NNP	O	fibromyalgia	nn	47	SENT_32	[p2l9t542r538b635],
47	syndrome	NN	O	syndrome	prep_of	44	SENT_32	[p2l574t534r1074b635],
48	.	.	O	.	_	0	SENT_32	[p2l574t534r1074b635],

1	[	NN	O	[	_	0	SENT_33	[p2l574t534r1074b635],
2	7	CD	NUMBER	7	num	3	SENT_33	[p2l574t534r1074b635],
3	]	NN	O	]	dep	1	SENT_33	[p2l574t534r1074b635],

1	After	IN	O	after	_	0	SENT_34	[p2l132t671r348b743],
2	oral	JJ	O	oral	amod	3	SENT_34	[p2l379t671r535b743],
3	administration	NN	O	administration	prep_after	7	SENT_34	[p2l569t671r1180b756],
4	,	,	O	,	_	0	SENT_34	[p2l569t671r1180b756],
5	duloxetine	NN	O	duloxetine	nsubjpass	7	SENT_34	[p2l1217t671r1647b743],
6	is	VBZ	O	be	auxpass	7	SENT_34	[p2l1679t671r1743b743],
7	eliminated	VBN	O	eliminate	_	0	SENT_34	[p2l1778t671r2142b743, p2l9t800r103b872],
8	mainly	RB	O	mainly	advmod	7	SENT_34	[p2l159t800r441b894],
9	through	IN	O	through	_	0	SENT_34	[p2l497t800r815b894],
10	hepatic	JJ	O	hepatic	amod	11	SENT_34	[p2l870t800r1163b893],
11	metabolism	NN	O	metabolism	prep_through	7	SENT_34	[p2l1221t800r1700b872],
12	involving	VBG	O	involve	_	0	SENT_34	[p2l1754t800r2145b894],
13	cytochrome	NN	O	cytochrome	nn	14	SENT_34	[p2l9t929r491b1023],
14	P450	NN	O	p450	prep_involving	11	SENT_34	[p2l533t929r741b1002],
15	(	CD	NUMBER	(	num	18	SENT_34	[p2l786t930r1046b1018],
16	CYP	NN	O	cyp	nn	18	SENT_34	[p2l786t930r1046b1018],
17	)	NN	O	)	nn	18	SENT_34	[p2l786t930r1046b1018],
18	enzymes	NNS	O	enzyme	dep	14	SENT_34	[p2l1092t952r1468b1023],
19	.	.	O	.	_	0	SENT_34	[p2l1092t952r1468b1023],

1	Duloxetine	NNP	O	Duloxetine	nsubj	2	SENT_35	[p2l1516t929r1969b1001],
2	undergoes	VBZ	O	undergo	conj_and	2	SENT_35	[p2l2011t952r2142b1001, p2l9t1058r323b1152],
3	oxidation	NN	O	oxidation	dobj	2	SENT_35	[p2l372t1058r757b1130],
4	primarily	RB	O	primarily	advmod	2	SENT_35	[p2l800t1058r1180b1152],
5	by	IN	O	by	_	0	SENT_35	[p2l1224t1058r1326b1152],
6	CYPlA2	NN	O	cypla2	prep_by	2	SENT_35	[p2l1372t1059r1745b1131],
7	and	CC	O	and	_	0	SENT_35	[p2l1792t1058r1937b1130],
8	to	TO	O	to	_	0	SENT_35	[p2l1980t1069r2057b1130],
9	a	DT	O	a	det	11	SENT_35	[p2l2105t1081r2147b1130],
10	lesser	JJR	O	lesser	amod	11	SENT_35	[p2l8t1187r242b1259],
11	extent	NN	O	extent	prep_to	2	SENT_35	[p2l275t1198r524b1259],
12	by	IN	O	by	_	0	SENT_35	[p2l555t1187r656b1281],
13	CYPZD6	NN	O	cypzd6	prep_by	11	SENT_35	[p2l692t1187r1088b1272],
14	,	,	O	,	_	0	SENT_35	[p2l692t1187r1088b1272],
15	followed	VBN	O	follow	partmod	11	SENT_35	[p2l1126t1187r1489b1260],
16	by	IN	O	by	_	0	SENT_35	[p2l1521t1187r1622b1281],
17	methylation	NN	O	methylation	agent	15	SENT_35	[p2l1657t1187r2146b1281],
18	or	CC	O	or	_	0	SENT_35	[p2l10t1339r93b1388],
19	conjugation	NN	O	conjugation	agent	15	SENT_35	[p2l128t1316r611b1410],
20	and	CC	O	and	_	0	SENT_35	[p2l648t1316r793b1388],
21	renal	JJ	O	renal	amod	22	SENT_35	[p2l827t1316r1031b1388],
22	excretion	NN	O	excretion	conj_and	11	SENT_35	[p2l1068t1316r1447b1388],
23	of	IN	O	of	_	0	SENT_35	[p2l1484t1316r1572b1388],
24	the	DT	O	the	prep_of	22	SENT_35	[p2l1601t1316r1724b1388],
25	conjugated	VBN	O	conjugate	partmod	24	SENT_35	[p2l1761t1316r2142b1410, p2l9t1445r103b1517],
26	metabolites	NNS	O	metabolite	dobj	25	SENT_35	[p2l166t1435r738b1517],
27	.	.	O	.	_	0	SENT_35	[p2l166t1435r738b1517],

1	[	NN	O	[	nsubj	21	SENT_36	[p2l166t1435r738b1517],
2	8	CD	NUMBER	8	number	3	SENT_36	[p2l166t1435r738b1517],
3	]	CD	NUMBER	]	num	1	SENT_36	[p2l166t1435r738b1517],
4	Based	VBN	O	base	_	0	SENT_36	[p2l805t1445r1054b1517],
5	on	IN	O	on	prepc_based_on	1	SENT_36	[p2l1118t1468r1217b1517],
6	in	FW	O	in	nn	7	SENT_36	[p2l1283t1448r1356b1517],
7	vitro	FW	O	vitro	dep	8	SENT_36	[p2l1421t1448r1610b1518],
8	assays	NNS	O	assay	dep	1	SENT_36	[p2l1676t1468r1956b1538],
9	,	,	O	,	_	0	SENT_36	[p2l1676t1468r1956b1538],
10	the	DT	O	the	det	11	SENT_36	[p2l2022t1445r2145b1517],
11	metabolites	NNS	O	metabolite	appos	8	SENT_36	[p2l8t1574r478b1646],
12	found	VBN	O	find	partmod	11	SENT_36	[p2l553t1574r790b1646],
13	in	IN	O	in	_	0	SENT_36	[p2l861t1574r938b1645],
14	plasma	NN	O	plasma	prep_in	12	SENT_36	[p2l1009t1574r1300b1667],
15	are	VBP	O	be	cop	21	SENT_36	[p2l1373t1597r1493b1646],
16	not	RB	O	not	neg	21	SENT_36	[p2l1565t1585r1695b1646],
17	serotonin	NN	O	serotonin	nn	21	SENT_36	[p2l1769t1574r2146b1646],
18	or	CC	O	or	_	0	SENT_36	[p2l9t1725r93b1773],
19	norepinephrine	NN	O	norepinephrine	conj_or	17	SENT_36	[p2l124t1702r744b1794],
20	reuptake	NN	O	reuptake	nn	21	SENT_36	[p2l776t1702r1128b1794],
21	inhibitors	NNS	O	inhibitor	_	0	SENT_36	[p2l1161t1692r1654b1773],
22	.	.	O	.	_	0	SENT_36	[p2l1161t1692r1654b1773],

1	[	NN	O	[	nn	4	SENT_37	[p2l1161t1692r1654b1773],
2	9	CD	NUMBER	9	num	4	SENT_37	[p2l1161t1692r1654b1773],
3	]	NN	O	]	nn	4	SENT_37	[p2l1161t1692r1654b1773],
4	Duloxetine	NN	O	duloxetine	_	0	SENT_37	[p2l1691t1702r2146b1773],
5	is	VBZ	O	be	cop	8	SENT_37	[p2l8t1831r72b1903],
6	a	DT	O	a	det	8	SENT_37	[p2l118t1854r160b1903],
7	moderate	JJ	O	moderate	amod	8	SENT_37	[p2l201t1831r580b1903],
8	inhibitor	NN	O	inhibitor	rcmod	4	SENT_37	[p2l623t1831r976b1903],
9	of	IN	O	of	_	0	SENT_37	[p2l1017t1831r1106b1903],
10	CYPZD6	NN	O	cypzd6	prep_of	8	SENT_37	[p2l1142t1831r1514b1904],
11	but	CC	O	but	_	0	SENT_37	[p2l1555t1831r1688b1903],
12	not	RB	O	not	_	0	SENT_37	[p2l1727t1842r1858b1903],
13	an	DT	O	a	det	14	SENT_37	[p2l1900t1854r1993b1903],
14	inhibitor	NN	O	inhibitor	conj_negcc	4	SENT_37	[p2l2034t1831r2142b1902, p2l7t1959r282b2031],
15	of	IN	O	of	_	0	SENT_37	[p2l385t1959r474b2031],
16	CYP1A2	NN	O	cyp1a2	prep_of	14	SENT_37	[p2l571t1960r967b2044],
17	,	,	O	,	_	0	SENT_37	[p2l571t1960r967b2044],
18	CYPZC9	NN	O	cypzc9	prep_of	14	SENT_37	[p2l1076t1960r1466b2044],
19	,	,	O	,	_	0	SENT_37	[p2l1076t1960r1466b2044],
20	CYP3A	NN	O	cyp3a	prep_of	14	SENT_37	[p2l1574t1960r1897b2031],
21	and	CC	O	and	_	0	SENT_37	[p2l2002t1959r2147b2031],
22	CYP2Cl9	NN	O	cyp2cl9	prep_of	14	SENT_37	[p2l9t2085r699b2168],
23	.	.	O	.	_	0	SENT_37	[p2l9t2085r699b2168],

1	[	NN	O	[	_	0	SENT_38	[p2l9t2085r699b2168],
2	6	CD	NUMBER	6	num	3	SENT_38	[p2l9t2085r699b2168],
3	’	NN	O	’	dep	1	SENT_38	[p2l9t2085r699b2168],
4	1	CD	NUMBER	1	number	5	SENT_38	[p2l9t2085r699b2168],
5	°	CD	NUMBER	°	num	7	SENT_38	[p2l9t2085r699b2168],
6	’“	NN	O	’“	nn	7	SENT_38	[p2l9t2085r699b2168],
7	]	NN	O	]	dep	3	SENT_38	[p2l9t2085r699b2168],

1	Both	DT	O	both	preconj	2	SENT_39	[p2l132t2222r329b2294],
2	CYP2D6	NN	O	cyp2d6	nsubj	6	SENT_39	[p2l386t2222r758b2295],
3	and	CC	O	and	_	0	SENT_39	[p2l816t2222r961b2294],
4	CYP1A2	NN	O	cyp1a2	nsubj	6	SENT_39	[p2l1016t2223r1389b2295],
5	are	VBP	O	be	cop	6	SENT_39	[p2l1447t2245r1567b2294],
6	polymorphic	JJ	O	polymorphic	_	0	SENT_39	[p2l1622t2222r2145b2316],
7	among	IN	O	among	_	0	SENT_39	[p2l11t2374r285b2445],
8	different	JJ	O	different	amod	9	SENT_39	[p2l343t2351r695b2423],
9	races	NNS	O	race	prep_among	6	SENT_39	[p2l748t2374r979b2423],
10	.	.	O	.	_	0	SENT_39	[p2l748t2374r979b2423],

1	Nearly	RB	O	nearly	advmod	5	SENT_40	[p2l1039t2351r1316b2445],
2	5	CD	PERCENT	5	number	3	SENT_40	[p2l1375t2351r1657b2424],
3	—	CD	PERCENT	—	num	5	SENT_40	[p2l1375t2351r1657b2424],
4	lO	JJ	PERCENT	lo	quantmod	3	SENT_40	[p2l1375t2351r1657b2424],
5	%	NN	PERCENT	%	nsubj	20	SENT_40	[p2l1375t2351r1657b2424],
6	of	IN	O	of	_	0	SENT_40	[p2l1720t2351r1808b2423],
7	Caucasians	NNPS	MISC	Caucasians	prep_of	5	SENT_40	[p2l1858t2352r2142b2424, p2l12t2480r233b2565],
8	,	,	O	,	_	0	SENT_40	[p2l1858t2352r2142b2424, p2l12t2480r233b2565],
9	1	CD	PERCENT	1	num	10	SENT_40	[p2l277t2481r397b2553],
10	%	NN	PERCENT	%	prep_of	5	SENT_40	[p2l277t2481r397b2553],
11	of	IN	O	of	_	0	SENT_40	[p2l433t2480r522b2552],
12	Asians	NNPS	MISC	Asians	prep_of	10	SENT_40	[p2l545t2480r820b2552],
13	and	CC	O	and	_	0	SENT_40	[p2l855t2480r999b2552],
14	up	RB	O	up	quantmod	16	SENT_40	[p2l1028t2503r1127b2574],
15	to	TO	O	to	dep	16	SENT_40	[p2l1159t2491r1235b2552],
16	19	CD	PERCENT	19	num	17	SENT_40	[p2l1276t2481r1448b2553],
17	%	NN	PERCENT	%	conj_and	7	SENT_40	[p2l1276t2481r1448b2553],
18	of	IN	O	of	_	0	SENT_40	[p2l1484t2480r1572b2552],
19	Africans	NNS	MISC	african	prep_of	17	SENT_40	[p2l1595t2480r1945b2552],
20	lack	VBP	O	lack	_	0	SENT_40	[p2l1978t2480r2148b2552],
21	CYPZD6	NN	O	cypzd6	nn	22	SENT_40	[p2l9t2616r381b2689],
22	activity	NN	O	activity	dobj	20	SENT_40	[p2l423t2606r861b2710],
23	.	.	O	.	_	0	SENT_40	[p2l423t2606r861b2710],

1	”	NN	O	”	nsubjpass	33	SENT_41	[p2l423t2606r861b2710],
2	2	CD	NUMBER	2	number	3	SENT_41	[p2l423t2606r861b2710],
3	]	CD	NUMBER	]	nsubjpass	15	SENT_41	[p2l423t2606r861b2710],
4	The	DT	O	the	det	8	SENT_41	[p2l903t2616r1059b2688],
5	CYP2D6	NN	O	cyp2d6	nn	8	SENT_41	[p2l1103t2616r1615b2689],
6	*	CD	NUMBER	*	num	8	SENT_41	[p2l1103t2616r1615b2689],
7	lO	NN	O	lo	nn	8	SENT_41	[p2l1103t2616r1615b2689],
8	allele	NN	O	allele	dep	3	SENT_41	[p2l1656t2616r1895b2701],
9	,	,	O	,	_	0	SENT_41	[p2l1656t2616r1895b2701],
10	common	JJ	O	common	amod	3	SENT_41	[p2l1938t2639r2142b2688, p2l8t2767r189b2816],
11	in	IN	O	in	_	0	SENT_41	[p2l219t2744r296b2815],
12	Asians	NNPS	MISC	Asians	prep_in	10	SENT_41	[p2l327t2744r626b2829],
13	,	,	O	,	_	0	SENT_41	[p2l327t2744r626b2829],
14	is	VBZ	O	be	auxpass	15	SENT_41	[p2l660t2744r724b2816],
15	associated	VBN	O	associate	rcmod	1	SENT_41	[p2l759t2744r1178b2816],
16	with	IN	O	with	_	0	SENT_41	[p2l1207t2744r1388b2816],
17	reduced	VBN	O	reduce	amod	19	SENT_41	[p2l1417t2744r1742b2816],
18	CYPZD6	NN	O	cypzd6	nn	19	SENT_41	[p2l1773t2744r2145b2817],
19	activity	NN	O	activity	prep_with	15	SENT_41	[p2l11t2863r449b2967],
20	,	,	O	,	_	0	SENT_41	[p2l11t2863r449b2967],
21	“	CD	NUMBER	“	number	22	SENT_41	[p2l11t2863r449b2967],
22	3	CD	NUMBER	3	num	23	SENT_41	[p2l11t2863r449b2967],
23	]	NN	O	]	appos	19	SENT_41	[p2l11t2863r449b2967],
24	and	CC	O	and	_	0	SENT_41	[p2l510t2873r654b2945],
25	individuals	NNS	O	individual	nsubjpass	33	SENT_41	[p2l707t2873r1159b2946],
26	who	WP	O	who	nsubj	28	SENT_41	[p2l1217t2873r1390b2946],
27	are	VBP	O	be	cop	28	SENT_41	[p2l1448t2896r1568b2945],
28	homozygous	JJ	O	homozygous	rcmod	25	SENT_41	[p2l1622t2873r2143b2967],
29	for	IN	O	for	_	0	SENT_41	[p2l9t3001r127b3073],
30	this	DT	O	this	det	31	SENT_41	[p2l204t3001r347b3073],
31	allele	NN	O	allele	prep_for	28	SENT_41	[p2l431t3001r648b3073],
32	are	VBP	O	be	auxpass	33	SENT_41	[p2l729t3024r849b3073],
33	categorised	VBN	O	categorise	_	0	SENT_41	[p2l929t3001r1395b3095],
34	as	IN	O	as	_	0	SENT_41	[p2l1475t3024r1553b3073],
35	intermediate	JJ	O	intermediate	prep_as	33	SENT_41	[p2l1634t3001r2145b3073],

1	©	RB	O	©	advmod	2	SENT_42	[p2l10t3284r53b3327],
2	2007	CD	DATE	2007	_	0	SENT_42	[p2l76t3280r207b3327],
3	Adis	NNP	PERSON	Adis	nn	5	SENT_42	[p2l230t3280r353b3327],
4	Doro	NNP	PERSON	Doro	nn	5	SENT_42	[p2l377t3280r520b3327],
5	Information	NNP	O	Information	dep	2	SENT_42	[p2l547t3280r880b3327],
6	BV	NN	O	bv	dep	5	SENT_42	[p2l907t3280r992b3326],
7	.	.	O	.	_	0	SENT_42	[p2l907t3280r992b3326],

1	All	DT	O	all	det	2	SENT_43	[p2l1017t3280r1084b3327],
2	rights	NNS	O	rights	nsubj	3	SENT_43	[p2l1109t3280r1259b3339],
3	reserved	VBN	O	reserve	_	0	SENT_43	[p2l1283t3280r1548b3327],
4	.	.	O	.	_	0	SENT_43	[p2l1283t3280r1548b3327],

1	metabolisers	NNS	O	metaboliser	_	0	SENT_44	[p2l7t3524r546b3596],
2	.	.	O	.	_	0	SENT_44	[p2l7t3524r546b3596],

1	The	DT	O	the	det	2	SENT_45	[p2l578t3524r734b3596],
2	variations	NNS	O	variation	nsubjpass	7	SENT_45	[p2l761t3524r1163b3597],
3	in	IN	O	in	_	0	SENT_45	[p2l1191t3524r1268b3596],
4	CYP1A2	NN	O	cyp1a2	nn	5	SENT_45	[p2l1295t3525r1669b3597],
5	activity	NN	O	activity	prep_in	2	SENT_45	[p2l1697t3524r2001b3618],
6	are	VBP	O	be	auxpass	7	SENT_45	[p2l2029t3547r2150b3596],
7	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_45	[p2l7t3655r441b3727],
8	by	IN	O	by	_	0	SENT_45	[p2l487t3655r588b3749],
9	various	JJ	O	various	amod	10	SENT_45	[p2l637t3655r935b3727],
10	factors	NNS	O	factor	agent	7	SENT_45	[p2l986t3655r1261b3727],
11	including	VBG	O	include	_	0	SENT_45	[p2l1312t3655r1698b3749],
12	race	NN	O	race	prep_including	10	SENT_45	[p2l1746t3678r1938b3740],
13	,	,	O	,	_	0	SENT_45	[p2l1746t3678r1938b3740],
14	sex	NN	O	sex	appos	12	SENT_45	[p2l1994t3678r2147b3740],
15	,	,	O	,	_	0	SENT_45	[p2l1994t3678r2147b3740],

1	smoking	NN	O	smoking	_	0	SENT_46	[p3l11t24r381b117],
2	,	,	O	,	_	0	SENT_46	[p3l11t24r381b117],
3	diet	NN	O	diet	appos	1	SENT_46	[p3l421t24r593b109],
4	,	,	O	,	_	0	SENT_46	[p3l421t24r593b109],
5	oral	JJ	O	oral	amod	7	SENT_46	[p3l632t24r788b96],
6	contraceptive	NN	O	contraceptive	nn	7	SENT_46	[p3l823t24r1375b117],
7	steroids	NNS	O	steroid	appos	1	SENT_46	[p3l1413t24r1725b96],
8	and	CC	O	and	_	0	SENT_46	[p3l1764t24r1908b96],
9	environmental	JJ	O	environmental	amod	10	SENT_46	[p3l1942t24r2148b96, p3l6t151r422b222],
10	factors	NNS	O	factor	appos	1	SENT_46	[p3l463t142r875b222],
11	.	.	O	.	_	0	SENT_46	[p3l463t142r875b222],

1	[	RB	O	[	advmod	21	SENT_47	[p3l463t142r875b222],
2	14	CD	NUMBER	14	number	3	SENT_47	[p3l463t142r875b222],
3	]	CD	NUMBER	]	num	4	SENT_47	[p3l463t142r875b222],
4	Differences	NNS	O	difference	nsubj	21	SENT_47	[p3l920t151r1395b222],
5	in	IN	O	in	_	0	SENT_47	[p3l1437t151r1515b222],
6	the	DT	O	the	det	7	SENT_47	[p3l1555t151r1678b222],
7	concentration	NN	O	concentration	prep_in	4	SENT_47	[p3l1719t162r2148b222, p3l7t281r166b353],
8	or	CC	O	or	_	0	SENT_47	[p3l201t304r285b353],
9	activity	NN	O	activity	conj_or	7	SENT_47	[p3l319t281r624b375],
10	of	IN	O	of	_	0	SENT_47	[p3l660t281r749b353],
11	the	DT	O	the	det	13	SENT_47	[p3l776t281r899b353],
12	metabolising	NN	O	metabolising	nn	13	SENT_47	[p3l935t281r1464b375],
13	enzymes	NNS	O	enzyme	prep_of	7	SENT_47	[p3l1500t304r1855b375],
14	due	JJ	O	due	_	0	SENT_47	[p3l1893t281r2038b353],
15	to	TO	O	to	_	0	SENT_47	[p3l2073t292r2149b353],
16	intrinsic	JJ	O	intrinsic	amod	19	SENT_47	[p3l7t410r341b482],
17	or	CC	O	or	_	0	SENT_47	[p3l395t432r479b482],
18	extrinsic	JJ	O	extrinsic	conj_or	16	SENT_47	[p3l528t410r878b482],
19	factors	NNS	O	factor	prep_due_to	13	SENT_47	[p3l931t410r1206b482],
20	may	MD	O	may	aux	21	SENT_47	[p3l1259t432r1433b503],
21	result	VB	O	result	_	0	SENT_47	[p3l1484t410r1713b482],
22	in	IN	O	in	_	0	SENT_47	[p3l1762t410r1840b481],
23	differences	NNS	O	difference	prep_in	21	SENT_47	[p3l1891t410r2148b482, p3l8t560r231b609],
24	in	IN	O	in	_	0	SENT_47	[p3l281t537r358b609],
25	the	DT	O	the	det	27	SENT_47	[p3l404t537r527b609],
26	systemic	JJ	O	systemic	amod	27	SENT_47	[p3l578t537r931b631],
27	exposure	NN	O	exposure	prep_in	23	SENT_47	[p3l980t560r1348b631],
28	to	TO	O	to	_	0	SENT_47	[p3l1395t548r1471b609],
29	duloxetine	NN	O	duloxetine	prep_to	21	SENT_47	[p3l1520t537r1951b609],
30	that	WDT	O	that	nsubj	32	SENT_47	[p3l1998t538r2152b609],
31	could	MD	O	could	aux	32	SENT_47	[p3l8t667r234b739],
32	lead	VB	O	lead	rcmod	29	SENT_47	[p3l276t667r446b739],
33	to	TO	O	to	_	0	SENT_47	[p3l486t678r562b739],
34	altered	JJ	O	altered	amod	35	SENT_47	[p3l608t667r884b739],
35	effectiveness	NN	O	effectiveness	prep_to	32	SENT_47	[p3l926t667r1458b739],
36	or	CC	O	or	_	0	SENT_47	[p3l1504t690r1588b739],
37	an	DT	O	a	det	39	SENT_47	[p3l1629t690r1722b739],
38	increased	VBN	O	increase	amod	39	SENT_47	[p3l1764t667r2152b739],
39	incidence	NN	O	incidence	conj_or	29	SENT_47	[p3l7t796r399b868],
40	of	IN	O	of	_	0	SENT_47	[p3l435t796r524b868],
41	adverse	JJ	O	adverse	amod	42	SENT_47	[p3l553t796r862b868],
42	events	NNS	O	event	prep_of	39	SENT_47	[p3l897t807r1155b868],
43	in	IN	O	in	_	0	SENT_47	[p3l1191t796r1269b867],
44	certain	JJ	O	certain	amod	45	SENT_47	[p3l1303t796r1581b868],
45	individuals	NNS	O	individual	prep_in	39	SENT_47	[p3l1614t796r2090b868],
46	.	.	O	.	_	0	SENT_47	[p3l1614t796r2090b868],

1	Rigorous	JJ	O	rigorous	amod	2	SENT_48	[p3l131t926r504b1019],
2	comparison	NN	O	comparison	nsubj	11	SENT_48	[p3l540t926r1018b1019],
3	of	IN	O	of	_	0	SENT_48	[p3l1052t926r1141b998],
4	duloxetine	NN	O	duloxetine	nn	5	SENT_48	[p3l1167t926r1599b998],
5	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	2	SENT_48	[p3l1631t926r2148b1019, p3l7t1054r243b1126],
6	between	IN	O	between	_	0	SENT_48	[p3l304t1054r647b1126],
7	Caucasian	JJ	LOCATION	caucasian	amod	10	SENT_48	[p3l709t1054r1129b1126],
8	and	CC	O	and	_	0	SENT_48	[p3l1192t1054r1336b1126],
9	Japanese	JJ	MISC	japanese	amod	10	SENT_48	[p3l1396t1055r1760b1147],
10	subjects	NNS	O	subject	prep_between	5	SENT_48	[p3l1825t1054r2148b1147],
11	demonstrate	VBP	O	demonstrate	_	0	SENT_48	[p3l8t1182r509b1254],
12	that	IN	O	that	complm	18	SENT_48	[p3l561t1182r714b1254],
13	duloxetine	NN	O	duloxetine	nn	14	SENT_48	[p3l766t1182r1197b1254],
14	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	18	SENT_48	[p3l1249t1182r1973b1276],
15	are	VBP	O	be	cop	18	SENT_48	[p3l2029t1205r2150b1254],
16	not	RB	O	not	neg	18	SENT_48	[p3l7t1324r138b1385],
17	statistically	RB	O	statistically	advmod	18	SENT_48	[p3l214t1313r677b1406],
18	different	JJ	O	different	ccomp	11	SENT_48	[p3l753t1313r1106b1385],
19	in	IN	O	in	_	0	SENT_48	[p3l1178t1313r1255b1384],
20	these	DT	O	these	det	22	SENT_48	[p3l1329t1313r1538b1385],
21	two	CD	NUMBER	two	num	22	SENT_48	[p3l1612t1324r1763b1385],
22	populations	NNS	O	population	prep_in	18	SENT_48	[p3l1837t1313r2147b1406, p3l7t1431r340b1514],
23	.	.	O	.	_	0	SENT_48	[p3l1837t1313r2147b1406, p3l7t1431r340b1514],

1	[	RB	O	[	advmod	18	SENT_49	[p3l1837t1313r2147b1406, p3l7t1431r340b1514],
2	15	CD	NUMBER	15	number	3	SENT_49	[p3l1837t1313r2147b1406, p3l7t1431r340b1514],
3	]	CD	NUMBER	]	nsubj	18	SENT_49	[p3l1837t1313r2147b1406, p3l7t1431r340b1514],
4	A	DT	O	a	det	9	SENT_49	[p3l372t1442r443b1513],
5	20	CD	PERCENT	20	num	6	SENT_49	[p3l473t1442r653b1514],
6	%	NN	PERCENT	%	npadvmod	7	SENT_49	[p3l473t1442r653b1514],
7	higher	JJR	O	higher	amod	9	SENT_49	[p3l684t1442r947b1535],
8	duloxetine	NN	O	duloxetine	nn	9	SENT_49	[p3l974t1442r1405b1514],
9	exposure	NN	O	exposure	npadvmod	13	SENT_49	[p3l1435t1464r1803b1535],
10	in	IN	O	in	_	0	SENT_49	[p3l1831t1442r1908b1513],
11	Japanese	JJ	MISC	japanese	amod	12	SENT_49	[p3l1935t1443r2147b1535, p3l7t1592r187b1641],
12	subjects	NNS	O	subject	prep_in	9	SENT_49	[p3l216t1569r540b1663],
13	than	IN	O	than	advmod	3	SENT_49	[p3l567t1569r742b1641],
14	in	IN	O	in	_	0	SENT_49	[p3l766t1569r843b1641],
15	Caucasian	JJ	LOCATION	caucasian	amod	16	SENT_49	[p3l869t1569r1289b1642],
16	subjects	NNS	O	subject	prep_in	3	SENT_49	[p3l1317t1569r1641b1663],
17	was	VBD	O	be	cop	18	SENT_49	[p3l1668t1592r1823b1642],
18	attributable	JJ	O	attributable	_	0	SENT_49	[p3l1852t1569r2148b1641, p3l7t1700r204b1772],
19	to	TO	O	to	_	0	SENT_49	[p3l237t1711r314b1772],
20	the	DT	O	the	det	23	SENT_49	[p3l347t1700r470b1772],
21	lower	JJR	O	lower	amod	23	SENT_49	[p3l504t1700r738b1772],
22	mean	NN	O	mean	nn	23	SENT_49	[p3l768t1723r989b1772],
23	bodyweight	NN	O	bodyweight	prep_to	18	SENT_49	[p3l1020t1700r1507b1793],
24	(	CD	PERCENT	(	number	25	SENT_49	[p3l1541t1700r1790b1789],
25	13	CD	PERCENT	13	dep	26	SENT_49	[p3l1541t1700r1790b1789],
26	%	NN	PERCENT	%	dep	23	SENT_49	[p3l1541t1700r1790b1789],
27	)	CD	NUMBER	)	tmod	18	SENT_49	[p3l1541t1700r1790b1789],
28	in	IN	O	in	_	0	SENT_49	[p3l1826t1700r1903b1771],
29	J	NNP	O	J	nn	31	SENT_49	[p3l1935t1702r1973b1772],
30	apanese	JJ	O	apanese	amod	31	SENT_49	[p3l1978t1723r2148b1793, p3l7t1850r187b1900],
31	subjects	NNS	O	subject	prep_in	18	SENT_49	[p3l282t1828r629b1921],
32	.	.	O	.	_	0	SENT_49	[p3l282t1828r629b1921],

1	Furthermore	RB	O	furthermore	advmod	16	SENT_50	[p3l724t1828r1259b1913],
2	,	,	O	,	_	0	SENT_50	[p3l724t1828r1259b1913],
3	the	DT	O	the	det	4	SENT_50	[p3l1353t1828r1476b1900],
4	frequency	NN	O	frequency	nsubj	16	SENT_50	[p3l1567t1828r1976b1921],
5	or	CC	O	or	_	0	SENT_50	[p3l2069t1850r2152b1900],
6	severity	NN	O	severity	nsubj	16	SENT_50	[p3l11t1956r331b2050],
7	of	IN	O	of	_	0	SENT_50	[p3l366t1956r454b2028],
8	adverse	JJ	O	adverse	amod	9	SENT_50	[p3l484t1956r793b2029],
9	events	NNS	O	event	prep_of	4	SENT_50	[p3l828t1967r1086b2029],
10	in	IN	O	in	_	0	SENT_50	[p3l1122t1956r1199b2028],
11	Japanese	JJ	MISC	japanese	amod	12	SENT_50	[p3l1232t1958r1596b2050],
12	subjects	NNS	O	subject	prep_in	9	SENT_50	[p3l1633t1956r1957b2050],
13	was	VBD	O	be	cop	16	SENT_50	[p3l1993t1979r2148b2029],
14	not	RB	O	not	neg	16	SENT_50	[p3l7t2098r138b2159],
15	meaningfully	RB	O	meaningfully	advmod	16	SENT_50	[p3l170t2087r717b2180],
16	different	JJ	O	different	_	0	SENT_50	[p3l753t2087r1106b2159],
17	from	IN	O	from	_	0	SENT_50	[p3l1138t2087r1337b2159],
18	those	DT	O	those	prep_from	16	SENT_50	[p3l1369t2087r1584b2159],
19	in	IN	O	in	_	0	SENT_50	[p3l1618t2087r1696b2158],
20	Caucasian	JJ	LOCATION	caucasian	amod	21	SENT_50	[p3l1731t2087r2151b2159],
21	subjects	NNS	O	subject	prep_in	18	SENT_50	[p3l11t2215r357b2308],
22	.	.	O	.	_	0	SENT_50	[p3l11t2215r357b2308],

1	Given	VBN	O	give	prep	18	SENT_51	[p3l133t2345r380b2417],
2	the	DT	O	the	det	3	SENT_51	[p3l406t2345r529b2417],
3	lack	NN	O	lack	dep	1	SENT_51	[p3l556t2345r726b2417],
4	of	IN	O	of	_	0	SENT_51	[p3l751t2345r840b2417],
5	duloxetine	NN	O	duloxetine	nn	6	SENT_51	[p3l860t2345r1290b2417],
6	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	3	SENT_51	[p3l1316t2345r2039b2438],
7	or	CC	O	or	_	0	SENT_51	[p3l2069t2367r2153b2417],
8	tolerability	NN	O	tolerability	nn	9	SENT_51	[p3l7t2472r457b2566],
9	differences	NNS	O	difference	prep_of	3	SENT_51	[p3l491t2472r942b2544],
10	between	IN	O	between	_	0	SENT_51	[p3l975t2472r1318b2545],
11	Caucasian	JJ	LOCATION	caucasian	amod	14	SENT_51	[p3l1351t2472r1772b2545],
12	and	CC	O	and	_	0	SENT_51	[p3l1805t2472r1950b2544],
13	Japanese	JJ	MISC	japanese	conj_and	11	SENT_51	[p3l1981t2474r2147b2566, p3l10t2624r233b2673],
14	subjects	NNS	O	subject	prep_between	6	SENT_51	[p3l276t2601r623b2695],
15	,	,	O	,	_	0	SENT_51	[p3l276t2601r623b2695],
16	it	PRP	O	it	nsubjpass	18	SENT_51	[p3l666t2601r722b2673],
17	was	VBD	O	be	auxpass	18	SENT_51	[p3l759t2624r913b2674],
18	hypothesised	VBN	O	hypothesise	_	0	SENT_51	[p3l953t2601r1491b2695],
19	that	IN	O	that	complm	28	SENT_51	[p3l1528t2601r1681b2673],
20	duloxetine	NN	O	duloxetine	nn	21	SENT_51	[p3l1719t2601r2150b2673],
21	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	28	SENT_51	[p3l6t2732r730b2825],
22	and	CC	O	and	_	0	SENT_51	[p3l803t2732r948b2804],
23	tolerability	NN	O	tolerability	conj_and	21	SENT_51	[p3l1015t2732r1465b2826],
24	would	MD	O	would	aux	28	SENT_51	[p3l1535t2732r1790b2804],
25	not	RB	O	not	neg	28	SENT_51	[p3l1858t2743r1989b2804],
26	be	VB	O	be	cop	28	SENT_51	[p3l2055t2732r2150b2804],
27	meaningfully	RB	O	meaningfully	advmod	28	SENT_51	[p3l7t2861r554b2954],
28	different	JJ	O	different	ccomp	18	SENT_51	[p3l606t2861r958b2933],
29	in	IN	O	in	_	0	SENT_51	[p3l1007t2861r1084b2932],
30	the	DT	O	the	det	32	SENT_51	[p3l1134t2861r1257b2933],
31	Chinese	JJ	LOCATION	chinese	amod	32	SENT_51	[p3l1308t2861r1636b2933],
32	population	NN	O	population	prep_in	28	SENT_51	[p3l1685t2861r2145b2954],
33	.	.	O	.	_	0	SENT_51	[p3l1685t2861r2145b2954],

1	To	TO	O	to	aux	2	SENT_52	[p3l7t2992r118b3062],
2	test	VB	O	test	purpcl	13	SENT_52	[p3l167t3001r309b3062],
3	this	DT	O	this	det	4	SENT_52	[p3l355t2990r499b3062],
4	hypothesis	NN	O	hypothesis	dobj	2	SENT_52	[p3l548t2990r1009b3083],
5	,	,	O	,	_	0	SENT_52	[p3l548t2990r1009b3083],
6	the	DT	O	the	det	7	SENT_52	[p3l1061t2990r1184b3062],
7	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	13	SENT_52	[p3l1231t2990r1955b3083],
8	and	CC	O	and	_	0	SENT_52	[p3l2007t2990r2152b3062],
9	tolerability	NN	O	tolerability	nsubjpass	13	SENT_52	[p3l7t3118r457b3211],
10	of	IN	O	of	_	0	SENT_52	[p3l496t3118r585b3190],
11	duloxetine	NN	O	duloxetine	prep_of	7	SENT_52	[p3l617t3118r1048b3190],
12	were	VBD	O	be	auxpass	13	SENT_52	[p3l1087t3140r1283b3190],
13	assessed	VBN	O	assess	_	0	SENT_52	[p3l1323t3118r1669b3190],
14	in	IN	O	in	_	0	SENT_52	[p3l1706t3118r1784b3189],
15	Chinese	JJ	LOCATION	chinese	prep_in	13	SENT_52	[p3l1822t3118r2150b3190],

1	Clin	NNP	O	Clin	nn	2	SENT_53	[p3l1206t3397r1313b3444],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_53	[p3l1339t3397r1793b3444],
3	2007	CD	DATE	2007	num	2	SENT_53	[p3l1814t3397r1962b3447],
4	;	:	O	;	_	0	SENT_53	[p3l1814t3397r1962b3447],
5	46	CD	NUMBER	46	number	6	SENT_53	[p3l1986t3397r2053b3444],
6	(	CD	NUMBER	(	dep	2	SENT_53	[p3l2075t3397r2149b3451],
7	9	CD	NUMBER	9	num	8	SENT_53	[p3l2075t3397r2149b3451],
8	)	NN	O	)	dep	6	SENT_53	[p3l2075t3397r2149b3451],

1	Duloxetine	NNP	O	Duloxetine	nn	2	SENT_54	[p3l184t3526r346b3551],
2	PK	NNP	O	PK	_	0	SENT_54	[p3l357t3527r401b3551],
3	in	IN	O	in	_	0	SENT_54	[p3l412t3527r440b3551],
4	Chinese	NNP	MISC	Chinese	nn	5	SENT_54	[p3l451t3526r568b3551],
5	Subjects	NNPS	O	Subjects	prep_in	2	SENT_54	[p3l579t3526r697b3560],
6	769	CD	NUMBER	769	dep	2	SENT_54	[p3l1927t3527r1975b3551],

1	subjects	NNS	O	subject	nsubj	2	SENT_55	[p4l12t99r334b193],
2	administered	VBN	O	administer	_	0	SENT_55	[p4l391t99r918b171],
3	duloxetine	NN	O	duloxetine	dobj	2	SENT_55	[p4l969t99r1399b171],
4	60mg	JJ	O	60mg	amod	3	SENT_55	[p4l1453t99r1681b193],
5	as	IN	O	as	_	0	SENT_55	[p4l1736t122r1814b171],
6	singleand	JJ	O	singleand	amod	10	SENT_55	[p4l1872t99r2142b193, p4l11t228r155b300],
7	multiple	JJ	O	multiple	amod	10	SENT_55	[p4l187t228r836b322],
8	—	NN	O	—	nn	10	SENT_55	[p4l187t228r836b322],
9	dosing	NN	O	dosing	nn	10	SENT_55	[p4l187t228r836b322],
10	regimens	NNS	O	regimen	prep_as	2	SENT_55	[p4l869t228r1265b322],
11	.	.	O	.	_	0	SENT_55	[p4l869t228r1265b322],

1	Methods	NNS	O	method	_	0	SENT_56	[p4l137t488r559b567],

1	Study	NNP	O	Study	nn	2	SENT_57	[p4l132t752r376b840],
2	Subjecfs	NNP	O	Subjecfs	_	0	SENT_57	[p4l407t752r775b840],

1	Healthy	JJ	O	healthy	amod	3	SENT_58	[p4l132t983r454b1076],
2	Chinese	JJ	MISC	chinese	amod	3	SENT_58	[p4l486t983r812b1055],
3	subjects	NNS	O	subject	nsubjpass	13	SENT_58	[p4l846t983r1169b1076],
4	between	IN	O	between	_	0	SENT_58	[p4l1200t983r1541b1055],
5	the	DT	O	the	det	6	SENT_58	[p4l1571t983r1693b1055],
6	ages	NNS	O	age	prep_between	3	SENT_58	[p4l1726t1005r1901b1076],
7	of	IN	O	of	_	0	SENT_58	[p4l1934t983r2022b1055],
8	20	CD	NUMBER	20	nn	11	SENT_58	[p4l2047t983r2145b1055],
9	and	CC	O	and	_	0	SENT_58	[p4l11t1112r155b1184],
10	45	CD	DURATION	45	nn	11	SENT_58	[p4l208t1111r304b1184],
11	years	NNS	NUMBER	year	prep_of	6	SENT_58	[p4l363t1134r575b1205],
12	were	VBD	O	be	auxpass	13	SENT_58	[p4l633t1134r828b1184],
13	enrolled	VBN	O	enrol	_	0	SENT_58	[p4l885t1112r1219b1184],
14	to	TO	O	to	aux	15	SENT_58	[p4l1273t1122r1349b1184],
15	participate	VB	O	participate	xcomp	13	SENT_58	[p4l1403t1112r1836b1205],
16	in	IN	O	in	_	0	SENT_58	[p4l1891t1112r1968b1183],
17	the	DT	O	the	det	21	SENT_58	[p4l2022t1112r2145b1184],
18	single-dosing	JJ	O	single-dosing	amod	21	SENT_58	[p4l12t1241r559b1334],
19	and	CC	O	and	_	0	SENT_58	[p4l604t1241r749b1313],
20	multiple-dosing	JJ	O	multiple-dosing	conj_and	18	SENT_58	[p4l790t1241r1438b1334],
21	regimens	NNS	O	regimen	prep_in	15	SENT_58	[p4l1480t1241r1853b1334],
22	of	IN	O	of	_	0	SENT_58	[p4l1899t1241r1988b1313],
23	the	DT	O	the	det	24	SENT_58	[p4l2023t1241r2145b1313],
24	study	NN	O	study	prep_of	21	SENT_58	[p4l12t1370r249b1463],
25	.	.	O	.	_	0	SENT_58	[p4l12t1370r249b1463],

1	Written	VBN	O	write	csubjpass	5	SENT_59	[p4l284t1370r597b1442],
2	informed	JJ	O	informed	amod	3	SENT_59	[p4l628t1370r1004b1442],
3	consent	NN	O	consent	dobj	1	SENT_59	[p4l1035t1380r1347b1442],
4	was	VBD	O	be	auxpass	5	SENT_59	[p4l1377t1392r1532b1442],
5	obtained	VBN	O	obtain	_	0	SENT_59	[p4l1567t1370r1918b1442],
6	from	IN	O	from	_	0	SENT_59	[p4l1949t1370r2147b1442],
7	the	DT	O	the	det	8	SENT_59	[p4l8t1499r131b1571],
8	participants	NNS	O	participant	prep_from	5	SENT_59	[p4l180t1499r656b1592],
9	before	IN	O	before	_	0	SENT_59	[p4l707t1499r968b1571],
10	the	DT	O	the	det	11	SENT_59	[p4l1018t1499r1141b1571],
11	commencement	NN	O	commencement	prep_before	5	SENT_59	[p4l1192t1509r1841b1571],
12	of	IN	O	of	_	0	SENT_59	[p4l1891t1499r1979b1571],
13	the	DT	O	the	det	14	SENT_59	[p4l2023t1499r2145b1571],
14	study	NN	O	study	prep_of	11	SENT_59	[p4l12t1628r249b1721],
15	.	.	O	.	_	0	SENT_59	[p4l12t1628r249b1721],

1	Subjects	NNS	O	subject	nsubjpass	3	SENT_60	[p4l291t1628r631b1721],
2	were	VBD	O	be	auxpass	3	SENT_60	[p4l667t1650r864b1700],
3	judged	VBN	O	judge	_	0	SENT_60	[p4l889t1628r1176b1721],
4	to	TO	O	to	aux	6	SENT_60	[p4l1208t1638r1284b1700],
5	be	VB	O	be	cop	6	SENT_60	[p4l1318t1628r1412b1700],
6	healthy	JJ	O	healthy	xcomp	3	SENT_60	[p4l1446t1628r1747b1721],
7	based	VBN	O	base	_	0	SENT_60	[p4l1779t1628r2013b1700],
8	on	IN	O	on	prepc_based_on	6	SENT_60	[p4l2047t1650r2146b1700],
9	the	DT	O	the	det	10	SENT_60	[p4l8t1757r131b1829],
10	review	NN	O	review	pobj	6	SENT_60	[p4l161t1757r438b1829],
11	of	IN	O	of	_	0	SENT_60	[p4l471t1757r559b1829],
12	their	PRP$	O	they	poss	14	SENT_60	[p4l583t1757r770b1829],
13	medical	JJ	O	medical	amod	14	SENT_60	[p4l800t1757r1122b1829],
14	history	NN	O	history	prep_of	10	SENT_60	[p4l1152t1757r1458b1850],
15	,	,	O	,	_	0	SENT_60	[p4l1152t1757r1458b1850],
16	physical	JJ	O	physical	amod	17	SENT_60	[p4l1491t1757r1832b1850],
17	examination	NN	O	examination	prep_of	10	SENT_60	[p4l1864t1757r2143b1829, p4l8t1886r285b1971],
18	,	,	O	,	_	0	SENT_60	[p4l1864t1757r2143b1829, p4l8t1886r285b1971],
19	vital	JJ	O	vital	amod	20	SENT_60	[p4l323t1886r502b1958],
20	signs	NNS	O	sign	prep_of	10	SENT_60	[p4l540t1886r768b1979],
21	,	,	O	,	_	0	SENT_60	[p4l540t1886r768b1979],
22	ECG	NN	O	ecg	conj_and	14	SENT_60	[p4l805t1886r1009b1958],
23	and	CC	O	and	_	0	SENT_60	[p4l1045t1886r1189b1958],
24	standard	JJ	O	standard	amod	27	SENT_60	[p4l1227t1886r1569b1958],
25	clinical	JJ	O	clinical	amod	27	SENT_60	[p4l1604t1886r1902b1958],
26	laboratory	NN	O	laboratory	nn	27	SENT_60	[p4l1937t1886r2143b1958, p4l7t2026r250b2109],
27	tests	NNS	O	test	conj_and	14	SENT_60	[p4l285t2026r485b2088],
28	.	.	O	.	_	0	SENT_60	[p4l285t2026r485b2088],

1	The	DT	O	the	det	2	SENT_61	[p4l132t2145r288b2217],
2	study	NN	O	study	nsubjpass	4	SENT_61	[p4l321t2145r537b2238],
3	was	VBD	O	be	auxpass	4	SENT_61	[p4l566t2167r720b2217],
4	approved	VBN	O	approve	_	0	SENT_61	[p4l753t2145r1131b2238],
5	by	IN	O	by	_	0	SENT_61	[p4l1157t2145r1258b2238],
6	the	DT	O	the	det	9	SENT_61	[p4l1286t2145r1409b2217],
7	Independent	NNP	ORGANIZATION	Independent	nn	9	SENT_61	[p4l1438t2145r1945b2238],
8	Ethics	NNPS	ORGANIZATION	Ethics	nn	9	SENT_61	[p4l1971t2145r2143b2217, p4l8t2274r117b2346],
9	Committee	NNP	ORGANIZATION	Committee	agent	4	SENT_61	[p4l181t2274r633b2346],
10	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l695t2274r783b2346],
11	Peking	NNP	ORGANIZATION	Peking	nn	13	SENT_61	[p4l835t2274r1117b2367],
12	University	NNP	ORGANIZATION	University	nn	13	SENT_61	[p4l1178t2274r1609b2367],
13	Institute	NNP	ORGANIZATION	Institute	prep_of	9	SENT_61	[p4l1669t2274r2003b2346],
14	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l2064t2274r2153b2346],
15	Mental	NNP	ORGANIZATION	Mental	nn	18	SENT_61	[p4l8t2403r296b2475],
16	Health	NNP	ORGANIZATION	Health	nn	18	SENT_61	[p4l322t2403r594b2475],
17	(	NNP	O	(	nn	18	SENT_61	[p4l622t2403r974b2496],
18	Beijing	NNP	LOCATION	Beijing	prep_of	13	SENT_61	[p4l622t2403r974b2496],
19	,	,	O	,	_	0	SENT_61	[p4l622t2403r974b2496],
20	China	NNP	LOCATION	China	appos	18	SENT_61	[p4l1005t2403r1278b2491],
21	)	CD	NUMBER	)	num	20	SENT_61	[p4l1005t2403r1278b2491],
22	and	CC	O	and	_	0	SENT_61	[p4l1307t2403r1452b2475],
23	performed	VBN	O	perform	conj_and	4	SENT_61	[p4l1475t2403r1902b2496],
24	at	IN	O	at	_	0	SENT_61	[p4l1928t2414r2000b2475],
25	the	DT	O	the	det	28	SENT_61	[p4l2022t2403r2145b2475],
26	Peking	NNP	ORGANIZATION	Peking	nn	28	SENT_61	[p4l8t2532r290b2625],
27	University	NNP	ORGANIZATION	University	nn	28	SENT_61	[p4l326t2532r757b2625],
28	Institute	NNP	ORGANIZATION	Institute	prep_at	23	SENT_61	[p4l793t2532r1127b2604],
29	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l1164t2532r1252b2604],
30	Mental	NNP	ORGANIZATION	Mental	nn	31	SENT_61	[p4l1280t2532r1569b2604],
31	Health	NNP	ORGANIZATION	Health	prep_of	28	SENT_61	[p4l1605t2532r1876b2604],
32	in	IN	O	in	_	0	SENT_61	[p4l1911t2532r1988b2603],
33	accordance	NN	O	accordance	prep_in	31	SENT_61	[p4l2025t2554r2143b2604, p4l9t2660r376b2732],
34	with	IN	O	with	_	0	SENT_61	[p4l411t2660r591b2732],
35	the	DT	O	the	det	36	SENT_61	[p4l624t2660r747b2732],
36	Declaration	NN	O	declaration	prep_with	23	SENT_61	[p4l781t2660r1258b2732],
37	of	IN	O	of	_	0	SENT_61	[p4l1293t2660r1381b2732],
38	Helsinki	NNP	LOCATION	Helsinki	prep_of	36	SENT_61	[p4l1409t2660r1775b2732],
39	.	.	O	.	_	0	SENT_61	[p4l1409t2660r1775b2732],

1	Study	NNP	O	Study	nn	2	SENT_62	[p4l133t2917r376b3005],
2	Design	NNP	O	Design	_	0	SENT_62	[p4l412t2918r702b3007],

1	The	DT	O	the	det	2	SENT_63	[p4l132t3147r289b3219],
2	study	NN	O	study	nsubj	4	SENT_63	[p4l319t3147r535b3241],
3	was	VBD	O	be	aux	4	SENT_63	[p4l562t3170r717b3220],
4	designed	VBN	O	design	_	0	SENT_63	[p4l747t3147r1109b3241],
5	as	IN	O	as	_	0	SENT_63	[p4l1137t3170r1215b3219],
6	a	DT	O	a	det	8	SENT_63	[p4l1246t3170r1289b3219],
7	double	JJ	O	double	amod	8	SENT_63	[p4l1315t3147r1837b3219],
8	—	NN	O	—	prep_as	4	SENT_63	[p4l1315t3147r1837b3219],
9	blind	JJ	O	blind	amod	12	SENT_63	[p4l1315t3147r1837b3219],
10	(	NN	O	(	nn	12	SENT_63	[p4l1866t3147r2143b3236, p4l8t3276r305b3370],
11	investigator	NN	O	investigator	nn	12	SENT_63	[p4l1866t3147r2143b3236, p4l8t3276r305b3370],
12	—	NN	O	—	tmod	4	SENT_63	[p4l1866t3147r2143b3236, p4l8t3276r305b3370],
13	and	CC	O	and	_	0	SENT_63	[p4l371t3276r516b3348],
14	subject	JJ	O	subject	advmod	12	SENT_63	[p4l579t3276r1166b3370],
15	—	NN	O	—	nn	17	SENT_63	[p4l579t3276r1166b3370],
16	blind	JJ	O	blind	amod	17	SENT_63	[p4l579t3276r1166b3370],
17	)	NN	O	)	tmod	4	SENT_63	[p4l579t3276r1166b3370],
18	,	,	O	,	_	0	SENT_63	[p4l579t3276r1166b3370],
19	randomised	VBN	O	randomise	dep	4	SENT_63	[p4l1229t3276r1730b3361],
20	,	,	O	,	_	0	SENT_63	[p4l1229t3276r1730b3361],
21	placebocontrolled	VBN	O	placebocontroll	dep	4	SENT_63	[p4l1793t3276r2143b3370, p4l9t3405r444b3491],
22	,	,	O	,	_	0	SENT_63	[p4l1793t3276r2143b3370, p4l9t3405r444b3491],
23	single	JJ	O	single	amod	26	SENT_63	[p4l487t3405r1025b3499],
24	—	JJ	O	—	amod	26	SENT_63	[p4l487t3405r1025b3499],
25	period	NN	O	period	nn	26	SENT_63	[p4l487t3405r1025b3499],
26	study	NN	O	study	dobj	4	SENT_63	[p4l1062t3405r1299b3499],
27	.	.	O	.	_	0	SENT_63	[p4l1062t3405r1299b3499],

1	Thirty	CD	NUMBER	thirty	num	2	SENT_64	[p4l1339t3405r1781b3499],
2	—	CD	NUMBER	—	nsubjpass	9	SENT_64	[p4l1339t3405r1781b3499],
3	two	CD	NUMBER	two	num	4	SENT_64	[p4l1339t3405r1781b3499],
4	subjects	NNS	O	subject	dep	2	SENT_64	[p4l1821t3405r2143b3499],
5	were	VBD	O	be	auxpass	6	SENT_64	[p4l9t3557r205b3607],
6	enrolled	VBN	O	enrol	_	0	SENT_64	[p4l264t3534r598b3606],
7	and	CC	O	and	_	0	SENT_64	[p4l657t3534r801b3606],
8	randomly	RB	O	randomly	advmod	6	SENT_64	[p4l857t3534r1249b3628],
9	assigned	VBN	O	assign	conj_and	6	SENT_64	[p4l1310t3534r1660b3628],
10	to	TO	O	to	aux	11	SENT_64	[p4l1716t3545r1793b3606],
11	receive	VB	O	receive	xcomp	9	SENT_64	[p4l1850t3534r2145b3607],
12	either	CC	O	either	prep	11	SENT_64	[p4l9t3663r242b3735],
13	duloxetine	NN	O	duloxetine	nn	16	SENT_64	[p4l296t3663r726b3735],
14	or	CC	O	or	_	0	SENT_64	[p4l784t3686r867b3735],
15	matching	VBG	O	match	nn	16	SENT_64	[p4l921t3663r1300b3757],
16	placebo	NN	O	placebo	dep	12	SENT_64	[p4l1355t3663r1672b3757],
17	in	IN	O	in	_	0	SENT_64	[p4l1729t3663r1806b3735],
18	a	DT	O	a	det	19	SENT_64	[p4l1864t3686r1906b3735],
19	3	CD	NUMBER	3	prep_in	16	SENT_64	[p4l1963t3664r2004b3736],
20	:	:	O	:	_	0	SENT_64	[p4l2044t3685r2062b3736],
21	1	CD	NUMBER	1	dep	19	SENT_64	[p4l2107t3664r2137b3735],

1	ratio	NN	O	ratio	_	0	SENT_65	[p5l7t24r214b96],
2	.	.	O	.	_	0	SENT_65	[p5l7t24r214b96],

1	Duloxetine	NNP	O	Duloxetine	nn	3	SENT_66	[p5l244t24r697b96],
2	60mg	JJ	O	60mg	amod	3	SENT_66	[p5l724t24r953b118],
3	(	NN	O	(	nsubjpass	19	SENT_66	[p5l981t24r1238b118],
4	given	VBN	O	give	prep	3	SENT_66	[p5l981t24r1238b118],
5	as	IN	O	as	pcomp	4	SENT_66	[p5l1264t47r1342b96],
6	two	CD	NUMBER	two	num	8	SENT_66	[p5l1369t35r1519b97],
7	30mg	JJ	O	30mg	amod	8	SENT_66	[p5l1547t25r1774b118],
8	capsules	NNS	O	capsule	pobj	5	SENT_66	[p5l1801t25r2143b118],
9	containing	VBG	O	contain	partmod	8	SENT_66	[p5l9t153r438b247],
10	enteric	JJ	O	enteric	amod	11	SENT_66	[p5l470t153r1049b225],
11	—	NN	O	—	dobj	9	SENT_66	[p5l470t153r1049b225],
12	coated	JJ	O	coated	amod	14	SENT_66	[p5l470t153r1049b225],
13	pellets	NNS	O	pellet	nn	14	SENT_66	[p5l1076t153r1374b247],
14	)	NN	O	)	tmod	9	SENT_66	[p5l1076t153r1374b247],
15	and	CC	O	and	_	0	SENT_66	[p5l1407t153r1552b225],
16	matching	VBG	O	match	amod	17	SENT_66	[p5l1580t153r1958b247],
17	placebo	NN	O	placebo	conj_and	14	SENT_66	[p5l1987t153r2142b247, p5l9t282r198b354],
18	were	VBD	O	be	auxpass	19	SENT_66	[p5l227t305r423b355],
19	supplied	VBN	O	supply	_	0	SENT_66	[p5l454t282r797b376],
20	by	IN	O	by	_	0	SENT_66	[p5l822t282r922b376],
21	Eli	NNP	PERSON	Eli	nn	22	SENT_66	[p5l949t282r1066b354],
22	Lilly	NNP	PERSON	Lilly	agent	19	SENT_66	[p5l1093t282r1290b376],
23	and	CC	O	and	_	0	SENT_66	[p5l1319t282r1464b354],
24	Company	NNP	O	Company	nn	26	SENT_66	[p5l1491t283r1887b376],
25	(	NNP	O	(	nn	26	SENT_66	[p5l1917t282r2142b371, p5l11t411r370b505],
26	Indianapolis	NNP	LOCATION	Indianapolis	agent	19	SENT_66	[p5l1917t282r2142b371, p5l11t411r370b505],
27	,	,	O	,	_	0	SENT_66	[p5l1917t282r2142b371, p5l11t411r370b505],
28	IN	IN	O	in	amod	26	SENT_66	[p5l404t413r532b496],
29	,	,	O	,	_	0	SENT_66	[p5l404t413r532b496],
30	USA	NNP	LOCATION	USA	appos	26	SENT_66	[p5l566t412r824b500],
31	)	CD	NUMBER	)	num	30	SENT_66	[p5l566t412r824b500],
32	.	.	O	.	_	0	SENT_66	[p5l566t412r824b500],

1	Subjects	NNS	O	subject	nsubj	2	SENT_67	[p5l862t411r1203b505],
2	received	VBD	O	receive	_	0	SENT_67	[p5l1235t411r1583b484],
3	orally	RB	O	orally	advmod	2	SENT_67	[p5l1613t411r1848b505],
4	Cl11lOXetine	NN	O	cl11loxetine	dobj	2	SENT_67	[p5l1881t411r2142b483, p5l9t540r205b612],
5	60mg	JJ	O	60mg	amod	4	SENT_67	[p5l256t540r484b634],
6	or	CC	O	or	_	0	SENT_67	[p5l535t563r619b612],
7	placebo	NN	O	placebo	conj_or	4	SENT_67	[p5l664t540r981b634],
8	on	IN	O	on	_	0	SENT_67	[p5l1033t563r1132b612],
9	the	DT	O	the	det	10	SENT_67	[p5l1180t540r1302b612],
10	morning	NN	TIME	morning	prep_on	2	SENT_67	[p5l1351t540r1696b634],
11	of	IN	O	of	_	0	SENT_67	[p5l1747t540r1836b612],
12	day	NN	DURATION	day	prep_of	10	SENT_67	[p5l1878t540r2022b634],
13	1	CD	NUMBER	1	num	12	SENT_67	[p5l2081t541r2142b626],
14	,	,	O	,	_	0	SENT_67	[p5l2081t541r2142b626],
15	followed	VBN	O	follow	_	0	SENT_67	[p5l9t669r372b741],
16	by	IN	O	by	prepc_followed_by	2	SENT_67	[p5l409t669r510b763],
17	a	DT	O	a	det	22	SENT_67	[p5l551t692r594b741],
18	once	RB	DATE	once	advmod	19	SENT_67	[p5l633t669r1062b763],
19	—	JJ	O	—	amod	22	SENT_67	[p5l633t669r1062b763],
20	daily	JJ	SET	daily	amod	22	SENT_67	[p5l633t669r1062b763],
21	morning	NN	SET	morning	nn	22	SENT_67	[p5l1102t669r1447b763],
22	dose	NN	O	dose	pobj	2	SENT_67	[p5l1488t669r1672b741],
23	of	IN	O	of	_	0	SENT_67	[p5l1713t669r1801b741],
24	duloXe	NN	O	duloxe	prep_of	22	SENT_67	[p5l1835t669r2142b741],
25	—	CD	NUMBER	—	num	26	SENT_67	[p5l1835t669r2142b741],
26	tine	NN	O	tine	npadvmod	27	SENT_67	[p5l8t798r159b870],
27	60mg	JJ	O	60mg	amod	24	SENT_67	[p5l198t798r427b892],
28	or	CC	O	or	_	0	SENT_67	[p5l467t821r550b870],
29	placebo	NN	O	placebo	pobj	2	SENT_67	[p5l584t798r901b892],
30	on	IN	O	on	_	0	SENT_67	[p5l941t821r1040b870],
31	days	NNS	DURATION	day	prep_on	29	SENT_67	[p5l1078t798r1260b892],
32	4	CD	NUMBER	4	num	31	SENT_67	[p5l1299t799r1347b870],
33	through	IN	O	through	_	0	SENT_67	[p5l1385t798r1703b892],
34	9	CD	NUMBER	9	prep_through	31	SENT_67	[p5l1741t799r1809b871],
35	.	.	O	.	_	0	SENT_67	[p5l1741t799r1809b871],

1	Dosing	NN	O	dosing	nsubj	2	SENT_68	[p5l1851t798r2144b892],
2	occurred	VBD	O	occur	_	0	SENT_68	[p5l9t927r366b999],
3	approximately	RB	O	approximately	advmod	2	SENT_68	[p5l407t927r995b1021],
4	at	IN	O	at	_	0	SENT_68	[p5l1038t938r1108b999],
5	the	DT	O	the	det	7	SENT_68	[p5l1145t927r1268b999],
6	same	JJ	O	same	amod	7	SENT_68	[p5l1311t950r1516b999],
7	time	NN	O	time	prep_at	3	SENT_68	[p5l1555t927r1736b999],
8	each	DT	SET	each	det	9	SENT_68	[p5l1776t927r1961b999],
9	day	NN	SET	day	dep	7	SENT_68	[p5l2001t927r2145b1021],
10	for	IN	O	for	_	0	SENT_68	[p5l9t1056r127b1128],
11	an	DT	O	a	det	13	SENT_68	[p5l169t1079r261b1128],
12	individual	JJ	O	individual	amod	13	SENT_68	[p5l302t1056r716b1129],
13	subject	NN	O	subject	prep_for	2	SENT_68	[p5l761t1056r1067b1150],
14	.	.	O	.	_	0	SENT_68	[p5l761t1056r1067b1150],

1	Blood	NN	O	blood	nn	2	SENT_69	[p5l1113t1056r1363b1128],
2	samples	NNS	O	sample	nsubjpass	4	SENT_69	[p5l1406t1056r1729b1150],
3	were	VBD	O	be	auxpass	4	SENT_69	[p5l1773t1079r1969b1129],
4	obtained	VBN	O	obtain	_	0	SENT_69	[p5l2012t1056r2142b1128, p5l8t1185r258b1257],
5	by	IN	O	by	_	0	SENT_69	[p5l280t1185r381b1279],
6	venipuncture	NN	O	venipuncture	agent	4	SENT_69	[p5l407t1185r962b1279],
7	.	.	O	.	_	0	SENT_69	[p5l407t1185r962b1279],

1	A	DT	O	a	det	3	SENT_70	[p5l991t1186r1063b1257],
2	blood	NN	O	blood	nn	3	SENT_70	[p5l1086t1185r1320b1257],
3	sample	NN	O	sample	nsubjpass	5	SENT_70	[p5l1348t1185r1632b1279],
4	was	VBD	O	be	auxpass	5	SENT_70	[p5l1658t1208r1812b1258],
5	collected	VBN	O	collect	_	0	SENT_70	[p5l1840t1185r2142b1257, p5l9t1314r103b1386],
6	from	IN	O	from	_	0	SENT_70	[p5l144t1314r342b1386],
7	all	DT	O	all	det	8	SENT_70	[p5l382t1314r480b1386],
8	subjects	NNS	O	subject	prep_from	5	SENT_70	[p5l524t1314r847b1408],
9	for	IN	O	for	_	0	SENT_70	[p5l890t1314r1009b1386],
10	CYPZD6	NN	O	cypzd6	nn	11	SENT_70	[p5l1052t1314r1414b1387],
11	genotyping	NN	O	genotyping	prep_for	8	SENT_70	[p5l1452t1314r1931b1408],
12	.	.	O	.	_	0	SENT_70	[p5l1452t1314r1931b1408],

1	Following	VBG	O	follow	_	0	SENT_71	[p5l1976t1314r2142b1386, p5l8t1443r290b1537],
2	single	JJ	O	single	amod	3	SENT_71	[p5l319t1443r558b1537],
3	dosing	NN	O	dosing	prep_following	9	SENT_71	[p5l583t1443r875b1537],
4	,	,	O	,	_	0	SENT_71	[p5l583t1443r875b1537],
5	sequential	JJ	O	sequential	amod	7	SENT_71	[p5l906t1443r1317b1537],
6	blood	NN	O	blood	nn	7	SENT_71	[p5l1339t1443r1573b1515],
7	samples	NNS	O	sample	nsubjpass	9	SENT_71	[p5l1600t1443r1922b1537],
8	were	VBD	O	be	auxpass	9	SENT_71	[p5l1949t1466r2145b1515],
9	collected	VBN	O	collect	_	0	SENT_71	[p5l9t1572r378b1644],
10	on	IN	O	on	_	0	SENT_71	[p5l402t1595r501b1644],
11	day	NN	DURATION	day	prep_on	9	SENT_71	[p5l527t1572r670b1666],
12	1	CD	NUMBER	1	num	11	SENT_71	[p5l706t1573r735b1644],
13	at	IN	O	at	_	0	SENT_71	[p5l771t1583r842b1644],
14	predose	NN	O	predose	prep_at	9	SENT_71	[p5l864t1572r1181b1666],
15	and	CC	O	and	_	0	SENT_71	[p5l1208t1572r1353b1644],
16	1	CD	NUMBER	1	prep_at	9	SENT_71	[p5l1386t1573r1447b1657],
17	,	,	O	,	_	0	SENT_71	[p5l1386t1573r1447b1657],
18	2	CD	NUMBER	2	appos	16	SENT_71	[p5l1476t1573r1545b1658],
19	,	,	O	,	_	0	SENT_71	[p5l1476t1573r1545b1658],
20	4	CD	NUMBER	4	appos	18	SENT_71	[p5l1573t1573r1644b1658],
21	,	,	O	,	_	0	SENT_71	[p5l1573t1573r1644b1658],
22	6	CD	NUMBER	6	appos	18	SENT_71	[p5l1674t1572r1742b1658],
23	,	,	O	,	_	0	SENT_71	[p5l1674t1572r1742b1658],
24	8	CD	NUMBER	8	appos	18	SENT_71	[p5l1775t1573r1841b1657],
25	,	,	O	,	_	0	SENT_71	[p5l1775t1573r1841b1657],
26	10	CD	NUMBER	10	appos	18	SENT_71	[p5l1879t1573r1991b1658],
27	,	,	O	,	_	0	SENT_71	[p5l1879t1573r1991b1658],
28	12	CD	NUMBER	12	appos	18	SENT_71	[p5l2029t1573r2142b1658],
29	,	,	O	,	_	0	SENT_71	[p5l2029t1573r2142b1658],

1	©	RB	O	©	advmod	2	SENT_72	[p5l10t1855r53b1898],
2	2007	CD	DATE	2007	_	0	SENT_72	[p5l76t1851r207b1898],
3	Adis	NNP	PERSON	Adis	nn	5	SENT_72	[p5l230t1851r353b1898],
4	Dcfrca	NNP	PERSON	Dcfrca	nn	5	SENT_72	[p5l377t1851r520b1898],
5	Information	NNP	O	Information	dep	2	SENT_72	[p5l546t1851r880b1898],
6	BV	NN	O	bv	dep	5	SENT_72	[p5l907t1851r992b1898],
7	.	.	O	.	_	0	SENT_72	[p5l907t1851r992b1898],

1	All	DT	O	all	det	2	SENT_73	[p5l1017t1851r1084b1898],
2	rights	NNS	O	rights	nsubj	3	SENT_73	[p5l1109t1851r1259b1910],
3	reserved	VBN	O	reserve	_	0	SENT_73	[p5l1282t1851r1548b1898],
4	.	.	O	.	_	0	SENT_73	[p5l1282t1851r1548b1898],

1	24	CD	NUMBER	24	_	0	SENT_74	[p5l16t2096r137b2181],
2	,	,	O	,	_	0	SENT_74	[p5l16t2096r137b2181],
3	36	CD	NUMBER	36	appos	1	SENT_74	[p5l173t2095r292b2180],
4	,	,	O	,	_	0	SENT_74	[p5l173t2095r292b2180],
5	48	CD	NUMBER	48	num	3	SENT_74	[p5l325t2096r447b2181],
6	,	,	O	,	_	0	SENT_74	[p5l325t2096r447b2181],
7	and	CC	DURATION	and	_	0	SENT_74	[p5l483t2095r627b2167],
8	72	CD	DURATION	72	appos	1	SENT_74	[p5l657t2096r755b2167],
9	hours	NNS	NUMBER	hour	nn	10	SENT_74	[p5l785t2095r1009b2167],
10	postdose	NN	O	postdose	dep	3	SENT_74	[p5l1040t2095r1419b2189],
11	.	.	O	.	_	0	SENT_74	[p5l1040t2095r1419b2189],

1	Following	VBG	O	follow	_	0	SENT_75	[p5l1453t2095r1873b2189],
2	multiple	JJ	O	multiple	amod	3	SENT_75	[p5l1903t2095r2149b2167, p5l13t2224r137b2318],
3	dosing	NN	O	dosing	prep_following	10	SENT_75	[p5l165t2224r458b2318],
4	,	,	O	,	_	0	SENT_75	[p5l165t2224r458b2318],
5	a	DT	O	a	det	8	SENT_75	[p5l490t2247r532b2296],
6	predose	NN	O	predose	nn	8	SENT_75	[p5l556t2224r873b2318],
7	blood	NN	O	blood	nn	8	SENT_75	[p5l899t2224r1133b2296],
8	sample	NN	O	sample	nsubjpass	10	SENT_75	[p5l1162t2224r1447b2318],
9	was	VBD	O	be	auxpass	10	SENT_75	[p5l1474t2247r1629b2297],
10	collected	VBN	O	collect	_	0	SENT_75	[p5l1658t2224r2027b2296],
11	on	IN	O	on	_	0	SENT_75	[p5l2054t2247r2153b2296],
12	days	NNS	DURATION	day	prep_on	10	SENT_75	[p5l16t2353r198b2447],
13	7	CD	NUMBER	7	num	12	SENT_75	[p5l242t2355r286b2425],
14	and	CC	O	and	_	0	SENT_75	[p5l332t2353r477b2425],
15	8	CD	NUMBER	8	conj_and	12	SENT_75	[p5l521t2354r586b2426],
16	.	.	O	.	_	0	SENT_75	[p5l521t2354r586b2426],

1	On	IN	O	on	_	0	SENT_76	[p5l633t2354r755b2426],
2	day	NN	DURATION	day	prep_on	9	SENT_76	[p5l796t2353r940b2447],
3	9	CD	NUMBER	9	num	2	SENT_76	[p5l983t2354r1052b2439],
4	,	,	O	,	_	0	SENT_76	[p5l983t2354r1052b2439],
5	sequential	JJ	O	sequential	amod	7	SENT_76	[p5l1100t2353r1511b2447],
6	blood	NN	O	blood	nn	7	SENT_76	[p5l1550t2353r1784b2425],
7	samples	NNS	O	sample	nsubjpass	9	SENT_76	[p5l1828t2353r2150b2447],
8	were	VBD	O	be	auxpass	9	SENT_76	[p5l15t2505r211b2555],
9	collected	VBN	O	collect	_	0	SENT_76	[p5l237t2482r605b2554],
10	at	IN	O	at	_	0	SENT_76	[p5l631t2493r702b2554],
11	predose	NN	O	predose	prep_at	9	SENT_76	[p5l723t2482r1041b2576],
12	and	CC	O	and	_	0	SENT_76	[p5l1068t2482r1212b2554],
13	1	CD	NUMBER	1	conj_and	11	SENT_76	[p5l1245t2483r1306b2568],
14	,	,	O	,	_	0	SENT_76	[p5l1245t2483r1306b2568],
15	2	CD	NUMBER	2	conj_and	11	SENT_76	[p5l1335t2483r1404b2568],
16	,	,	O	,	_	0	SENT_76	[p5l1335t2483r1404b2568],
17	4	CD	NUMBER	4	conj_and	11	SENT_76	[p5l1431t2483r1502b2567],
18	,	,	O	,	_	0	SENT_76	[p5l1431t2483r1502b2567],
19	6	CD	NUMBER	6	conj_and	13	SENT_76	[p5l1532t2482r1601b2567],
20	,	,	O	,	_	0	SENT_76	[p5l1532t2482r1601b2567],
21	8	CD	NUMBER	8	conj_and	11	SENT_76	[p5l1633t2483r1699b2568],
22	,	,	O	,	_	0	SENT_76	[p5l1633t2483r1699b2568],
23	10	CD	NUMBER	10	conj_and	11	SENT_76	[p5l1737t2483r1849b2568],
24	,	,	O	,	_	0	SENT_76	[p5l1737t2483r1849b2568],
25	12	CD	NUMBER	12	conj_and	11	SENT_76	[p5l1886t2483r1999b2567],
26	,	,	O	,	_	0	SENT_76	[p5l1886t2483r1999b2567],
27	24	CD	NUMBER	24	conj_and	13	SENT_76	[p5l2028t2483r2148b2568],
28	,	,	O	,	_	0	SENT_76	[p5l2028t2483r2148b2568],
29	36	CD	NUMBER	36	conj_and	11	SENT_76	[p5l18t2611r137b2697],
30	,	,	O	,	_	0	SENT_76	[p5l18t2611r137b2697],
31	48	CD	NUMBER	48	conj_and	11	SENT_76	[p5l168t2612r290b2696],
32	,	,	O	,	_	0	SENT_76	[p5l168t2612r290b2696],
33	and	CC	DURATION	and	_	0	SENT_76	[p5l325t2611r469b2683],
34	72	CD	DURATION	72	num	35	SENT_76	[p5l497t2612r595b2683],
35	hours	NNS	NUMBER	hour	conj_and	13	SENT_76	[p5l623t2611r847b2683],
36	after	IN	O	after	_	0	SENT_76	[p5l880t2611r1066b2683],
37	the	DT	O	the	det	39	SENT_76	[p5l1092t2611r1214b2683],
38	last	JJ	O	last	amod	39	SENT_76	[p5l1243t2611r1384b2683],
39	dose	NN	O	dose	prep_after	9	SENT_76	[p5l1412t2611r1617b2683],
40	.	.	O	.	_	0	SENT_76	[p5l1412t2611r1617b2683],

1	A	DT	O	a	_	0	SENT_77	[p5l1650t2612r1722b2683],
2	follow	VBP	O	follow	csubj	6	SENT_77	[p5l1750t2611r2152b2705],
3	—	CD	NUMBER	—	dobj	2	SENT_77	[p5l1750t2611r2152b2705],
4	up	IN	O	up	_	0	SENT_77	[p5l1750t2611r2152b2705],
5	visit	NN	O	visit	prep_up	2	SENT_77	[p5l15t2740r190b2813],
6	occurred	VBD	O	occur	dep	1	SENT_77	[p5l223t2740r579b2812],
7	within	IN	O	within	_	0	SENT_77	[p5l611t2740r872b2813],
8	3	CD	DURATION	3	number	10	SENT_77	[p5l906t2741r946b2813],
9	to	TO	DURATION	to	dep	10	SENT_77	[p5l984t2751r1060b2812],
10	7	CD	DURATION	7	num	11	SENT_77	[p5l1094t2742r1139b2812],
11	days	NNS	NUMBER	day	prep_within	6	SENT_77	[p5l1176t2740r1358b2834],
12	after	IN	O	after	_	0	SENT_77	[p5l1395t2740r1580b2812],
13	the	DT	O	the	det	16	SENT_77	[p5l1610t2740r1733b2812],
14	last	JJ	O	last	amod	16	SENT_77	[p5l1766t2740r1907b2812],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_77	[p5l1937t2740r2149b2834, p5l15t2869r514b2941],
16	sample	NN	O	sample	prep_after	6	SENT_77	[p5l602t2869r908b2963],
17	.	.	O	.	_	0	SENT_77	[p5l602t2869r908b2963],

1	Consumption	NN	O	consumption	nsubj	13	SENT_78	[p5l998t2869r1549b2963],
2	of	IN	O	of	_	0	SENT_78	[p5l1634t2869r1722b2941],
3	caffeine	NN	O	caffeine	prep_of	1	SENT_78	[p5l1799t2869r2149b2955],
4	,	,	O	,	_	0	SENT_78	[p5l1799t2869r2149b2955],
5	grilled	JJ	O	grilled	amod	8	SENT_78	[p5l16t2998r282b3092],
6	or	CC	O	or	_	0	SENT_78	[p5l317t3021r400b3070],
7	barbecued	JJ	O	barbecued	conj_or	5	SENT_78	[p5l432t2998r855b3070],
8	foods	NNS	O	food	conj_and	3	SENT_78	[p5l890t2998r1137b3084],
9	,	,	O	,	_	0	SENT_78	[p5l890t2998r1137b3084],
10	and	CC	O	and	_	0	SENT_78	[p5l1178t2998r1323b3070],
11	cruciferous	JJ	O	cruciferous	amod	12	SENT_78	[p5l1358t2998r1815b3070],
12	vegetables	NNS	O	vegetable	conj_and	3	SENT_78	[p5l1853t3009r2150b3092, p5l13t3127r175b3199],
13	(	VBP	O	(	ccomp	19	SENT_78	[p5l228t3127r616b3221],
14	cabbage	NN	O	cabbage	dobj	13	SENT_78	[p5l228t3127r616b3221],
15	,	,	O	,	_	0	SENT_78	[p5l228t3127r616b3221],
16	broccoli	JJ	O	broccoli	amod	17	SENT_78	[p5l666t3127r1033b3216],
17	)	NN	O	)	nsubjpass	19	SENT_78	[p5l666t3127r1033b3216],
18	was	VBD	O	be	auxpass	19	SENT_78	[p5l1084t3150r1239b3199],
19	restricted	VBN	O	restrict	_	0	SENT_78	[p5l1287t3127r1670b3199],
20	during	IN	O	during	_	0	SENT_78	[p5l1718t3127r1981b3221],
21	the	DT	O	the	det	22	SENT_78	[p5l2030t3127r2152b3199],
22	study	NN	O	study	prep_during	19	SENT_78	[p5l18t3257r235b3350],
23	to	TO	O	to	_	0	SENT_78	[p5l265t3267r342b3328],
24	minimise	NN	O	minimise	nn	26	SENT_78	[p5l373t3256r753b3328],
25	dietary	JJ	O	dietary	amod	26	SENT_78	[p5l785t3256r1066b3350],
26	effects	NNS	O	effect	prep_to	19	SENT_78	[p5l1099t3256r1367b3328],
27	on	IN	O	on	_	0	SENT_78	[p5l1401t3279r1500b3328],
28	CYP1A2	NN	O	cyp1a2	prep_on	26	SENT_78	[p5l1531t3257r1926b3329],
29	.	.	O	.	_	0	SENT_78	[p5l1531t3257r1926b3329],

1	Subjects	NNS	O	subject	nsubjpass	4	SENT_79	[p5l1964t3256r2149b3329, p5l6t3385r198b3479],
2	were	VBD	O	be	auxpass	4	SENT_79	[p5l233t3408r430b3458],
3	also	RB	O	also	advmod	4	SENT_79	[p5l465t3385r624b3457],
4	asked	VBN	O	ask	_	0	SENT_79	[p5l661t3385r891b3457],
5	to	TO	O	to	aux	6	SENT_79	[p5l922t3396r998b3457],
6	abstain	VB	O	abstain	xcomp	4	SENT_79	[p5l1034t3385r1321b3457],
7	from	IN	O	from	_	0	SENT_79	[p5l1353t3385r1552b3457],
8	alcohol	NN	O	alcohol	nn	11	SENT_79	[p5l1585t3385r1883b3457],
9	(	CD	NUMBER	(	num	11	SENT_79	[p5l1919t3385r2149b3474, p5l15t3515r174b3603],
10	ethanol	NN	O	ethanol	nn	11	SENT_79	[p5l1919t3385r2149b3474, p5l15t3515r174b3603],
11	)	NN	O	)	prep_from	6	SENT_79	[p5l1919t3385r2149b3474, p5l15t3515r174b3603],
12	for	IN	O	for	_	0	SENT_79	[p5l223t3514r342b3586],
13	24	CD	DURATION	24	num	14	SENT_79	[p5l386t3515r484b3586],
14	hours	NNS	NUMBER	hour	prep_for	6	SENT_79	[p5l529t3514r753b3586],
15	before	IN	O	before	_	0	SENT_79	[p5l800t3514r1061b3586],
16	dosing	NN	O	dosing	prep_before	14	SENT_79	[p5l1108t3514r1377b3608],
17	and	CC	O	and	_	0	SENT_79	[p5l1425t3514r1570b3586],
18	until	IN	O	until	_	0	SENT_79	[p5l1613t3514r1799b3586],
19	the	DT	O	the	det	22	SENT_79	[p5l1844t3514r1967b3586],
20	last	JJ	O	last	amod	22	SENT_79	[p5l2013t3514r2154b3586],
21	multiple	JJ	O	multiple	amod	22	SENT_79	[p5l15t3643r354b3737],
22	dosing	NN	O	dosing	prep_until	27	SENT_79	[p5l400t3643r669b3737],
23	pharmacokinetic	JJ	O	pharmacokinetic	amod	24	SENT_79	[p5l712t3643r1395b3737],
24	sample	NN	O	sample	nsubjpass	27	SENT_79	[p5l1444t3643r1728b3737],
25	had	VBD	O	have	aux	27	SENT_79	[p5l1771t3643r1919b3715],
26	been	VBN	O	be	auxpass	27	SENT_79	[p5l1960t3643r2153b3715],
27	collected	VBN	O	collect	conj_and	4	SENT_79	[p6l16t24r404b96],
28	.	.	O	.	_	0	SENT_79	[p6l16t24r404b96],

1	Anolyticonl	NNP	O	Anolyticonl	nn	2	SENT_80	[p6l138t281r579b369],
2	Methods	NNS	O	method	_	0	SENT_80	[p6l620t281r1004b352],

1	Plasma	NN	O	plasma	nn	2	SENT_81	[p6l138t519r435b591],
2	samples	NNS	O	sample	nsubjpass	4	SENT_81	[p6l490t519r813b612],
3	were	VBD	O	be	auxpass	4	SENT_81	[p6l868t542r1065b591],
4	analysed	VBN	O	analyse	_	0	SENT_81	[p6l1121t519r1476b613],
5	by	IN	O	by	_	0	SENT_81	[p6l1528t519r1628b613],
6	a	DT	O	a	agent	4	SENT_81	[p6l1684t542r1727b591],
7	validated	VBN	O	validate	partmod	6	SENT_81	[p6l1778t519r2154b591],
8	liquid	JJ	O	liquid	amod	10	SENT_81	[p6l15t647r253b740],
9	chromatography	NN	O	chromatography	nn	10	SENT_81	[p6l305t647r1314b741],
10	—	NN	O	—	dobj	7	SENT_81	[p6l305t647r1314b741],
11	tandem	JJ	O	tandem	amod	14	SENT_81	[p6l305t647r1314b741],
12	mass	NN	O	mass	nn	14	SENT_81	[p6l1364t670r1564b719],
13	spectrometry	NN	O	spectrometry	nn	14	SENT_81	[p6l1622t658r2152b741],
14	method	NN	O	method	dep	10	SENT_81	[p6l15t765r506b847],
15	.	.	O	.	_	0	SENT_81	[p6l15t765r506b847],

1	[	NN	O	[	nsubjpass	10	SENT_82	[p6l15t765r506b847],
2	8	CD	NUMBER	8	num	1	SENT_82	[p6l15t765r506b847],
3	’	NN	O	’	dep	1	SENT_82	[p6l15t765r506b847],
4	1	CD	NUMBER	1	num	3	SENT_82	[p6l15t765r506b847],
5	°	CD	NUMBER	°	number	6	SENT_82	[p6l15t765r506b847],
6	]	CD	NUMBER	]	dep	1	SENT_82	[p6l15t765r506b847],
7	The	DT	O	the	det	8	SENT_82	[p6l540t775r696b847],
8	assay	NN	O	assay	dep	6	SENT_82	[p6l728t798r946b869],
9	was	VBD	O	be	auxpass	10	SENT_82	[p6l976t798r1130b847],
10	validated	VBN	O	validate	_	0	SENT_82	[p6l1162t775r1537b847],
11	over	IN	O	over	_	0	SENT_82	[p6l1567t798r1748b847],
12	the	DT	O	the	det	13	SENT_82	[p6l1775t775r1897b847],
13	range	NN	O	range	prep_over	10	SENT_82	[p6l1926t798r2152b869],
14	of	IN	O	of	_	0	SENT_82	[p6l16t903r105b975],
15	0.5	CD	NUMBER	0.5	num	16	SENT_82	[p6l140t903r261b976],
16	ng/mL	NN	O	ng/ml	prep_of	13	SENT_82	[p6l306t904r578b997],
17	to	TO	O	to	_	0	SENT_82	[p6l619t914r695b975],
18	100.0	CD	NUMBER	100.0	num	19	SENT_82	[p6l748t904r966b976],
19	ng/mL	NN	O	ng/ml	prep_to	10	SENT_82	[p6l1008t904r1300b997],
20	.	.	O	.	_	0	SENT_82	[p6l1008t904r1300b997],

1	Duloxetine	NNP	O	Duloxetine	nsubj	7	SENT_83	[p6l1346t903r1801b975],
2	and	CC	O	and	_	0	SENT_83	[p6l1845t903r1989b975],
3	the	DT	O	the	det	6	SENT_83	[p6l2029t903r2152b975],
4	stable	JJ	O	stable	amod	6	SENT_83	[p6l18t1031r252b1103],
5	isotope	NN	O	isotope	nn	6	SENT_83	[p6l325t1031r980b1124],
6	—	NN	O	—	conj_and	1	SENT_83	[p6l325t1031r980b1124],
7	labelled	VBD	O	label	dep	16	SENT_83	[p6l325t1031r980b1124],
8	internal	JJ	O	internal	amod	12	SENT_83	[p6l1052t1031r1363b1103],
9	standard	JJ	O	standard	amod	12	SENT_83	[p6l1440t1031r1783b1103],
10	(	NN	O	(	nn	12	SENT_83	[p6l1858t1025r2149b1120],
11	13CD3	NN	O	13cd3	nn	12	SENT_83	[p6l1858t1025r2149b1120],
12	duloxetine	NN	O	duloxetine	dobj	7	SENT_83	[p6l16t1159r446b1231],
13	HCl	NN	O	hcl	nsubjpass	16	SENT_83	[p6l484t1159r684b1248],
14	)	CD	NUMBER	)	num	13	SENT_83	[p6l484t1159r684b1248],
15	were	VBD	O	be	auxpass	16	SENT_83	[p6l725t1182r921b1231],
16	extracted	VBN	O	extract	_	0	SENT_83	[p6l961t1159r1335b1231],
17	from	IN	O	from	_	0	SENT_83	[p6l1372t1159r1570b1231],
18	plasma	NN	O	plasma	prep_from	16	SENT_83	[p6l1605t1159r1897b1252],
19	using	VBG	O	use	partmod	18	SENT_83	[p6l1932t1159r2152b1253],
20	solid	JJ	O	solid	amod	23	SENT_83	[p6l18t1287r480b1380],
21	—	NN	O	—	nn	23	SENT_83	[p6l18t1287r480b1380],
22	phase	NN	O	phase	nn	23	SENT_83	[p6l18t1287r480b1380],
23	extraction	NN	O	extraction	dobj	19	SENT_83	[p6l544t1287r952b1359],
24	with	IN	O	with	_	0	SENT_83	[p6l1016t1287r1196b1359],
25	a	DT	O	a	det	27	SENT_83	[p6l1261t1310r1303b1359],
26	C8	NN	O	c8	nn	27	SENT_83	[p6l1366t1288r1477b1360],
27	cartridge	NN	O	cartridge	prep_with	23	SENT_83	[p6l1545t1287r1928b1381],
28	.	.	O	.	_	0	SENT_83	[p6l1545t1287r1928b1381],

1	The	DT	O	the	det	2	SENT_84	[p6l1996t1287r2153b1359],
2	analytes	NNS	O	analyte	nsubjpass	4	SENT_84	[p6l17t1415r347b1509],
3	were	VBD	O	be	auxpass	4	SENT_84	[p6l380t1438r576b1487],
4	eluted	VBN	O	elute	_	0	SENT_84	[p6l607t1415r856b1487],
5	from	IN	O	from	_	0	SENT_84	[p6l886t1415r1084b1487],
6	the	DT	O	the	det	7	SENT_84	[p6l1113t1415r1235b1487],
7	cartridge	NN	O	cartridge	prep_from	4	SENT_84	[p6l1267t1415r1628b1509],
8	with	IN	O	with	_	0	SENT_84	[p6l1660t1415r1840b1487],
9	methanol	NN	O	methanol	prep_with	7	SENT_84	[p6l1870t1415r2149b1487, p6l15t1543r164b1615],
10	.	.	O	.	_	0	SENT_84	[p6l1870t1415r2149b1487, p6l15t1543r164b1615],

1	The	DT	O	the	det	2	SENT_85	[p6l219t1543r375b1615],
2	compounds	NNS	O	compound	nsubjpass	4	SENT_85	[p6l426t1543r895b1636],
3	were	VBD	O	be	auxpass	4	SENT_85	[p6l947t1566r1143b1615],
4	chromatographed	VBN	O	chromatograph	_	0	SENT_85	[p6l1194t1543r1912b1637],
5	on	IN	O	on	_	0	SENT_85	[p6l1962t1566r2060b1615],
6	a	DT	O	a	det	9	SENT_85	[p6l2112t1566r2154b1615],
7	Luna	NNP	MISC	Luna	nn	9	SENT_85	[p6l14t1673r225b1743],
8	C18	NN	MISC	c18	nn	9	SENT_85	[p6l283t1672r446b1744],
9	(	NN	O	(	prep_on	4	SENT_85	[p6l511t1672r590b1760],
10	2	CD	NUMBER	2	num	11	SENT_85	[p6l511t1672r590b1760],
11	X	NN	O	x	dep	16	SENT_85	[p6l649t1688r703b1741],
12	50mm	CD	NUMBER	50mm	num	13	SENT_85	[p6l763t1671r1052b1760],
13	)	CD	NUMBER	)	dep	11	SENT_85	[p6l763t1671r1052b1760],
14	analytical	JJ	O	analytical	amod	15	SENT_85	[p6l1115t1671r1510b1765],
15	column	NN	O	column	dep	16	SENT_85	[p6l1570t1671r1875b1743],
16	(	CD	NUMBER	(	dep	9	SENT_85	[p6l1936t1671r2149b1760, p6l15t1822r411b1885],
17	Phenomenex	NNP	PERSON	Phenomenex	nn	23	SENT_85	[p6l1936t1671r2149b1760, p6l15t1822r411b1885],
18	,	,	O	,	_	0	SENT_85	[p6l1936t1671r2149b1760, p6l15t1822r411b1885],
19	Torrance	NNP	PERSON	Torrance	appos	23	SENT_85	[p6l456t1801r846b1885],
20	,	,	O	,	_	0	SENT_85	[p6l456t1801r846b1885],
21	CA	NNP	LOCATION	CA	appos	23	SENT_85	[p6l893t1800r1053b1885],
22	,	,	O	,	_	0	SENT_85	[p6l893t1800r1053b1885],
23	USA	NNP	LOCATION	USA	dep	16	SENT_85	[p6l1098t1800r1332b1888],
24	)	CD	NUMBER	)	num	23	SENT_85	[p6l1098t1800r1332b1888],
25	with	IN	O	with	_	0	SENT_85	[p6l1377t1799r1557b1871],
26	mobile	JJ	O	mobile	amod	27	SENT_85	[p6l1597t1799r1880b1871],
27	phase	NN	O	phase	prep_with	4	SENT_85	[p6l1920t1799r2153b1892],
28	composed	VBN	O	compose	partmod	27	SENT_85	[p6l16t1927r430b2020],
29	of	IN	O	of	_	0	SENT_85	[p6l465t1927r553b1999],
30	55	CD	NUMBER	55	prep_of	28	SENT_85	[p6l583t1927r676b2000],
31	:	:	O	:	_	0	SENT_85	[p6l716t1949r734b1999],
32	45	CD	NUMBER	45	num	33	SENT_85	[p6l769t1927r865b2000],
33	acetonitrile	NN	O	acetonitrile	num	40	SENT_85	[p6l906t1927r1364b1999],
34	and	CC	O	and	_	0	SENT_85	[p6l1400t1927r1545b1999],
35	10	CD	NUMBER	10	num	36	SENT_85	[p6l1588t1928r1677b2000],
36	mol/L	NN	O	mol/l	num	40	SENT_85	[p6l1713t1927r1961b2000],
37	ammonium	NN	O	ammonium	nn	40	SENT_85	[p6l1998t1950r2149b1999, p6l15t2055r357b2127],
38	acetate	NN	O	acetate	nn	40	SENT_85	[p6l391t2066r672b2127],
39	(	CD	NUMBER	(	num	40	SENT_85	[p6l710t2056r863b2148],
40	pH	NN	O	ph	dep	30	SENT_85	[p6l710t2056r863b2148],
41	5.0	CD	NUMBER	5.0	num	42	SENT_85	[p6l900t2055r1055b2144],
42	)	NN	O	)	dep	40	SENT_85	[p6l900t2055r1055b2144],
43	with	IN	O	with	_	0	SENT_85	[p6l1093t2055r1273b2127],
44	acetic	JJ	O	acetic	amod	45	SENT_85	[p6l1309t2055r1542b2127],
45	acid	NN	O	acid	prep_with	28	SENT_85	[p6l1580t2055r1767b2127],
46	.	.	O	.	_	0	SENT_85	[p6l1580t2055r1767b2127],

1	Samples	NNS	O	sample	nsubjpass	11	SENT_86	[p6l1809t2055r2150b2148],
2	above	IN	O	above	_	0	SENT_86	[p6l17t2183r257b2255],
3	the	DT	O	the	det	5	SENT_86	[p6l288t2183r411b2255],
4	upper	JJ	O	upper	amod	5	SENT_86	[p6l442t2206r676b2276],
5	limit	NN	O	limit	prep_above	1	SENT_86	[p6l705t2183r898b2255],
6	of	IN	O	of	_	0	SENT_86	[p6l929t2183r1017b2255],
7	quantification	NN	O	quantification	prep_of	5	SENT_86	[p6l1042t2183r1611b2276],
8	were	VBD	O	be	auxpass	9	SENT_86	[p6l1641t2206r1838b2255],
9	diluted	VBN	O	dilute	_	0	SENT_86	[p6l1870t2183r2153b2255],
10	and	CC	O	and	_	0	SENT_86	[p6l17t2311r161b2383],
11	reanalysed	VBN	O	reanalyse	conj_and	9	SENT_86	[p6l191t2311r630b2405],
12	to	TO	O	to	aux	13	SENT_86	[p6l661t2322r737b2383],
13	yield	VB	O	yield	xcomp	9	SENT_86	[p6l770t2311r974b2405],
14	results	NNS	O	result	dobj	13	SENT_86	[p6l1004t2311r1269b2383],
15	within	IN	O	within	_	0	SENT_86	[p6l1303t2311r1563b2383],
16	the	DT	O	the	det	18	SENT_86	[p6l1594t2311r1717b2383],
17	calibrated	VBN	O	calibrate	amod	18	SENT_86	[p6l1750t2311r2153b2383],
18	range	NN	O	range	prep_within	13	SENT_86	[p6l13t2462r261b2533],
19	.	.	O	.	_	0	SENT_86	[p6l13t2462r261b2533],

1	The	DT	O	the	det	3	SENT_87	[p6l300t2439r457b2511],
2	interassay	JJ	O	interassay	amod	3	SENT_87	[p6l492t2439r900b2533],
3	accuracy	NN	O	accuracy	nsubj	15	SENT_87	[p6l937t2462r1320b2532],
4	,	,	O	,	_	0	SENT_87	[p6l937t2462r1320b2532],
5	expressed	VBN	O	express	partmod	3	SENT_87	[p6l1359t2439r1762b2532],
6	as	IN	O	as	quantmod	7	SENT_87	[p6l1797t2462r1876b2511],
7	the	DT	O	the	num	8	SENT_87	[p6l1912t2439r2035b2511],
8	%	NN	O	%	npadvmod	9	SENT_87	[p6l2074t2440r2148b2511],
9	relative	JJ	O	relative	amod	10	SENT_87	[p6l13t2567r320b2639],
10	error	NN	O	error	dobj	5	SENT_87	[p6l376t2590r574b2639],
11	during	IN	O	during	_	0	SENT_87	[p6l627t2567r891b2661],
12	validation	NN	O	validation	prep_during	5	SENT_87	[p6l947t2567r1377b2652],
13	,	,	O	,	_	0	SENT_87	[p6l947t2567r1377b2652],
14	was	VBD	O	be	cop	15	SENT_87	[p6l1436t2590r1590b2639],
15	S3	NN	O	s3	_	0	SENT_87	[p6l1649t2567r1936b2640],
16	.6	CD	PERCENT	.6	num	17	SENT_87	[p6l1649t2567r1936b2640],
17	%	NN	PERCENT	%	dep	15	SENT_87	[p6l1649t2567r1936b2640],
18	.	.	O	.	_	0	SENT_87	[p6l1649t2567r1936b2640],

1	The	DT	O	the	det	3	SENT_88	[p6l1996t2567r2152b2639],
2	interassay	JJ	O	interassay	amod	3	SENT_88	[p6l15t2695r423b2789],
3	precision	NN	O	precision	nsubj	17	SENT_88	[p6l465t2695r862b2789],
4	,	,	O	,	_	0	SENT_88	[p6l465t2695r862b2789],
5	expressed	VBN	O	express	partmod	3	SENT_88	[p6l910t2695r1313b2788],
6	as	IN	O	as	_	0	SENT_88	[p6l1357t2718r1435b2767],
7	%	NN	O	%	nn	10	SENT_88	[p6l1486t2696r1559b2767],
8	relative	JJ	O	relative	amod	10	SENT_88	[p6l1605t2695r1912b2767],
9	standard	JJ	O	standard	amod	10	SENT_88	[p6l1959t2706r2149b2767, p6l16t2823r195b2895],
10	deviation	NN	O	deviation	prep_as	5	SENT_88	[p6l229t2823r609b2895],
11	during	IN	O	during	_	0	SENT_88	[p6l643t2823r907b2917],
12	validation	NN	O	validation	prep_during	5	SENT_88	[p6l942t2823r1372b2908],
13	,	,	O	,	_	0	SENT_88	[p6l942t2823r1372b2908],
14	was	VBD	O	be	cop	17	SENT_88	[p6l1411t2846r1565b2895],
15	S4	NN	O	s4	nn	17	SENT_88	[p6l1603t2824r1890b2896],
16	.3	NN	PERCENT	.3	nn	17	SENT_88	[p6l1603t2824r1890b2896],
17	%	NN	PERCENT	%	_	0	SENT_88	[p6l1603t2824r1890b2896],
18	.	.	O	.	_	0	SENT_88	[p6l1603t2824r1890b2896],

1	Subjects	NNS	O	subject	dep	107	SENT_89	[p6l141t2949r482b3043],
2	were	VBD	O	be	dep	107	SENT_89	[p6l516t2972r712b3022],
3	genotyped	VBN	O	genotype	dep	107	SENT_89	[p6l745t2949r1171b3043],
4	for	IN	O	for	dep	107	SENT_89	[p6l1201t2949r1320b3021],
5	the	DT	O	the	dep	107	SENT_89	[p6l1350t2949r1472b3021],
6	C	NN	O	c	dep	107	SENT_89	[p6l1509t2951r1574b3022],
7	YP2D6	NN	O	yp2d6	dep	107	SENT_89	[p6l1579t2949r1991b3035],
8	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1579t2949r1991b3035],
9	l	NN	O	l	dep	107	SENT_89	[p6l1579t2949r1991b3035],
10	,	,	O	,	_	0	SENT_89	[p6l1579t2949r1991b3035],
11	*	NN	O	*	dep	107	SENT_89	[p6l2033t2950r2149b3035],
12	2	CD	NUMBER	2	dep	107	SENT_89	[p6l2033t2950r2149b3035],
13	,	,	O	,	_	0	SENT_89	[p6l2033t2950r2149b3035],
14	*	CD	NUMBER	*	dep	107	SENT_89	[p6l20t3078r136b3162],
15	3	CD	NUMBER	3	dep	107	SENT_89	[p6l20t3078r136b3162],
16	,	,	O	,	_	0	SENT_89	[p6l20t3078r136b3162],
17	*	CD	NUMBER	*	dep	107	SENT_89	[p6l186t3078r303b3162],
18	4	CD	NUMBER	4	dep	107	SENT_89	[p6l186t3078r303b3162],
19	,	,	O	,	_	0	SENT_89	[p6l186t3078r303b3162],
20	*	CD	NUMBER	*	dep	107	SENT_89	[p6l353t3077r469b3162],
21	5	CD	NUMBER	5	dep	107	SENT_89	[p6l353t3077r469b3162],
22	,	,	O	,	_	0	SENT_89	[p6l353t3077r469b3162],
23	*	CD	NUMBER	*	dep	107	SENT_89	[p6l519t3077r635b3162],
24	6	CD	NUMBER	6	dep	107	SENT_89	[p6l519t3077r635b3162],
25	,	,	O	,	_	0	SENT_89	[p6l519t3077r635b3162],
26	*	CD	NUMBER	*	dep	107	SENT_89	[p6l685t3078r802b3162],
27	7	CD	NUMBER	7	dep	107	SENT_89	[p6l685t3078r802b3162],
28	,	,	O	,	_	0	SENT_89	[p6l685t3078r802b3162],
29	*	CD	NUMBER	*	dep	107	SENT_89	[p6l852t3078r968b3162],
30	8	CD	NUMBER	8	dep	107	SENT_89	[p6l852t3078r968b3162],
31	,	,	O	,	_	0	SENT_89	[p6l852t3078r968b3162],
32	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1018t3078r1134b3162],
33	9	CD	NUMBER	9	dep	107	SENT_89	[p6l1018t3078r1134b3162],
34	,	,	O	,	_	0	SENT_89	[p6l1018t3078r1134b3162],
35	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1184t3078r1352b3162],
36	lo	NN	O	lo	dep	107	SENT_89	[p6l1184t3078r1352b3162],
37	,	,	O	,	_	0	SENT_89	[p6l1184t3078r1352b3162],
38	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1402t3078r1570b3162],
39	l1	NN	O	l1	dep	107	SENT_89	[p6l1402t3078r1570b3162],
40	,	,	O	,	_	0	SENT_89	[p6l1402t3078r1570b3162],
41	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1620t3078r1862b3162],
42	l4A	NN	O	l4a	dep	107	SENT_89	[p6l1620t3078r1862b3162],
43	,	,	O	,	_	0	SENT_89	[p6l1620t3078r1862b3162],
44	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1912t3078r2148b3162],
45	l4B	NN	O	l4b	dep	107	SENT_89	[p6l1912t3078r2148b3162],
46	,	,	O	,	_	0	SENT_89	[p6l1912t3078r2148b3162],
47	*	CD	NUMBER	*	dep	107	SENT_89	[p6l20t3204r188b3289],
48	l5	NN	O	l5	dep	107	SENT_89	[p6l20t3204r188b3289],
49	,	,	O	,	_	0	SENT_89	[p6l20t3204r188b3289],
50	*	CD	NUMBER	*	dep	107	SENT_89	[p6l238t3205r405b3289],
51	l7	NN	O	l7	dep	107	SENT_89	[p6l238t3205r405b3289],
52	,	,	O	,	_	0	SENT_89	[p6l238t3205r405b3289],
53	*	CD	NUMBER	*	dep	107	SENT_89	[p6l455t3205r624b3289],
54	l9	NN	O	l9	dep	107	SENT_89	[p6l455t3205r624b3289],
55	,	,	O	,	_	0	SENT_89	[p6l455t3205r624b3289],
56	*	CD	NUMBER	*	dep	107	SENT_89	[p6l673t3205r841b3289],
57	20	CD	NUMBER	20	dep	107	SENT_89	[p6l673t3205r841b3289],
58	,	,	O	,	_	0	SENT_89	[p6l673t3205r841b3289],
59	*	CD	NUMBER	*	dep	107	SENT_89	[p6l891t3204r1059b3289],
60	25	CD	NUMBER	25	dep	107	SENT_89	[p6l891t3204r1059b3289],
61	,	,	O	,	_	0	SENT_89	[p6l891t3204r1059b3289],
62	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1109t3204r1277b3289],
63	26	CD	NUMBER	26	dep	107	SENT_89	[p6l1109t3204r1277b3289],
64	,	,	O	,	_	0	SENT_89	[p6l1109t3204r1277b3289],
65	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1327t3205r1495b3289],
66	29	CD	NUMBER	29	dep	107	SENT_89	[p6l1327t3205r1495b3289],
67	,	,	O	,	_	0	SENT_89	[p6l1327t3205r1495b3289],
68	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1545t3205r1713b3289],
69	30	CD	NUMBER	30	dep	107	SENT_89	[p6l1545t3205r1713b3289],
70	,	,	O	,	_	0	SENT_89	[p6l1545t3205r1713b3289],
71	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1762t3205r1931b3289],
72	3l	NN	O	3l	dep	107	SENT_89	[p6l1762t3205r1931b3289],
73	,	,	O	,	_	0	SENT_89	[p6l1762t3205r1931b3289],
74	*	CD	NUMBER	*	dep	107	SENT_89	[p6l1981t3204r2148b3289],
75	35	CD	NUMBER	35	dep	107	SENT_89	[p6l1981t3204r2148b3289],
76	,	,	O	,	_	0	SENT_89	[p6l1981t3204r2148b3289],
77	*	CD	NUMBER	*	dep	107	SENT_89	[p6l20t3331r188b3416],
78	36	CD	NUMBER	36	dep	107	SENT_89	[p6l20t3331r188b3416],
79	,	,	O	,	_	0	SENT_89	[p6l20t3331r188b3416],
80	*	CD	NUMBER	*	dep	107	SENT_89	[p6l227t3332r373b3404],
81	40	CD	NUMBER	40	dep	107	SENT_89	[p6l227t3332r373b3404],
82	and	CC	O	and	dep	107	SENT_89	[p6l406t3331r550b3403],
83	*	CD	NUMBER	*	dep	107	SENT_89	[p6l584t3332r721b3403],
84	4l	NN	O	4l	dep	107	SENT_89	[p6l584t3332r721b3403],
85	alleles	NNS	O	allele	dep	107	SENT_89	[p6l763t3331r1019b3403],
86	using	VBG	O	use	dep	107	SENT_89	[p6l1050t3331r1270b3425],
87	a	DT	O	a	dep	107	SENT_89	[p6l1303t3354r1345b3403],
88	validated	VBN	O	validate	dep	107	SENT_89	[p6l1374t3331r1749b3404],
89	polymerase	NN	O	polymerase	dep	107	SENT_89	[p6l1777t3331r2149b3425, p6l17t3482r143b3531],
90	chain	NN	O	chain	dep	107	SENT_89	[p6l181t3459r400b3531],
91	reaction	NN	O	reaction	dep	107	SENT_89	[p6l436t3459r1035b3531],
92	—	NN	O	—	dep	107	SENT_89	[p6l436t3459r1035b3531],
93	based	VBN	O	base	dep	107	SENT_89	[p6l436t3459r1035b3531],
94	method	NN	O	method	dep	107	SENT_89	[p6l1070t3459r1377b3531],
95	(	CD	NUMBER	(	dep	107	SENT_89	[p6l1416t3459r1707b3548],
96	Roche	NNP	O	Roche	dep	107	SENT_89	[p6l1416t3459r1707b3548],
97	AmpliCip	NNP	O	AmpliCip	dep	107	SENT_89	[p6l1744t3459r2152b3553],
98	CYP450	NNP	O	CYP450	dep	107	SENT_89	[p6l16t3587r388b3672],
99	,	,	O	,	_	0	SENT_89	[p6l16t3587r388b3672],
100	MDS	NN	ORGANIZATION	md	dep	107	SENT_89	[p6l426t3588r641b3660],
101	Pharma	NNP	ORGANIZATION	Pharma	dep	107	SENT_89	[p6l680t3587r993b3659],
102	Services	NNP	ORGANIZATION	Services	dep	107	SENT_89	[p6l1028t3587r1393b3673],
103	,	,	O	,	_	0	SENT_89	[p6l1028t3587r1393b3673],
104	Beijing	NNP	LOCATION	Beijing	dep	107	SENT_89	[p6l1430t3587r1753b3681],
105	,	,	O	,	_	0	SENT_89	[p6l1430t3587r1753b3681],
106	China	NNP	LOCATION	China	dep	107	SENT_89	[p6l1792t3587r2088b3676],
107	)	CD	NUMBER	)	_	0	SENT_89	[p6l1792t3587r2088b3676],
108	.	.	O	.	_	0	SENT_89	[p6l1792t3587r2088b3676],

1	Clin	NNP	O	Clin	nn	2	SENT_90	[p7l1210t115r1317b162],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_90	[p7l1344t115r1796b162],
3	2007	CD	DATE	2007	num	2	SENT_90	[p7l1817t115r1965b165],
4	;	:	O	;	_	0	SENT_90	[p7l1817t115r1965b165],
5	46	CD	NUMBER	46	number	6	SENT_90	[p7l1988t115r2055b162],
6	(	CD	NUMBER	(	dep	2	SENT_90	[p7l2078t115r2152b169],
7	9	CD	NUMBER	9	num	8	SENT_90	[p7l2078t115r2152b169],
8	)	NN	O	)	dep	6	SENT_90	[p7l2078t115r2152b169],

1	770	CD	NUMBER	770	num	2	SENT_91	[p7l185t245r233b270],
2	Tinmmei	NNP	O	Tinmmei	_	0	SENT_91	[p7l1790t245r1899b270],
3	et	FW	O	et	nn	4	SENT_91	[p7l1910t247r1933b270],
4	al.	FW	O	al.	dep	2	SENT_91	[p7l1943t244r1973b269],
5	.	.	O	.	_	0	SENT_91	[p7l1943t244r1973b269],

1	Phourmolcokinefic	JJ	O	phourmolcokinefic	amod	2	SENT_92	[p7l136t488r890b559],
2	Analysis	NN	O	analysis	_	0	SENT_92	[p7l923t488r1267b576],

1	Plasma	NN	O	plasma	nn	3	SENT_93	[p7l131t737r427b809],
2	duloxetine	NN	O	duloxetine	nn	3	SENT_93	[p7l479t737r909b809],
3	concentration	NN	O	concentration	nsubj	17	SENT_93	[p7l964t737r1736b809],
4	—	CD	NUMBER	—	num	6	SENT_93	[p7l964t737r1736b809],
5	time	NN	O	time	nn	6	SENT_93	[p7l964t737r1736b809],
6	data	NNS	O	datum	nsubjpass	12	SENT_93	[p7l1791t737r1960b809],
7	obtained	VBN	O	obtain	partmod	6	SENT_93	[p7l2012t737r2142b809, p7l7t866r257b938],
8	from	IN	O	from	_	0	SENT_93	[p7l286t866r484b938],
9	individual	JJ	O	individual	amod	10	SENT_93	[p7l512t866r926b939],
10	subjects	NNS	O	subject	prep_from	7	SENT_93	[p7l958t866r1281b960],
11	were	VBD	O	be	auxpass	12	SENT_93	[p7l1313t889r1509b939],
12	analysed	VBN	O	analyse	rcmod	3	SENT_93	[p7l1541t866r1897b960],
13	using	VBG	O	use	xcomp	12	SENT_93	[p7l1924t866r2144b960],
14	noncompartmental	JJ	O	noncompartmental	amod	16	SENT_93	[p7l8t995r776b1089],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_93	[p7l807t995r1490b1089],
16	methods	NNS	O	method	dobj	13	SENT_93	[p7l1524t995r1868b1067],
17	(	VBP	O	(	_	0	SENT_93	[p7l1905t995r2142b1084, p7l7t1120r353b1197],
18	WinNonlin	NNP	O	WinNonlin	nn	21	SENT_93	[p7l1905t995r2142b1084, p7l7t1120r353b1197],
19	®	NNP	O	®	nn	21	SENT_93	[p7l1905t995r2142b1084, p7l7t1120r353b1197],
20	Professional	NNP	O	Professional	nn	21	SENT_93	[p7l386t1125r892b1197],
21	version	NN	O	version	dobj	17	SENT_93	[p7l923t1125r1224b1198],
22	4.1	CD	NUMBER	4.1	num	21	SENT_93	[p7l1254t1126r1405b1211],
23	;	:	O	;	_	0	SENT_93	[p7l1254t1126r1405b1211],
24	Pharsight	NNP	ORGANIZATION	Pharsight	nn	25	SENT_93	[p7l1439t1125r1827b1219],
25	Corporation	NNP	ORGANIZATION	Corporation	dep	21	SENT_93	[p7l1858t1126r2142b1219, p7l7t1253r267b1338],
26	,	,	O	,	_	0	SENT_93	[p7l1858t1126r2142b1219, p7l7t1253r267b1338],
27	Mountain	NNP	ORGANIZATION	Mountain	nn	32	SENT_93	[p7l321t1253r719b1325],
28	View	NNP	ORGANIZATION	View	nn	32	SENT_93	[p7l770t1253r1011b1339],
29	,	,	O	,	_	0	SENT_93	[p7l770t1253r1011b1339],
30	CA	NNP	O	CA	appos	32	SENT_93	[p7l1068t1254r1228b1339],
31	,	,	O	,	_	0	SENT_93	[p7l1068t1254r1228b1339],
32	USA	NNP	LOCATION	USA	appos	25	SENT_93	[p7l1283t1254r1541b1342],
33	)	CD	NUMBER	)	num	32	SENT_93	[p7l1283t1254r1541b1342],
34	.	.	O	.	_	0	SENT_93	[p7l1283t1254r1541b1342],

1	The	DT	O	the	dep	128	SENT_94	[p7l1597t1253r1753b1325],
2	pharmacokinetic	JJ	O	pharmacokinetic	dep	128	SENT_94	[p7l1804t1253r2142b1347, p7l8t1382r380b1454],
3	parameters	NNS	O	parameter	dep	128	SENT_94	[p7l419t1393r867b1476],
4	determined	VBN	O	determine	dep	128	SENT_94	[p7l909t1382r1369b1454],
5	for	IN	O	for	dep	128	SENT_94	[p7l1407t1382r1526b1454],
6	duloxetine	NN	O	duloxetine	dep	128	SENT_94	[p7l1564t1382r1994b1454],
7	included	VBD	O	include	dep	128	SENT_94	[p7l2033t1382r2142b1454, p7l8t1511r280b1583],
8	the	DT	O	the	dep	128	SENT_94	[p7l317t1511r439b1583],
9	time	NN	O	time	dep	128	SENT_94	[p7l478t1511r658b1583],
10	before	IN	O	before	dep	128	SENT_94	[p7l695t1511r956b1583],
11	the	DT	O	the	dep	128	SENT_94	[p7l995t1511r1117b1583],
12	start	NN	O	start	dep	128	SENT_94	[p7l1159t1522r1332b1583],
13	of	IN	O	of	dep	128	SENT_94	[p7l1370t1511r1458b1583],
14	drug	NN	O	drug	dep	128	SENT_94	[p7l1491t1511r1674b1605],
15	absorption	NN	O	absorption	dep	128	SENT_94	[p7l1716t1511r2146b1605],
16	(	NN	O	(	dep	128	SENT_94	[p7l11t1641r224b1739],
17	nag	NN	O	nag	dep	128	SENT_94	[p7l11t1641r224b1739],
18	)	NN	O	)	dep	128	SENT_94	[p7l11t1641r224b1739],
19	,	,	O	,	_	0	SENT_94	[p7l11t1641r224b1739],
20	maximum	NN	O	maximum	dep	128	SENT_94	[p7l288t1640r704b1712],
21	plasma	NN	O	plasma	dep	128	SENT_94	[p7l760t1640r1052b1734],
22	concentration	NN	O	concentration	dep	128	SENT_94	[p7l1111t1640r1668b1712],
23	(	CD	NUMBER	(	dep	128	SENT_94	[p7l1730t1641r2000b1729],
24	Cmax	NN	O	cmax	dep	128	SENT_94	[p7l1730t1641r2000b1729],
25	)	NN	O	)	dep	128	SENT_94	[p7l1730t1641r2000b1729],
26	or	CC	O	or	dep	128	SENT_94	[p7l2063t1663r2147b1712],
27	Cmax	NN	O	cmax	dep	128	SENT_94	[p7l9t1770r215b1851],
28	at	IN	O	at	dep	128	SENT_94	[p7l256t1780r327b1841],
29	steady	JJ	O	steady	dep	128	SENT_94	[p7l368t1769r624b1863],
30	state	NN	O	state	dep	128	SENT_94	[p7l667t1780r848b1841],
31	(	CD	NUMBER	(	dep	128	SENT_94	[p7l891t1770r1271b1862],
32	Cmams	NNS	O	cmam	dep	128	SENT_94	[p7l891t1770r1271b1862],
33	)	CD	NUMBER	)	dep	128	SENT_94	[p7l891t1770r1271b1862],
34	,	,	O	,	_	0	SENT_94	[p7l891t1770r1271b1862],
35	time	NN	O	time	dep	128	SENT_94	[p7l1313t1769r1493b1841],
36	to	TO	O	to	dep	128	SENT_94	[p7l1532t1780r1609b1841],
37	reach	VB	O	reach	dep	128	SENT_94	[p7l1648t1769r1869b1841],
38	maximum	NN	O	maximum	dep	128	SENT_94	[p7l1908t1769r2142b1841, p7l7t1921r217b1970],
39	plasma	NN	O	plasma	dep	128	SENT_94	[p7l253t1898r544b1992],
40	concentration	NN	O	concentration	dep	128	SENT_94	[p7l581t1898r1138b1970],
41	(	CD	NUMBER	(	dep	128	SENT_94	[p7l1179t1899r1409b1987],
42	tmax	NN	O	tmax	dep	128	SENT_94	[p7l1179t1899r1409b1987],
43	)	NN	O	)	dep	128	SENT_94	[p7l1179t1899r1409b1987],
44	or	CC	O	or	dep	128	SENT_94	[p7l1451t1921r1535b1970],
45	tmax	NN	O	tmax	dep	128	SENT_94	[p7l1570t1909r1738b1980],
46	at	IN	O	at	dep	128	SENT_94	[p7l1778t1909r1848b1970],
47	steady	JJ	O	steady	dep	128	SENT_94	[p7l1889t1899r2145b1992],
48	state	NN	O	state	dep	128	SENT_94	[p7l11t2038r192b2099],
49	(	NN	O	(	dep	128	SENT_94	[p7l255t2028r594b2120],
50	tmams	NNS	O	tmam	dep	128	SENT_94	[p7l255t2028r594b2120],
51	)	VBP	O	)	dep	128	SENT_94	[p7l255t2028r594b2120],
52	,	,	O	,	_	0	SENT_94	[p7l255t2028r594b2120],
53	minimum	JJ	O	minimum	dep	128	SENT_94	[p7l656t2027r1055b2099],
54	plasma	NN	O	plasma	dep	128	SENT_94	[p7l1111t2027r1402b2121],
55	concentration	NN	O	concentration	dep	128	SENT_94	[p7l1459t2027r2016b2099],
56	at	IN	O	at	dep	128	SENT_94	[p7l2075t2038r2146b2099],
57	steady	JJ	O	steady	dep	128	SENT_94	[p7l11t2156r267b2250],
58	state	NN	O	state	dep	128	SENT_94	[p7l311t2167r492b2228],
59	(	NN	O	(	dep	128	SENT_94	[p7l535t2157r901b2249],
60	Cmimss	NN	O	cmimss	dep	128	SENT_94	[p7l535t2157r901b2249],
61	)	NN	O	)	dep	128	SENT_94	[p7l535t2157r901b2249],
62	,	,	O	,	_	0	SENT_94	[p7l535t2157r901b2249],
63	average	JJ	O	average	dep	128	SENT_94	[p7l946t2179r1260b2250],
64	steady	JJ	O	steady	dep	128	SENT_94	[p7l1304t2156r1783b2250],
65	—	NN	O	—	dep	128	SENT_94	[p7l1304t2156r1783b2250],
66	state	NN	O	state	dep	128	SENT_94	[p7l1304t2156r1783b2250],
67	concentration	NN	O	concentration	dep	128	SENT_94	[p7l1823t2179r2142b2228, p7l7t2285r274b2357],
68	(	CD	NUMBER	(	dep	128	SENT_94	[p7l301t2286r616b2378],
69	Cav	NNP	O	Cav	dep	128	SENT_94	[p7l301t2286r616b2378],
70	,	,	O	,	_	0	SENT_94	[p7l301t2286r616b2378],
71	ss	VBP	O	ss	dep	128	SENT_94	[p7l301t2286r616b2378],
72	)	NN	O	)	dep	128	SENT_94	[p7l301t2286r616b2378],
73	,	,	O	,	_	0	SENT_94	[p7l301t2286r616b2378],
74	area	NN	O	area	dep	128	SENT_94	[p7l647t2308r815b2357],
75	under	IN	O	under	dep	128	SENT_94	[p7l837t2285r1070b2357],
76	the	DT	O	the	dep	128	SENT_94	[p7l1093t2285r1215b2357],
77	plasma	NN	O	plasma	dep	128	SENT_94	[p7l1239t2285r1531b2379],
78	concentrationtime	NN	O	concentrationtime	dep	128	SENT_94	[p7l1554t2285r2142b2357, p7l7t2414r187b2486],
79	curve	NN	O	curve	dep	128	SENT_94	[p7l263t2437r487b2486],
80	(	CD	NUMBER	(	dep	128	SENT_94	[p7l565t2415r842b2503],
81	AUC	NN	O	auc	dep	128	SENT_94	[p7l565t2415r842b2503],
82	)	CD	NUMBER	)	dep	128	SENT_94	[p7l565t2415r842b2503],
83	from	IN	O	from	dep	128	SENT_94	[p7l919t2414r1117b2486],
84	time	NN	O	time	dep	128	SENT_94	[p7l1190t2414r1370b2486],
85	zero	CD	NUMBER	zero	dep	128	SENT_94	[p7l1446t2437r1618b2486],
86	to	TO	O	to	dep	128	SENT_94	[p7l1694t2425r1769b2486],
87	infinity	VB	O	infinity	dep	128	SENT_94	[p7l1845t2414r2145b2508],
88	(	JJ	O	(	dep	128	SENT_94	[p7l11t2544r346b2632],
89	AUCOO	NN	O	aucoo	dep	128	SENT_94	[p7l11t2544r346b2632],
90	)	CD	NUMBER	)	dep	128	SENT_94	[p7l11t2544r346b2632],
91	or	CC	O	or	dep	128	SENT_94	[p7l401t2566r485b2615],
92	during	IN	O	during	dep	128	SENT_94	[p7l534t2543r798b2637],
93	the	DT	O	the	dep	128	SENT_94	[p7l849t2544r972b2615],
94	dosing	NN	O	dosing	dep	128	SENT_94	[p7l1024t2543r1293b2637],
95	interval	NN	O	interval	dep	128	SENT_94	[p7l1345t2543r1656b2616],
96	1	CD	NUMBER	1	dep	128	SENT_94	[p7l1707t2562r1749b2616],
97	:	:	O	:	_	0	SENT_94	[p7l1707t2562r1749b2616],
98	(	CD	NUMBER	(	dep	128	SENT_94	[p7l1803t2544r2141b2632],
99	AUCT	NN	O	auct	dep	128	SENT_94	[p7l1803t2544r2141b2632],
100	)	NN	O	)	dep	128	SENT_94	[p7l1803t2544r2141b2632],
101	,	,	O	,	_	0	SENT_94	[p7l1803t2544r2141b2632],
102	apparent	JJ	O	apparent	dep	128	SENT_94	[p7l10t2683r360b2766],
103	oral	JJ	O	oral	dep	128	SENT_94	[p7l393t2672r548b2744],
104	clearance	NN	O	clearance	dep	128	SENT_94	[p7l582t2672r966b2744],
105	(	CD	NUMBER	(	dep	128	SENT_94	[p7l1002t2673r1304b2761],
106	CL/F	NN	O	cl/f	dep	128	SENT_94	[p7l1002t2673r1304b2761],
107	)	NN	O	)	dep	128	SENT_94	[p7l1002t2673r1304b2761],
108	,	,	O	,	_	0	SENT_94	[p7l1002t2673r1304b2761],
109	apparent	JJ	O	apparent	dep	128	SENT_94	[p7l1342t2683r1693b2766],
110	volume	NN	O	volume	dep	128	SENT_94	[p7l1724t2672r2029b2745],
111	of	IN	O	of	dep	128	SENT_94	[p7l2063t2672r2152b2744],
112	distribution	NN	O	distribution	dep	128	SENT_94	[p7l9t2801r480b2873],
113	at	IN	O	at	dep	128	SENT_94	[p7l539t2812r610b2873],
114	steady	JJ	O	steady	dep	128	SENT_94	[p7l670t2801r926b2895],
115	state	NN	O	state	dep	128	SENT_94	[p7l988t2812r1169b2873],
116	(	CD	NUMBER	(	dep	128	SENT_94	[p7l1231t2802r1540b2890],
117	V35/F	NN	O	v35/f	dep	128	SENT_94	[p7l1231t2802r1540b2890],
118	)	NN	O	)	dep	128	SENT_94	[p7l1231t2802r1540b2890],
119	,	,	O	,	_	0	SENT_94	[p7l1231t2802r1540b2890],
120	and	CC	O	and	dep	128	SENT_94	[p7l1603t2801r1748b2873],
121	terminal	JJ	O	terminal	dep	128	SENT_94	[p7l1805t2801r2145b2873],
122	elimination	NN	O	elimination	dep	128	SENT_94	[p7l8t2931r474b3003],
123	half	NN	O	half	dep	128	SENT_94	[p7l526t2931r854b3003],
124	—	CD	NUMBER	—	dep	128	SENT_94	[p7l526t2931r854b3003],
125	life	NN	O	life	dep	128	SENT_94	[p7l526t2931r854b3003],
126	(	CD	NUMBER	(	dep	128	SENT_94	[p7l911t2932r1086b3020],
127	t1/2	NN	O	t1/2	dep	128	SENT_94	[p7l911t2932r1086b3020],
128	)	NN	O	)	_	0	SENT_94	[p7l911t2932r1086b3020],
129	.	.	O	.	_	0	SENT_94	[p7l911t2932r1086b3020],

1	The	DT	O	the	det	3	SENT_95	[p7l1144t2931r1301b3003],
2	accumulation	NN	O	accumulation	nn	3	SENT_95	[p7l1357t2931r1906b3003],
3	ratio	NN	O	ratio	nsubjpass	5	SENT_95	[p7l1958t2931r2144b3003],
4	was	VBD	O	be	auxpass	5	SENT_95	[p7l8t3082r163b3131],
5	calculated	VBN	O	calculate	_	0	SENT_95	[p7l208t3059r623b3131],
6	as	IN	O	as	_	0	SENT_95	[p7l667t3082r745b3131],
7	the	DT	O	the	det	8	SENT_95	[p7l791t3059r913b3131],
8	ratio	NN	O	ratio	prep_as	5	SENT_95	[p7l955t3059r1141b3131],
9	of	IN	O	of	_	0	SENT_95	[p7l1186t3059r1275b3131],
10	the	DT	O	the	det	11	SENT_95	[p7l1311t3059r1433b3131],
11	AUCT	NN	O	auct	prep_of	8	SENT_95	[p7l1477t3060r1727b3142],
12	at	IN	O	at	_	0	SENT_95	[p7l1773t3070r1843b3131],
13	steady	JJ	O	steady	amod	14	SENT_95	[p7l1888t3059r2144b3153],
14	state	NN	O	state	prep_at	5	SENT_95	[p7l11t3199r192b3260],
15	(	CD	NUMBER	(	num	17	SENT_95	[p7l253t3189r651b3281],
16	AUC	NN	O	auc	nn	17	SENT_95	[p7l253t3189r651b3281],
17	¢	NN	O	¢	dep	14	SENT_95	[p7l253t3189r651b3281],
18	,	,	O	,	_	0	SENT_95	[p7l253t3189r651b3281],
19	sS	NN	O	ss	appos	14	SENT_95	[p7l253t3189r651b3281],
20	)	CD	NUMBER	)	num	19	SENT_95	[p7l253t3189r651b3281],
21	to	TO	O	to	_	0	SENT_95	[p7l711t3199r786b3260],
22	the	DT	O	the	det	23	SENT_95	[p7l844t3188r967b3260],
23	AUCT	NN	O	auct	prep_to	19	SENT_95	[p7l1024t3189r1274b3271],
24	after	IN	O	after	_	0	SENT_95	[p7l1333t3188r1519b3260],
25	single	JJ	O	single	amod	28	SENT_95	[p7l1577t3188r1816b3282],
26	dosing	NN	O	dosing	nn	28	SENT_95	[p7l1874t3188r2144b3282],
27	(	CD	NUMBER	(	num	28	SENT_95	[p7l11t3318r510b3416],
28	AUCq	NN	O	aucq	prep_after	23	SENT_95	[p7l11t3318r510b3416],
29	;	:	O	;	_	0	SENT_95	[p7l11t3318r510b3416],
30	,	,	O	,	_	0	SENT_95	[p7l11t3318r510b3416],
31	s1ng1e	NN	O	s1ng1e	appos	14	SENT_95	[p7l11t3318r510b3416],
32	(	CD	NUMBER	(	number	33	SENT_95	[p7l533t3318r736b3406],
33	1036	CD	DATE	1036	num	34	SENT_95	[p7l533t3318r736b3406],
34	)	NN	O	)	dep	31	SENT_95	[p7l533t3318r736b3406],
35	,	,	O	,	_	0	SENT_95	[p7l533t3318r736b3406],
36	and	CC	O	and	_	0	SENT_95	[p7l770t3317r914b3389],
37	the	DT	O	the	det	39	SENT_95	[p7l940t3317r1063b3389],
38	linearity	NN	O	linearity	nn	39	SENT_95	[p7l1091t3317r1431b3411],
39	index	NN	O	index	nsubjpass	41	SENT_95	[p7l1459t3317r1684b3389],
40	was	VBD	O	be	auxpass	41	SENT_95	[p7l1712t3340r1867b3390],
41	calculated	VBN	O	calculate	conj_and	5	SENT_95	[p7l1897t3317r2142b3389, p7l8t3446r206b3518],
42	as	IN	O	as	_	0	SENT_95	[p7l240t3469r319b3518],
43	the	DT	O	the	det	44	SENT_95	[p7l355t3446r478b3518],
44	ratio	NN	O	ratio	prep_as	41	SENT_95	[p7l511t3446r696b3518],
45	of	IN	O	of	_	0	SENT_95	[p7l733t3446r821b3518],
46	the	DT	O	the	det	47	SENT_95	[p7l848t3446r970b3518],
47	AUCI	NN	O	aucus	prep_of	44	SENT_95	[p7l1005t3447r1861b3545],
48	,	,	O	,	_	0	SENT_95	[p7l1005t3447r1861b3545],
49	ss/AUCw	NN	O	ss/aucw	nn	53	SENT_95	[p7l1005t3447r1861b3545],
50	,	,	O	,	_	0	SENT_95	[p7l1005t3447r1861b3545],
51	sing1e	NN	O	sing1e	dep	53	SENT_95	[p7l1005t3447r1861b3545],
52	dose	NN	O	dose	nn	53	SENT_95	[p7l1889t3471r2053b3528],
53	_	NN	O	_	appos	47	SENT_95	[p7l1889t3471r2053b3528],

1	S’ro	FW	O	s’ro	nn	6	SENT_96	[p8l132t99r542b171],
2	’	FW	O	’	nn	6	SENT_96	[p8l132t99r542b171],
3	ris	FW	O	ris	nn	6	SENT_96	[p8l132t99r542b171],
4	’	FW	O	’	nn	6	SENT_96	[p8l132t99r542b171],
5	rico	FW	O	rico	nn	6	SENT_96	[p8l132t99r542b171],
6	|	FW	O	|	_	0	SENT_96	[p8l132t99r542b171],
7	Analysis	NN	O	analysis	dep	6	SENT_96	[p8l577t100r920b187],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_97	[p8l131t348r818b420],
2	parameters	NNS	O	parameter	nsubjpass	10	SENT_97	[p8l861t359r1309b441],
3	obtained	VBN	O	obtain	partmod	2	SENT_97	[p8l1355t348r1706b420],
4	following	VBG	O	follow	_	0	SENT_97	[p8l1748t348r2144b441],
5	single	JJ	O	single	amod	8	SENT_97	[p8l11t476r250b569],
6	and	CC	O	and	_	0	SENT_97	[p8l280t476r424b548],
7	multiple	JJ	O	multiple	amod	8	SENT_97	[p8l450t476r790b569],
8	dosing	NN	O	dosing	prep_following	3	SENT_97	[p8l818t476r1088b569],
9	were	VBD	O	be	auxpass	10	SENT_97	[p8l1116t498r1312b548],
10	evaluated	VBN	O	evaluate	_	0	SENT_97	[p8l1341t476r1732b548],
11	for	IN	O	for	_	0	SENT_97	[p8l1758t476r1877b548],
12	statistical	JJ	O	statistical	amod	13	SENT_97	[p8l1905t476r2142b548, p8l7t604r181b676],
13	difference	NN	O	difference	prep_for	10	SENT_97	[p8l212t604r625b676],
14	using	VBG	O	use	xcomp	10	SENT_97	[p8l654t604r874b697],
15	a	DT	O	a	det	17	SENT_97	[p8l907t626r949b676],
16	mixed-effect	JJ	O	mixed-effect	amod	17	SENT_97	[p8l976t604r1501b676],
17	model	NN	O	model	nn	25	SENT_97	[p8l1529t604r1783b676],
18	with	IN	O	with	_	0	SENT_97	[p8l1813t604r1993b676],
19	the	DT	O	the	det	21	SENT_97	[p8l2022t604r2144b676],
20	dose	NN	O	dose	nn	21	SENT_97	[p8l9t732r192b804],
21	(	NN	O	(	prep_with	17	SENT_97	[p8l239t732r512b825],
22	single	JJ	O	single	amod	25	SENT_97	[p8l239t732r512b825],
23	or	CC	O	or	_	0	SENT_97	[p8l557t754r641b804],
24	multiple	JJ	O	multiple	amod	25	SENT_97	[p8l681t732r1053b825],
25	)	NN	O	)	dobj	14	SENT_97	[p8l681t732r1053b825],
26	as	IN	O	as	_	0	SENT_97	[p8l1100t754r1179b804],
27	a	DT	O	a	det	29	SENT_97	[p8l1226t754r1268b804],
28	fixed	JJ	O	fixed	amod	29	SENT_97	[p8l1309t732r1518b804],
29	effect	NN	O	effect	prep_as	14	SENT_97	[p8l1561t732r1793b804],
30	and	CC	O	and	_	0	SENT_97	[p8l1836t732r1981b804],
31	the	DT	O	the	det	32	SENT_97	[p8l2022t732r2145b804],
32	subject	NN	O	subject	prep_as	14	SENT_97	[p8l11t860r298b953],
33	as	IN	O	as	_	0	SENT_97	[p8l351t882r429b932],
34	a	DT	O	a	det	36	SENT_97	[p8l486t882r528b932],
35	random	JJ	O	random	amod	36	SENT_97	[p8l579t860r893b932],
36	effect	NN	O	effect	prep_as	14	SENT_97	[p8l945t860r1196b932],
37	.	.	O	.	_	0	SENT_97	[p8l945t860r1196b932],

1	The	DT	O	the	det	4	SENT_98	[p8l1254t860r1410b932],
2	geometric	JJ	O	geometric	amod	4	SENT_98	[p8l1465t860r1871b953],
3	mean	JJ	O	mean	amod	4	SENT_98	[p8l1925t882r2145b932],
4	ratios	NNS	O	ratio	nsubj	5	SENT_98	[p8l7t988r231b1060],
5	(	VBP	O	(	_	0	SENT_98	[p8l271t988r484b1077],
6	90	CD	PERCENT	90	num	9	SENT_98	[p8l271t988r484b1077],
7	%	NN	PERCENT	%	nn	9	SENT_98	[p8l271t988r484b1077],
8	confidence	NN	O	confidence	nn	9	SENT_98	[p8l524t988r971b1060],
9	interval	NN	O	interval	nsubjpass	27	SENT_98	[p8l1007t988r1317b1060],
10	[	CD	NUMBER	[	num	11	SENT_98	[p8l1360t988r1553b1076],
11	CI	NN	O	ci	dep	9	SENT_98	[p8l1360t988r1553b1076],
12	]	CD	NUMBER	]	num	13	SENT_98	[p8l1360t988r1553b1076],
13	)	NN	O	)	dep	9	SENT_98	[p8l1360t988r1553b1076],
14	of	IN	O	of	_	0	SENT_98	[p8l1592t988r1680b1060],
15	the	DT	O	the	det	16	SENT_98	[p8l1709t988r1831b1060],
16	Cmmss	NN	MISC	cmmss	prep_of	13	SENT_98	[p8l1868t988r2143b1081],
17	on	IN	O	on	_	0	SENT_98	[p8l9t1138r108b1188],
18	day	NN	DURATION	day	prep_on	16	SENT_98	[p8l137t1116r281b1209],
19	9	CD	NUMBER	9	num	18	SENT_98	[p8l312t1116r357b1189],
20	versus	CC	O	versus	prep	18	SENT_98	[p8l388t1138r645b1188],
21	day	NN	DURATION	day	dep	20	SENT_98	[p8l677t1116r821b1209],
22	7	CD	NUMBER	7	num	21	SENT_98	[p8l851t1118r895b1188],
23	and	CC	O	and	_	0	SENT_98	[p8l930t1116r1074b1188],
24	day	NN	DURATION	day	dep	20	SENT_98	[p8l1103t1116r1247b1209],
25	8	CD	NUMBER	8	num	24	SENT_98	[p8l1280t1116r1321b1188],
26	were	VBD	O	be	auxpass	27	SENT_98	[p8l1354t1138r1550b1188],
27	determined	VBN	O	determine	ccomp	5	SENT_98	[p8l1580t1116r2040b1188],
28	to	TO	O	to	aux	29	SENT_98	[p8l2067t1127r2143b1188],
29	assess	VB	O	assess	xcomp	27	SENT_98	[p8l10t1266r254b1316],
30	the	DT	O	the	det	31	SENT_98	[p8l287t1244r410b1316],
31	attainment	NN	O	attainment	dobj	29	SENT_98	[p8l443t1244r874b1316],
32	of	IN	O	of	_	0	SENT_98	[p8l905t1244r994b1316],
33	steady	JJ	O	steady	amod	34	SENT_98	[p8l1021t1244r1277b1337],
34	state	NN	O	state	prep_of	31	SENT_98	[p8l1312t1255r1494b1316],
35	following	VBG	O	follow	_	0	SENT_98	[p8l1526t1244r1921b1337],
36	multiple	JJ	O	multiple	amod	37	SENT_98	[p8l1953t1244r2142b1316, p8l7t1372r187b1465],
37	dosing	NN	O	dosing	prep_following	34	SENT_98	[p8l227t1372r517b1465],
38	.	.	O	.	_	0	SENT_98	[p8l227t1372r517b1465],

1	Vital	JJ	O	vital	amod	2	SENT_99	[p8l560t1372r763b1444],
2	signs	NNS	O	sign	nsubjpass	17	SENT_99	[p8l805t1372r1007b1465],
3	collected	VBN	O	collect	partmod	2	SENT_99	[p8l1049t1372r1417b1444],
4	on	IN	O	on	_	0	SENT_99	[p8l1455t1394r1554b1444],
5	day	NN	DURATION	day	prep_on	3	SENT_99	[p8l1593t1372r1736b1465],
6	1	CD	NUMBER	1	num	5	SENT_99	[p8l1785t1372r1846b1457],
7	,	,	O	,	_	0	SENT_99	[p8l1785t1372r1846b1457],
8	day	NN	DURATION	day	prep_on	3	SENT_99	[p8l1889t1372r2032b1465],
9	2	CD	NUMBER	2	num	8	SENT_99	[p8l2073t1372r2141b1457],
10	,	,	O	,	_	0	SENT_99	[p8l2073t1372r2141b1457],
11	day	NN	DURATION	day	conj_and	5	SENT_99	[p8l9t1500r153b1593],
12	9	CD	NUMBER	9	num	11	SENT_99	[p8l185t1500r230b1573],
13	and	CC	O	and	_	0	SENT_99	[p8l265t1500r409b1572],
14	day	NN	DURATION	day	prep_on	3	SENT_99	[p8l440t1500r584b1593],
15	10	CD	NUMBER	10	num	14	SENT_99	[p8l625t1500r715b1572],
16	were	VBD	O	be	auxpass	17	SENT_99	[p8l746t1522r942b1572],
17	summarised	VBN	O	summarise	_	0	SENT_99	[p8l976t1500r1468b1572],
18	with	IN	O	with	_	0	SENT_99	[p8l1499t1500r1678b1572],
19	means	NNS	O	means	prep_with	17	SENT_99	[p8l1709t1522r1966b1572],
20	and	CC	O	and	_	0	SENT_99	[p8l2001t1500r2146b1572],
21	standard	JJ	O	standard	amod	22	SENT_99	[p8l11t1627r354b1699],
22	deviations	NNS	O	deviation	conj_and	19	SENT_99	[p8l388t1627r827b1699],
23	.	.	O	.	_	0	SENT_99	[p8l388t1627r827b1699],

1	In	IN	O	in	_	0	SENT_100	[p8l131t1758r214b1827],
2	addition	NN	O	addition	prep_in	23	SENT_100	[p8l245t1756r599b1841],
3	,	,	O	,	_	0	SENT_100	[p8l245t1756r599b1841],
4	an	DT	O	a	det	5	SENT_100	[p8l634t1779r726b1828],
5	ANOVA	NNP	ORGANIZATION	ANOVA	nsubjpass	23	SENT_100	[p8l755t1757r1146b1841],
6	,	,	O	,	_	0	SENT_100	[p8l755t1757r1146b1841],
7	with	IN	O	with	_	0	SENT_100	[p8l1179t1756r1358b1828],
8	ethnic	JJ	O	ethnic	amod	9	SENT_100	[p8l1388t1756r1634b1828],
9	group	NN	O	group	prep_with	5	SENT_100	[p8l1666t1779r1900b1849],
10	(	CD	NUMBER	(	npadvmod	11	SENT_100	[p8l1934t1756r2142b1845, p8l8t1907r210b1970],
11	Chinese	JJ	MISC	chinese	amod	9	SENT_100	[p8l1934t1756r2142b1845, p8l8t1907r210b1970],
12	,	,	O	,	_	0	SENT_100	[p8l1934t1756r2142b1845, p8l8t1907r210b1970],
13	Caucasian	JJ	MISC	caucasian	amod	16	SENT_100	[p8l241t1884r682b1969],
14	,	,	O	,	_	0	SENT_100	[p8l241t1884r682b1969],
15	Japanese	JJ	MISC	japanese	amod	16	SENT_100	[p8l712t1885r1106b1977],
16	)	NN	O	)	appos	5	SENT_100	[p8l712t1885r1106b1977],
17	as	IN	O	as	_	0	SENT_100	[p8l1138t1907r1217b1956],
18	a	DT	O	a	det	20	SENT_100	[p8l1248t1907r1290b1956],
19	categorical	JJ	O	categorical	amod	20	SENT_100	[p8l1316t1884r1763b1977],
20	variable	NN	O	variable	prep_as	16	SENT_100	[p8l1791t1884r2141b1969],
21	,	,	O	,	_	0	SENT_100	[p8l1791t1884r2141b1969],
22	was	VBD	O	be	auxpass	23	SENT_100	[p8l8t2035r163b2084],
23	performed	VBN	O	perform	_	0	SENT_100	[p8l207t2012r635b2105],
24	on	IN	O	on	_	0	SENT_100	[p8l679t2035r778b2084],
25	the	DT	O	the	det	28	SENT_100	[p8l821t2012r943b2084],
26	duloxetine	NN	O	duloxetine	nn	28	SENT_100	[p8l988t2012r1418b2084],
27	pharmacokinetic	JJ	O	pharmacokinetic	amod	28	SENT_100	[p8l1461t2012r2143b2105],
28	parameters	NNS	O	parameter	prep_on	23	SENT_100	[p8l7t2151r454b2233],
29	to	TO	O	to	aux	30	SENT_100	[p8l517t2151r593b2212],
30	evaluate	VB	O	evaluate	xcomp	23	SENT_100	[p8l655t2140r994b2212],
31	statistical	JJ	O	statistical	amod	32	SENT_100	[p8l1059t2140r1441b2212],
32	differences	NNS	O	difference	dobj	30	SENT_100	[p8l1502t2140r1953b2212],
33	be	VB	O	be	dep	30	SENT_100	[p8l2015t2140r2142b2212, p8l9t2423r52b2467],
34	©	IN	O	©	prep	33	SENT_100	[p8l2015t2140r2142b2212, p8l9t2423r52b2467],

1	2007	CD	DATE	2007	_	0	SENT_101	[p8l75t2418r207b2467],
2	Adis	NNP	ORGANIZATION	Adis	nn	4	SENT_101	[p8l229t2419r352b2467],
3	Data	NNP	ORGANIZATION	Data	nn	4	SENT_101	[p8l376t2419r520b2467],
4	Information	NNP	ORGANIZATION	Information	dep	1	SENT_101	[p8l546t2419r879b2467],
5	BV	NN	ORGANIZATION	bv	dep	4	SENT_101	[p8l906t2419r991b2466],
6	.	.	O	.	_	0	SENT_101	[p8l906t2419r991b2466],

1	All	DT	O	all	det	2	SENT_102	[p8l1017t2419r1083b2466],
2	rights	NNS	O	rights	nsubj	3	SENT_102	[p8l1108t2419r1258b2479],
3	reserved	VBN	O	reserve	_	0	SENT_102	[p8l1281t2419r1547b2467],
4	.	.	O	.	_	0	SENT_102	[p8l1281t2419r1547b2467],

1	tween	JJ	O	tween	amod	3	SENT_103	[p8l16t2675r259b2736],
2	Chinese	JJ	MISC	chinese	amod	3	SENT_103	[p8l288t2664r614b2736],
3	subjects	NNS	O	subject	nsubj	7	SENT_103	[p8l647t2664r969b2757],
4	and	CC	O	and	_	0	SENT_103	[p8l1002t2664r1146b2736],
5	those	DT	O	those	conj_and	3	SENT_103	[p8l1173t2664r1386b2736],
6	previously	RB	DATE	previously	advmod	7	SENT_103	[p8l1414t2664r1846b2757],
7	reported	VBN	O	report	_	0	SENT_103	[p8l1873t2675r2148b2757, p8l17t2793r111b2864],
8	in	IN	O	in	_	0	SENT_103	[p8l144t2793r222b2863],
9	Caucasian	JJ	LOCATION	caucasian	amod	12	SENT_103	[p8l256t2793r674b2864],
10	and	CC	O	and	_	0	SENT_103	[p8l710t2793r854b2864],
11	Japanese	JJ	MISC	japanese	amod	12	SENT_103	[p8l886t2795r1249b2885],
12	subjects	NNS	O	subject	prep_in	7	SENT_103	[p8l1287t2783r1746b2885],
13	.	.	O	.	_	0	SENT_103	[p8l1287t2783r1746b2885],

1	[	NN	O	[	_	0	SENT_104	[p8l1287t2783r1746b2885],
2	15	CD	NUMBER	15	num	3	SENT_104	[p8l1287t2783r1746b2885],
3	]	NN	O	]	dep	1	SENT_104	[p8l1287t2783r1746b2885],

1	Safety	NN	O	safety	_	0	SENT_105	[p8l140t3046r417b3134],
2	and	CC	O	and	_	0	SENT_105	[p8l449t3046r623b3117],
3	Tolerobility	NN	MISC	tolerobility	nn	4	SENT_105	[p8l657t3046r1125b3134],
4	Evoluotions	NNS	MISC	evoluotion	conj_and	1	SENT_105	[p8l1159t3046r1655b3117],

1	Safety	NNP	O	Safety	nn	2	SENT_106	[p8l142t3263r398b3357],
2	data	NNS	O	datum	nsubj	3	SENT_106	[p8l439t3263r608b3335],
3	collected	VBN	O	collect	_	0	SENT_106	[p8l646t3263r1014b3335],
4	in	IN	O	in	_	0	SENT_106	[p8l1051t3263r1128b3335],
5	the	DT	O	the	det	6	SENT_106	[p8l1166t3263r1289b3335],
6	form	NN	O	form	prep_in	3	SENT_106	[p8l1328t3263r1526b3335],
7	of	IN	O	of	_	0	SENT_106	[p8l1565t3263r1652b3335],
8	clinical	JJ	O	clinical	amod	9	SENT_106	[p8l1685t3263r1984b3335],
9	examinations	NNS	O	examination	prep_of	6	SENT_106	[p8l2023t3286r2148b3335, p8l18t3391r486b3476],
10	,	,	O	,	_	0	SENT_106	[p8l2023t3286r2148b3335, p8l18t3391r486b3476],
11	clinical	JJ	O	clinical	amod	13	SENT_106	[p8l550t3391r848b3463],
12	laboratory	NN	O	laboratory	nn	13	SENT_106	[p8l908t3391r1327b3485],
13	testing	NN	O	testing	conj_and	9	SENT_106	[p8l1387t3391r1680b3485],
14	,	,	O	,	_	0	SENT_106	[p8l1387t3391r1680b3485],
15	vital	JJ	O	vital	amod	19	SENT_106	[p8l1743t3391r1923b3464],
16	sign	NN	O	sign	nn	19	SENT_106	[p8l1986t3391r2151b3485],
17	(	NN	O	(	nn	19	SENT_106	[p8l19t3519r253b3613],
18	body	NN	O	body	nn	19	SENT_106	[p8l19t3519r253b3613],
19	temperature	NN	O	temperature	conj_and	9	SENT_106	[p8l284t3530r794b3613],
20	,	,	O	,	_	0	SENT_106	[p8l284t3530r794b3613],
21	supine	NN	O	supine	nn	23	SENT_106	[p8l833t3519r1095b3613],
22	blood	NN	O	blood	nn	23	SENT_106	[p8l1125t3519r1359b3591],
23	pressure	NN	O	pressure	prep_of	6	SENT_106	[p8l1388t3542r1728b3613],
24	and	CC	O	and	_	0	SENT_106	[p8l1762t3519r1907b3591],
25	pulse	NN	O	pulse	nn	26	SENT_106	[p8l1936t3519r2151b3613],
26	rate	NN	O	rate	prep_of	6	SENT_106	[p8l15t3648r198b3736],
27	)	CD	NUMBER	)	num	28	SENT_106	[p8l15t3648r198b3736],
28	measurements	NNS	O	measurement	dep	26	SENT_106	[p8l231t3658r815b3719],
29	and	CC	O	and	_	0	SENT_106	[p8l849t3647r993b3719],
30	adverse	JJ	O	adverse	amod	32	SENT_106	[p8l1024t3647r1333b3720],
31	event	NN	O	event	nn	32	SENT_106	[p8l1364t3658r1585b3720],
32	profiles	NNS	O	profile	nsubjpass	34	SENT_106	[p8l1612t3647r1921b3741],
33	were	VBD	O	be	auxpass	34	SENT_106	[p8l1954t3670r2151b3720],
34	monitored	VBN	O	monitor	conj_and	3	SENT_106	[p9l17t24r436b96],
35	throughout	IN	O	throughout	_	0	SENT_106	[p9l469t24r919b118],
36	the	DT	O	the	det	37	SENT_106	[p9l951t24r1074b96],
37	study	NN	O	study	prep_throughout	34	SENT_106	[p9l1111t24r1348b118],
38	.	.	O	.	_	0	SENT_106	[p9l1111t24r1348b118],

1	Results	NNS	O	result	_	0	SENT_107	[p9l145t272r469b350],

1	Demographics	NNS	MISC	demographic	_	0	SENT_108	[p9l145t535r799b624],

1	A	DT	O	a	det	2	SENT_109	[p9l139t753r211b823],
2	total	NN	O	total	nsubj	6	SENT_109	[p9l259t752r439b824],
3	of	IN	O	of	_	0	SENT_109	[p9l489t752r577b824],
4	24	CD	NUMBER	24	num	5	SENT_109	[p9l620t752r718b823],
5	subjects	NNS	O	subject	prep_of	2	SENT_109	[p9l770t752r1093b845],
6	received	VBD	O	receive	_	0	SENT_109	[p9l1143t752r1490b824],
7	duloxetine	NN	O	duloxetine	iobj	6	SENT_109	[p9l1539t752r1968b824],
8	(	CD	NUMBER	(	number	9	SENT_109	[p9l2020t752r2150b841],
9	14	CD	NUMBER	14	num	10	SENT_109	[p9l2020t752r2150b841],
10	men	NNS	O	man	dobj	6	SENT_109	[p9l16t903r212b965],
11	,	,	O	,	_	0	SENT_109	[p9l16t903r212b965],
12	10	CD	NUMBER	10	num	13	SENT_109	[p9l261t881r350b952],
13	women	NNS	O	woman	dobj	6	SENT_109	[p9l386t881r716b969],
14	)	CD	NUMBER	)	num	17	SENT_109	[p9l386t881r716b969],
15	and	CC	O	and	_	0	SENT_109	[p9l757t880r900b952],
16	8	CD	NUMBER	8	num	17	SENT_109	[p9l939t881r979b952],
17	subjects	NNS	O	subject	nsubj	24	SENT_109	[p9l1022t880r1344b973],
18	(	JJ	O	(	amod	17	SENT_109	[p9l1384t880r1459b969],
19	5	CD	NUMBER	5	num	20	SENT_109	[p9l1384t880r1459b969],
20	men	NNS	O	man	tmod	18	SENT_109	[p9l1499t903r1694b965],
21	,	,	O	,	_	0	SENT_109	[p9l1499t903r1694b965],
22	3	CD	NUMBER	3	num	23	SENT_109	[p9l1736t881r1777b952],
23	women	NNS	O	woman	appos	20	SENT_109	[p9l1817t881r2148b969],
24	)	VBP	O	)	rcmod	13	SENT_109	[p9l1817t881r2148b969],
25	received	VBN	O	receive	dep	24	SENT_109	[p9l15t1008r362b1080],
26	placebo	NN	O	placebo	nn	27	SENT_109	[p9l393t1008r710b1101],
27	treatment	NN	O	treatment	dobj	25	SENT_109	[p9l743t1019r1149b1080],
28	.	.	O	.	_	0	SENT_109	[p9l743t1019r1149b1080],

1	Two	CD	NUMBER	two	num	3	SENT_110	[p9l1188t1010r1372b1080],
2	duloxetine	NN	O	duloxetine	nn	3	SENT_110	[p9l1407t1008r2152b1080],
3	—	NN	O	—	nsubj	5	SENT_110	[p9l1407t1008r2152b1080],
4	treated	JJ	O	treated	amod	5	SENT_110	[p9l1407t1008r2152b1080],
5	subjects	NNS	O	subject	_	0	SENT_110	[p9l20t1136r342b1229],
6	discontinued	VBN	O	discontinue	partmod	5	SENT_110	[p9l373t1136r895b1208],
7	after	IN	O	after	_	0	SENT_110	[p9l923t1136r1109b1208],
8	single	JJ	O	single	amod	9	SENT_110	[p9l1138t1136r1376b1229],
9	dosing	NN	O	dosing	prep_after	6	SENT_110	[p9l1405t1136r1697b1229],
10	,	,	O	,	_	0	SENT_110	[p9l1405t1136r1697b1229],
11	one	CD	NUMBER	one	dobj	5	SENT_110	[p9l1730t1159r1873b1208],
12	due	JJ	O	due	_	0	SENT_110	[p9l1902t1136r2046b1208],
13	to	TO	O	to	_	0	SENT_110	[p9l2074t1147r2150b1208],
14	an	DT	O	a	det	16	SENT_110	[p9l18t1287r111b1336],
15	adverse	JJ	O	adverse	amod	16	SENT_110	[p9l150t1264r459b1336],
16	event	NN	O	event	prep_due_to	11	SENT_110	[p9l498t1275r719b1336],
17	and	CC	O	and	_	0	SENT_110	[p9l757t1264r901b1336],
18	another	DT	O	another	prep_due_to	11	SENT_110	[p9l940t1264r1245b1336],
19	for	IN	O	for	_	0	SENT_110	[p9l1282t1264r1401b1336],
20	personal	JJ	O	personal	amod	21	SENT_110	[p9l1435t1264r1782b1357],
21	reasons	NNS	O	reason	prep_for	18	SENT_110	[p9l1819t1287r2146b1336],
22	.	.	O	.	_	0	SENT_110	[p9l1819t1287r2146b1336],

1	The	DT	O	the	det	3	SENT_111	[p9l17t1392r173b1464],
2	average	JJ	O	average	amod	3	SENT_111	[p9l217t1415r530b1485],
3	age	NN	O	age	nsubj	18	SENT_111	[p9l574t1415r734b1485],
4	,	,	O	,	_	0	SENT_111	[p9l574t1415r734b1485],
5	screening	VBG	O	screen	dep	18	SENT_111	[p9l782t1392r1168b1485],
6	bodyweight	NN	O	bodyweight	dobj	5	SENT_111	[p9l1209t1392r1715b1485],
7	,	,	O	,	_	0	SENT_111	[p9l1209t1392r1715b1485],
8	screening	VBG	O	screen	dep	5	SENT_111	[p9l1763t1392r2149b1485],
9	height	NN	O	height	nn	13	SENT_111	[p9l15t1520r272b1613],
10	and	CC	O	and	_	0	SENT_111	[p9l314t1520r458b1592],
11	body	NN	O	body	conj_and	9	SENT_111	[p9l498t1520r701b1613],
12	mass	NN	O	mass	nn	13	SENT_111	[p9l743t1543r944b1592],
13	index	NN	O	index	dobj	8	SENT_111	[p9l988t1520r1213b1592],
14	were	VBD	O	be	cop	18	SENT_111	[p9l1256t1543r1451b1592],
15	26	CD	DURATION	26	num	16	SENT_111	[p9l1495t1520r1592b1592],
16	years	NNS	NUMBER	year	tmod	17	SENT_111	[p9l1635t1543r1847b1613],
17	(	JJ	O	(	amod	18	SENT_111	[p9l1894t1521r2150b1613],
18	range	NN	O	range	_	0	SENT_111	[p9l1894t1521r2150b1613],
19	20-39	CD	NUMBER	20-39	num	20	SENT_111	[p9l18t1648r268b1721],
20	years	NNS	NUMBER	year	tmod	21	SENT_111	[p9l302t1649r572b1741],
21	)	RB	O	)	amod	18	SENT_111	[p9l302t1649r572b1741],
22	,	,	O	,	_	0	SENT_111	[p9l302t1649r572b1741],
23	61kg	JJ	O	61kg	amod	25	SENT_111	[p9l610t1648r809b1741],
24	(	NN	O	(	nn	25	SENT_111	[p9l846t1649r1101b1741],
25	range	NN	O	range	dep	37	SENT_111	[p9l846t1649r1101b1741],
26	47	CD	NUMBER	47	number	27	SENT_111	[p9l1133t1648r1547b1741],
27	—	CD	NUMBER	—	num	29	SENT_111	[p9l1133t1648r1547b1741],
28	86kg	JJ	O	86kg	amod	29	SENT_111	[p9l1133t1648r1547b1741],
29	)	NN	O	)	dep	25	SENT_111	[p9l1133t1648r1547b1741],
30	,	,	O	,	_	0	SENT_111	[p9l1133t1648r1547b1741],
31	165cm	NN	O	165cm	nn	32	SENT_111	[p9l1592t1648r1861b1720],
32	(	NN	O	(	appos	29	SENT_111	[p9l1894t1649r2150b1741],
33	range	NN	O	range	dep	37	SENT_111	[p9l1894t1649r2150b1741],
34	152	CD	NUMBER	152	num	33	SENT_111	[p9l26t1776r530b1865],
35	—	CD	NUMBER	—	num	37	SENT_111	[p9l26t1776r530b1865],
36	181cm	NN	O	181cm	nn	37	SENT_111	[p9l26t1776r530b1865],
37	)	NN	O	)	dep	42	SENT_111	[p9l26t1776r530b1865],
38	and	CC	O	and	_	0	SENT_111	[p9l577t1776r721b1848],
39	22.4	CD	NUMBER	22.4	num	41	SENT_111	[p9l763t1777r938b1848],
40	kg/m3	NN	O	kg/m3	nn	41	SENT_111	[p9l979t1770r1229b1869],
41	(	NN	O	(	conj_and	37	SENT_111	[p9l1275t1777r1530b1869],
42	range	NN	O	range	dep	45	SENT_111	[p9l1275t1777r1530b1869],
43	19.5-26	CD	NUMBER	19.5-26	num	42	SENT_111	[p9l1582t1776r1977b1849],
44	.8	CD	NUMBER	.8	num	45	SENT_111	[p9l1582t1776r1977b1849],
45	kg	NN	O	kg	dep	48	SENT_111	[p9l2021t1776r2153b1869],
46	/	:	O	/	punct	48	SENT_111	[p9l2021t1776r2153b1869],
47	m2	NN	O	m2	nn	48	SENT_111	[p9l16t1898r190b1993],
48	)	NN	O	)	dep	18	SENT_111	[p9l16t1898r190b1993],
49	,	,	O	,	_	0	SENT_111	[p9l16t1898r190b1993],
50	respectively	RB	O	respectively	advmod	18	SENT_111	[p9l225t1904r740b1997],
51	.	.	O	.	_	0	SENT_111	[p9l225t1904r740b1997],

1	Of	IN	O	of	_	0	SENT_112	[p9l779t1904r889b1976],
2	the	DT	O	the	det	5	SENT_112	[p9l914t1904r1037b1976],
3	24	CD	NUMBER	24	num	5	SENT_112	[p9l1070t1905r1168b1975],
4	duloxetine	NN	O	duloxetine	nn	5	SENT_112	[p9l1201t1904r1946b1976],
5	—	NN	O	—	prep_of	11	SENT_112	[p9l1201t1904r1946b1976],
6	treated	JJ	O	treated	amod	7	SENT_112	[p9l1201t1904r1946b1976],
7	subjects	NNS	O	subject	dep	5	SENT_112	[p9l1980t1904r2148b1976, p9l7t2032r223b2125],
8	,	,	O	,	_	0	SENT_112	[p9l1980t1904r2148b1976, p9l7t2032r223b2125],
9	14	CD	NUMBER	14	nsubjpass	11	SENT_112	[p9l273t2032r362b2103],
10	were	VBD	O	be	auxpass	11	SENT_112	[p9l400t2055r596b2104],
11	genotyped	VBN	O	genotype	_	0	SENT_112	[p9l633t2032r1059b2125],
12	as	IN	O	as	_	0	SENT_112	[p9l1096t2055r1174b2104],
13	extensive	JJ	O	extensive	amod	14	SENT_112	[p9l1214t2032r1597b2104],
14	metabolisers	NNS	O	metaboliser	prep_as	11	SENT_112	[p9l1634t2032r2148b2104],
15	and	CC	O	and	_	0	SENT_112	[p9l18t2159r163b2231],
16	9	CD	NUMBER	9	prep_as	11	SENT_112	[p9l187t2160r232b2232],
17	as	IN	O	as	_	0	SENT_112	[p9l261t2182r339b2231],
18	intermediate	JJ	O	intermediate	amod	19	SENT_112	[p9l365t2159r875b2231],
19	metabolisers	NNS	O	metaboliser	prep_as	11	SENT_112	[p9l900t2159r1414b2231],
20	for	IN	O	for	_	0	SENT_112	[p9l1441t2159r1560b2231],
21	CYP2D6	NN	O	cyp2d6	prep_for	19	SENT_112	[p9l1583t2159r1978b2244],
22	,	,	O	,	_	0	SENT_112	[p9l1583t2159r1978b2244],
23	and	CC	O	and	_	0	SENT_112	[p9l2008t2159r2152b2231],
24	one	CD	NUMBER	one	poss	27	SENT_112	[p9l18t2310r161b2359],
25	subject	JJ	O	subject	amod	24	SENT_112	[p9l212t2287r568b2380],
26	’s	POS	O	’s	_	0	SENT_112	[p9l212t2287r568b2380],
27	genotype	NN	O	genotype	nsubjpass	30	SENT_112	[p9l619t2298r991b2380],
28	was	VBD	O	be	auxpass	30	SENT_112	[p9l1038t2310r1192b2359],
29	not	RB	O	not	neg	30	SENT_112	[p9l1241t2298r1371b2359],
30	determined	VBN	O	determine	conj_and	11	SENT_112	[p9l1418t2287r1897b2359],
31	.	.	O	.	_	0	SENT_112	[p9l1418t2287r1897b2359],

1	Only	RB	O	only	advmod	2	SENT_113	[p9l1950t2287r2151b2380],
2	two	CD	NUMBER	two	nsubj	10	SENT_113	[p9l16t2426r166b2487],
3	of	IN	O	of	_	0	SENT_113	[p9l192t2415r281b2487],
4	the	DT	O	the	det	8	SENT_113	[p9l298t2415r420b2487],
5	duloxetine	NN	O	duloxetine	nn	8	SENT_113	[p9l445t2415r1190b2487],
6	—	NN	O	—	nn	8	SENT_113	[p9l445t2415r1190b2487],
7	treated	JJ	O	treated	amod	8	SENT_113	[p9l445t2415r1190b2487],
8	subjects	NNS	O	subject	prep_of	2	SENT_113	[p9l1217t2415r1539b2508],
9	were	VBD	O	be	cop	10	SENT_113	[p9l1566t2438r1761b2487],
10	smokers	NNS	O	smoker	_	0	SENT_113	[p9l1789t2415r2146b2487],
11	.	.	O	.	_	0	SENT_113	[p9l1789t2415r2146b2487],

1	Phormctcokinetics	NNS	O	phormctcokinetic	_	0	SENT_114	[p9l145t2669r936b2738],

1	Following	VBG	O	follow	_	0	SENT_115	[p9l139t2884r558b2977],
2	both	DT	O	both	det	6	SENT_115	[p9l602t2884r783b2956],
3	single	JJ	O	single	amod	6	SENT_115	[p9l831t2884r1069b2977],
4	and	CC	O	and	_	0	SENT_115	[p9l1116t2884r1260b2956],
5	multiple	JJ	O	multiple	conj_and	3	SENT_115	[p9l1303t2884r1643b2977],
6	dosing	NN	O	dosing	dobj	1	SENT_115	[p9l1688t2884r1980b2977],
7	,	,	O	,	_	0	SENT_115	[p9l1688t2884r1980b2977],
8	the	DT	O	the	det	10	SENT_115	[p9l2027t2884r2150b2956],
9	time	NN	O	time	nn	10	SENT_115	[p9l16t3011r195b3083],
10	course	NN	O	course	appos	6	SENT_115	[p9l236t3033r500b3083],
11	of	IN	O	of	_	0	SENT_115	[p9l542t3011r630b3083],
12	the	DT	O	the	det	15	SENT_115	[p9l662t3011r784b3083],
13	mean	NN	O	mean	nn	15	SENT_115	[p9l825t3033r1044b3083],
14	duloxetine	NN	O	duloxetine	nn	15	SENT_115	[p9l1085t3011r1514b3083],
15	concentrations	NNS	O	concentration	prep_of	10	SENT_115	[p9l1556t3011r2148b3083],
16	demonstrated	VBD	O	demonstrate	dep	1	SENT_115	[p9l17t3140r568b3212],
17	the	DT	O	the	det	18	SENT_115	[p9l607t3140r729b3212],
18	characteristics	NNS	O	characteristic	dobj	16	SENT_115	[p9l770t3140r1353b3212],
19	of	IN	O	of	_	0	SENT_115	[p9l1396t3140r1484b3212],
20	a	DT	O	a	det	23	SENT_115	[p9l1519t3162r1561b3212],
21	onecompartment	JJ	O	onecompartment	amod	23	SENT_115	[p9l1601t3151r2148b3233, p9l17t3279r221b3340],
22	pharmacokinetic	JJ	O	pharmacokinetic	amod	23	SENT_115	[p9l242t3268r924b3361],
23	model	NN	O	model	prep_of	18	SENT_115	[p9l950t3268r1203b3340],
24	(	CD	NUMBER	(	num	27	SENT_115	[p9l1232t3268r1504b3361],
25	figure	NN	O	figure	nn	27	SENT_115	[p9l1232t3268r1504b3361],
26	1	CD	NUMBER	1	num	27	SENT_115	[p9l1539t3268r1633b3356],
27	)	NN	O	)	nsubj	1	SENT_115	[p9l1539t3268r1633b3356],
28	.	.	O	.	_	0	SENT_115	[p9l1539t3268r1633b3356],

1	The	DT	O	the	det	2	SENT_116	[p9l1662t3268r1818b3340],
2	tlag	NN	O	tlag	nsubj	6	SENT_116	[p9l1843t3279r1969b3367],
3	was	VBD	O	be	cop	6	SENT_116	[p9l1994t3290r2148b3340],
4	approximately	RB	O	approximately	quantmod	6	SENT_116	[p9l18t3396r606b3489],
5	1	CD	DURATION	1	number	6	SENT_116	[p9l641t3396r671b3467],
6	hour	NN	NUMBER	hour	_	0	SENT_116	[p9l704t3396r892b3468],
7	and	CC	O	and	_	0	SENT_116	[p9l917t3396r1061b3468],
8	the	DT	O	the	det	9	SENT_116	[p9l1085t3396r1207b3468],
9	tmax	NN	O	tmax	nsubj	13	SENT_116	[p9l1232t3407r1400b3478],
10	was	VBD	O	be	cop	13	SENT_116	[p9l1425t3418r1579b3468],
11	approximately	RB	O	approximately	quantmod	12	SENT_116	[p9l1608t3396r2148b3489, p9l17t3524r92b3617],
12	6	CD	DURATION	6	num	13	SENT_116	[p9l137t3524r182b3596],
13	hours	NNS	NUMBER	hour	conj_and	6	SENT_116	[p9l225t3524r471b3596],
14	.	.	O	.	_	0	SENT_116	[p9l225t3524r471b3596],

1	The	DT	O	the	det	4	SENT_117	[p9l519t3524r675b3596],
2	mean	NN	O	mean	nn	4	SENT_117	[p9l717t3546r937b3596],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_117	[p9l977t3524r1659b3617],
4	parameters	NNS	O	parameter	nsubjpass	8	SENT_117	[p9l1701t3535r2148b3617],
5	for	IN	O	for	_	0	SENT_117	[p9l17t3651r135b3723],
6	duloxetine	NN	O	duloxetine	prep_for	4	SENT_117	[p9l168t3651r597b3723],
7	are	VBP	O	be	auxpass	8	SENT_117	[p9l634t3673r753b3723],
8	summarised	VBN	O	summarise	_	0	SENT_117	[p9l791t3651r1283b3723],
9	in	IN	O	in	_	0	SENT_117	[p9l1316t3651r1393b3722],
10	table	NN	O	table	nn	11	SENT_117	[p9l1426t3651r1623b3723],
11	I.	NN	O	i.	prep_in	8	SENT_117	[p9l1657t3652r1709b3723],

1	Following	VBG	O	follow	csubj	19	SENT_118	[p10l139t35r558b128],
2	multiple	JJ	O	multiple	amod	3	SENT_118	[p10l600t35r939b128],
3	dosing	NN	O	dosing	dobj	1	SENT_118	[p10l982t35r1274b128],
4	,	,	O	,	_	0	SENT_118	[p10l982t35r1274b128],
5	the	DT	O	the	det	9	SENT_118	[p10l1318t35r1440b107],
6	geometric	JJ	O	geometric	amod	9	SENT_118	[p10l1483t35r1888b128],
7	mean	NN	O	mean	nn	9	SENT_118	[p10l1931t58r2151b107],
8	Cmimss	NNP	O	Cmimss	nn	9	SENT_118	[p10l18t163r293b256],
9	Values	NNS	O	value	appos	3	SENT_118	[p10l327t163r584b235],
10	on	IN	O	on	_	0	SENT_118	[p10l620t186r719b235],
11	days	NNS	DURATION	day	prep_on	9	SENT_118	[p10l752t163r934b256],
12	7	CD	NUMBER	7	tmod	1	SENT_118	[p10l970t165r1039b249],
13	,	,	O	,	_	0	SENT_118	[p10l970t165r1039b249],
14	8	CD	NUMBER	8	num	12	SENT_118	[p10l1080t164r1120b235],
15	and	CC	O	and	_	0	SENT_118	[p10l1159t163r1303b235],
16	9	CD	NUMBER	9	conj_and	12	SENT_118	[p10l1335t164r1380b236],
17	were	VBD	O	be	cop	19	SENT_118	[p10l1415t186r1612b235],
18	15.5	CD	NUMBER	15.5	num	19	SENT_118	[p10l1654t163r1817b235],
19	ng/mL	NN	O	ng/ml	_	0	SENT_118	[p10l1854t163r2147b256],
20	,	,	O	,	_	0	SENT_118	[p10l1854t163r2147b256],
21	16.1	CD	NUMBER	16.1	num	22	SENT_118	[p10l26t291r184b363],
22	ng/mL	NN	O	ng/ml	conj_and	19	SENT_118	[p10l223t291r494b384],
23	and	CC	O	and	_	0	SENT_118	[p10l525t291r669b363],
24	15.4	CD	NUMBER	15.4	num	25	SENT_118	[p10l707t291r874b363],
25	ng/mL	NN	O	ng/ml	conj_and	19	SENT_118	[p10l904t291r1197b384],
26	,	,	O	,	_	0	SENT_118	[p10l904t291r1197b384],
27	respectively	RB	O	respectively	advmod	19	SENT_118	[p10l1229t291r1745b384],
28	.	.	O	.	_	0	SENT_118	[p10l1229t291r1745b384],

1	The	DT	O	the	det	2	SENT_119	[p10l1779t291r1935b363],
2	ratio	NN	O	ratio	dep	8	SENT_119	[p10l1964t291r2149b363],
3	of	IN	O	of	_	0	SENT_119	[p10l18t419r106b491],
4	the	DT	O	the	det	6	SENT_119	[p10l142t419r265b491],
5	geometric	JJ	O	geometric	amod	6	SENT_119	[p10l310t419r715b512],
6	mean	NN	O	mean	prep_of	2	SENT_119	[p10l760t442r980b491],
7	Cmimss	NNP	O	Cmimss	dep	8	SENT_119	[p10l1025t419r1301b512],
8	Values	NNS	O	value	_	0	SENT_119	[p10l1346t419r1603b491],
9	on	IN	O	on	_	0	SENT_119	[p10l1651t442r1749b491],
10	day	NN	DURATION	day	prep_on	8	SENT_119	[p10l1794t419r1937b512],
11	9	CD	NUMBER	9	num	10	SENT_119	[p10l1983t420r2028b492],
12	to	TO	O	to	dep	8	SENT_119	[p10l2074t430r2150b491],

1	Clin	NNP	O	Clin	nn	2	SENT_120	[p10l1210t697r1317b745],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_120	[p10l1343t698r1795b745],
3	2007	CD	DATE	2007	num	2	SENT_120	[p10l1816t697r1963b748],
4	;	:	O	;	_	0	SENT_120	[p10l1816t697r1963b748],
5	46	CD	NUMBER	46	number	6	SENT_120	[p10l1986t698r2053b745],
6	(	CD	NUMBER	(	dep	2	SENT_120	[p10l2076t697r2149b751],
7	9	CD	NUMBER	9	num	8	SENT_120	[p10l2076t697r2149b751],
8	)	NN	O	)	dep	6	SENT_120	[p10l2076t697r2149b751],

1	Duloxetine	NNP	O	Duloxetine	nn	2	SENT_121	[p10l185t826r346b851],
2	PK	NNP	O	PK	_	0	SENT_121	[p10l358t827r401b851],
3	in	IN	O	in	_	0	SENT_121	[p10l412t828r440b851],
4	Chinese	NNP	MISC	Chinese	nn	5	SENT_121	[p10l451t826r568b851],
5	Subjects	NNPS	O	Subjects	prep_in	2	SENT_121	[p10l579t826r697b860],
6	771	CD	NUMBER	771	dep	2	SENT_121	[p10l1927t827r1974b851],

1	80	CD	NUMBER	80	num	2	SENT_122	[p10l307t1172r383b1225],
2	o	NN	O	o	_	0	SENT_122	[p10l1405t1168r1462b1226],
3	Multiple	JJ	O	multiple	amod	5	SENT_122	[p10l1510t1170r1751b1237],
4	dosing	NN	O	dosing	nn	5	SENT_122	[p10l1777t1170r1983b1238],
5	o	NN	O	o	dep	2	SENT_122	[p10l1405t1254r1462b1311],
6	Single	JJ	O	single	amod	7	SENT_122	[p10l1508t1256r1703b1326],
7	dosing	NN	O	dosing	dep	2	SENT_122	[p10l1728t1258r1936b1326],

1	Duloxetine	NNP	O	Duloxetine	_	0	SENT_123	[p10l188t2045r242b2379],
2	plasma	NN	O	plasma	nn	3	SENT_123	[p10l188t1791r256b2019],
3	concentration	NN	O	concentration	dep	1	SENT_123	[p10l188t1340r242b1768],
4	(	CD	NUMBER	(	num	6	SENT_123	[p10l187t1070r257b1310],
5	ng/mL	NN	O	ng/ml	nn	6	SENT_123	[p10l187t1070r257b1310],
6	)	NN	O	)	dep	1	SENT_123	[p10l187t1070r257b1310],

1	Time	NNP	O	Time	_	0	SENT_124	[p10l1062t2424r1217b2478],
2	(	CD	NUMBER	(	num	3	SENT_124	[p10l1244t2424r1322b2492],
3	h	NN	O	h	dep	1	SENT_124	[p10l1244t2424r1322b2492],
4	)	CD	NUMBER	)	dep	1	SENT_124	[p10l1244t2424r1322b2492],

1	Fig	NN	O	fig	_	0	SENT_125	[p10l10t2529r129b2597],
2	.	.	O	.	_	0	SENT_125	[p10l10t2529r129b2597],

1	1	LS	NUMBER	1	_	0	SENT_126	[p10l162t2529r213b2581],
2	.	.	O	.	_	0	SENT_126	[p10l162t2529r213b2581],

1	The	DT	O	the	det	3	SENT_127	[p10l241t2529r363b2582],
2	time	NN	O	time	nn	3	SENT_127	[p10l390t2529r523b2582],
3	course	NN	O	course	_	0	SENT_127	[p10l551t2542r764b2582],
4	of	IN	O	of	_	0	SENT_127	[p10l792t2528r850b2582],
5	mean	JJ	O	mean	amod	10	SENT_127	[p10l878t2542r1050b2582],
6	(	JJ	O	(	amod	10	SENT_127	[p10l1083t2528r1223b2596],
7	SD	NN	O	sd	nn	10	SENT_127	[p10l1083t2528r1223b2596],
8	)	NN	O	)	nn	10	SENT_127	[p10l1083t2528r1223b2596],
9	duloxetine	NN	O	duloxetine	nn	10	SENT_127	[p10l1253t2529r1578b2582],
10	concentrations	NNS	O	concentration	prep_of	3	SENT_127	[p10l1606t2529r2072b2582],
11	in	IN	O	in	_	0	SENT_127	[p10l2103t2529r2150b2581],
12	plasma	NN	O	plasma	prep_in	10	SENT_127	[p10l8t2620r237b2687],
13	following	VBG	O	follow	_	0	SENT_127	[p10l268t2619r545b2688],
14	oral	JJ	O	oral	amod	15	SENT_127	[p10l581t2620r695b2673],
15	administration	NN	O	administration	prep_following	12	SENT_127	[p10l731t2620r1175b2673],
16	of	IN	O	of	_	0	SENT_127	[p10l1211t2619r1268b2673],
17	60mg	JJ	O	60mg	prep_of	15	SENT_127	[p10l1301t2621r1476b2688],
18	as	IN	O	as	_	0	SENT_127	[p10l1511t2633r1583b2673],
19	a	DT	O	a	det	21	SENT_127	[p10l1617t2633r1654b2673],
20	single	JJ	O	single	amod	21	SENT_127	[p10l1687t2620r1871b2688],
21	dose	NN	O	dose	prep_as	17	SENT_127	[p10l1906t2620r2057b2673],
22	or	CC	O	or	_	0	SENT_127	[p10l2092t2633r2154b2673],
23	multiple	JJ	O	multiple	amod	24	SENT_127	[p10l9t2712r252b2778],
24	doses	NNS	O	dose	conj_or	17	SENT_127	[p10l281t2712r470b2766],
25	in	IN	O	in	_	0	SENT_127	[p10l502t2712r549b2765],
26	healthy	JJ	O	healthy	amod	28	SENT_127	[p10l584t2712r812b2778],
27	Chinese	JJ	MISC	chinese	amod	28	SENT_127	[p10l841t2711r1100b2766],
28	subjects	NNS	O	subject	prep_in	24	SENT_127	[p10l1131t2712r1408b2778],
29	.	.	O	.	_	0	SENT_127	[p10l1131t2712r1408b2778],

1	those	DT	O	those	nsubj	12	SENT_128	[p10l6t2964r221b3036],
2	on	IN	O	on	_	0	SENT_128	[p10l249t2987r348b3036],
3	days	NNS	DURATION	day	prep_on	1	SENT_128	[p10l375t2964r558b3057],
4	7	CD	NUMBER	7	num	3	SENT_128	[p10l587t2966r632b3036],
5	and	CC	O	and	_	0	SENT_128	[p10l663t2964r809b3036],
6	8	CD	NUMBER	8	prep_on	1	SENT_128	[p10l838t2965r879b3036],
7	were	VBD	O	be	cop	12	SENT_128	[p10l910t2987r1106b3036],
8	1.00	CD	PERCENT	1.00	num	12	SENT_128	[p10l1143t2965r1310b3036],
9	(	CD	PERCENT	(	number	10	SENT_128	[p10l1340t2964r1554b3053],
10	90	CD	PERCENT	90	dep	11	SENT_128	[p10l1340t2964r1554b3053],
11	%	NN	PERCENT	%	dep	12	SENT_128	[p10l1340t2964r1554b3053],
12	CI	NN	O	ci	_	0	SENT_128	[p10l1585t2964r1684b3036],
13	0.94	CD	NUMBER	0.94	dep	12	SENT_128	[p10l1711t2964r1911b3049],
14	,	,	O	,	_	0	SENT_128	[p10l1711t2964r1911b3049],
15	1.06	CD	NUMBER	1.06	num	16	SENT_128	[p10l1950t2964r2150b3053],
16	)	NN	O	)	conj_and	12	SENT_128	[p10l1950t2964r2150b3053],
17	and	CC	O	and	_	0	SENT_128	[p10l8t3093r153b3165],
18	0.96	CD	PERCENT	0.96	number	19	SENT_128	[p10l187t3093r363b3166],
19	(	CD	PERCENT	(	conj_and	12	SENT_128	[p10l401t3093r615b3182],
20	90	CD	PERCENT	90	num	21	SENT_128	[p10l401t3093r615b3182],
21	%	NN	PERCENT	%	dep	19	SENT_128	[p10l401t3093r615b3182],
22	CI	NN	O	ci	dep	19	SENT_128	[p10l654t3093r754b3165],
23	0.9	CD	NUMBER	0.9	num	22	SENT_128	[p10l788t3093r936b3179],
24	,	,	O	,	_	0	SENT_128	[p10l788t3093r936b3179],
25	1.01	CD	NUMBER	1.01	num	26	SENT_128	[p10l983t3094r1208b3182],
26	)	NN	O	)	appos	22	SENT_128	[p10l983t3094r1208b3182],
27	,	,	O	,	_	0	SENT_128	[p10l983t3094r1208b3182],
28	respectively	RB	O	respectively	advmod	12	SENT_128	[p10l1245t3093r1762b3186],
29	.	.	O	.	_	0	SENT_128	[p10l1245t3093r1762b3186],

1	The	DT	O	the	det	3	SENT_129	[p10l130t3222r288b3294],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_129	[p10l333t3222r1018b3315],
3	parameters	NNS	O	parameter	nsubj	17	SENT_129	[p10l1066t3233r1515b3315],
4	of	IN	O	of	_	0	SENT_129	[p10l1565t3222r1654b3294],
5	duloxetine	NN	O	duloxetine	prep_of	3	SENT_129	[p10l1695t3222r2149b3308],
6	,	,	O	,	_	0	SENT_129	[p10l1695t3222r2149b3308],
7	such	JJ	O	such	_	0	SENT_129	[p10l10t3351r193b3423],
8	as	IN	O	as	_	0	SENT_129	[p10l220t3374r299b3423],
9	CL/F	NN	O	cl/f	prep_such_as	3	SENT_129	[p10l328t3351r543b3423],
10	and	CC	O	and	_	0	SENT_129	[p10l570t3351r715b3423],
11	Vss/F	NN	O	vss/f	prep_such_as	3	SENT_129	[p10l740t3351r984b3437],
12	,	,	O	,	_	0	SENT_129	[p10l740t3351r984b3437],
13	were	VBD	O	be	cop	17	SENT_129	[p10l1014t3374r1211b3423],
14	not	RB	O	not	neg	17	SENT_129	[p10l1237t3362r1368b3423],
15	statistically	RB	O	statistically	advmod	17	SENT_129	[p10l1396t3351r1859b3444],
16	significantly	RB	O	significantly	advmod	17	SENT_129	[p10l1890t3351r2149b3444, p10l6t3480r284b3573],
17	different	JJ	O	different	_	0	SENT_129	[p10l311t3480r664b3552],
18	following	VBG	O	follow	_	0	SENT_129	[p10l688t3480r1085b3573],
19	single	JJ	O	single	amod	22	SENT_129	[p10l1115t3480r1354b3573],
20	or	CC	O	or	_	0	SENT_129	[p10l1381t3503r1465b3552],
21	multiple	JJ	O	multiple	conj_or	19	SENT_129	[p10l1488t3480r1829b3573],
22	dosing	NN	O	dosing	prep_following	17	SENT_129	[p10l1855t3480r2148b3573],
23	.	.	O	.	_	0	SENT_129	[p10l1855t3480r2148b3573],

1	Although	IN	O	although	mark	6	SENT_130	[p10l6t3609r394b3702],
2	the	DT	O	the	det	3	SENT_130	[p10l498t3609r621b3681],
3	t1/2	NN	O	t1/2	nsubj	6	SENT_130	[p10l725t3620r816b3692],
4	was	VBD	O	be	cop	6	SENT_130	[p10l920t3632r1075b3681],
5	significantly	RB	O	significantly	advmod	6	SENT_130	[p10l1185t3609r1695b3702],
6	different	JJ	O	different	_	0	SENT_130	[p10l1801t3609r2154b3681],

1	(	NN	O	(	nn	2	SENT_131	[p11l12t26r90b118],
2	p	NN	O	p	nsubj	32	SENT_131	[p11l12t26r90b118],
3	<	JJR	O	<	amod	2	SENT_131	[p11l133t42r185b97],
4	0.001	CD	NUMBER	0.001	num	5	SENT_131	[p11l228t26r486b114],
5	)	NN	O	)	nsubj	29	SENT_131	[p11l228t26r486b114],
6	following	VBG	O	follow	_	0	SENT_131	[p11l530t25r926b118],
7	single	JJ	O	single	amod	9	SENT_131	[p11l971t25r1210b118],
8	(	NN	O	(	nn	9	SENT_131	[p11l1254t26r1505b114],
9	mean	NN	O	mean	prep_following	5	SENT_131	[p11l1254t26r1505b114],
10	10.3	CD	DURATION	10.3	num	11	SENT_131	[p11l1555t26r1717b97],
11	hours	NNS	NUMBER	hour	tmod	9	SENT_131	[p11l1762t25r2020b114],
12	)	CD	NUMBER	)	dep	9	SENT_131	[p11l1762t25r2020b114],
13	or	CC	O	or	_	0	SENT_131	[p11l2064t48r2147b97],
14	multiple	JJ	O	multiple	amod	15	SENT_131	[p11l8t152r348b246],
15	dosing	NN	O	dosing	prep_following	5	SENT_131	[p11l374t152r643b246],
16	(	FW	O	(	nsubj	17	SENT_131	[p11l672t153r923b241],
17	mean	VB	O	mean	rcmod	15	SENT_131	[p11l672t153r923b241],
18	11.0	CD	DURATION	11.0	num	19	SENT_131	[p11l958t153r1124b225],
19	hours	NNS	NUMBER	hour	dobj	17	SENT_131	[p11l1149t152r1431b241],
20	)	RB	O	)	advmod	17	SENT_131	[p11l1149t152r1431b241],
21	,	,	O	,	_	0	SENT_131	[p11l1149t152r1431b241],
22	the	DT	O	the	det	23	SENT_131	[p11l1459t153r1582b224],
23	magnitude	NN	O	magnitude	appos	15	SENT_131	[p11l1607t152r2038b246],
24	of	IN	O	of	_	0	SENT_131	[p11l2064t152r2152b224],
25	the	DT	O	the	det	27	SENT_131	[p11l8t282r131b354],
26	mean	NN	O	mean	nn	27	SENT_131	[p11l176t304r396b354],
27	differences	NNS	O	difference	prep_of	23	SENT_131	[p11l441t282r891b354],
28	was	VBD	O	be	cop	29	SENT_131	[p11l939t304r1093b354],
29	small	JJ	O	small	ccomp	3	SENT_131	[p11l1143t282r1359b354],
30	with	IN	O	with	_	0	SENT_131	[p11l1405t282r1584b354],
31	considerable	JJ	O	considerable	prep_with	3	SENT_131	[p11l1629t282r2145b354],
32	overlap	VBP	O	overlap	_	0	SENT_131	[p11l9t412r313b505],
33	in	IN	O	in	_	0	SENT_131	[p11l369t412r447b483],
34	the	DT	O	the	det	35	SENT_131	[p11l501t412r623b484],
35	range	NN	O	range	prep_in	32	SENT_131	[p11l677t435r904b505],
36	of	IN	O	of	_	0	SENT_131	[p11l960t412r1049b484],
37	t1/2	NN	O	t1/2	nn	38	SENT_131	[p11l1096t423r1186b495],
38	values	NNS	O	value	prep_of	35	SENT_131	[p11l1241t412r1499b484],
39	(	RB	O	(	advmod	35	SENT_131	[p11l1559t412r1787b501],
40	table	NN	O	table	dep	35	SENT_131	[p11l1559t412r1787b501],
41	I	PRP	O	I	nsubj	42	SENT_131	[p11l1843t413r1929b501],
42	)	VBP	O	)	rcmod	40	SENT_131	[p11l1843t413r1929b501],
43	.	.	O	.	_	0	SENT_131	[p11l1843t413r1929b501],

1	The	DT	O	the	det	3	SENT_132	[p11l1989t412r2145b484],
2	linearity	NN	O	linearity	nn	3	SENT_132	[p11l8t539r348b633],
3	index	NN	O	index	nsubj	4	SENT_132	[p11l419t539r645b611],
4	showed	VBD	O	show	_	0	SENT_132	[p11l720t539r1028b612],
5	a	DT	O	a	det	8	SENT_132	[p11l1101t562r1143b611],
6	15	CD	PERCENT	15	number	7	SENT_132	[p11l1222t539r1394b612],
7	%	NN	PERCENT	%	amod	8	SENT_132	[p11l1222t539r1394b612],
8	increase	NN	O	increase	dobj	4	SENT_132	[p11l1469t539r1803b611],
9	in	IN	O	in	_	0	SENT_132	[p11l1874t539r1952b611],
10	the	DT	O	the	det	11	SENT_132	[p11l2022t540r2145b611],
11	AUCLSS	NN	O	auclss	prep_in	4	SENT_132	[p11l8t669r342b761],
12	following	VBG	O	follow	_	0	SENT_132	[p11l386t669r781b762],
13	multiple	JJ	O	multiple	amod	14	SENT_132	[p11l825t669r1164b762],
14	dosing	NN	O	dosing	prep_following	11	SENT_132	[p11l1208t669r1478b762],
15	compared	VBN	O	compare	_	0	SENT_132	[p11l1522t669r1925b762],
16	with	IN	O	with	prepc_compared_with	14	SENT_132	[p11l1966t669r2146b741],
17	the	DT	O	the	det	18	SENT_132	[p11l8t799r131b871],
18	AUCOO	NN	O	aucoo	pobj	14	SENT_132	[p11l170t799r443b871],
19	after	IN	O	after	_	0	SENT_132	[p11l485t799r670b871],
20	single	JJ	O	single	amod	21	SENT_132	[p11l711t799r949b892],
21	dosing	NN	O	dosing	prep_after	18	SENT_132	[p11l990t799r1281b892],
22	.	.	O	.	_	0	SENT_132	[p11l990t799r1281b892],

1	There	EX	O	there	expl	2	SENT_133	[p11l1326t799r1562b871],
2	was	VBD	O	be	_	0	SENT_133	[p11l1602t822r1757b871],
3	50	CD	PERCENT	50	number	4	SENT_133	[p11l1800t799r1979b871],
4	%	NN	PERCENT	%	amod	5	SENT_133	[p11l1800t799r1979b871],
5	accumulation	NN	O	accumulation	nsubj	2	SENT_133	[p11l2025t822r2142b871, p11l9t926r469b998],
6	in	IN	O	in	_	0	SENT_133	[p11l500t926r577b998],
7	duloxetine	NN	O	duloxetine	nn	8	SENT_133	[p11l608t926r1038b998],
8	exposure	NN	O	exposure	prep_in	2	SENT_133	[p11l1070t949r1437b1020],
9	following	VBG	O	follow	_	0	SENT_133	[p11l1469t926r1865b1020],
10	multiple	JJ	O	multiple	amod	11	SENT_133	[p11l1897t926r2143b998, p11l7t1056r131b1149],
11	dosing	NN	O	dosing	prep_following	8	SENT_133	[p11l166t1056r436b1149],
12	relative	JJ	O	relative	advmod	11	SENT_133	[p11l470t1056r775b1128],
13	to	TO	O	to	_	0	SENT_133	[p11l810t1066r886b1128],
14	the	DT	O	the	det	16	SENT_133	[p11l921t1056r1043b1128],
15	first	JJ	ORDINAL	first	amod	16	SENT_133	[p11l1078t1056r1242b1128],
16	dose	NN	O	dose	prep_to	12	SENT_133	[p11l1275t1056r1480b1128],
17	.	.	O	.	_	0	SENT_133	[p11l1275t1056r1480b1128],

1	Duloxetine	NNP	O	Duloxetine	nn	2	SENT_134	[p11l132t1186r586b1258],
2	CL/F	NN	O	cl/f	nsubj	4	SENT_134	[p11l633t1186r847b1258],
3	was	VBD	O	be	cop	4	SENT_134	[p11l892t1208r1047b1258],
4	similar	JJ	O	similar	dep	7	SENT_134	[p11l1098t1186r1379b1258],
5	in	IN	O	in	_	0	SENT_134	[p11l1423t1186r1501b1257],
6	women	NNS	O	woman	prep_in	4	SENT_134	[p11l1547t1208r1846b1258],
7	(	VBP	O	(	_	0	SENT_134	[p11l1895t1186r2146b1275],
8	mean	JJ	O	mean	dobj	7	SENT_134	[p11l1895t1186r2146b1275],
9	97.3	CD	NUMBER	97.3	num	10	SENT_134	[p11l10t1316r180b1388],
10	L/h	NN	O	l/h	nsubj	7	SENT_134	[p11l222t1315r385b1400],
11	,	,	O	,	_	0	SENT_134	[p11l222t1315r385b1400],
12	coefficient	NN	O	coefficient	appos	10	SENT_134	[p11l427t1315r864b1387],
13	of	IN	O	of	_	0	SENT_134	[p11l901t1315r990b1387],
14	variation	NN	O	variation	nn	16	SENT_134	[p11l1020t1315r1383b1387],
15	[	NN	O	[	nn	16	SENT_134	[p11l1427t1316r1621b1402],
16	CV	NN	O	cv	prep_of	12	SENT_134	[p11l1427t1316r1621b1402],
17	]	CD	PERCENT	]	number	18	SENT_134	[p11l1427t1316r1621b1402],
18	57.5	CD	PERCENT	57.5	dep	19	SENT_134	[p11l1668t1315r1960b1404],
19	%	NN	PERCENT	%	dep	16	SENT_134	[p11l1668t1315r1960b1404],
20	)	CD	NUMBER	)	nsubj	23	SENT_134	[p11l1668t1315r1960b1404],
21	and	CC	O	and	_	0	SENT_134	[p11l2002t1315r2147b1387],
22	men	NNS	O	man	nsubj	23	SENT_134	[p11l8t1465r183b1514],
23	(	VBP	O	(	rcmod	16	SENT_134	[p11l231t1443r482b1531],
24	mean	JJ	O	mean	amod	26	SENT_134	[p11l231t1443r482b1531],
25	105	CD	NUMBER	105	num	26	SENT_134	[p11l537t1442r674b1515],
26	L/h	NN	O	l/h	dobj	23	SENT_134	[p11l723t1442r885b1528],
27	,	,	O	,	_	0	SENT_134	[p11l723t1442r885b1528],
28	CV	NN	O	cv	appos	26	SENT_134	[p11l935t1443r1073b1515],
29	71.0	CD	PERCENT	71.0	num	30	SENT_134	[p11l1119t1443r1413b1531],
30	%	NN	PERCENT	%	dep	28	SENT_134	[p11l1119t1443r1413b1531],
31	)	CD	NUMBER	)	dep	12	SENT_134	[p11l1119t1443r1413b1531],
32	following	VBG	O	follow	_	0	SENT_134	[p11l1461t1442r1857b1536],
33	single	JJ	O	single	amod	34	SENT_134	[p11l1906t1442r2145b1536],
34	dosing	NN	O	dosing	prep_following	31	SENT_134	[p11l9t1573r300b1666],
35	.	.	O	.	_	0	SENT_134	[p11l9t1573r300b1666],

1	At	IN	O	at	_	0	SENT_135	[p11l345t1573r447b1645],
2	steady	JJ	O	steady	amod	3	SENT_135	[p11l489t1573r744b1666],
3	state	NN	O	state	prep_at	10	SENT_135	[p11l789t1584r993b1658],
4	,	,	O	,	_	0	SENT_135	[p11l789t1584r993b1658],
5	duloxetine	NN	O	duloxetine	nn	6	SENT_135	[p11l1038t1573r1468b1645],
6	CL/F	NN	O	cl/f	nsubj	10	SENT_135	[p11l1510t1573r1724b1645],
7	was	VBD	O	be	cop	10	SENT_135	[p11l1763t1595r1918b1645],
8	36	CD	PERCENT	36	num	9	SENT_135	[p11l1963t1573r2141b1645],
9	%	NN	PERCENT	%	npadvmod	10	SENT_135	[p11l1963t1573r2141b1645],
10	lower	JJR	O	lower	dep	13	SENT_135	[p11l8t1702r242b1774],
11	in	IN	O	in	_	0	SENT_135	[p11l285t1702r363b1773],
12	women	NNS	O	woman	prep_in	10	SENT_135	[p11l408t1725r708b1774],
13	(	VBP	O	(	_	0	SENT_135	[p11l756t1703r1007b1791],
14	mean	JJ	O	mean	dobj	13	SENT_135	[p11l756t1703r1007b1791],
15	67	CD	NUMBER	67	num	16	SENT_135	[p11l1054t1702r1149b1775],
16	L/h	NN	O	l/h	nsubj	13	SENT_135	[p11l1197t1702r1360b1787],
17	,	,	O	,	_	0	SENT_135	[p11l1197t1702r1360b1787],
18	CV	NN	O	cv	appos	16	SENT_135	[p11l1411t1703r1548b1775],
19	43.4	CD	PERCENT	43.4	num	20	SENT_135	[p11l1594t1703r1889b1791],
20	%	NN	PERCENT	%	nsubj	35	SENT_135	[p11l1594t1703r1889b1791],
21	)	CD	NUMBER	)	nsubj	25	SENT_135	[p11l1594t1703r1889b1791],
22	compared	VBN	O	compare	_	0	SENT_135	[p11l1938t1725r2142b1774, p11l7t1829r235b1923],
23	with	IN	O	with	prepc_compared_with	21	SENT_135	[p11l269t1829r448b1902],
24	men	NNS	O	man	pobj	21	SENT_135	[p11l482t1852r657b1901],
25	(	VBP	O	(	rcmod	20	SENT_135	[p11l693t1830r944b1918],
26	mean	JJ	O	mean	amod	28	SENT_135	[p11l693t1830r944b1918],
27	105	CD	NUMBER	105	num	28	SENT_135	[p11l988t1829r1125b1902],
28	L/h	NN	O	l/h	dobj	25	SENT_135	[p11l1163t1829r1326b1914],
29	,	,	O	,	_	0	SENT_135	[p11l1163t1829r1326b1914],
30	CV	NN	O	cv	appos	28	SENT_135	[p11l1365t1830r1503b1902],
31	56.8	CD	PERCENT	56.8	num	32	SENT_135	[p11l1539t1829r1831b1918],
32	%	NN	PERCENT	%	dep	30	SENT_135	[p11l1539t1829r1831b1918],
33	)	CD	NUMBER	)	number	34	SENT_135	[p11l1539t1829r1831b1918],
34	[	CD	NUMBER	[	num	32	SENT_135	[p11l1876t1829r2145b1923],
35	figure	NN	O	figure	rcmod	18	SENT_135	[p11l1876t1829r2145b1923],
36	2	CD	NUMBER	2	num	37	SENT_135	[p11l10t1960r112b2047],
37	]	NN	O	]	dobj	35	SENT_135	[p11l10t1960r112b2047],
38	.	.	O	.	_	0	SENT_135	[p11l10t1960r112b2047],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_136	[p11l144t1960r831b2032],
2	parameters	NNS	O	parameter	_	0	SENT_136	[p11l858t1971r1305b2053],
3	such	JJ	O	such	_	0	SENT_136	[p11l1337t1960r1520b2032],
4	as	IN	O	as	_	0	SENT_136	[p11l1548t1982r1626b2032],
5	CL/F	NN	O	cl/f	prep_such_as	2	SENT_136	[p11l1657t1960r1871b2032],
6	(	CD	NUMBER	(	dep	37	SENT_136	[p11l1900t1960r2030b2048],
7	90	CD	NUMBER	90	num	8	SENT_136	[p11l1900t1960r2030b2048],
8	L	NN	O	l	dep	6	SENT_136	[p11l2057t1960r2148b2032],
9	/	:	O	/	punct	6	SENT_136	[p11l2057t1960r2148b2032],
10	h	NN	O	h	dep	6	SENT_136	[p11l8t2089r79b2174],
11	,	,	O	,	_	0	SENT_136	[p11l8t2089r79b2174],
12	91	CD	NUMBER	91	num	14	SENT_136	[p11l108t2090r198b2162],
13	L/h	NN	O	l/h	nn	14	SENT_136	[p11l231t2089r427b2178],
14	)	NN	O	)	appos	10	SENT_136	[p11l231t2089r427b2178],
15	,	,	O	,	_	0	SENT_136	[p11l231t2089r427b2178],
16	Vss/F	NN	O	vss/f	nn	18	SENT_136	[p11l455t2090r678b2171],
17	(	CD	NUMBER	(	num	18	SENT_136	[p11l704t2089r1022b2178],
18	1630L	NN	O	1630l	appos	10	SENT_136	[p11l704t2089r1022b2178],
19	,	,	O	,	_	0	SENT_136	[p11l704t2089r1022b2178],
20	1590L	NN	O	1590l	nn	21	SENT_136	[p11l1060t2089r1348b2178],
21	)	NN	O	)	appos	10	SENT_136	[p11l1060t2089r1348b2178],
22	and	CC	O	and	_	0	SENT_136	[p11l1377t2089r1521b2161],
23	t1/2	NN	O	t1/2	appos	10	SENT_136	[p11l1544t2100r1635b2171],
24	(	CD	NUMBER	(	number	25	SENT_136	[p11l1662t2089r1868b2178],
25	10.6	CD	DURATION	10.6	num	26	SENT_136	[p11l1662t2089r1868b2178],
26	hours	NNS	NUMBER	hour	tmod	21	SENT_136	[p11l1893t2089r2142b2174],
27	,	,	O	,	_	0	SENT_136	[p11l1893t2089r2142b2174],
28	10.6	CD	DURATION	10.6	num	29	SENT_136	[p11l18t2217r184b2290],
29	hours	NNS	NUMBER	hour	dep	37	SENT_136	[p11l213t2218r471b2306],
30	)	RB	O	)	advmod	37	SENT_136	[p11l213t2218r471b2306],
31	in	IN	O	in	_	0	SENT_136	[p11l502t2218r580b2289],
32	the	DT	O	the	det	35	SENT_136	[p11l607t2218r730b2290],
33	two	CD	NUMBER	two	num	35	SENT_136	[p11l759t2229r909b2290],
34	male	JJ	O	male	amod	35	SENT_136	[p11l938t2218r1135b2290],
35	smokers	NNS	O	smoker	prep_in	37	SENT_136	[p11l1168t2218r1501b2290],
36	were	VBD	O	be	cop	37	SENT_136	[p11l1533t2240r1729b2290],
37	similar	JJ	O	similar	rcmod	5	SENT_136	[p11l1761t2218r2042b2290],
38	to	TO	O	to	_	0	SENT_136	[p11l2069t2228r2145b2290],
39	the	DT	O	the	det	41	SENT_136	[p11l8t2347r131b2419],
40	overall	JJ	O	overall	amod	41	SENT_136	[p11l185t2347r466b2419],
41	mean	NN	O	mean	prep_to	37	SENT_136	[p11l518t2370r738b2419],
42	and	CC	O	and	_	0	SENT_136	[p11l792t2347r936b2419],
43	within	IN	O	within	_	0	SENT_136	[p11l987t2347r1248b2419],
44	the	DT	O	the	det	45	SENT_136	[p11l1299t2347r1421b2419],
45	range	NN	O	range	prep_within	37	SENT_136	[p11l1473t2370r1699b2441],
46	of	IN	O	of	_	0	SENT_136	[p11l1753t2347r1841b2419],
47	values	NNS	O	value	prep_of	45	SENT_136	[p11l1886t2347r2144b2419],

1	Table	NNP	O	Table	dep	132	SENT_137	[p11l184t2498r260b2520],
2	I.	NNP	O	I.	dep	132	SENT_137	[p11l272t2498r285b2520],
3	Pharmacokinetic	JJ	O	pharmacokinetic	dep	132	SENT_137	[p11l299t2498r512b2520],
4	parameters	NNS	O	parameter	dep	132	SENT_137	[p11l524t2500r669b2526],
5	of	IN	O	of	dep	132	SENT_137	[p11l681t2498r704b2520],
6	duloxetine	NN	O	duloxetine	dep	132	SENT_137	[p11l716t2498r847b2520],
7	following	VBG	O	follow	dep	132	SENT_137	[p11l858t2498r970b2526],
8	single	JJ	O	single	dep	132	SENT_137	[p11l982t2498r1057b2526],
9	or	CC	O	or	dep	132	SENT_137	[p11l1069t2504r1094b2520],
10	multiple	JJ	O	multiple	dep	132	SENT_137	[p11l1106t2498r1204b2526],
11	60mg	JJ	O	60mg	dep	132	SENT_137	[p11l1216t2499r1286b2526],
12	once-daily	JJ	O	once-daily	dep	132	SENT_137	[p11l1299t2498r1431b2526],
13	dosing	NN	O	dosing	dep	132	SENT_137	[p11l1442t2498r1537b2526],
14	“	CD	NUMBER	“	dep	132	SENT_137	[p11l1442t2498r1537b2526],
15	No.	NN	O	no.	dep	132	SENT_137	[p11l11t2607r113b2660],
16	of	IN	O	of	dep	132	SENT_137	[p11l146t2607r203b2660],
17	subjects	NNS	O	subject	dep	132	SENT_137	[p11l231t2607r492b2675],
18	(	JJ	O	(	dep	132	SENT_137	[p11l524t2606r604b2674],
19	n	NN	O	n	dep	132	SENT_137	[p11l524t2606r604b2674],
20	)	CD	NUMBER	)	dep	132	SENT_137	[p11l524t2606r604b2674],
21	9	CD	NUMBER	9	dep	132	SENT_137	[p11l787t2557r801b2579],
22	9	CD	NUMBER	9	dep	132	SENT_137	[p11l906t2557r919b2579],
23	P23	NN	O	p23	dep	132	SENT_137	[p11l1388t2557r1472b2661],
24	9	CD	NUMBER	9	dep	132	SENT_137	[p11l1506t2557r1520b2579],
25	tmax	NN	O	tmax	dep	132	SENT_137	[p11l7t2722r134b2779],
26	(	CD	NUMBER	(	dep	132	SENT_137	[p11l165t2718r271b2786],
27	h	NN	O	h	dep	132	SENT_137	[p11l165t2718r271b2786],
28	)	CD	NUMBER	)	dep	132	SENT_137	[p11l165t2718r271b2786],
29	°	CD	NUMBER	°	dep	132	SENT_137	[p11l165t2718r271b2786],
30	6	CD	NUMBER	6	dep	132	SENT_137	[p11l1396t2720r1432b2772],
31	[	NN	O	[	dep	132	SENT_137	[p11l1464t2718r1616b2785],
32	4	CD	NUMBER	4	dep	132	SENT_137	[p11l1464t2718r1616b2785],
33	—	NN	O	—	dep	132	SENT_137	[p11l1464t2718r1616b2785],
34	8	CD	NUMBER	8	dep	132	SENT_137	[p11l1464t2718r1616b2785],
35	]	NN	O	]	dep	132	SENT_137	[p11l1464t2718r1616b2785],
36	nag	NN	O	nag	dep	132	SENT_137	[p11l7t2835r100b2903],
37	(	CD	NUMBER	(	dep	132	SENT_137	[p11l133t2830r240b2898],
38	h	NN	O	h	dep	132	SENT_137	[p11l133t2830r240b2898],
39	)	CD	NUMBER	)	dep	132	SENT_137	[p11l133t2830r240b2898],
40	°	NN	O	°	dep	132	SENT_137	[p11l133t2830r240b2898],
41	1	CD	NUMBER	1	dep	132	SENT_137	[p11l1401t2832r1420b2884],
42	[	NN	O	[	dep	132	SENT_137	[p11l1464t2831r1616b2898],
43	0	CD	NUMBER	0	dep	132	SENT_137	[p11l1464t2831r1616b2898],
44	—	NN	O	—	dep	132	SENT_137	[p11l1464t2831r1616b2898],
45	2	CD	NUMBER	2	dep	132	SENT_137	[p11l1464t2831r1616b2898],
46	]	CD	NUMBER	]	dep	132	SENT_137	[p11l1464t2831r1616b2898],
47	Cmax	NN	O	cmax	dep	132	SENT_137	[p11l8t2941r167b3002],
48	(	CD	NUMBER	(	dep	132	SENT_137	[p11l197t2941r437b3010],
49	ng/mL	NN	O	ng/ml	dep	132	SENT_137	[p11l197t2941r437b3010],
50	)	CD	NUMBER	)	dep	132	SENT_137	[p11l197t2941r437b3010],
51	36.3	CD	NUMBER	36.3	dep	132	SENT_137	[p11l1396t2943r1532b2995],
52	(	NN	O	(	dep	132	SENT_137	[p11l1564t2941r1744b3009],
53	46.7	CD	NUMBER	46.7	dep	132	SENT_137	[p11l1564t2941r1744b3009],
54	)	CD	NUMBER	)	dep	132	SENT_137	[p11l1564t2941r1744b3009],
55	[	NN	O	[	dep	132	SENT_137	[p11l1779t2941r2132b3008],
56	13.0	CD	NUMBER	13.0	dep	132	SENT_137	[p11l1779t2941r2132b3008],
57	—	CD	NUMBER	—	dep	132	SENT_137	[p11l1779t2941r2132b3008],
58	74.8	CD	NUMBER	74.8	dep	132	SENT_137	[p11l1779t2941r2132b3008],
59	]	NN	O	]	dep	132	SENT_137	[p11l1779t2941r2132b3008],
60	Cmin	NN	O	cmin	dep	132	SENT_137	[p11l8t3051r223b3120],
61	,	,	O	,	_	0	SENT_137	[p11l8t3051r223b3120],
62	ss	VBP	O	ss	dep	132	SENT_137	[p11l8t3051r223b3120],
63	(	CD	NUMBER	(	dep	132	SENT_137	[p11l255t3051r495b3120],
64	ng/mL	NN	O	ng/ml	dep	132	SENT_137	[p11l255t3051r495b3120],
65	)	CD	NUMBER	)	dep	132	SENT_137	[p11l255t3051r495b3120],
66	NA	NN	O	na	dep	132	SENT_137	[p11l1399t3052r1493b3105],
67	CaV	NN	O	cav	dep	132	SENT_137	[p11l8t3163r191b3232],
68	,	,	O	,	_	0	SENT_137	[p11l8t3163r191b3232],
69	ss	VBP	O	ss	dep	132	SENT_137	[p11l8t3163r191b3232],
70	(	CD	NUMBER	(	dep	132	SENT_137	[p11l223t3163r463b3232],
71	ng/mL	NN	O	ng/ml	dep	132	SENT_137	[p11l223t3163r463b3232],
72	)	CD	NUMBER	)	dep	132	SENT_137	[p11l223t3163r463b3232],
73	NA	NNP	O	NA	dep	132	SENT_137	[p11l1399t3164r1494b3216],
74	AUC	NN	O	auc	dep	132	SENT_137	[p11l7t3274r156b3328],
75	(	CD	NUMBER	(	dep	132	SENT_137	[p11l188t3274r285b3343],
76	ng	NN	O	ng	dep	132	SENT_137	[p11l188t3274r285b3343],
77	-	:	O	-	_	0	SENT_137	[p11l307t3289r331b3312],
78	h/mL	NN	O	h/ml	dep	132	SENT_137	[p11l354t3269r559b3342],
79	)	CD	NUMBER	)	dep	132	SENT_137	[p11l354t3269r559b3342],
80	°	NN	O	°	dep	132	SENT_137	[p11l354t3269r559b3342],
81	'	''	O	'	_	0	SENT_137	[p11l354t3269r559b3342],
82	591	CD	NUMBER	591	dep	132	SENT_137	[p11l1396t3276r1501b3328],
83	(	CD	NUMBER	(	dep	132	SENT_137	[p11l1544t3274r1724b3342],
84	63.7	CD	NUMBER	63.7	dep	132	SENT_137	[p11l1544t3274r1724b3342],
85	)	CD	NUMBER	)	dep	132	SENT_137	[p11l1544t3274r1724b3342],
86	[	NN	O	[	dep	132	SENT_137	[p11l1758t3274r2111b3341],
87	117	CD	NUMBER	117	dep	132	SENT_137	[p11l1758t3274r2111b3341],
88	—	CD	NUMBER	—	dep	132	SENT_137	[p11l1758t3274r2111b3341],
89	1630	CD	DATE	1630	dep	132	SENT_137	[p11l1758t3274r2111b3341],
90	]	CD	NUMBER	]	dep	132	SENT_137	[p11l1758t3274r2111b3341],
91	CL/F	NN	O	cl/f	dep	132	SENT_137	[p11l8t3384r161b3439],
92	(	CD	NUMBER	(	dep	132	SENT_137	[p11l193t3384r332b3453],
93	L/h	NN	O	l/h	dep	132	SENT_137	[p11l193t3384r332b3453],
94	)	NN	O	)	dep	132	SENT_137	[p11l193t3384r332b3453],
95	102	CD	NUMBER	102	dep	132	SENT_137	[p11l1401t3386r1511b3439],
96	(	CD	NUMBER	(	dep	132	SENT_137	[p11l1544t3384r1724b3453],
97	63.7	CD	NUMBER	63.7	dep	132	SENT_137	[p11l1544t3384r1724b3453],
98	)	NN	O	)	dep	132	SENT_137	[p11l1544t3384r1724b3453],
99	[	CD	NUMBER	[	dep	132	SENT_137	[p11l1758t3385r2091b3452],
100	36.8	CD	NUMBER	36.8	dep	132	SENT_137	[p11l1758t3385r2091b3452],
101	—	NN	O	—	dep	132	SENT_137	[p11l1758t3385r2091b3452],
102	513	CD	NUMBER	513	dep	132	SENT_137	[p11l1758t3385r2091b3452],
103	]	NN	O	]	dep	132	SENT_137	[p11l1758t3385r2091b3452],
104	Vss/F	NN	O	vss/f	dep	132	SENT_137	[p11l7t3497r175b3559],
105	(	CD	NUMBER	(	dep	132	SENT_137	[p11l206t3497r285b3565],
106	L	NN	O	l	dep	132	SENT_137	[p11l206t3497r285b3565],
107	)	CD	NUMBER	)	dep	132	SENT_137	[p11l206t3497r285b3565],
108	1730	CD	DATE	1730	dep	132	SENT_137	[p11l1401t3499r1552b3552],
109	(	CD	NUMBER	(	dep	132	SENT_137	[p11l1584t3497r1764b3565],
110	47.4	CD	NUMBER	47.4	dep	132	SENT_137	[p11l1584t3497r1764b3565],
111	)	CD	NUMBER	)	dep	132	SENT_137	[p11l1584t3497r1764b3565],
112	[	NN	O	[	dep	132	SENT_137	[p11l1798t3498r2152b3565],
113	863	CD	NUMBER	863	dep	132	SENT_137	[p11l1798t3498r2152b3565],
114	—	CD	NUMBER	—	dep	132	SENT_137	[p11l1798t3498r2152b3565],
115	5640	CD	NUMBER	5640	dep	132	SENT_137	[p11l1798t3498r2152b3565],
116	]	CD	NUMBER	]	dep	132	SENT_137	[p11l1798t3498r2152b3565],
117	t1/2	NN	O	t1/2	dep	132	SENT_137	[p11l7t3614r73b3671],
118	(	CD	NUMBER	(	dep	132	SENT_137	[p11l105t3609r183b3677],
119	h	NN	O	h	dep	132	SENT_137	[p11l105t3609r183b3677],
120	)	CD	NUMBER	)	dep	132	SENT_137	[p11l105t3609r183b3677],
121	10.3	CD	NUMBER	10.3	dep	132	SENT_137	[p11l1401t3611r1532b3664],
122	[	NN	O	[	dep	132	SENT_137	[p11l1564t3609r1918b3676],
123	6.33	CD	NUMBER	6.33	dep	132	SENT_137	[p11l1564t3609r1918b3676],
124	—	CD	NUMBER	—	dep	132	SENT_137	[p11l1564t3609r1918b3676],
125	16.3	CD	NUMBER	16.3	dep	132	SENT_137	[p11l1564t3609r1918b3676],
126	]	CD	NUMBER	]	dep	132	SENT_137	[p11l1564t3609r1918b3676],
127	Rac	NN	O	rac	dep	132	SENT_137	[p11l12t3715r305b3787],
128	(	CD	NUMBER	(	dep	132	SENT_137	[p11l12t3715r305b3787],
129	AUC	NN	O	auc	dep	132	SENT_137	[p11l12t3715r305b3787],
130	)	CD	NUMBER	)	dep	132	SENT_137	[p11l12t3715r305b3787],
131	e	SYM	O	e	dep	132	SENT_137	[p11l12t3715r305b3787],
132	NA	SYM	O	na	_	0	SENT_137	[p11l1399t3715r1494b3768],

1	21	CD	NUMBER	21	num	2	SENT_138	[p12l6t634r189b778],
2	b	NN	O	b	_	0	SENT_138	[p12l238t613r302b715],
3	4	CD	NUMBER	4	num	4	SENT_138	[p12l6t958r108b1105],
4	[	NN	O	[	dep	2	SENT_138	[p12l199t954r633b1144],
5	4	CD	NUMBER	4	num	6	SENT_138	[p12l199t954r633b1144],
6	—	NN	O	—	dep	4	SENT_138	[p12l199t954r633b1144],
7	8	CD	NUMBER	8	num	9	SENT_138	[p12l199t954r633b1144],
8	]	NN	O	]	nn	9	SENT_138	[p12l199t954r633b1144],
9	o	NN	O	o	dep	2	SENT_138	[p12l9t1284r108b1433],
10	[	CD	NUMBER	[	num	13	SENT_138	[p12l199t1281r633b1471],
11	o	NN	O	o	nn	13	SENT_138	[p12l199t1281r633b1471],
12	—	NN	O	—	nn	13	SENT_138	[p12l199t1281r633b1471],
13	o	NN	O	o	dep	9	SENT_138	[p12l199t1281r633b1471],
14	]	CD	NUMBER	]	number	15	SENT_138	[p12l199t1281r633b1471],
15	53.2	CD	NUMBER	53.2	dep	2	SENT_138	[p12l9t1611r393b1759],
16	(	NN	O	(	dep	15	SENT_138	[p12l488t1604r995b1798],
17	50.9	CD	NUMBER	50.9	number	18	SENT_138	[p12l488t1604r995b1798],
18	)	CD	NUMBER	)	dep	2	SENT_138	[p12l488t1604r995b1798],
19	[	NN	O	[	dep	18	SENT_138	[p12l1093t1604r1727b1795],
20	19	CD	NUMBER	19	num	19	SENT_138	[p12l1093t1604r1727b1795],
21	.	.	O	.	_	0	SENT_138	[p12l1093t1604r1727b1795],

1	o	NN	O	o	_	0	SENT_139	[p12l1093t1604r1727b1795],
2	—	CD	NUMBER	—	num	1	SENT_139	[p12l1093t1604r1727b1795],
3	1	CD	NUMBER	1	number	4	SENT_139	[p12l1093t1604r1727b1795],
4	151	CD	NUMBER	151	num	5	SENT_139	[p12l1787t1607r2122b1795],
5	*	NN	O	*	dep	1	SENT_139	[p12l1787t1607r2122b1795],
6	13.8	CD	NUMBER	13.8	num	7	SENT_139	[p12l20t1930r393b2081],
7	(	CD	NUMBER	(	dep	1	SENT_139	[p12l488t1923r995b2120],
8	71.1	CD	NUMBER	71.1	num	9	SENT_139	[p12l488t1923r995b2120],
9	)	NN	O	)	rcmod	7	SENT_139	[p12l488t1923r995b2120],
10	[	CD	NUMBER	[	number	11	SENT_139	[p12l1093t1926r1981b2117],
11	2.3	CD	NUMBER	2.3	num	12	SENT_139	[p12l1093t1926r1981b2117],
12	—	NN	O	—	rcmod	9	SENT_139	[p12l1093t1926r1981b2117],
13	39.5	CD	NUMBER	39.5	number	14	SENT_139	[p12l1093t1926r1981b2117],
14	]	CD	NUMBER	]	num	12	SENT_139	[p12l1093t1926r1981b2117],
15	28.8	CD	NUMBER	28.8	num	16	SENT_139	[p12l6t2256r393b2405],
16	(	NN	O	(	dep	12	SENT_139	[p12l488t2249r995b2443],
17	56.0	CD	NUMBER	56.0	num	18	SENT_139	[p12l488t2249r995b2443],
18	)	CD	NUMBER	)	dep	25	SENT_139	[p12l488t2249r995b2443],
19	[	CD	NUMBER	[	num	20	SENT_139	[p12l1093t2252r2097b2443],
20	7176	CD	NUMBER	7176	dep	18	SENT_139	[p12l1093t2252r2097b2443],
21	—	CD	NUMBER	—	number	22	SENT_139	[p12l1093t2252r2097b2443],
22	66.9	CD	NUMBER	66.9	num	23	SENT_139	[p12l1093t2252r2097b2443],
23	]	NN	O	]	dep	20	SENT_139	[p12l1093t2252r2097b2443],
24	691	CD	NUMBER	691	num	25	SENT_139	[p12l9t2579r305b2727],
25	(	NN	O	(	dep	12	SENT_139	[p12l428t2572r939b2766],
26	56	CD	NUMBER	56	dep	25	SENT_139	[p12l428t2572r939b2766],
27	.	.	O	.	_	0	SENT_139	[p12l428t2572r939b2766],
28	)	SYM	O	)	dep	9	SENT_139	[p12l428t2572r939b2766],

1	[	NN	O	[	nn	3	SENT_140	[p12l1037t2572r2040b2763],
2	186	CD	NUMBER	186	num	3	SENT_140	[p12l1037t2572r2040b2763],
3	—	NN	O	—	dep	9	SENT_140	[p12l1037t2572r2040b2763],
4	1	CD	NUMBER	1	num	5	SENT_140	[p12l1037t2572r2040b2763],
5	|	NN	O	|	dep	3	SENT_140	[p12l1037t2572r2040b2763],
6	61	CD	NUMBER	61	num	7	SENT_140	[p12l1037t2572r2040b2763],
7	|	NN	O	|	dep	9	SENT_140	[p12l1037t2572r2040b2763],
8	0	CD	NUMBER	0	num	9	SENT_140	[p12l1037t2572r2040b2763],
9	]	CD	NUMBER	]	dep	16	SENT_140	[p12l1037t2572r2040b2763],
10	86.8	CD	NUMBER	86.8	num	11	SENT_140	[p12l9t2898r393b3049],
11	(	NN	O	(	dep	9	SENT_140	[p12l488t2891r995b3088],
12	56.0	CD	NUMBER	56.0	number	13	SENT_140	[p12l488t2891r995b3088],
13	)	CD	NUMBER	)	num	14	SENT_140	[p12l488t2891r995b3088],
14	[	NN	O	[	dep	11	SENT_140	[p12l1093t2894r2040b3085],
15	374	CD	NUMBER	374	num	16	SENT_140	[p12l1093t2894r2040b3085],
16	—	NN	O	—	dep	24	SENT_140	[p12l1093t2894r2040b3085],
17	322	CD	NUMBER	322	number	18	SENT_140	[p12l1093t2894r2040b3085],
18	]	CD	NUMBER	]	num	20	SENT_140	[p12l1093t2894r2040b3085],
19	1570	CD	DATE	1570	number	20	SENT_140	[p12l20t3224r453b3373],
20	(	CD	NUMBER	(	dep	16	SENT_140	[p12l544t3217r1055b3411],
21	43.5	CD	NUMBER	43.5	number	22	SENT_140	[p12l544t3217r1055b3411],
22	)	CD	NUMBER	)	num	23	SENT_140	[p12l544t3217r1055b3411],
23	[	NN	O	[	dep	20	SENT_140	[p12l1150t3220r2153b3411],
24	794	CD	NUMBER	794	dep	29	SENT_140	[p12l1150t3220r2153b3411],
25	—	CD	NUMBER	—	number	26	SENT_140	[p12l1150t3220r2153b3411],
26	3630	CD	NUMBER	3630	dep	24	SENT_140	[p12l1150t3220r2153b3411],
27	]	CD	NUMBER	]	num	28	SENT_140	[p12l1150t3220r2153b3411],
28	11.0	CD	NUMBER	11.0	dep	26	SENT_140	[p12l20t3546r394b3694],
29	[	NN	O	[	dep	32	SENT_140	[p12l485t3542r1572b3729],
30	6.36-17	CD	NUMBER	6.36-17	num	29	SENT_140	[p12l485t3542r1572b3729],
31	.8	CD	NUMBER	.8	num	32	SENT_140	[p12l485t3542r1572b3729],
32	]	NN	O	]	dep	33	SENT_140	[p12l485t3542r1572b3729],
33	*	NN	O	*	_	0	SENT_140	[p12l485t3542r1572b3729],

1	1.15	CD	NUMBER	1.15	_	0	SENT_141	[p13l20t416r393b641],
2	(	CD	NUMBER	(	number	3	SENT_141	[p13l488t409r995b603],
3	35.7	CD	NUMBER	35.7	num	4	SENT_141	[p13l488t409r995b603],
4	)	NN	O	)	dep	1	SENT_141	[p13l488t409r995b603],
5	[	CD	NUMBER	[	num	6	SENT_141	[p13l1093t412r2097b603],
6	o.	NN	O	o.	dep	1	SENT_141	[p13l1093t412r2097b603],
7	77	CD	NUMBER	77	number	8	SENT_141	[p13l1093t412r2097b603],
8	—	CD	NUMBER	—	dep	6	SENT_141	[p13l1093t412r2097b603],
9	3.33	CD	NUMBER	3.33	num	10	SENT_141	[p13l1093t412r2097b603],
10	]	NN	O	]	dep	8	SENT_141	[p13l1093t412r2097b603],

1	Values	NNS	O	value	nsubjpass	3	SENT_142	[p13l236t619r323b641],
2	are	VBP	O	be	auxpass	3	SENT_142	[p13l335t624r376b641],
3	expressed	VBN	O	express	_	0	SENT_142	[p13l388t619r520b647],
4	as	IN	O	as	_	0	SENT_142	[p13l532t624r561b641],
5	the	DT	O	the	det	7	SENT_142	[p13l573t619r612b641],
6	geometric	JJ	O	geometric	amod	7	SENT_142	[p13l624t619r751b647],
7	mean	NN	O	mean	prep_as	3	SENT_142	[p13l763t624r833b641],
8	(	CD	PERCENT	(	number	9	SENT_142	[p13l846t618r929b647],
9	CV	CD	PERCENT	cv	num	10	SENT_142	[p13l846t618r929b647],
10	%	NN	PERCENT	%	dobj	3	SENT_142	[p13l846t618r929b647],
11	)	CD	NUMBER	)	num	13	SENT_142	[p13l846t618r929b647],
12	[	NN	O	[	nn	13	SENT_142	[p13l942t618r1030b647],
13	range	NN	O	range	dep	10	SENT_142	[p13l942t618r1030b647],
14	]	CD	NUMBER	]	dep	13	SENT_142	[p13l942t618r1030b647],
15	unless	IN	O	unless	mark	16	SENT_142	[p13l1043t619r1125b641],
16	specified	VBN	O	specify	dep	10	SENT_142	[p13l1137t618r1250b647],
17	otherwise	RB	O	otherwise	advmod	16	SENT_142	[p13l1262t619r1392b641],
18	.	.	O	.	_	0	SENT_142	[p13l1262t619r1392b641],

1	One	CD	NUMBER	one	nsubj	10	SENT_143	[p13l236t659r289b681],
2	subject	JJ	O	subject	advmod	3	SENT_143	[p13l301t660r392b687],
3	discontinued	VBN	O	discontinue	partmod	1	SENT_143	[p13l404t660r565b681],
4	after	IN	O	after	_	0	SENT_143	[p13l578t659r635b681],
5	single	JJ	O	single	amod	6	SENT_143	[p13l646t660r721b687],
6	dosing	NN	O	dosing	prep_after	3	SENT_143	[p13l733t660r816b687],
7	and	CC	O	and	_	0	SENT_143	[p13l829t660r875b681],
8	another	DT	O	another	det	9	SENT_143	[p13l888t660r986b681],
9	subject	NN	O	subject	prep_after	3	SENT_143	[p13l997t660r1088b687],
10	had	VBD	O	have	_	0	SENT_143	[p13l1100t660r1146b681],
11	duloxetine	NN	O	duloxetine	nn	12	SENT_143	[p13l1158t660r1289b681],
12	concentrations	NNS	O	concentration	dobj	10	SENT_143	[p13l1301t660r1489b681],
13	below	IN	O	below	_	0	SENT_143	[p13l1502t660r1576b681],
14	the	DT	O	the	det	15	SENT_143	[p13l1587t660r1626b681],
15	limit	NN	O	limit	prep_below	10	SENT_143	[p13l1639t660r1689b681],
16	of	IN	O	of	_	0	SENT_143	[p13l1700t659r1724b681],
17	quantitation	NN	O	quantitation	prep_of	15	SENT_143	[p13l1735t660r1891b687],
18	.	.	O	.	_	0	SENT_143	[p13l1735t660r1891b687],

1	Therefore	RB	O	therefore	dep	3	SENT_144	[p13l235t698r367b724],
2	,	,	O	,	_	0	SENT_144	[p13l235t698r367b724],
3	n	NN	O	n	_	0	SENT_144	[p13l381t703r394b720],
4	=	JJ	O	=	amod	3	SENT_144	[p13l407t708r422b716],
5	21	CD	NUMBER	21	tmod	4	SENT_144	[p13l434t698r460b720],
6	in	IN	O	in	_	0	SENT_144	[p13l478t698r497b720],
7	multiple	JJ	O	multiple	amod	8	SENT_144	[p13l511t698r608b726],
8	dosing	NN	O	dosing	prep_in	3	SENT_144	[p13l621t698r704b726],
9	relative	JJ	O	relative	advmod	8	SENT_144	[p13l718t698r809b720],
10	to	TO	O	to	_	0	SENT_144	[p13l820t699r843b720],
11	single	JJ	O	single	amod	12	SENT_144	[p13l855t698r930b726],
12	dosing	NN	O	dosing	prep_to	9	SENT_144	[p13l942t698r1033b726],
13	.	.	O	.	_	0	SENT_144	[p13l942t698r1033b726],

1	Median	JJ	O	median	amod	2	SENT_145	[p13l237t740r329b762],
2	[	NN	O	[	_	0	SENT_145	[p13l342t740r437b768],
3	range	NN	O	range	nn	4	SENT_145	[p13l342t740r437b768],
4	]	NN	O	]	dep	2	SENT_145	[p13l342t740r437b768],
5	.	.	O	.	_	0	SENT_145	[p13l342t740r437b768],

1	The	DT	O	the	det	2	SENT_146	[p13l235t781r284b803],
2	AUC	NN	O	auc	nsubjpass	4	SENT_146	[p13l296t780r356b803],
3	is	VBZ	O	be	auxpass	4	SENT_146	[p13l369t781r387b803],
4	reported	VBN	O	report	_	0	SENT_146	[p13l401t781r506b809],
5	as	IN	O	as	_	0	SENT_146	[p13l518t786r547b803],
6	the	DT	O	the	det	10	SENT_146	[p13l558t781r598b803],
7	AUCoo	NN	O	aucoo	nn	10	SENT_146	[p13l610t780r687b803],
8	and	CC	O	and	_	0	SENT_146	[p13l698t781r745b803],
9	AUC	NN	O	auc	nn	10	SENT_146	[p13l757t780r857b809],
10	¢	NN	O	¢	prep_as	4	SENT_146	[p13l757t780r857b809],
11	,	,	O	,	_	0	SENT_146	[p13l757t780r857b809],
12	ss	NN	O	ss	appos	10	SENT_146	[p13l757t780r857b809],
13	for	IN	O	for	_	0	SENT_146	[p13l868t780r902b803],
14	single	JJ	O	single	amod	17	SENT_146	[p13l913t781r988b809],
15	and	CC	O	and	_	0	SENT_146	[p13l1000t781r1046b803],
16	multiple	JJ	O	multiple	conj_and	14	SENT_146	[p13l1059t781r1157b809],
17	dosing	NN	O	dosing	prep_for	12	SENT_146	[p13l1169t781r1260b809],
18	,	,	O	,	_	0	SENT_146	[p13l1169t781r1260b809],
19	respectively	RB	O	respectively	advmod	4	SENT_146	[p13l1275t781r1432b809],
20	.	.	O	.	_	0	SENT_146	[p13l1275t781r1432b809],

1	The	DT	O	the	det	5	SENT_147	[p13l235t822r284b843],
2	Rac	NN	O	rac	nn	5	SENT_147	[p13l298t822r405b851],
3	(	CD	NUMBER	(	num	5	SENT_147	[p13l298t822r405b851],
4	Auc	NN	MISC	auc	nn	5	SENT_147	[p13l298t822r405b851],
5	)	NN	O	)	nsubjpass	7	SENT_147	[p13l298t822r405b851],
6	is	VBZ	O	be	auxpass	7	SENT_147	[p13l418t822r436b843],
7	calculated	VBN	O	calculate	_	0	SENT_147	[p13l448t822r577b843],
8	as	IN	O	as	_	0	SENT_147	[p13l590t827r619b843],
9	[	NN	O	[	nn	10	SENT_147	[p13l632t821r888b851],
10	AUC1	NN	O	auc1	prep_as	7	SENT_147	[p13l632t821r888b851],
11	,	,	O	,	_	0	SENT_147	[p13l632t821r888b851],
12	ss/AUCr	NN	O	ss/aucr	nn	15	SENT_147	[p13l632t821r888b851],
13	,5	CD	NUMBER	,5	num	15	SENT_147	[p13l632t821r888b851],
14	ing	NN	O	ing	nn	15	SENT_147	[p13l632t821r888b851],
15	|	NN	O	|	appos	10	SENT_147	[p13l632t821r888b851],
16	e	SYM	O	e	dep	18	SENT_147	[p13l632t821r888b851],
17	dose	NN	O	dose	nn	18	SENT_147	[p13l897t821r961b849],
18	]	NN	O	]	rcmod	15	SENT_147	[p13l897t821r961b849],
19	,	,	O	,	_	0	SENT_147	[p13l897t821r961b849],
20	where	WRB	O	where	advmod	26	SENT_147	[p13l974t822r1052b843],
21	T	NN	O	t	nsubj	26	SENT_147	[p13l1064t828r1076b843],
22	is	VBZ	O	be	cop	26	SENT_147	[p13l1088t822r1107b843],
23	the	DT	O	the	det	26	SENT_147	[p13l1118t822r1157b843],
24	24-hour	JJ	DURATION	24-hour	amod	26	SENT_147	[p13l1169t822r1269b843],
25	dosing	NN	O	dosing	nn	26	SENT_147	[p13l1280t822r1364b849],
26	interval	NN	O	interval	rcmod	10	SENT_147	[p13l1377t822r1475b843],
27	.	.	O	.	_	0	SENT_147	[p13l1377t822r1475b843],

1	f	LS	O	f	dep	5	SENT_148	[p13l184t862r192b884],
2	The	DT	O	the	det	3	SENT_148	[p13l235t862r284b885],
3	LI	NNP	O	LI	nsubjpass	5	SENT_148	[p13l298t862r317b884],
4	is	VBZ	O	be	auxpass	5	SENT_148	[p13l332t862r350b885],
5	calculated	VBN	O	calculate	_	0	SENT_148	[p13l362t862r491b885],
6	as	IN	O	as	mark	14	SENT_148	[p13l504t868r533b884],
7	[	NN	O	[	nn	8	SENT_148	[p13l545t862r807b892],
8	AUCt	NN	O	auct	nsubj	14	SENT_148	[p13l545t862r807b892],
9	,	,	O	,	_	0	SENT_148	[p13l545t862r807b892],
10	ss/AUC	NN	O	ss/auc	nn	11	SENT_148	[p13l545t862r807b892],
11	»	NN	O	»	appos	8	SENT_148	[p13l545t862r807b892],
12	<	JJR	O	<	dep	11	SENT_148	[p13l545t862r807b892],
13	,	,	O	,	_	0	SENT_148	[p13l545t862r807b892],
14	sing	VB	O	sing	advcl	5	SENT_148	[p13l545t862r807b892],
15	|	RB	O	|	advmod	14	SENT_148	[p13l545t862r807b892],
16	e	LS	O	e	prep	14	SENT_148	[p13l545t862r807b892],
17	dose	NN	O	dose	nn	18	SENT_148	[p13l816t862r880b890],
18	]	NN	O	]	dep	16	SENT_148	[p13l816t862r880b890],
19	.	.	O	.	_	0	SENT_148	[p13l816t862r880b890],

1	AUC	NN	O	auc	dep	131	SENT_149	[p13l185t903r246b926],
2	=	JJ	O	=	dep	131	SENT_149	[p13l257t913r272b922],
3	area	NN	O	area	dep	131	SENT_149	[p13l283t909r340b926],
4	under	IN	O	under	dep	131	SENT_149	[p13l351t904r424b926],
5	the	DT	O	the	dep	131	SENT_149	[p13l433t904r473b926],
6	plasma	NN	O	plasma	dep	131	SENT_149	[p13l484t904r576b932],
7	concentration	NN	O	concentration	dep	131	SENT_149	[p13l586t904r824b926],
8	—	CD	NUMBER	—	dep	131	SENT_149	[p13l586t904r824b926],
9	time	NN	O	time	dep	131	SENT_149	[p13l586t904r824b926],
10	curve	NN	O	curve	dep	131	SENT_149	[p13l835t909r911b930],
11	;	:	O	;	_	0	SENT_149	[p13l835t909r911b930],
12	AUCM	NN	O	aucm	dep	131	SENT_149	[p13l923t903r1002b926],
13	=	JJ	O	=	dep	131	SENT_149	[p13l1012t913r1028b922],
14	AUC	NN	O	auc	dep	131	SENT_149	[p13l1038t903r1098b926],
15	from	IN	O	from	dep	131	SENT_149	[p13l1108t903r1165b926],
16	time	NN	O	time	dep	131	SENT_149	[p13l1176t904r1230b926],
17	zero	CD	NUMBER	zero	dep	131	SENT_149	[p13l1240t909r1295b926],
18	to	TO	O	to	dep	131	SENT_149	[p13l1305t905r1329b926],
19	infinity	NN	O	infinity	dep	131	SENT_149	[p13l1340t903r1427b932],
20	;	:	O	;	_	0	SENT_149	[p13l1340t903r1427b932],
21	AUC	NN	O	auc	dep	131	SENT_149	[p13l1439t903r1511b929],
22	:	:	O	:	_	0	SENT_149	[p13l1439t903r1511b929],
23	=	JJ	O	=	dep	131	SENT_149	[p13l1521t913r1537b922],
24	AUC	NN	O	auc	dep	131	SENT_149	[p13l1547t903r1607b926],
25	during	IN	O	during	dep	131	SENT_149	[p13l1618t904r1697b932],
26	the	DT	O	the	dep	131	SENT_149	[p13l1707t904r1747b926],
27	dosing	NN	O	dosing	dep	131	SENT_149	[p13l1757t904r1841b932],
28	interval	NN	O	interval	dep	131	SENT_149	[p13l1853t904r1944b926],
29	1	CD	NUMBER	1	dep	131	SENT_149	[p13l1955t910r1973b930],
30	:	:	O	:	_	0	SENT_149	[p13l1955t910r1973b930],
31	;	:	O	;	_	0	SENT_149	[p13l1955t910r1973b930],
32	AUC	NN	O	auc	dep	131	SENT_149	[p13l185t942r289b971],
33	¢	NN	O	¢	dep	131	SENT_149	[p13l185t942r289b971],
34	,	,	O	,	_	0	SENT_149	[p13l185t942r289b971],
35	ss	NN	O	ss	dep	131	SENT_149	[p13l185t942r289b971],
36	=	JJ	O	=	dep	131	SENT_149	[p13l301t952r316b961],
37	AUC	NN	O	auc	dep	131	SENT_149	[p13l327t942r398b968],
38	:	:	O	:	_	0	SENT_149	[p13l327t942r398b968],
39	at	IN	O	at	dep	131	SENT_149	[p13l409t944r432b965],
40	steady	JJ	O	steady	dep	131	SENT_149	[p13l443t943r528b971],
41	state	NN	O	state	dep	131	SENT_149	[p13l539t944r607b969],
42	;	:	O	;	_	0	SENT_149	[p13l539t944r607b969],
43	Cams	NNS	O	cam	dep	131	SENT_149	[p13l620t942r698b971],
44	;	:	O	;	_	0	SENT_149	[p13l620t942r698b971],
45	=	JJ	O	=	dep	131	SENT_149	[p13l709t952r724b961],
46	average	JJ	O	average	dep	131	SENT_149	[p13l736t948r839b971],
47	steady-state	JJ	O	steady-state	dep	131	SENT_149	[p13l851t943r1008b971],
48	concentration	NN	O	concentration	dep	131	SENT_149	[p13l1020t943r1200b969],
49	;	:	O	;	_	0	SENT_149	[p13l1020t943r1200b969],
50	CLIF	NN	O	clif	dep	131	SENT_149	[p13l1213t942r1276b965],
51	=	JJ	O	=	dep	131	SENT_149	[p13l1287t952r1303b961],
52	apparent	JJ	O	apparent	dep	131	SENT_149	[p13l1314t944r1428b971],
53	oral	JJ	O	oral	dep	131	SENT_149	[p13l1439t943r1485b965],
54	clearance	NN	O	clearance	dep	131	SENT_149	[p13l1497t943r1629b968],
55	;	:	O	;	_	0	SENT_149	[p13l1497t943r1629b968],
56	Cmax	NN	O	cmax	dep	131	SENT_149	[p13l1642t942r1708b968],
57	=	JJ	O	=	dep	131	SENT_149	[p13l1719t952r1735b961],
58	rnaximum	NN	O	rnaximum	dep	131	SENT_149	[p13l1747t943r1870b965],
59	plasma	NN	O	plasma	dep	131	SENT_149	[p13l1883t943r1975b971],
60	concentration	NN	O	concentration	dep	131	SENT_149	[p13l185t982r365b1008],
61	;	:	O	;	_	0	SENT_149	[p13l185t982r365b1008],
62	cmin	NN	O	cmin	dep	131	SENT_149	[p13l377t981r470b1010],
63	,	,	O	,	_	0	SENT_149	[p13l377t981r470b1010],
64	ss	NN	O	ss	dep	131	SENT_149	[p13l377t981r470b1010],
65	=	JJ	O	=	dep	131	SENT_149	[p13l480t991r496b1000],
66	minimum	JJ	O	minimum	dep	131	SENT_149	[p13l507t982r622b1004],
67	plasma	NN	O	plasma	dep	131	SENT_149	[p13l634t982r726b1010],
68	concentration	NN	O	concentration	dep	131	SENT_149	[p13l736t982r908b1004],
69	at	IN	O	at	dep	131	SENT_149	[p13l920t983r943b1004],
70	steady	JJ	O	steady	dep	131	SENT_149	[p13l953t982r1037b1010],
71	state	NN	O	state	dep	131	SENT_149	[p13l1047t983r1115b1008],
72	;	:	O	;	_	0	SENT_149	[p13l1047t983r1115b1008],
73	Ll	NN	O	ll	dep	131	SENT_149	[p13l1128t982r1151b1003],
74	=	JJ	O	=	dep	131	SENT_149	[p13l1162t991r1177b1000],
75	linearity	NN	O	linearity	dep	131	SENT_149	[p13l1188t982r1287b1010],
76	index	NN	O	index	dep	131	SENT_149	[p13l1298t982r1371b1008],
77	;	:	O	;	_	0	SENT_149	[p13l1298t982r1371b1008],
78	NA	NN	O	na	dep	131	SENT_149	[p13l1384t982r1424b1003],
79	=	JJ	O	=	dep	131	SENT_149	[p13l1434t991r1449b1000],
80	not	RB	O	not	dep	131	SENT_149	[p13l1461t983r1499b1004],
81	applicable	JJ	O	applicable	dep	131	SENT_149	[p13l1509t982r1645b1010],
82	;	:	O	;	_	0	SENT_149	[p13l1509t982r1645b1010],
83	Racuruc	NN	O	racuruc	dep	131	SENT_149	[p13l1658t982r1769b1011],
84	)	NN	O	)	dep	131	SENT_149	[p13l1658t982r1769b1011],
85	=	JJ	O	=	dep	131	SENT_149	[p13l1779t991r1794b1000],
86	accumulation	NN	O	accumulation	dep	131	SENT_149	[p13l1805t982r1974b1004],
87	ratio	NN	O	ratio	dep	131	SENT_149	[p13l186t1021r246b1046],
88	;	:	O	;	_	0	SENT_149	[p13l186t1021r246b1046],
89	tr/2	NN	O	tr/2	dep	131	SENT_149	[p13l257t1022r286b1045],
90	=	JJ	O	=	dep	131	SENT_149	[p13l295t1030r310b1039],
91	elimination	NN	O	elimination	dep	131	SENT_149	[p13l320t1021r457b1042],
92	half	NN	O	half	dep	131	SENT_149	[p13l469t1020r567b1046],
93	—	CD	NUMBER	—	dep	131	SENT_149	[p13l469t1020r567b1046],
94	life	NN	O	life	dep	131	SENT_149	[p13l469t1020r567b1046],
95	;	:	O	;	_	0	SENT_149	[p13l469t1020r567b1046],
96	tnag	NN	O	tnag	dep	131	SENT_149	[p13l577t1022r619b1050],
97	=	JJ	O	=	dep	131	SENT_149	[p13l630t1030r645b1039],
98	time	NN	O	time	dep	131	SENT_149	[p13l654t1021r708b1042],
99	before	IN	O	before	dep	131	SENT_149	[p13l719t1020r799b1042],
100	start	NN	O	start	dep	131	SENT_149	[p13l809t1022r864b1042],
101	of	IN	O	of	dep	131	SENT_149	[p13l874t1020r897b1042],
102	drug	NN	O	drug	dep	131	SENT_149	[p13l906t1021r962b1048],
103	absorption	NN	O	absorption	dep	131	SENT_149	[p13l973t1021r1114b1048],
104	;	:	O	;	_	0	SENT_149	[p13l973t1021r1114b1048],
105	tmax	NN	O	tmax	dep	131	SENT_149	[p13l1124t1022r1180b1045],
106	=	JJ	O	=	dep	131	SENT_149	[p13l1190t1030r1205b1039],
107	time	NN	O	time	dep	131	SENT_149	[p13l1214t1021r1268b1042],
108	to	TO	O	to	dep	131	SENT_149	[p13l1277t1022r1301b1042],
109	reach	VB	O	reach	dep	131	SENT_149	[p13l1312t1021r1381b1042],
110	Cmax	NNP	O	Cmax	dep	131	SENT_149	[p13l1392t1020r1461b1046],
111	;	:	O	;	_	0	SENT_149	[p13l1392t1020r1461b1046],
112	VsslF	NN	O	vsslf	dep	131	SENT_149	[p13l1473t1020r1543b1045],
113	=	JJ	O	=	dep	131	SENT_149	[p13l1552t1030r1568b1039],
114	apparent	JJ	O	apparent	dep	131	SENT_149	[p13l1577t1022r1691b1048],
115	volume	NN	O	volume	dep	131	SENT_149	[p13l1700t1021r1793b1042],
116	of	IN	O	of	dep	131	SENT_149	[p13l1803t1020r1826b1042],
117	distribution	NN	O	distribution	dep	131	SENT_149	[p13l1835t1021r1974b1042],
118	at	IN	O	at	dep	131	SENT_149	[p13l185t1061r208b1081],
119	steady	JJ	O	steady	dep	131	SENT_149	[p13l219t1059r304b1087],
120	state	NN	O	state	dep	131	SENT_149	[p13l316t1061r377b1081],
121	after	IN	O	after	dep	131	SENT_149	[p13l389t1059r447b1081],
122	oral	JJ	O	oral	dep	131	SENT_149	[p13l458t1059r504b1081],
123	administration	NN	O	administration	dep	131	SENT_149	[p13l516t1059r703b1085],
124	;	:	O	;	_	0	SENT_149	[p13l516t1059r703b1085],
125	*	CD	NUMBER	*	dep	131	SENT_149	[p13l716t1059r726b1069],
126	p	NN	O	p	dep	131	SENT_149	[p13l738t1064r752b1087],
127	<	JJR	O	<	dep	131	SENT_149	[p13l764t1066r779b1080],
128	0.001	CD	NUMBER	0.001	dep	131	SENT_149	[p13l791t1060r858b1081],
129	vs	CC	O	vs	dep	131	SENT_149	[p13l874t1064r902b1081],
130	single	JJ	O	single	dep	131	SENT_149	[p13l914t1059r988b1087],
131	dosing	NN	O	dosing	_	0	SENT_149	[p13l1000t1059r1091b1087],
132	.	.	O	.	_	0	SENT_149	[p13l1000t1059r1091b1087],

1	o	NN	O	o	_	0	SENT_150	[p13l185t660r199b681],
2	'	''	O	'	_	0	SENT_150	[p13l185t660r199b681],

1	CDQO	NN	O	cdqo	_	0	SENT_151	[p13l185t745r199b843],

1	©	RB	O	©	advmod	2	SENT_152	[p13l185t1174r203b1192],
2	2007	CD	DATE	2007	_	0	SENT_152	[p13l212t1172r265b1192],
3	Adis	NNP	ORGANIZATION	Adis	nn	5	SENT_152	[p13l275t1172r324b1192],
4	Data	NNP	ORGANIZATION	Data	nn	5	SENT_152	[p13l334t1172r392b1192],
5	Information	NNP	ORGANIZATION	Information	dep	2	SENT_152	[p13l402t1172r538b1192],
6	BV	NN	ORGANIZATION	bv	dep	5	SENT_152	[p13l548t1172r583b1192],
7	.	.	O	.	_	0	SENT_152	[p13l548t1172r583b1192],

1	All	DT	O	all	det	2	SENT_153	[p13l593t1172r620b1192],
2	rights	NNS	O	rights	nsubj	3	SENT_153	[p13l630t1172r691b1197],
3	reserved	VBN	O	reserve	_	0	SENT_153	[p13l700t1172r808b1192],
4	.	.	O	.	_	0	SENT_153	[p13l700t1172r808b1192],

1	Clin	NNP	O	Clin	nn	2	SENT_154	[p13l1594t1172r1637b1192],
2	Phdrmocokinef	NNP	O	Phdrmocokinef	_	0	SENT_154	[p13l1647t1172r1831b1192],
3	2007	CD	DATE	2007	dep	2	SENT_154	[p13l1839t1172r1899b1193],
4	:	:	O	:	_	0	SENT_154	[p13l1839t1172r1899b1193],
5	46	CD	NUMBER	46	dep	2	SENT_154	[p13l1908t1172r1935b1192],
6	(	CD	NUMBER	(	number	7	SENT_154	[p13l1945t1172r1974b1195],
7	9	CD	NUMBER	9	num	8	SENT_154	[p13l1945t1172r1974b1195],
8	)	NN	O	)	dep	5	SENT_154	[p13l1945t1172r1974b1195],

1	772	CD	NUMBER	772	num	2	SENT_155	[p13l185t1273r233b1297],
2	Tiunmei	NNP	O	Tiunmei	_	0	SENT_155	[p13l1790t1272r1899b1297],
3	et	FW	O	et	nn	4	SENT_155	[p13l1910t1275r1933b1297],
4	ul	FW	O	ul	dep	2	SENT_155	[p13l1944t1272r1973b1297],
5	.	.	O	.	_	0	SENT_155	[p13l1944t1272r1973b1297],

1	E	NN	O	e	_	0	SENT_156	[p13l38t1961r107b2017],
2	EL	NN	O	el	dep	1	SENT_156	[p13l38t2020r107b2101],
3	.	.	O	.	_	0	SENT_156	[p13l1798t2068r1823b2093],

1	,	,	O	,	_	0	SENT_157	[p13l39t2128r92b2164],
2	_	NN	O	_	_	0	SENT_157	[p13l39t2128r92b2164],
3	,	,	O	,	_	0	SENT_157	[p13l39t2128r92b2164],
4	_	NN	O	_	dobj	2	SENT_157	[p13l39t2128r92b2164],
5	300	CD	NUMBER	300	number	7	SENT_157	[p13l157t2092r274b2145],
6	3	CD	NUMBER	3	number	7	SENT_157	[p13l38t2169r93b2225],
7	O	NN	O	o	amod	4	SENT_157	[p13l38t2233r93b2280],

1	200	CD	NUMBER	200	_	0	SENT_158	[p13l157t2284r274b2337],
2	Q	NNP	O	Q	nn	3	SENT_158	[p13l528t2341r699b2643],
3	Q	NNP	O	Q	dep	1	SENT_158	[p13l1371t2452r1543b2632],

1	Women	NNP	O	Women	nn	4	SENT_159	[p13l493t2756r738b2809],
2	Men	NNP	O	Men	nn	4	SENT_159	[p13l903t2756r1034b2809],
3	Women	NNP	O	Women	nn	4	SENT_159	[p13l1333t2756r1577b2809],
4	Men	NNP	O	Men	_	0	SENT_159	[p13l1745t2756r1876b2809],
5	(	CD	NUMBER	(	num	6	SENT_159	[p13l496t2842r738b2910],
6	n	NN	O	n	dep	4	SENT_159	[p13l496t2842r738b2910],
7	=	JJ	O	=	quantmod	9	SENT_159	[p13l496t2842r738b2910],
8	10	CD	NUMBER	10	number	9	SENT_159	[p13l496t2842r738b2910],
9	)	CD	NUMBER	)	num	24	SENT_159	[p13l496t2842r738b2910],
10	(	NN	O	(	nn	24	SENT_159	[p13l848t2842r1090b2910],
11	n	NN	O	n	nn	24	SENT_159	[p13l848t2842r1090b2910],
12	=	JJ	O	=	amod	24	SENT_159	[p13l848t2842r1090b2910],
13	13	CD	NUMBER	13	number	14	SENT_159	[p13l848t2842r1090b2910],
14	)	CD	NUMBER	)	num	24	SENT_159	[p13l848t2842r1090b2910],
15	(	NN	O	(	nn	24	SENT_159	[p13l1355t2842r1558b2910],
16	n	NN	O	n	nn	24	SENT_159	[p13l1355t2842r1558b2910],
17	=	JJ	O	=	amod	24	SENT_159	[p13l1355t2842r1558b2910],
18	9	CD	NUMBER	9	num	19	SENT_159	[p13l1355t2842r1558b2910],
19	)	NN	O	)	amod	24	SENT_159	[p13l1355t2842r1558b2910],
20	(	NN	O	(	nn	24	SENT_159	[p13l1690t2842r1932b2910],
21	n	NN	O	n	nn	24	SENT_159	[p13l1690t2842r1932b2910],
22	=	JJ	O	=	amod	24	SENT_159	[p13l1690t2842r1932b2910],
23	12	CD	NUMBER	12	num	24	SENT_159	[p13l1690t2842r1932b2910],
24	)	NN	O	)	dep	6	SENT_159	[p13l1690t2842r1932b2910],

1	Single	JJ	O	single	amod	2	SENT_160	[p13l597t2943r792b3012],
2	dose	NN	O	dose	_	0	SENT_160	[p13l817t2944r970b2997],
3	Multiple	JJ	O	multiple	amod	4	SENT_160	[p13l1398t2944r1640b3011],
4	doses	NNS	O	dose	dep	2	SENT_160	[p13l1665t2944r1853b2997],

1	Fig	NN	O	fig	_	0	SENT_161	[p13l11t3044r130b3112],
2	.	.	O	.	_	0	SENT_161	[p13l11t3044r130b3112],

1	2	LS	NUMBER	2	_	0	SENT_162	[p13l158t3045r212b3097],
2	.	.	O	.	_	0	SENT_162	[p13l158t3045r212b3097],

1	Comparison	NN	O	comparison	_	0	SENT_163	[p13l242t3043r625b3112],
2	of	IN	O	of	_	0	SENT_163	[p13l653t3044r711b3098],
3	duloxetine	NN	O	duloxetine	nn	9	SENT_163	[p13l736t3044r1060b3098],
4	apparent	JJ	O	apparent	amod	9	SENT_163	[p13l1088t3048r1370b3112],
5	oral	JJ	O	oral	amod	9	SENT_163	[p13l1395t3044r1509b3098],
6	clearance	NN	O	clearance	nn	9	SENT_163	[p13l1538t3044r1847b3098],
7	(	CD	NUMBER	(	num	9	SENT_163	[p13l1876t3043r2072b3112],
8	CL/F	NN	O	cl/f	nn	9	SENT_163	[p13l1876t3043r2072b3112],
9	)	NN	O	)	prep_of	1	SENT_163	[p13l1876t3043r2072b3112],
10	in	IN	O	in	_	0	SENT_163	[p13l2103t3044r2151b3097],
11	healthy	JJ	O	healthy	amod	13	SENT_163	[p13l10t3135r238b3203],
12	Chinese	JJ	MISC	chinese	amod	13	SENT_163	[p13l272t3134r532b3189],
13	men	NNS	O	man	prep_in	9	SENT_163	[p13l569t3149r702b3189],
14	and	CC	O	and	_	0	SENT_163	[p13l739t3135r853b3189],
15	women	NNS	O	woman	conj_and	13	SENT_163	[p13l888t3149r1116b3189],
16	following	VBG	O	follow	_	0	SENT_163	[p13l1152t3135r1429b3203],
17	oral	JJ	O	oral	amod	18	SENT_163	[p13l1465t3135r1579b3189],
18	administration	NN	O	administration	prep_following	13	SENT_163	[p13l1616t3135r2060b3189],
19	of	IN	O	of	_	0	SENT_163	[p13l2097t3135r2154b3189],
20	60mg	JJ	O	60mg	prep_of	18	SENT_163	[p13l8t3228r182b3295],
21	as	IN	O	as	_	0	SENT_163	[p13l209t3240r280b3281],
22	a	DT	O	a	det	24	SENT_163	[p13l305t3240r342b3281],
23	single	JJ	O	single	amod	24	SENT_163	[p13l365t3227r549b3295],
24	dose	NN	O	dose	prep_as	20	SENT_163	[p13l574t3227r726b3281],
25	or	CC	O	or	_	0	SENT_163	[p13l751t3240r813b3280],
26	as	IN	O	as	_	0	SENT_163	[p13l835t3240r907b3281],
27	multiple	JJ	O	multiple	amod	28	SENT_163	[p13l934t3227r1176b3295],
28	doses	NNS	O	dose	prep_as	20	SENT_163	[p13l1201t3227r1406b3281],
29	.	.	O	.	_	0	SENT_163	[p13l1201t3227r1406b3281],

1	The	DT	O	the	det	3	SENT_164	[p13l1432t3227r1554b3281],
2	box	NN	O	box	nn	3	SENT_164	[p13l1580t3227r1692b3281],
3	plots	NNS	O	plot	nsubj	4	SENT_164	[p13l1716t3227r1864b3295],
4	illustrate	VBP	O	illustrate	_	0	SENT_164	[p13l1890t3227r2153b3281],
5	the	DT	O	the	det	6	SENT_164	[p13l6t3318r103b3372],
6	medians	NNS	O	median	nsubj	9	SENT_164	[p13l138t3318r405b3372],
7	and	CC	O	and	_	0	SENT_164	[p13l438t3318r552b3372],
8	interquartile	NN	O	interquartile	nsubj	9	SENT_164	[p13l588t3318r959b3386],
9	ranges	VBZ	O	range	ccomp	4	SENT_164	[p13l995t3332r1208b3386],
10	(	RB	O	(	advmod	11	SENT_164	[p13l1244t3317r1580b3386],
11	25th	JJ	ORDINAL	25th	amod	14	SENT_164	[p13l1244t3317r1580b3386],
12	—	NN	O	—	nn	14	SENT_164	[p13l1244t3317r1580b3386],
13	75th	JJ	ORDINAL	75th	amod	14	SENT_164	[p13l1244t3317r1580b3386],
14	percentiles	NNS	O	percentile	dobj	9	SENT_164	[p13l1617t3317r2000b3386],
15	)	RB	O	)	advmod	9	SENT_164	[p13l1617t3317r2000b3386],
16	,	,	O	,	_	0	SENT_164	[p13l1617t3317r2000b3386],
17	and	CC	O	and	_	0	SENT_164	[p13l2036t3318r2151b3372],
18	the	DT	O	the	det	19	SENT_164	[p13l6t3410r103b3464],
19	whiskers	NNS	O	whisker	nsubj	20	SENT_164	[p13l132t3410r410b3464],
20	represent	VBP	O	represent	conj_and	4	SENT_164	[p13l443t3414r743b3476],
21	the	DT	O	the	det	25	SENT_164	[p13l770t3410r867b3464],
22	10th	JJ	ORDINAL	10th	amod	25	SENT_164	[p13l902t3410r1032b3465],
23	and	CC	ORDINAL	and	_	0	SENT_164	[p13l1063t3410r1178b3464],
24	90th	JJ	ORDINAL	90th	amod	25	SENT_164	[p13l1210t3410r1343b3465],
25	percentiles	NNS	O	percentile	dobj	20	SENT_164	[p13l1377t3410r1737b3476],
26	.	.	O	.	_	0	SENT_164	[p13l1377t3410r1737b3476],

1	reported	VBN	O	report	dep	5	SENT_165	[p13l6t3662r349b3756],
2	(	RB	O	(	advmod	1	SENT_165	[p13l389t3662r618b3751],
3	table	NN	O	table	dobj	1	SENT_165	[p13l389t3662r618b3751],
4	I	PRP	O	I	nsubj	5	SENT_165	[p13l656t3663r742b3751],
5	)	VBP	O	)	_	0	SENT_165	[p13l656t3663r742b3751],
6	.	.	O	.	_	0	SENT_165	[p13l656t3663r742b3751],

1	The	DT	O	the	det	3	SENT_166	[p13l785t3662r942b3734],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_166	[p13l979t3662r1664b3756],
3	parameters	NNS	O	parameter	nsubj	5	SENT_166	[p13l1702t3673r2152b3756],
4	were	VBD	O	be	cop	5	SENT_166	[p14l7t47r204b97],
5	similar	JJ	O	similar	_	0	SENT_166	[p14l269t25r552b97],
6	in	IN	O	in	_	0	SENT_166	[p14l611t25r688b96],
7	CYP2D6	NN	O	cyp2d6	prep_in	5	SENT_166	[p14l750t24r1124b97],
8	extensive	JJ	O	extensive	amod	9	SENT_166	[p14l1187t25r1573b97],
9	metabolisers	NNS	O	metaboliser	nsubj	10	SENT_166	[p14l1634t25r2151b97],
10	(	VBP	O	(	rcmod	7	SENT_166	[p14l10t156r90b244],
11	n	NN	O	n	dobj	10	SENT_166	[p14l10t156r90b244],
12	=	JJ	O	=	amod	11	SENT_166	[p14l123t186r176b213],
13	12	CD	NUMBER	12	tmod	12	SENT_166	[p14l219t155r331b240],
14	,	,	O	,	_	0	SENT_166	[p14l219t155r331b240],
15	mean	VB	O	mean	dep	10	SENT_166	[p14l367t178r589b227],
16	CL/F	NN	O	cl/f	dobj	15	SENT_166	[p14l621t155r836b227],
17	86.2	CD	NUMBER	86.2	num	25	SENT_166	[p14l871t155r1044b227],
18	L/h	NN	O	l/h	nn	25	SENT_166	[p14l1077t155r1240b240],
19	,	,	O	,	_	0	SENT_166	[p14l1077t155r1240b240],
20	Vss/F	NN	O	vss/f	dep	25	SENT_166	[p14l1276t155r1498b237],
21	1507L	NN	O	1507l	nn	25	SENT_166	[p14l1539t155r1818b240],
22	,	,	O	,	_	0	SENT_166	[p14l1539t155r1818b240],
23	t1/2	NN	O	t1/2	dep	25	SENT_166	[p14l1854t166r1944b238],
24	10.6	CD	DURATION	10.6	num	25	SENT_166	[p14l1985t155r2152b227],
25	hours	NNS	NUMBER	hour	tmod	15	SENT_166	[p14l6t282r265b371],
26	)	CD	NUMBER	)	nsubj	32	SENT_166	[p14l6t282r265b371],
27	compared	VBN	O	compare	_	0	SENT_166	[p14l372t282r776b376],
28	with	IN	O	with	prepc_compared_with	26	SENT_166	[p14l878t282r1059b355],
29	CYP2D6	NN	O	cyp2d6	nn	31	SENT_166	[p14l1163t282r1536b355],
30	intermediate	JJ	O	intermediate	amod	31	SENT_166	[p14l1640t282r2153b354],
31	metabolisers	NNS	O	metaboliser	pobj	26	SENT_166	[p14l7t413r524b485],
32	(	VBP	O	(	rcmod	25	SENT_166	[p14l581t414r661b501],
33	n	NN	O	n	dobj	32	SENT_166	[p14l581t414r661b501],
34	=	JJ	O	=	amod	33	SENT_166	[p14l714t443r766b471],
35	8	CD	NUMBER	8	tmod	34	SENT_166	[p14l823t413r890b498],
36	,	,	O	,	_	0	SENT_166	[p14l823t413r890b498],
37	mean	VB	O	mean	dep	10	SENT_166	[p14l945t435r1166b485],
38	CL/F	NN	O	cl/f	nn	40	SENT_166	[p14l1219t413r1434b485],
39	74.6	CD	NUMBER	74.6	num	40	SENT_166	[p14l1485t413r1661b485],
40	L/h	NN	O	l/h	dobj	37	SENT_166	[p14l1713t413r1876b498],
41	,	,	O	,	_	0	SENT_166	[p14l1713t413r1876b498],
42	Vss/F	NN	O	vss/f	nn	43	SENT_166	[p14l1932t413r2154b495],
43	1505L	NN	O	1505l	appos	40	SENT_166	[p14l17t540r296b626],
44	,	,	O	,	_	0	SENT_166	[p14l17t540r296b626],
45	t1/2	NN	O	t1/2	appos	40	SENT_166	[p14l333t551r424b623],
46	12.5	CD	DURATION	12.5	num	47	SENT_166	[p14l467t540r631b613],
47	hours	NNS	NUMBER	hour	tmod	45	SENT_166	[p14l668t540r951b628],
48	)	RB	O	)	advmod	37	SENT_166	[p14l668t540r951b628],
49	.	.	O	.	_	0	SENT_166	[p14l668t540r951b628],

1	Comparison	NN	O	comparison	_	0	SENT_167	[p14l140t677r680b765],
2	of	IN	O	of	_	0	SENT_167	[p14l717t678r803b749],
3	Duloxeiine	NNP	PERSON	Duloxeiine	nn	4	SENT_167	[p14l837t678r1303b749],
4	Pharmacokineiics	NNP	PERSON	Pharmacokineiics	prep_of	1	SENT_167	[p14l1341t678r2133b749],
5	in	IN	O	in	_	0	SENT_167	[p14l142t813r206b883],
6	Chinese	NNP	MISC	Chinese	nn	11	SENT_167	[p14l243t812r626b889],
7	,	,	O	,	_	0	SENT_167	[p14l243t812r626b889],
8	Japanese	NNP	MISC	Japanese	nn	11	SENT_167	[p14l657t813r1100b900],
9	and	CC	O	and	_	0	SENT_167	[p14l1135t813r1309b884],
10	Caucasian	NNP	MISC	Caucasian	nn	11	SENT_167	[p14l140t947r624b1019],
11	Subjecis	NNP	MISC	Subjecis	prep_in	1	SENT_167	[p14l658t947r1026b1035],

1	Statistical	JJ	O	statistical	amod	2	SENT_168	[p14l141t1191r541b1263],
2	analyses	NNS	O	analysis	nsubj	3	SENT_168	[p14l569t1191r910b1284],
3	revealed	VBD	O	reveal	_	0	SENT_168	[p14l937t1191r1285b1263],
4	no	DT	O	no	det	6	SENT_168	[p14l1309t1214r1408b1263],
5	significant	JJ	O	significant	amod	6	SENT_168	[p14l1439t1191r1868b1284],
6	differences	NNS	O	difference	dobj	3	SENT_168	[p14l1893t1191r2149b1263, p14l15t1342r238b1391],
7	across	IN	O	across	_	0	SENT_168	[p14l280t1342r530b1391],
8	the	DT	O	the	det	11	SENT_168	[p14l569t1319r692b1391],
9	three	CD	NUMBER	three	num	11	SENT_168	[p14l730t1319r932b1391],
10	racial	JJ	O	racial	amod	11	SENT_168	[p14l969t1319r1196b1391],
11	groups	NNS	O	group	prep_across	3	SENT_168	[p14l1235t1342r1508b1412],
12	for	IN	O	for	_	0	SENT_168	[p14l1549t1319r1667b1391],
13	all	DT	O	all	det	16	SENT_168	[p14l1705t1319r1803b1391],
14	duloxetine	JJ	O	duloxetine	amod	16	SENT_168	[p14l1842t1319r2149b1391, p14l14t1447r165b1519],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_168	[p14l191t1447r873b1540],
16	parameters	NNS	O	parameter	prep_for	11	SENT_168	[p14l900t1458r1348b1540],
17	following	VBG	O	follow	_	0	SENT_168	[p14l1377t1447r1773b1540],
18	single	JJ	O	single	amod	21	SENT_168	[p14l1804t1447r2043b1540],
19	or	CC	O	or	_	0	SENT_168	[p14l2071t1470r2154b1519],
20	multiple	JJ	O	multiple	conj_or	18	SENT_168	[p14l14t1575r354b1668],
21	dosing	NN	O	dosing	prep_following	3	SENT_168	[p14l389t1575r682b1668],
22	,	,	O	,	_	0	SENT_168	[p14l389t1575r682b1668],
23	except	IN	O	except	_	0	SENT_168	[p14l721t1586r987b1668],
24	for	IN	O	for	prepc_except_for	3	SENT_168	[p14l1020t1575r1138b1647],
25	the	DT	O	the	det	30	SENT_168	[p14l1169t1575r1292b1647],
26	tmax	NN	O	tmax	nn	30	SENT_168	[p14l1326t1586r1494b1657],
27	(	NN	O	(	nn	30	SENT_168	[p14l1531t1575r1759b1664],
28	table	NN	O	table	nn	30	SENT_168	[p14l1531t1575r1759b1664],
29	II	CD	NUMBER	ii	num	30	SENT_168	[p14l1793t1576r1913b1664],
30	)	NN	O	)	pobj	3	SENT_168	[p14l1793t1576r1913b1664],
31	.	.	O	.	_	0	SENT_168	[p14l1793t1576r1913b1664],

1	Safeiy	NNP	PERSON	Safeiy	_	0	SENT_169	[p14l138t1853r415b1941],
2	and	CC	O	and	_	0	SENT_169	[p14l448t1854r622b1925],
3	Tolerabiliiy	NNP	PERSON	Tolerabiliiy	conj_and	1	SENT_169	[p14l656t1854r1124b1941],

1	Twenty-six	CD	NUMBER	twenty-six	number	2	SENT_170	[p14l138t2096r604b2190],
2	(	CD	NUMBER	(	nsubj	12	SENT_170	[p14l636t2097r761b2185],
3	23	CD	NUMBER	23	num	4	SENT_170	[p14l636t2097r761b2185],
4	duloxetine	NN	O	duloxetine	dep	2	SENT_170	[p14l796t2096r1249b2181],
5	,	,	O	,	_	0	SENT_170	[p14l796t2096r1249b2181],
6	3	CD	NUMBER	3	num	8	SENT_170	[p14l1284t2097r1324b2169],
7	placebo	NN	O	placebo	nn	8	SENT_170	[p14l1357t2096r1706b2190],
8	)	NN	O	)	appos	2	SENT_170	[p14l1357t2096r1706b2190],
9	of	IN	O	of	_	0	SENT_170	[p14l1739t2096r1828b2168],
10	32	CD	NUMBER	32	num	11	SENT_170	[p14l1852t2097r1949b2169],
11	subjects	NNS	O	subject	prep_of	8	SENT_170	[p14l1981t2096r2149b2168, p14l6t2225r198b2319],
12	reported	VBD	O	report	dep	33	SENT_170	[p14l246t2225r588b2319],
13	a	DT	O	a	det	14	SENT_170	[p14l636t2248r678b2297],
14	total	NN	O	total	nsubj	19	SENT_170	[p14l724t2225r904b2297],
15	of	IN	O	of	_	0	SENT_170	[p14l952t2225r1041b2297],
16	84	CD	NUMBER	84	num	18	SENT_170	[p14l1085t2226r1180b2298],
17	adverse	JJ	O	adverse	amod	18	SENT_170	[p14l1230t2225r1539b2298],
18	events	NNS	O	event	prep_of	14	SENT_170	[p14l1587t2236r1844b2298],
19	(	VBP	O	(	ccomp	12	SENT_170	[p14l1897t2226r2027b2314],
20	80	CD	NUMBER	80	dobj	19	SENT_170	[p14l1897t2226r2027b2314],
21	in	IN	O	in	_	0	SENT_170	[p14l2075t2225r2152b2297],
22	duloxetine	NN	O	duloxetine	prep_in	19	SENT_170	[p14l16t2354r761b2426],
23	—	CD	NUMBER	—	num	25	SENT_170	[p14l16t2354r761b2426],
24	treated	JJ	O	treated	amod	25	SENT_170	[p14l16t2354r761b2426],
25	subjects	NNS	O	subject	dep	22	SENT_170	[p14l796t2354r1119b2448],
26	and	CC	O	and	_	0	SENT_170	[p14l1156t2354r1300b2426],
27	4	CD	NUMBER	4	conj_and	22	SENT_170	[p14l1330t2355r1378b2426],
28	in	IN	O	in	_	0	SENT_170	[p14l1412t2354r1489b2426],
29	placebo	NN	O	placebo	prep_in	27	SENT_170	[p14l1519t2354r2153b2448],
30	—	CD	NUMBER	—	num	32	SENT_170	[p14l1519t2354r2153b2448],
31	treated	JJ	O	treated	amod	32	SENT_170	[p14l1519t2354r2153b2448],
32	subjects	NNS	O	subject	nsubj	33	SENT_170	[p14l18t2483r374b2577],
33	)	VBP	O	)	conj_or	33	SENT_170	[p14l18t2483r374b2577],
34	on	IN	O	on	_	0	SENT_170	[p14l409t2506r507b2555],
35	or	CC	O	or	_	0	SENT_170	[p14l538t2506r622b2555],
36	after	IN	O	after	_	0	SENT_170	[p14l652t2483r837b2555],
37	the	DT	O	the	det	39	SENT_170	[p14l864t2483r987b2555],
38	first	JJ	ORDINAL	first	amod	39	SENT_170	[p14l1018t2483r1182b2555],
39	dose	NN	O	dose	prep_on	33	SENT_170	[p14l1211t2483r1395b2555],
40	of	IN	O	of	_	0	SENT_170	[p14l1427t2483r1515b2555],
41	the	DT	O	the	det	43	SENT_170	[p14l1538t2483r1660b2555],
42	study	NN	O	study	nn	43	SENT_170	[p14l1694t2483r1910b2577],
43	drug	NN	O	drug	prep_of	39	SENT_170	[p14l1941t2483r2147b2577],
44	.	.	O	.	_	0	SENT_170	[p14l1941t2483r2147b2577],

1	Eighty	CD	NUMBER	eighty	num	5	SENT_171	[p14l14t2612r525b2706],
2	—	CD	NUMBER	—	num	5	SENT_171	[p14l14t2612r525b2706],
3	three	CD	NUMBER	three	num	5	SENT_171	[p14l14t2612r525b2706],
4	adverse	JJ	O	adverse	amod	5	SENT_171	[p14l560t2612r869b2685],
5	events	NNS	O	event	nsubjpass	24	SENT_171	[p14l903t2623r1159b2685],
6	(	VBP	O	(	rcmod	5	SENT_171	[p14l1197t2613r1328b2701],
7	80	CD	NUMBER	80	nsubj	11	SENT_171	[p14l1197t2613r1328b2701],
8	in	IN	O	in	_	0	SENT_171	[p14l1360t2612r1438b2684],
9	duloxetine	NN	O	duloxetine	prep_in	7	SENT_171	[p14l1470t2612r2149b2684],
10	—	RB	O	—	advmod	11	SENT_171	[p14l1470t2612r2149b2684],
11	treat	VB	O	treat	ccomp	6	SENT_171	[p14l1470t2612r2149b2684],
12	—	CD	NUMBER	—	num	14	SENT_171	[p14l1470t2612r2149b2684],
13	ed	JJ	O	ed	amod	14	SENT_171	[p14l15t2741r110b2813],
14	subjects	NNS	O	subject	nsubj	22	SENT_171	[p14l148t2741r471b2835],
15	and	CC	O	and	_	0	SENT_171	[p14l511t2741r656b2813],
16	3	CD	NUMBER	3	nsubj	22	SENT_171	[p14l694t2742r734b2814],
17	in	IN	O	in	_	0	SENT_171	[p14l775t2741r853b2813],
18	placebo	NN	O	placebo	prep_in	16	SENT_171	[p14l888t2741r1521b2835],
19	—	CD	NUMBER	—	num	21	SENT_171	[p14l888t2741r1521b2835],
20	treated	JJ	O	treated	amod	21	SENT_171	[p14l888t2741r1521b2835],
21	subjects	NNS	O	subject	dep	16	SENT_171	[p14l1560t2741r1916b2835],
22	)	JJ	O	)	xcomp	11	SENT_171	[p14l1560t2741r1916b2835],
23	were	VBD	O	be	auxpass	24	SENT_171	[p14l1955t2764r2152b2814],
24	judged	VBN	O	judge	_	0	SENT_171	[p14l6t2870r293b2964],
25	by	IN	O	by	_	0	SENT_171	[p14l322t2870r423b2964],
26	the	DT	O	the	det	27	SENT_171	[p14l455t2870r578b2942],
27	investigator	NN	O	investigator	agent	24	SENT_171	[p14l610t2870r1095b2964],
28	to	TO	O	to	aux	30	SENT_171	[p14l1124t2881r1201b2942],
29	be	VB	O	be	auxpass	30	SENT_171	[p14l1232t2870r1327b2942],
30	related	VBN	O	relate	xcomp	24	SENT_171	[p14l1358t2870r1638b2942],
31	to	TO	O	to	_	0	SENT_171	[p14l1668t2881r1744b2942],
32	the	DT	O	the	det	34	SENT_171	[p14l1777t2870r1900b2942],
33	study	NN	O	study	nn	34	SENT_171	[p14l1935t2870r2152b2964],
34	drug	NN	O	drug	prep_to	30	SENT_171	[p14l16t2999r221b3093],
35	.	.	O	.	_	0	SENT_171	[p14l16t2999r221b3093],

1	The	DT	O	the	det	6	SENT_172	[p14l275t2999r432b3071],
2	six	CD	NUMBER	six	num	6	SENT_172	[p14l485t2999r599b3071],
3	most	RBS	O	most	advmod	4	SENT_172	[p14l648t3010r847b3071],
4	common	JJ	O	common	amod	6	SENT_172	[p14l896t3022r1252b3071],
5	adverse	JJ	O	adverse	amod	6	SENT_172	[p14l1304t2999r1613b3072],
6	events	NNS	O	event	nsubj	18	SENT_172	[p14l1663t3010r1921b3072],
7	with	IN	O	with	_	0	SENT_172	[p14l1972t2999r2153b3072],
8	single	JJ	O	single	amod	9	SENT_172	[p14l18t3128r289b3222],
9	—	NN	O	—	prep_with	16	SENT_172	[p14l18t3128r289b3222],
10	and	CC	O	and	_	0	SENT_172	[p14l338t3128r482b3200],
11	multiple	JJ	O	multiple	amod	14	SENT_172	[p14l526t3128r1088b3222],
12	—	NN	O	—	nn	14	SENT_172	[p14l526t3128r1088b3222],
13	dose	NN	O	dose	nn	14	SENT_172	[p14l526t3128r1088b3222],
14	duloxetine	NN	O	duloxetine	prep_with	16	SENT_172	[p14l1134t3128r1564b3200],
15	were	VBD	O	be	cop	16	SENT_172	[p14l1609t3151r1805b3201],
16	nausea	NN	O	nausea	ccomp	18	SENT_172	[p14l1850t3151r2148b3214],
17	,	,	O	,	_	0	SENT_172	[p14l1850t3151r2148b3214],
18	decreased	VBD	O	decrease	_	0	SENT_172	[p14l16t3257r418b3329],
19	appetite	NN	O	appetite	nn	25	SENT_172	[p14l467t3257r809b3351],
20	,	,	O	,	_	0	SENT_172	[p14l467t3257r809b3351],
21	dizziness	NN	O	dizziness	conj_and	25	SENT_172	[p14l862t3257r1256b3343],
22	,	,	O	,	_	0	SENT_172	[p14l862t3257r1256b3343],
23	somnolence	NN	O	somnolence	nn	28	SENT_172	[p14l1311t3257r1818b3342],
24	,	,	O	,	_	0	SENT_172	[p14l1311t3257r1818b3342],
25	fatigue	NN	O	fatigue	nn	28	SENT_172	[p14l1870t3257r2152b3351],
26	and	CC	O	and	_	0	SENT_172	[p14l17t3386r161b3458],
27	dry	JJ	O	dry	nn	28	SENT_172	[p14l212t3386r345b3480],
28	mouth	NN	O	mouth	dobj	18	SENT_172	[p14l396t3386r677b3458],
29	.	.	O	.	_	0	SENT_172	[p14l396t3386r677b3458],

1	All	DT	O	all	det	3	SENT_173	[p14l732t3386r861b3458],
2	adverse	JJ	O	adverse	amod	3	SENT_173	[p14l914t3386r1223b3459],
3	events	NNS	O	event	nsubj	4	SENT_173	[p14l1275t3397r1532b3459],
4	were	VBD	O	be	_	0	SENT_173	[p14l1586t3409r1781b3459],
5	of	IN	O	of	_	0	SENT_173	[p14l1834t3386r1923b3458],
6	mild	JJ	O	mild	amod	7	SENT_173	[p14l1966t3386r2153b3458],
7	severity	NN	O	severity	prep_of	4	SENT_173	[p14l18t3515r358b3609],
8	.	.	O	.	_	0	SENT_173	[p14l18t3515r358b3609],

1	All	DT	O	all	det	3	SENT_174	[p14l404t3515r532b3587],
2	adverse	JJ	O	adverse	amod	3	SENT_174	[p14l577t3515r886b3587],
3	events	NNS	O	event	_	0	SENT_174	[p14l928t3526r1185b3588],
4	except	IN	O	except	_	0	SENT_174	[p14l1230t3526r1496b3609],
5	for	IN	O	for	prepc_except_for	3	SENT_174	[p14l1536t3515r1655b3587],
6	one	CD	NUMBER	one	number	7	SENT_174	[p14l1695t3538r1839b3587],
7	(	CD	NUMBER	(	num	8	SENT_174	[p14l1884t3515r2149b3609, p15l184t36r260b57],
8	bodyTable	NN	O	bodytable	pobj	3	SENT_174	[p14l1884t3515r2149b3609, p15l184t36r260b57],

1	II	NNP	O	II	_	0	SENT_175	[p15l272t36r293b57],
2	.	.	O	.	_	0	SENT_175	[p15l272t36r293b57],

1	Statistical	JJ	O	statistical	amod	2	SENT_176	[p15l307t35r428b57],
2	comparison	NN	O	comparison	nsubj	15	SENT_176	[p15l441t36r589b63],
3	of	IN	O	of	_	0	SENT_176	[p15l602t35r625b57],
4	duloxetlne	NN	O	duloxetlne	nn	6	SENT_176	[p15l637t36r768b57],
5	harmacoklnetlc	NN	O	harmacoklnetlc	nn	6	SENT_176	[p15l797t36r991b57],
6	arameters	NNS	O	arameter	prep_of	2	SENT_176	[p15l1018t37r1148b57],
7	In	IN	O	in	_	0	SENT_176	[p15l1161t41r1180b57],
8	hlnese	NN	O	hlnese	prep_in	15	SENT_176	[p15l1215t36r1305b61],
9	,	,	O	,	_	0	SENT_176	[p15l1215t36r1305b61],
10	Ja	NN	O	ja	nn	11	SENT_176	[p15l1318t36r1348b57],
11	anese	NN	O	anese	nsubj	15	SENT_176	[p15l1365t41r1443b57],
12	and	CC	O	and	_	0	SENT_176	[p15l1455t36r1501b57],
13	aucaslan	JJ	O	aucaslan	amod	14	SENT_176	[p15l1535t41r1649b57],
14	sub	NN	O	sub	conj_and	11	SENT_176	[p15l1662t36r1707b57],
15	ects	VBZ	O	ect	_	0	SENT_176	[p15l1715t37r1767b57],
16	Parameter	NNP	O	Parameter	nn	17	SENT_176	[p15l187t88r321b110],
17	Chinesea	NNP	O	Chinesea	dobj	15	SENT_176	[p15l563t88r679b110],
18	Single	JJ	O	single	amod	20	SENT_176	[p15l9t178r196b239],
19	dosing	NN	O	dosing	nn	20	SENT_176	[p15l222t179r425b239],
20	(	NN	O	(	dep	17	SENT_176	[p15l453t178r658b239],
21	60mg	JJ	O	60mg	amod	23	SENT_176	[p15l453t178r658b239],
22	)	CD	NUMBER	)	tmod	21	SENT_176	[p15l453t178r658b239],
23	No.	NN	O	no.	dep	29	SENT_176	[p15l11t277r101b324],
24	of	IN	O	of	_	0	SENT_176	[p15l130t276r180b324],
25	subjects	NNS	O	subject	prep_of	23	SENT_176	[p15l205t277r435b336],
26	(	JJ	O	(	amod	27	SENT_176	[p15l463t276r533b336],
27	n	NN	O	n	dep	29	SENT_176	[p15l463t276r533b336],
28	)	CD	NUMBER	)	num	29	SENT_176	[p15l463t276r533b336],
29	Bodyweight	NNP	O	Bodyweight	dep	36	SENT_176	[p15l11t374r335b434],
30	(	CD	NUMBER	(	num	29	SENT_176	[p15l362t369r490b434],
31	kg	NN	O	kg	nn	34	SENT_176	[p15l362t369r490b434],
32	)	NN	O	)	nn	34	SENT_176	[p15l362t369r490b434],
33	b	NN	O	b	nn	34	SENT_176	[p15l362t369r490b434],
34	tmax	NN	O	tmax	dep	29	SENT_176	[p15l7t473r120b524],
35	(	CD	NUMBER	(	num	36	SENT_176	[p15l147t469r241b529],
36	h	NN	O	h	dep	38	SENT_176	[p15l147t469r241b529],
37	)	CD	NUMBER	)	num	38	SENT_176	[p15l147t469r241b529],
38	°	NN	O	°	dep	39	SENT_176	[p15l147t469r241b529],
39	Cmax	NN	O	cmax	dep	41	SENT_176	[p15l9t567r148b621],
40	(	CD	NUMBER	(	num	39	SENT_176	[p15l175t567r386b628],
41	ng/mL	NN	O	ng/ml	dep	43	SENT_176	[p15l175t567r386b628],
42	)	CD	NUMBER	)	num	41	SENT_176	[p15l175t567r386b628],
43	CL/F	NN	O	cl/f	dep	45	SENT_176	[p15l9t663r143b712],
44	(	CD	NUMBER	(	num	43	SENT_176	[p15l171t663r294b724],
45	L/h	NN	O	l/h	dep	47	SENT_176	[p15l171t663r294b724],
46	)	CD	NUMBER	)	num	45	SENT_176	[p15l171t663r294b724],
47	Vss/F	NN	O	vss/f	dep	49	SENT_176	[p15l8t761r155b816],
48	(	CD	NUMBER	(	num	47	SENT_176	[p15l183t761r253b821],
49	L	NN	O	l	dep	51	SENT_176	[p15l183t761r253b821],
50	)	CD	NUMBER	)	num	49	SENT_176	[p15l183t761r253b821],
51	t1/2	NN	O	t1/2	dep	53	SENT_176	[p15l7t862r66b912],
52	(	CD	NUMBER	(	num	51	SENT_176	[p15l93t858r163b918],
53	h	NN	O	h	dep	56	SENT_176	[p15l93t858r163b918],
54	)	CD	NUMBER	)	num	53	SENT_176	[p15l93t858r163b918],
55	Multiple	JJ	O	multiple	amod	56	SENT_176	[p15l11t955r246b1015],
56	dosing	NN	O	dosing	dep	58	SENT_176	[p15l271t955r498b1015],
57	°	CD	NUMBER	°	num	58	SENT_176	[p15l271t955r498b1015],
58	No.	NN	O	no.	dep	62	SENT_176	[p15l11t1053r100b1100],
59	of	IN	O	of	_	0	SENT_176	[p15l130t1053r180b1100],
60	subjects	NNS	O	subject	prep_of	58	SENT_176	[p15l205t1053r435b1113],
61	(	JJ	O	(	amod	62	SENT_176	[p15l463t1052r533b1112],
62	n	NN	O	n	dep	64	SENT_176	[p15l463t1052r533b1112],
63	)	CD	NUMBER	)	num	64	SENT_176	[p15l463t1052r533b1112],
64	Bodyweight	NNP	O	Bodyweight	dep	69	SENT_176	[p15l11t1150r335b1210],
65	(	CD	NUMBER	(	num	64	SENT_176	[p15l362t1145r490b1210],
66	kg	NN	O	kg	nn	68	SENT_176	[p15l362t1145r490b1210],
67	)	NN	O	)	nn	68	SENT_176	[p15l362t1145r490b1210],
68	b	NN	O	b	dep	64	SENT_176	[p15l362t1145r490b1210],
69	CL/F	NN	O	cl/f	dep	71	SENT_176	[p15l9t1245r143b1294],
70	(	CD	NUMBER	(	num	69	SENT_176	[p15l171t1245r294b1306],
71	L/h	NN	O	l/h	dep	73	SENT_176	[p15l171t1245r294b1306],
72	)	CD	NUMBER	)	num	71	SENT_176	[p15l171t1245r294b1306],
73	Vss/F	NN	O	vss/f	dep	75	SENT_176	[p15l8t1343r155b1398],
74	(	CD	NUMBER	(	num	73	SENT_176	[p15l183t1343r253b1403],
75	L	NN	O	l	dep	77	SENT_176	[p15l183t1343r253b1403],
76	)	CD	NUMBER	)	num	75	SENT_176	[p15l183t1343r253b1403],
77	t1/2	NN	O	t1/2	dep	79	SENT_176	[p15l7t1444r66b1494],
78	(	CD	NUMBER	(	num	77	SENT_176	[p15l93t1440r163b1500],
79	h	NN	O	h	dep	17	SENT_176	[p15l93t1440r163b1500],
80	)	CD	NUMBER	)	num	79	SENT_176	[p15l93t1440r163b1500],

1	ues	NNS	O	ue	nsubjpass	3	SENT_177	[p16l279t891r324b907],
2	are	VBP	O	be	auxpass	3	SENT_177	[p16l336t891r376b907],
3	expressed	VBN	O	express	_	0	SENT_177	[p16l388t885r520b913],
4	as	IN	O	as	_	0	SENT_177	[p16l533t891r562b907],
5	the	DT	O	the	det	7	SENT_177	[p16l573t885r612b907],
6	least	JJS	O	least	amod	7	SENT_177	[p16l625t885r685b907],
7	squares	NNS	O	square	prep_as	3	SENT_177	[p16l696t891r798b913],
8	geometric	JJ	O	geometric	amod	10	SENT_177	[p16l810t885r937b913],
9	mean	NN	O	mean	nn	10	SENT_177	[p16l949t891r1019b907],
10	(	NN	O	(	dep	7	SENT_177	[p16l1033t885r1098b913],
11	90	CD	PERCENT	90	number	12	SENT_177	[p16l1033t885r1098b913],
12	%	NN	PERCENT	%	amod	10	SENT_177	[p16l1033t885r1098b913],
13	Cl	NN	O	cl	dep	10	SENT_177	[p16l1110t885r1146b913],
14	)	CD	NUMBER	)	num	13	SENT_177	[p16l1110t885r1146b913],
15	unless	IN	O	unless	mark	16	SENT_177	[p16l1160t885r1241b907],
16	specified	VBN	O	specify	advcl	3	SENT_177	[p16l1253t885r1366b913],
17	otherwise	RB	O	otherwise	advmod	16	SENT_177	[p16l1379t885r1508b907],
18	.	.	O	.	_	0	SENT_177	[p16l1379t885r1508b907],

1	b	NN	O	b	nn	2	SENT_178	[p16l186t931r200b953],
2	Arithmetic	NNP	O	Arithmetic	nsubj	3	SENT_178	[p16l236t931r364b953],
3	mean	VB	O	mean	_	0	SENT_178	[p16l377t937r446b953],
4	(	JJ	O	(	amod	6	SENT_178	[p16l460t931r558b959],
5	range	NN	O	range	nn	6	SENT_178	[p16l460t931r558b959],
6	)	NN	O	)	dobj	3	SENT_178	[p16l460t931r558b959],
7	.	.	O	.	_	0	SENT_178	[p16l460t931r558b959],

1	c	NN	O	c	nn	2	SENT_179	[p16l185t977r198b994],
2	Parameters	NNS	O	parameter	_	0	SENT_179	[p16l238t972r385b994],
3	from	IN	O	from	_	0	SENT_179	[p16l396t971r453b994],
4	60mg	JJ	O	60mg	prep_from	2	SENT_179	[p16l466t972r536b1000],
5	for	IN	O	for	_	0	SENT_179	[p16l548t971r582b994],
6	Chinese	JJ	MISC	chinese	prep_for	4	SENT_179	[p16l593t971r705b998],
7	,	,	O	,	_	0	SENT_179	[p16l593t971r705b998],
8	20mg	JJ	O	20mg	prep_for	4	SENT_179	[p16l718t972r789b1000],
9	and	CC	O	and	_	0	SENT_179	[p16l802t972r848b994],
10	40mg	JJ	O	40mg	prep_for	4	SENT_179	[p16l860t972r931b1000],
11	for	IN	O	for	_	0	SENT_179	[p16l943t971r977b994],
12	Caucasian	JJ	MISC	caucasian	amod	15	SENT_179	[p16l988t971r1123b994],
13	and	CC	O	and	_	0	SENT_179	[p16l1136t972r1182b994],
14	Japanese	JJ	MISC	japanese	conj_and	12	SENT_179	[p16l1194t972r1319b1000],
15	subjects	NNS	O	subject	prep_for	2	SENT_179	[p16l1331t972r1443b1000],
16	.	.	O	.	_	0	SENT_179	[p16l1331t972r1443b1000],

1	CL/F	NN	O	cl/f	_	0	SENT_180	[p16l185t1012r249b1034],
2	=	SYM	O	=	dep	6	SENT_180	[p16l262t1022r277b1030],
3	a	DT	O	a	det	6	SENT_180	[p16l291t1018r305b1034],
4	arent	JJ	O	arent	amod	6	SENT_180	[p16l339t1014r405b1034],
5	oral	JJ	O	oral	amod	6	SENT_180	[p16l418t1012r464b1034],
6	clearance	NN	O	clearance	rcmod	1	SENT_180	[p16l478t1012r609b1038],
7	;	:	O	;	_	0	SENT_180	[p16l478t1012r609b1038],
8	Cmax	NN	O	cmax	dep	1	SENT_180	[p16l625t1012r691b1037],
9	=	JJ	O	=	amod	12	SENT_180	[p16l704t1022r719b1031],
10	maximum	NN	O	maximum	nn	12	SENT_180	[p16l733t1013r857b1034],
11	plasma	NN	O	plasma	nn	12	SENT_180	[p16l871t1013r964b1040],
12	concentration	NN	O	concentration	dep	8	SENT_180	[p16l977t1013r1157b1038],
13	;	:	O	;	_	0	SENT_180	[p16l977t1013r1157b1038],
14	ti/2	NN	O	ti/2	nn	16	SENT_180	[p16l1171t1014r1200b1037],
15	=	JJ	O	=	amod	16	SENT_180	[p16l1213t1022r1228b1031],
16	elimination	NN	O	elimination	dep	1	SENT_180	[p16l1242t1013r1378b1034],
17	half	NN	O	half	nn	19	SENT_180	[p16l1394t1012r1492b1038],
18	—	CD	NUMBER	—	num	19	SENT_180	[p16l1394t1012r1492b1038],
19	life	NN	O	life	dep	16	SENT_180	[p16l1394t1012r1492b1038],
20	;	:	O	;	_	0	SENT_180	[p16l1394t1012r1492b1038],
21	tmax	NN	O	tmax	nn	23	SENT_180	[p16l1506t1014r1562b1037],
22	=	JJ	O	=	amod	23	SENT_180	[p16l1575t1022r1590b1031],
23	time	NN	O	time	dep	1	SENT_180	[p16l1603t1013r1657b1034],
24	to	TO	O	to	aux	25	SENT_180	[p16l1670t1014r1693b1034],
25	reach	VB	O	reach	infmod	23	SENT_180	[p16l1708t1013r1777b1034],
26	Cmax	NNP	O	Cmax	dobj	25	SENT_180	[p16l1792t1012r1861b1038],
27	;	:	O	;	_	0	SENT_180	[p16l1792t1012r1861b1038],
28	VsslF	NN	O	vsslf	dep	26	SENT_180	[p16l1876t1012r1946b1037],
29	=	JJ	O	=	amod	32	SENT_180	[p16l1960t1022r1975b1031],
30	apparen	NN	O	apparen	nn	32	SENT_180	[p16l185t1054r290b1077],
31	vo	NN	O	vo	nn	32	SENT_180	[p16l310t1054r340b1071],
32	ume	NN	O	ume	dep	28	SENT_180	[p16l349t1054r403b1071],
33	of	IN	O	of	_	0	SENT_180	[p16l415t1049r438b1071],
34	distribution	NN	O	distribution	prep_of	32	SENT_180	[p16l449t1049r588b1071],
35	at	IN	O	at	_	0	SENT_180	[p16l600t1050r624b1071],
36	steady	JJ	O	steady	amod	37	SENT_180	[p16l635t1049r720b1077],
37	state	NN	O	state	prep_at	25	SENT_180	[p16l731t1050r792b1071],
38	after	IN	O	after	_	0	SENT_180	[p16l805t1049r862b1071],
39	oral	JJ	O	oral	amod	40	SENT_180	[p16l873t1049r919b1071],
40	administration	NN	O	administration	prep_after	25	SENT_180	[p16l932t1049r1118b1071],
41	.	.	O	.	_	0	SENT_180	[p16l932t1049r1118b1071],

1	©	RB	O	©	advmod	2	SENT_181	[p16l185t1186r203b1203],
2	2007	CD	DATE	2007	_	0	SENT_181	[p16l212t1184r266b1203],
3	Adis	NNP	ORGANIZATION	Adis	nn	5	SENT_181	[p16l275t1184r324b1203],
4	Data	NNP	ORGANIZATION	Data	nn	5	SENT_181	[p16l334t1184r392b1203],
5	Information	NNP	ORGANIZATION	Information	dep	2	SENT_181	[p16l403t1184r538b1203],
6	BV	NN	ORGANIZATION	bv	dep	5	SENT_181	[p16l548t1184r583b1203],
7	.	.	O	.	_	0	SENT_181	[p16l548t1184r583b1203],

1	All	DT	O	all	det	2	SENT_182	[p16l593t1184r620b1203],
2	rights	NNS	O	rights	nsubj	3	SENT_182	[p16l630t1184r691b1208],
3	resen/ed	VBN	O	resen/ed	_	0	SENT_182	[p16l701t1184r808b1203],
4	.	.	O	.	_	0	SENT_182	[p16l701t1184r808b1203],

1	Clin	NNP	O	Clin	nn	2	SENT_183	[p16l1594t1184r1637b1203],
2	Phormocokinet	NNP	O	Phormocokinet	dep	10	SENT_183	[p16l1648t1184r1831b1203],
3	2007	CD	DATE	2007	num	5	SENT_183	[p16l1839t1184r1900b1205],
4	;	:	O	;	_	0	SENT_183	[p16l1839t1184r1900b1205],
5	46	CD	NUMBER	46	dep	2	SENT_183	[p16l1909t1184r1936b1203],
6	(	CD	NUMBER	(	dep	10	SENT_183	[p16l1945t1184r1975b1206],
7	9	CD	NUMBER	9	num	10	SENT_183	[p16l1945t1184r1975b1206],
8	)	NN	O	)	nn	10	SENT_183	[p16l1945t1184r1975b1206],
9	Duloxetine	NN	O	duloxetine	nn	10	SENT_183	[p16l184t1221r346b1246],
10	PK	NN	O	pk	dep	14	SENT_183	[p16l357t1222r401b1246],
11	in	IN	O	in	_	0	SENT_183	[p16l411t1222r440b1246],
12	Chinese	JJ	MISC	chinese	amod	13	SENT_183	[p16l451t1221r567b1246],
13	Subjects	NNS	O	subject	prep_in	10	SENT_183	[p16l579t1221r697b1255],
14	773	CD	NUMBER	773	_	0	SENT_183	[p16l1927t1222r1975b1246],

1	weight	NN	O	weight	nn	3	SENT_184	[p16l9t1464r287b1557],
2	decrease	NN	O	decrease	nn	3	SENT_184	[p16l322t1464r703b1552],
3	)	NN	O	)	nsubj	5	SENT_184	[p16l322t1464r703b1552],
4	had	VBD	O	have	aux	5	SENT_184	[p16l740t1464r887b1536],
5	resolved	VBN	O	resolve	_	0	SENT_184	[p16l920t1464r1268b1536],
6	by	IN	O	by	_	0	SENT_184	[p16l1300t1464r1401b1557],
7	the	DT	O	the	det	8	SENT_184	[p16l1436t1464r1558b1536],
8	time	NN	O	time	prep_by	5	SENT_184	[p16l1593t1464r1773b1536],
9	of	IN	O	of	_	0	SENT_184	[p16l1810t1464r1898b1536],
10	study	NN	O	study	nn	11	SENT_184	[p16l1929t1464r2145b1557],
11	completion	NN	O	completion	prep_of	8	SENT_184	[p16l10t1593r490b1686],
12	.	.	O	.	_	0	SENT_184	[p16l10t1593r490b1686],

1	One	CD	NUMBER	one	nsubj	3	SENT_185	[p16l566t1593r733b1665],
2	subject	JJ	O	subject	amod	1	SENT_185	[p16l807t1592r1094b1686],
3	discontinued	VBN	O	discontinue	_	0	SENT_185	[p16l1164t1593r1686b1665],
4	from	IN	O	from	_	0	SENT_185	[p16l1756t1593r1954b1665],
5	the	DT	O	the	det	6	SENT_185	[p16l2023t1593r2146b1665],
6	study	NN	O	study	prep_from	3	SENT_185	[p16l12t1722r228b1815],
7	on	IN	O	on	_	0	SENT_185	[p16l273t1744r371b1794],
8	day	NN	DURATION	day	prep_on	6	SENT_185	[p16l415t1722r559b1815],
9	4	CD	NUMBER	4	num	8	SENT_185	[p16l601t1722r649b1793],
10	after	IN	O	after	_	0	SENT_185	[p16l695t1722r880b1794],
11	completing	VBG	O	complete	prepc_after	3	SENT_185	[p16l922t1722r1380b1815],
12	the	DT	O	the	det	15	SENT_185	[p16l1423t1722r1546b1794],
13	single	JJ	O	single	amod	15	SENT_185	[p16l1592t1722r1831b1815],
14	dosing	NN	O	dosing	nn	15	SENT_185	[p16l1875t1722r2145b1815],
15	phase	NN	O	phase	dobj	11	SENT_185	[p16l8t1851r260b1944],
16	.	.	O	.	_	0	SENT_185	[p16l8t1851r260b1944],

1	This	DT	O	this	det	2	SENT_186	[p16l291t1851r468b1923],
2	subject	NN	O	subject	nsubj	4	SENT_186	[p16l499t1851r786b1944],
3	had	VBD	O	have	aux	4	SENT_186	[p16l808t1851r956b1923],
4	experienced	VBN	O	experience	_	0	SENT_186	[p16l981t1851r1475b1944],
5	a	DT	O	a	det	7	SENT_186	[p16l1501t1873r1543b1923],
6	single	JJ	O	single	amod	7	SENT_186	[p16l1570t1851r1809b1944],
7	episode	NN	O	episode	dobj	4	SENT_186	[p16l1836t1851r2146b1944],
8	of	IN	O	of	_	0	SENT_186	[p16l10t1980r99b2052],
9	mild	JJ	O	mild	prep_of	7	SENT_186	[p16l138t1980r325b2052],
10	vomiting	VBG	O	vomit	amod	9	SENT_186	[p16l371t1980r761b2073],
11	,	,	O	,	_	0	SENT_186	[p16l371t1980r761b2073],
12	dizziness	NN	O	dizziness	prep_of	7	SENT_186	[p16l813t1980r1183b2052],
13	and	CC	O	and	_	0	SENT_186	[p16l1234t1980r1379b2052],
14	nausea	NN	O	nausea	conj_and	9	SENT_186	[p16l1424t2002r1703b2052],
15	about	IN	DURATION	about	_	0	SENT_186	[p16l1750t1980r1975b2052],
16	2.5	CD	DURATION	2.5	num	17	SENT_186	[p16l2022t1979r2141b2052],
17	hours	NNS	NUMBER	hour	prep_about	14	SENT_186	[p16l8t2109r232b2181],
18	after	IN	O	after	_	0	SENT_186	[p16l262t2109r447b2181],
19	dosing	NN	O	dosing	prep_after	17	SENT_186	[p16l471t2109r741b2202],
20	on	IN	O	on	_	0	SENT_186	[p16l769t2131r867b2181],
21	day	NN	DURATION	day	prep_on	19	SENT_186	[p16l893t2109r1037b2202],
22	1	CD	NUMBER	1	num	21	SENT_186	[p16l1073t2109r1132b2181],
23	.	.	O	.	_	0	SENT_186	[p16l1073t2109r1132b2181],

1	During	IN	O	during	_	0	SENT_187	[p16l1163t2109r1450b2202],
2	the	DT	O	the	det	3	SENT_187	[p16l1476t2109r1599b2181],
3	course	NN	O	course	prep_during	9	SENT_187	[p16l1626t2131r1890b2181],
4	of	IN	O	of	_	0	SENT_187	[p16l1917t2109r2005b2181],
5	the	DT	O	the	det	6	SENT_187	[p16l2023t2109r2146b2181],
6	study	NN	O	study	prep_of	3	SENT_187	[p16l12t2238r251b2331],
7	,	,	O	,	_	0	SENT_187	[p16l12t2238r251b2331],
8	there	EX	O	there	expl	9	SENT_187	[p16l280t2238r483b2310],
9	were	VBD	O	be	_	0	SENT_187	[p16l509t2260r705b2310],
10	no	DT	O	no	det	13	SENT_187	[p16l732t2260r831b2310],
11	clinically	RB	O	clinically	advmod	12	SENT_187	[p16l858t2238r1237b2331],
12	significant	JJ	O	significant	amod	13	SENT_187	[p16l1266t2238r1696b2331],
13	alterations	NNS	O	alteration	nsubj	9	SENT_187	[p16l1722t2238r2143b2310],
14	in	IN	O	in	_	0	SENT_187	[p16l9t2368r86b2439],
15	laboratory	NN	O	laboratory	nn	16	SENT_187	[p16l120t2368r539b2461],
16	values	NNS	O	value	prep_in	13	SENT_187	[p16l574t2368r831b2440],
17	and	CC	O	and	_	0	SENT_187	[p16l870t2368r1014b2440],
18	vital	JJ	O	vital	amod	20	SENT_187	[p16l1047t2368r1226b2440],
19	sign	NN	O	sign	nn	20	SENT_187	[p16l1264t2368r1429b2461],
20	values	NNS	O	value	prep_in	13	SENT_187	[p16l1463t2368r1743b2440],
21	.	.	O	.	_	0	SENT_187	[p16l1463t2368r1743b2440],

1	Discussion	NN	O	discussion	_	0	SENT_188	[p16l138t2633r638b2711],

1	The	DT	O	the	det	3	SENT_189	[p16l133t2875r289b2947],
2	present	JJ	DATE	present	amod	3	SENT_189	[p16l334t2886r631b2969],
3	study	NN	O	study	nsubj	30	SENT_189	[p16l679t2875r895b2969],
4	is	VBZ	O	be	cop	30	SENT_189	[p16l941t2875r1004b2947],
5	the	DT	O	the	det	30	SENT_189	[p16l1052t2875r1174b2947],
6	first	JJ	ORDINAL	first	amod	30	SENT_189	[p16l1221t2875r1385b2947],
7	in	IN	O	in	_	0	SENT_189	[p16l1429t2875r1506b2947],
8	healthy	JJ	O	healthy	amod	11	SENT_189	[p16l1551t2875r1852b2969],
9	native	JJ	O	native	amod	11	SENT_189	[p16l1897t2875r2146b2948],
10	Chinese	JJ	MISC	chinese	amod	11	SENT_189	[p16l10t3004r337b3077],
11	subjects	NNS	O	subject	prep_in	6	SENT_189	[p16l380t3004r702b3098],
12	to	TO	O	to	aux	13	SENT_189	[p16l743t3015r818b3076],
13	evaluate	VB	O	evaluate	xcomp	6	SENT_189	[p16l859t3004r1197b3077],
14	the	DT	O	the	det	15	SENT_189	[p16l1236t3004r1359b3076],
15	pharmacokinetics	NNS	O	pharmacokinetic	dobj	13	SENT_189	[p16l1396t3004r2142b3098],
16	,	,	O	,	_	0	SENT_189	[p16l1396t3004r2142b3098],
17	safety	NN	O	safety	conj_and	15	SENT_189	[p16l12t3133r251b3227],
18	and	CC	O	and	_	0	SENT_189	[p16l293t3133r438b3205],
19	tolerability	NN	O	tolerability	dobj	13	SENT_189	[p16l476t3133r925b3227],
20	of	IN	O	of	_	0	SENT_189	[p16l966t3133r1054b3205],
21	duloxetine	NN	O	duloxetine	prep_of	13	SENT_189	[p16l1088t3133r1518b3205],
22	following	VBG	O	follow	_	0	SENT_189	[p16l1558t3133r1954b3227],
23	single	JJ	O	single	amod	24	SENT_189	[p16l1998t3133r2143b3205, p16l10t3262r163b3356],
24	—	NN	O	—	prep_following	21	SENT_189	[p16l1998t3133r2143b3205, p16l10t3262r163b3356],
25	and	CC	O	and	_	0	SENT_189	[p16l201t3262r344b3334],
26	mu1tiple	JJ	O	mu1tiple	amod	28	SENT_189	[p16l376t3262r938b3356],
27	—	NN	O	—	nn	28	SENT_189	[p16l376t3262r938b3356],
28	dose	NN	O	dose	prep_following	21	SENT_189	[p16l376t3262r938b3356],
29	oral	JJ	O	oral	amod	30	SENT_189	[p16l973t3262r1128b3334],
30	administration	NN	O	administration	_	0	SENT_189	[p16l1164t3262r1753b3334],
31	at	IN	O	at	_	0	SENT_189	[p16l1787t3273r1858b3334],
32	60mg	JJ	O	60mg	prep_at	30	SENT_189	[p16l1890t3262r2141b3356],
33	.	.	O	.	_	0	SENT_189	[p16l1890t3262r2141b3356],

1	The	DT	O	the	det	2	SENT_190	[p16l9t3391r165b3463],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	18	SENT_190	[p16l204t3391r926b3485],
3	of	IN	O	of	_	0	SENT_190	[p16l968t3391r1057b3463],
4	an	DT	O	a	det	8	SENT_190	[p16l1091t3414r1183b3463],
5	enteric	JJ	O	enteric	amod	8	SENT_190	[p16l1222t3391r1802b3463],
6	—	NN	O	—	nn	8	SENT_190	[p16l1222t3391r1802b3463],
7	coated	JJ	O	coated	amod	8	SENT_190	[p16l1222t3391r1802b3463],
8	capsule	NN	O	capsule	prep_of	2	SENT_190	[p16l1841t3391r2146b3485],
9	of	IN	O	of	_	0	SENT_190	[p16l10t3520r99b3592],
10	duloxetine	NN	O	duloxetine	prep_of	8	SENT_190	[p16l143t3520r573b3592],
11	administered	VBN	O	administer	partmod	10	SENT_190	[p16l625t3520r1152b3592],
12	as	IN	O	as	_	0	SENT_190	[p16l1203t3543r1282b3592],
13	a	DT	O	a	det	15	SENT_190	[p16l1336t3543r1379b3592],
14	single	JJ	O	single	amod	15	SENT_190	[p16l1430t3520r1669b3614],
15	dose	NN	O	dose	prep_as	11	SENT_190	[p16l1721t3520r1905b3592],
16	have	VBP	O	have	aux	18	SENT_190	[p16l1954t3520r2146b3593],
17	been	VBN	O	be	auxpass	18	SENT_190	[p16l7t3650r201b3722],
18	investigated	VBN	O	investigate	_	0	SENT_190	[p16l226t3650r721b3744],
19	in	IN	O	in	_	0	SENT_190	[p16l746t3650r823b3722],
20	Chinese	JJ	MISC	chinese	amod	21	SENT_190	[p16l850t3650r1178b3723],
21	subjects	NNS	O	subject	prep_in	18	SENT_190	[p16l1207t3640r1667b3744],
22	.	.	O	.	_	0	SENT_190	[p16l1207t3640r1667b3744],

1	”	NN	O	”	tmod	24	SENT_191	[p16l1207t3640r1667b3744],
2	6	CD	NUMBER	6	num	3	SENT_191	[p16l1207t3640r1667b3744],
3	]	CD	NUMBER	]	dep	1	SENT_191	[p16l1207t3640r1667b3744],
4	Because	IN	O	because	_	0	SENT_191	[p16l1697t3652r2037b3722],
5	of	IN	O	of	prepc_because_of	24	SENT_191	[p16l2064t3650r2153b3722],
6	the	DT	O	the	det	7	SENT_191	[p17l8t25r131b96],
7	difference	NN	O	difference	pobj	24	SENT_191	[p17l181t24r594b96],
8	in	IN	O	in	_	0	SENT_191	[p17l643t24r720b96],
9	the	DT	O	the	det	12	SENT_191	[p17l769t24r891b96],
10	duloxetine	NN	O	duloxetine	nn	12	SENT_191	[p17l941t24r1371b96],
11	dosage	NN	O	dosage	nn	12	SENT_191	[p17l1421t24r1702b118],
12	form	NN	O	form	prep_in	7	SENT_191	[p17l1752t24r1970b109],
13	,	,	O	,	_	0	SENT_191	[p17l1752t24r1970b109],
14	the	DT	O	the	det	16	SENT_191	[p17l2023t24r2145b96],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_191	[p17l7t153r690b247],
16	parameters	NNS	O	parameter	nsubjpass	24	SENT_191	[p17l732t164r1179b247],
17	obtained	VBN	O	obtain	partmod	16	SENT_191	[p17l1223t153r1575b225],
18	in	IN	O	in	_	0	SENT_191	[p17l1615t153r1693b225],
19	that	DT	O	that	det	20	SENT_191	[p17l1733t153r1886b225],
20	study	NN	O	study	prep_in	17	SENT_191	[p17l1929t153r2146b247],
21	can	MD	O	can	aux	24	SENT_191	[p17l9t293r281b354],
22	not	RB	O	not	neg	24	SENT_191	[p17l9t293r281b354],
23	be	VB	O	be	auxpass	24	SENT_191	[p17l309t282r405b354],
24	compared	VBN	O	compare	_	0	SENT_191	[p17l438t282r840b376],
25	with	IN	O	with	_	0	SENT_191	[p17l871t282r1051b355],
26	the	DT	O	the	det	27	SENT_191	[p17l1081t283r1204b354],
27	results	NNS	O	result	prep_with	24	SENT_191	[p17l1234t282r1499b354],
28	obtained	VBN	O	obtain	partmod	27	SENT_191	[p17l1533t282r1885b354],
29	in	IN	O	in	_	0	SENT_191	[p17l1915t282r1992b354],
30	the	DT	O	the	det	32	SENT_191	[p17l2023t282r2146b354],
31	present	JJ	DATE	present	amod	32	SENT_191	[p17l7t422r305b505],
32	study	NN	O	study	prep_in	28	SENT_191	[p17l359t411r597b505],
33	,	,	O	,	_	0	SENT_191	[p17l359t411r597b505],
34	where	WRB	O	where	advmod	39	SENT_191	[p17l654t411r901b484],
35	the	DT	O	the	det	38	SENT_191	[p17l954t411r1077b483],
36	duloxetine	NN	O	duloxetine	nn	38	SENT_191	[p17l1131t411r1561b483],
37	dosage	NN	O	dosage	nn	38	SENT_191	[p17l1615t411r1896b505],
38	form	NN	O	form	nsubj	39	SENT_191	[p17l1949t411r2147b483],
39	consisted	VBD	O	consist	rcmod	32	SENT_191	[p17l9t540r390b612],
40	of	IN	O	of	_	0	SENT_191	[p17l424t540r512b612],
41	enteric-coated	JJ	O	enteric-coated	amod	42	SENT_191	[p17l540t540r1120b612],
42	pellets	NNS	O	pellet	prep_of	39	SENT_191	[p17l1151t540r1416b634],
43	in	IN	O	in	_	0	SENT_191	[p17l1453t540r1530b612],
44	a	DT	O	a	det	45	SENT_191	[p17l1565t563r1607b612],
45	capsule	NN	O	capsule	prep_in	39	SENT_191	[p17l1641t540r1966b634],
46	.	.	O	.	_	0	SENT_191	[p17l1641t540r1966b634],

1	The	DT	O	the	det	3	SENT_192	[p17l132t669r289b741],
2	time	NN	O	time	nn	3	SENT_192	[p17l318t669r498b741],
3	course	NN	O	course	nsubj	8	SENT_192	[p17l529t692r794b741],
4	of	IN	O	of	_	0	SENT_192	[p17l824t669r913b741],
5	duloxetine	NN	O	duloxetine	nn	7	SENT_192	[p17l937t669r1367b741],
6	plasma	NN	O	plasma	nn	7	SENT_192	[p17l1395t669r1687b763],
7	concentration	NN	O	concentration	prep_of	3	SENT_192	[p17l1716t680r2143b741, p17l8t798r166b870],
8	followed	VBD	O	follow	_	0	SENT_192	[p17l208t798r572b871],
9	a	DT	O	a	det	12	SENT_192	[p17l615t821r658b870],
10	one	CD	NUMBER	one	num	12	SENT_192	[p17l700t809r1422b892],
11	—	NN	O	—	nn	12	SENT_192	[p17l700t809r1422b892],
12	compartment	NN	O	compartment	dobj	8	SENT_192	[p17l700t809r1422b892],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_192	[p17l1462t798r2144b892],
14	disposition	NN	O	disposition	dep	12	SENT_192	[p17l9t927r478b1021],
15	.	.	O	.	_	0	SENT_192	[p17l9t927r478b1021],

1	The	DT	O	the	det	4	SENT_193	[p17l507t927r664b999],
2	typical	JJ	O	typical	amod	4	SENT_193	[p17l689t927r965b1021],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_193	[p17l989t927r1672b1021],
4	parameters	NNS	O	parameter	nsubj	5	SENT_193	[p17l1696t938r2143b1021],
5	estimated	VBN	O	estimate	dep	32	SENT_193	[p17l9t1056r401b1128],
6	in	IN	O	in	_	0	SENT_193	[p17l475t1056r552b1128],
7	Chinese	JJ	MISC	chinese	amod	8	SENT_193	[p17l627t1056r954b1129],
8	subjects	NNS	O	subject	prep_in	5	SENT_193	[p17l1033t1056r1355b1150],
9	(	JJ	O	(	amod	10	SENT_193	[p17l1435t1057r1681b1145],
10	CL/F	NN	O	cl/f	dep	8	SENT_193	[p17l1435t1057r1681b1145],
11	102	CD	NUMBER	102	num	12	SENT_193	[p17l1764t1057r1905b1129],
12	L/h	NN	O	l/h	dep	8	SENT_193	[p17l1980t1056r2142b1141],
13	,	,	O	,	_	0	SENT_193	[p17l1980t1056r2142b1141],
14	86.8	CD	NUMBER	86.8	num	15	SENT_193	[p17l13t1185r182b1258],
15	L/h	NN	O	l/h	appos	12	SENT_193	[p17l235t1185r400b1270],
16	;	:	O	;	_	0	SENT_193	[p17l235t1185r400b1270],
17	t1/2	NN	O	t1/2	dep	12	SENT_193	[p17l454t1196r544b1268],
18	10	CD	DURATION	10	num	19	SENT_193	[p17l604t1186r694b1258],
19	hours	NNS	NUMBER	hour	tmod	17	SENT_193	[p17l744t1185r992b1271],
20	,	,	O	,	_	0	SENT_193	[p17l744t1185r992b1271],
21	11	CD	DURATION	11	num	22	SENT_193	[p17l1055t1186r1137b1257],
22	hours	NNS	NUMBER	hour	npadvmod	8	SENT_193	[p17l1195t1185r1419b1257],
23	after	IN	O	after	_	0	SENT_193	[p17l1474t1185r1659b1257],
24	single	JJ	O	single	amod	27	SENT_193	[p17l1711t1185r1950b1279],
25	and	CC	O	and	_	0	SENT_193	[p17l2002t1185r2147b1257],
26	multiple	JJ	O	multiple	conj_and	24	SENT_193	[p17l9t1314r348b1408],
27	dosing	NN	O	dosing	prep_after	8	SENT_193	[p17l402t1314r694b1408],
28	,	,	O	,	_	0	SENT_193	[p17l402t1314r694b1408],
29	respectively	RB	O	respectively	advmod	8	SENT_193	[p17l749t1314r1275b1408],
30	)	CD	NUMBER	)	dep	8	SENT_193	[p17l749t1314r1275b1408],
31	are	VBP	O	be	cop	32	SENT_193	[p17l1333t1337r1453b1386],
32	consistent	JJ	O	consistent	_	0	SENT_193	[p17l1506t1314r1916b1386],
33	with	IN	O	with	_	0	SENT_193	[p17l1966t1314r2147b1387],
34	those	DT	O	those	det	41	SENT_193	[p17l9t1444r222b1515],
35	previously	RB	DATE	previously	advmod	36	SENT_193	[p17l255t1443r687b1537],
36	reported	VBN	O	report	amod	41	SENT_193	[p17l719t1443r1061b1537],
37	in	IN	O	in	_	0	SENT_193	[p17l1093t1443r1170b1515],
38	healthy	JJ	O	healthy	amod	39	SENT_193	[p17l1202t1443r1502b1537],
39	subjects	NNS	O	subject	prep_in	36	SENT_193	[p17l1539t1443r1862b1537],
40	(	JJ	O	(	amod	41	SENT_193	[p17l1901t1444r2147b1532],
41	CL/F	NN	O	cl/f	prep_with	32	SENT_193	[p17l1901t1444r2147b1532],
42	114	CD	NUMBER	114	num	43	SENT_193	[p17l18t1574r159b1644],
43	L/h	NN	O	l/h	nsubj	32	SENT_193	[p17l187t1564r463b1659],
44	,	,	O	,	_	0	SENT_193	[p17l187t1564r463b1659],
45	[	CD	NUMBER	[	number	46	SENT_193	[p17l187t1564r463b1659],
46	17	CD	NUMBER	17	num	47	SENT_193	[p17l187t1564r463b1659],
47	]	NN	O	]	appos	43	SENT_193	[p17l187t1564r463b1659],
48	84	CD	NUMBER	84	num	49	SENT_193	[p17l498t1574r593b1646],
49	L/h	NN	O	l/h	dep	47	SENT_193	[p17l622t1564r900b1658],
50	;	:	O	;	_	0	SENT_193	[p17l622t1564r900b1658],
51	[	CD	NUMBER	[	number	52	SENT_193	[p17l622t1564r900b1658],
52	1	CD	NUMBER	1	num	53	SENT_193	[p17l622t1564r900b1658],
53	°	NN	O	°	dep	43	SENT_193	[p17l622t1564r900b1658],
54	]	CD	NUMBER	]	num	55	SENT_193	[p17l622t1564r900b1658],
55	t1/2	NN	O	t1/2	dep	53	SENT_193	[p17l931t1584r1021b1656],
56	10	CD	DURATION	10	num	57	SENT_193	[p17l1058t1574r1148b1646],
57	hours	NNS	NUMBER	hour	tmod	53	SENT_193	[p17l1175t1564r1536b1658],
58	,	,	O	,	_	0	SENT_193	[p17l1175t1564r1536b1658],
59	[	NN	O	[	appos	43	SENT_193	[p17l1175t1564r1536b1658],
60	1	CD	NUMBER	1	number	61	SENT_193	[p17l1175t1564r1536b1658],
61	°	CD	NUMBER	°	num	62	SENT_193	[p17l1175t1564r1536b1658],
62	]	NN	O	]	nsubj	65	SENT_193	[p17l1175t1564r1536b1658],
63	12.5	CD	DURATION	12.5	num	64	SENT_193	[p17l1578t1573r1740b1646],
64	hours	NNS	NUMBER	hour	tmod	62	SENT_193	[p17l1772t1564r2143b1662],
65	[	VBP	O	[	rcmod	59	SENT_193	[p17l1772t1564r2143b1662],
66	17	CD	NUMBER	17	num	68	SENT_193	[p17l1772t1564r2143b1662],
67	]	CD	NUMBER	]	num	68	SENT_193	[p17l1772t1564r2143b1662],
68	)	NN	O	)	dobj	65	SENT_193	[p17l1772t1564r2143b1662],
69	after	IN	O	after	_	0	SENT_193	[p17l11t1701r196b1773],
70	multiple	JJ	O	multiple	amod	71	SENT_193	[p17l228t1701r568b1795],
71	dosing	NN	O	dosing	prep_after	65	SENT_193	[p17l603t1701r894b1795],
72	.	.	O	.	_	0	SENT_193	[p17l603t1701r894b1795],

1	There	EX	O	there	expl	2	SENT_194	[p17l132t1831r369b1903],
2	were	VBD	O	be	_	0	SENT_194	[p17l396t1853r591b1903],
3	no	DT	O	no	det	6	SENT_194	[p17l618t1853r716b1903],
4	statistically	RB	O	statistically	advmod	5	SENT_194	[p17l747t1831r1209b1924],
5	significant	JJ	O	significant	amod	6	SENT_194	[p17l1238t1831r1668b1924],
6	differences	NNS	O	difference	nsubj	2	SENT_194	[p17l1693t1831r2143b1903],
7	in	IN	O	in	_	0	SENT_194	[p17l9t1960r86b2031],
8	CL/F	NN	O	cl/f	prep_in	6	SENT_194	[p17l128t1960r342b2032],
9	and	CC	O	and	_	0	SENT_194	[p17l385t1960r529b2032],
10	V35/F	NN	O	v35/f	prep_in	6	SENT_194	[p17l570t1960r792b2042],
11	after	IN	O	after	_	0	SENT_194	[p17l834t1960r1020b2032],
12	single	JJ	O	single	amod	15	SENT_194	[p17l1063t1960r1301b2053],
13	or	CC	O	or	_	0	SENT_194	[p17l1344t1982r1428b2032],
14	multiple	JJ	O	multiple	conj_or	12	SENT_194	[p17l1467t1960r1807b2053],
15	dosing	NN	O	dosing	prep_after	2	SENT_194	[p17l1850t1960r2142b2053],
16	,	,	O	,	_	0	SENT_194	[p17l1850t1960r2142b2053],
17	suggesting	VBG	O	suggest	partmod	2	SENT_194	[p17l12t2089r445b2182],
18	that	IN	O	that	complm	25	SENT_194	[p17l484t2089r637b2161],
19	the	DT	O	the	det	20	SENT_194	[p17l673t2089r795b2161],
20	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	25	SENT_194	[p17l832t2089r1554b2182],
21	of	IN	O	of	_	0	SENT_194	[p17l1595t2089r1684b2161],
22	duloxetine	NN	O	duloxetine	prep_of	20	SENT_194	[p17l1716t2089r2146b2161],
23	are	VBP	O	be	cop	25	SENT_194	[p17l11t2240r131b2290],
24	not	RB	O	not	neg	25	SENT_194	[p17l155t2228r285b2290],
25	time-dependent	JJ	O	time-dependent	ccomp	17	SENT_194	[p17l308t2218r965b2311],
26	.	.	O	.	_	0	SENT_194	[p17l308t2218r965b2311],

1	Although	IN	O	although	mark	6	SENT_195	[p17l995t2218r1381b2311],
2	the	DT	O	the	det	3	SENT_195	[p17l1405t2218r1527b2290],
3	t1/2	NN	O	t1/2	nsubj	6	SENT_195	[p17l1551t2229r1641b2300],
4	was	VBD	O	be	cop	6	SENT_195	[p17l1665t2240r1820b2290],
5	statistically	RB	O	statistically	advmod	6	SENT_195	[p17l1849t2218r2143b2290, p17l9t2347r205b2440],
6	different	JJ	O	different	advcl	13	SENT_195	[p17l266t2347r638b2432],
7	,	,	O	,	_	0	SENT_195	[p17l266t2347r638b2432],
8	the	DT	O	the	det	9	SENT_195	[p17l701t2347r823b2419],
9	magnitude	NN	O	magnitude	nsubj	16	SENT_195	[p17l883t2347r1314b2440],
10	of	IN	O	of	_	0	SENT_195	[p17l1375t2347r1463b2419],
11	difference	NN	O	difference	prep_of	9	SENT_195	[p17l1517t2347r1929b2419],
12	was	VBD	O	be	cop	13	SENT_195	[p17l1989t2369r2143b2419],
13	small	JJ	O	small	_	0	SENT_195	[p17l12t2476r228b2548],
14	and	CC	O	and	_	0	SENT_195	[p17l265t2476r409b2548],
15	not	RB	O	not	neg	16	SENT_195	[p17l442t2486r572b2548],
16	meaningful	JJ	O	meaningful	conj_and	13	SENT_195	[p17l604t2476r1069b2569],
17	following	VBG	O	follow	_	0	SENT_195	[p17l1104t2476r1500b2569],
18	single	JJ	O	single	amod	20	SENT_195	[p17l1538t2476r1777b2569],
19	(	NN	O	(	nn	20	SENT_195	[p17l1815t2477r1936b2564],
20	t1/2	NN	O	t1/2	prep_following	13	SENT_195	[p17l1815t2477r1936b2564],
21	10.3	CD	DURATION	10.3	num	22	SENT_195	[p17l1979t2476r2141b2548],
22	hours	NNS	NUMBER	hour	tmod	20	SENT_195	[p17l8t2605r266b2693],
23	)	CD	NUMBER	)	dep	20	SENT_195	[p17l8t2605r266b2693],
24	or	CC	O	or	_	0	SENT_195	[p17l301t2627r385b2677],
25	multiple	JJ	O	multiple	amod	26	SENT_195	[p17l414t2605r754b2698],
26	dosing	NN	O	dosing	prep_following	13	SENT_195	[p17l787t2605r1056b2698],
27	(	CD	NUMBER	(	num	30	SENT_195	[p17l1092t2605r1212b2693],
28	t1/2	NN	O	t1/2	nn	30	SENT_195	[p17l1092t2605r1212b2693],
29	11	CD	DURATION	11	num	30	SENT_195	[p17l1253t2605r1334b2676],
30	hours	NNS	NUMBER	hour	tmod	26	SENT_195	[p17l1374t2605r1655b2693],
31	)	RB	O	)	advmod	30	SENT_195	[p17l1374t2605r1655b2693],
32	.	.	O	.	_	0	SENT_195	[p17l1374t2605r1655b2693],

1	Duloxetine	NNP	O	Duloxetine	nn	4	SENT_196	[p17l1691t2605r2146b2677],
2	steady-state	JJ	O	steady-state	amod	4	SENT_196	[p17l12t2734r491b2827],
3	plasma	NN	O	plasma	nn	4	SENT_196	[p17l543t2734r834b2827],
4	concentrations	NNS	O	concentration	nsubjpass	6	SENT_196	[p17l886t2734r1479b2806],
5	were	VBD	O	be	auxpass	6	SENT_196	[p17l1534t2756r1731b2806],
6	achieved	VBN	O	achieve	_	0	SENT_196	[p17l1785t2734r2147b2806],
7	on	IN	O	on	_	0	SENT_196	[p17l10t2885r109b2935],
8	the	DT	O	the	det	10	SENT_196	[p17l174t2863r296b2935],
9	third	JJ	ORDINAL	third	amod	10	SENT_196	[p17l362t2863r554b2935],
10	day	NN	DURATION	day	prep_on	6	SENT_196	[p17l620t2863r764b2956],
11	following	VBG	O	follow	_	0	SENT_196	[p17l830t2863r1226b2956],
12	continuous	JJ	O	continuous	amod	15	SENT_196	[p17l1293t2863r1738b2935],
13	multiple	JJ	O	multiple	amod	15	SENT_196	[p17l1806t2863r2146b2956],
14	60mg	JJ	O	60mg	amod	15	SENT_196	[p17l11t2991r239b3085],
15	doses	NNS	O	dose	prep_following	10	SENT_196	[p17l275t2992r497b3064],
16	of	IN	O	of	_	0	SENT_196	[p17l535t2992r623b3064],
17	duloxetine	NN	O	duloxetine	prep_of	15	SENT_196	[p17l651t2992r1104b3077],
18	,	,	O	,	_	0	SENT_196	[p17l651t2992r1104b3077],
19	which	WDT	O	which	nsubj	21	SENT_196	[p17l1142t2992r1390b3064],
20	is	VBZ	O	be	cop	21	SENT_196	[p17l1424t2992r1487b3064],
21	consistent	JJ	O	consistent	rcmod	17	SENT_196	[p17l1524t2992r1933b3064],
22	with	IN	O	with	prep	21	SENT_196	[p17l1966t2992r2146b3064],

1	©	RB	O	©	advmod	2	SENT_197	[p17l10t3275r53b3318],
2	2007	CD	DATE	2007	_	0	SENT_197	[p17l76t3270r208b3318],
3	Adis	NNP	PERSON	Adis	nn	4	SENT_197	[p17l231t3270r353b3318],
4	Dofro	NNP	PERSON	Dofro	dep	2	SENT_197	[p17l377t3270r521b3318],
5	lnformdrion	NN	O	lnformdrion	nn	6	SENT_197	[p17l547t3270r880b3318],
6	BV	NN	O	bv	dep	4	SENT_197	[p17l907t3270r992b3317],
7	.	.	O	.	_	0	SENT_197	[p17l907t3270r992b3317],

1	All	DT	O	all	det	2	SENT_198	[p17l1018t3270r1084b3317],
2	righfs	NNS	O	righf	nsubj	3	SENT_198	[p17l1109t3270r1259b3330],
3	reserved	VBN	O	reserve	_	0	SENT_198	[p17l1283t3270r1548b3318],
4	.	.	O	.	_	0	SENT_198	[p17l1283t3270r1548b3318],

1	the	DT	O	the	det	2	SENT_199	[p17l9t3517r131b3589],
2	t1/2	NN	O	t1/2	_	0	SENT_199	[p17l160t3527r249b3599],
3	of	IN	O	of	_	0	SENT_199	[p17l279t3517r368b3589],
4	approximately	RB	O	approximately	quantmod	5	SENT_199	[p17l391t3517r980b3610],
5	10	CD	DURATION	10	num	6	SENT_199	[p17l1019t3517r1109b3589],
6	hours	NNS	NUMBER	hour	prep_of	2	SENT_199	[p17l1137t3517r1384b3589],
7	.	.	O	.	_	0	SENT_199	[p17l1137t3517r1384b3589],

1	The	DT	O	the	det	2	SENT_200	[p17l1417t3517r1574b3589],
2	magnitude	NN	O	magnitude	_	0	SENT_200	[p17l1603t3517r2034b3610],
3	of	IN	O	of	_	0	SENT_200	[p17l2064t3517r2153b3589],
4	accumulation	NN	O	accumulation	prep_of	2	SENT_200	[p17l11t3645r560b3717],
5	in	IN	O	in	_	0	SENT_200	[p17l607t3645r685b3717],
6	the	DT	O	the	det	9	SENT_200	[p17l731t3645r853b3717],
7	duloxetine	NN	O	duloxetine	nn	9	SENT_200	[p17l902t3645r1332b3717],
8	plasma	NN	O	plasma	nn	9	SENT_200	[p17l1378t3645r1669b3739],
9	concentration	NN	O	concentration	prep_in	2	SENT_200	[p17l1716t3656r2143b3717, p18l9t24r166b96],

1	during	IN	O	during	_	0	SENT_201	[p18l204t24r467b118],
2	the	DT	DURATION	the	det	4	SENT_201	[p18l505t24r627b96],
3	24	CD	DURATION	24	num	4	SENT_201	[p18l666t25r764b96],
4	hours	NNS	NUMBER	hour	prep_during	14	SENT_201	[p18l801t24r1025b96],
5	following	VBG	O	follow	csubj	14	SENT_201	[p18l1064t24r1459b118],
6	multiple	JJ	O	multiple	amod	7	SENT_201	[p18l1497t24r1837b118],
7	dosing	NN	O	dosing	dobj	5	SENT_201	[p18l1875t24r2145b118],
8	relative	JJ	O	relative	advmod	5	SENT_201	[p18l8t155r314b227],
9	to	TO	O	to	_	0	SENT_201	[p18l340t166r416b227],
10	single	JJ	O	single	amod	11	SENT_201	[p18l448t155r686b249],
11	dosing	NN	O	dosing	prep_to	8	SENT_201	[p18l714t155r983b249],
12	was	VBD	O	be	cop	14	SENT_201	[p18l1011t178r1165b227],
13	also	RB	O	also	advmod	14	SENT_201	[p18l1196t155r1355b227],
14	consistent	JJ	O	consistent	_	0	SENT_201	[p18l1384t155r1793b227],
15	with	IN	O	with	_	0	SENT_201	[p18l1817t155r1998b227],
16	the	DT	O	the	det	17	SENT_201	[p18l2023t155r2146b227],
17	t1/2	NN	O	t1/2	prep_with	14	SENT_201	[p18l8t295r98b367],
18	and	CC	O	and	_	0	SENT_201	[p18l127t284r271b356],
19	the	DT	O	the	det	21	SENT_201	[p18l297t284r420b356],
20	dosing	NN	O	dosing	nn	21	SENT_201	[p18l449t284r718b377],
21	interval	NN	O	interval	conj_and	17	SENT_201	[p18l746t284r1078b356],
22	.	.	O	.	_	0	SENT_201	[p18l746t284r1078b356],

1	The	DT	O	the	det	2	SENT_202	[p18l1110t284r1267b356],
2	time	NN	O	time	_	0	SENT_202	[p18l1293t284r1474b356],
3	to	TO	O	to	aux	4	SENT_202	[p18l1501t295r1577b356],
4	reach	VB	O	reach	infmod	2	SENT_202	[p18l1604t284r1825b356],
5	steadystate	NN	O	steadystate	nn	7	SENT_202	[p18l1855t284r2143b377, p18l12t424r194b485],
6	plasma	NN	O	plasma	nn	7	SENT_202	[p18l240t413r532b506],
7	concentrations	NNS	O	concentration	dobj	4	SENT_202	[p18l578t413r1172b485],
8	and	CC	O	and	_	0	SENT_202	[p18l1224t413r1368b485],
9	the	DT	O	the	det	10	SENT_202	[p18l1414t413r1537b485],
10	magnitude	NN	O	magnitude	dobj	4	SENT_202	[p18l1585t413r2016b506],
11	of	IN	O	of	_	0	SENT_202	[p18l2064t413r2153b485],
12	accumulation	NN	O	accumulation	nn	14	SENT_202	[p18l11t541r560b613],
13	further	JJ	O	further	amod	14	SENT_202	[p18l611t541r890b613],
14	support	NN	O	support	prep_of	10	SENT_202	[p18l942t552r1245b634],
15	the	DT	O	the	det	16	SENT_202	[p18l1294t541r1416b613],
16	observation	NN	O	observation	dep	2	SENT_202	[p18l1469t541r1944b613],
17	that	IN	O	that	complm	22	SENT_202	[p18l1995t541r2148b613],
18	duloxetine	NN	O	duloxetine	nn	19	SENT_202	[p18l10t669r440b741],
19	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	22	SENT_202	[p18l498t669r1220b763],
20	are	VBP	O	be	aux	22	SENT_202	[p18l1284t692r1404b741],
21	not	RB	O	not	neg	22	SENT_202	[p18l1464t680r1594b741],
22	time	NN	O	time	dep	16	SENT_202	[p18l1652t669r2143b763],
23	—	JJ	O	—	amod	26	SENT_202	[p18l1652t669r2143b763],
24	depen	NN	O	depen	nn	26	SENT_202	[p18l1652t669r2143b763],
25	—	NN	O	—	nn	26	SENT_202	[p18l1652t669r2143b763],
26	dent	NN	O	dent	dobj	22	SENT_202	[p18l10t798r203b870],
27	.	.	O	.	_	0	SENT_202	[p18l10t798r203b870],

1	Racial	JJ	O	racial	amod	4	SENT_203	[p18l133t927r392b999],
2	or	CC	O	or	_	0	SENT_203	[p18l435t950r519b999],
3	ethnic	JJ	O	ethnic	amod	4	SENT_203	[p18l560t927r806b999],
4	differences	NNS	O	difference	nsubjpass	14	SENT_203	[p18l850t927r1301b999],
5	in	IN	O	in	_	0	SENT_203	[p18l1345t927r1422b999],
6	the	DT	O	the	det	7	SENT_203	[p18l1464t927r1586b999],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	4	SENT_203	[p18l1628t927r2143b1021, p18l9t1056r244b1128],
8	of	IN	O	of	_	0	SENT_203	[p18l299t1056r388b1128],
9	a	DT	O	a	det	10	SENT_203	[p18l435t1079r477b1128],
10	drug	NN	O	drug	prep_of	7	SENT_203	[p18l529t1056r712b1150],
11	can	MD	O	can	aux	14	SENT_203	[p18l766t1079r906b1128],
12	usually	RB	O	usually	advmod	14	SENT_203	[p18l957t1056r1252b1150],
13	be	VB	O	be	auxpass	14	SENT_203	[p18l1302t1056r1398b1128],
14	attributed	VBN	O	attribute	_	0	SENT_203	[p18l1453t1056r1843b1128],
15	to	TO	O	to	_	0	SENT_203	[p18l1894t1067r1970b1128],
16	the	DT	O	the	det	17	SENT_203	[p18l2023t1056r2146b1128],
17	differences	NNS	O	difference	prep_to	14	SENT_203	[p18l10t1187r460b1259],
18	in	IN	O	in	_	0	SENT_203	[p18l509t1187r586b1258],
19	absorption	NN	O	absorption	nn	25	SENT_203	[p18l635t1187r1086b1280],
20	,	,	O	,	_	0	SENT_203	[p18l635t1187r1086b1280],
21	distribution	NN	O	distribution	dep	25	SENT_203	[p18l1138t1187r1630b1273],
22	,	,	O	,	_	0	SENT_203	[p18l1138t1187r1630b1273],
23	elimination	NN	O	elimination	dep	25	SENT_203	[p18l1681t1187r2147b1259],
24	and/or	NN	O	and/or	nn	25	SENT_203	[p18l11t1316r271b1388],
25	excretion	NN	O	excretion	prep_in	17	SENT_203	[p18l301t1316r680b1388],
26	of	IN	O	of	_	0	SENT_203	[p18l712t1316r801b1388],
27	the	DT	O	the	det	28	SENT_203	[p18l824t1316r947b1388],
28	drug	NN	O	drug	prep_of	25	SENT_203	[p18l980t1316r1163b1409],
29	because	IN	O	because	_	0	SENT_203	[p18l1194t1316r1517b1388],
30	of	IN	O	of	prepc_because_of	14	SENT_203	[p18l1551t1316r1639b1388],
31	both	DT	O	both	preconj	32	SENT_203	[p18l1662t1316r1844b1388],
32	extrinsic	JJ	O	extrinsic	amod	35	SENT_203	[p18l1875t1316r2143b1388, p18l12t1444r118b1516],
33	and	CC	O	and	_	0	SENT_203	[p18l172t1444r316b1516],
34	intrinsic	JJ	O	intrinsic	conj_and	32	SENT_203	[p18l365t1444r698b1516],
35	factors	NNS	O	factor	pobj	14	SENT_203	[p18l749t1444r1046b1516],
36	.	.	O	.	_	0	SENT_203	[p18l749t1444r1046b1516],

1	Extrinsic	JJ	O	extrinsic	amod	2	SENT_204	[p18l1101t1444r1468b1516],
2	factors	NNS	O	factor	nsubj	3	SENT_204	[p18l1519t1444r1794b1516],
3	include	VBP	O	include	_	0	SENT_204	[p18l1846t1444r2146b1516],
4	environmental	JJ	O	environmental	amod	5	SENT_204	[p18l10t1573r600b1645],
5	factors	NNS	O	factor	nsubj	6	SENT_204	[p18l649t1572r923b1645],
6	(	VBP	O	(	ccomp	3	SENT_204	[p18l977t1574r1070b1661],
7	e.	NN	O	e.	nn	9	SENT_204	[p18l977t1574r1070b1661],
8	g.	NN	O	g.	nn	9	SENT_204	[p18l1080t1595r1148b1666],
9	exposure	NN	O	exposure	dobj	6	SENT_204	[p18l1202t1595r1569b1666],
10	to	TO	O	to	_	0	SENT_204	[p18l1618t1583r1694b1645],
11	pollution	NN	O	pollution	nn	12	SENT_204	[p18l1742t1573r2143b1666],
12	)	NN	O	)	prep_to	9	SENT_204	[p18l1742t1573r2143b1666],
13	and	CC	O	and	_	0	SENT_204	[p18l11t1701r155b1773],
14	cultural	JJ	O	cultural	amod	15	SENT_204	[p18l183t1701r493b1773],
15	differences	NNS	O	difference	dobj	6	SENT_204	[p18l522t1701r973b1773],
16	such	JJ	O	such	_	0	SENT_204	[p18l1006t1701r1189b1773],
17	as	IN	O	as	_	0	SENT_204	[p18l1218t1724r1296b1773],
18	diet	NN	O	diet	prep_such_as	15	SENT_204	[p18l1327t1701r1500b1786],
19	,	,	O	,	_	0	SENT_204	[p18l1327t1701r1500b1786],
20	use	NN	O	use	dobj	6	SENT_204	[p18l1530t1724r1665b1773],
21	of	IN	O	of	_	0	SENT_204	[p18l1694t1701r1783b1773],
22	tobacco	NN	O	tobacco	prep_of	20	SENT_204	[p18l1803t1701r2142b1786],
23	,	,	O	,	_	0	SENT_204	[p18l1803t1701r2142b1786],
24	use	NN	O	use	dobj	6	SENT_204	[p18l8t1852r143b1901],
25	of	IN	O	of	_	0	SENT_204	[p18l202t1829r290b1901],
26	alcohol	NN	O	alcohol	prep_of	24	SENT_204	[p18l342t1829r640b1901],
27	and	CC	O	and	_	0	SENT_204	[p18l700t1829r844b1901],
28	compliance	NN	O	compliance	dobj	6	SENT_204	[p18l901t1829r1371b1923],
29	with	IN	O	with	_	0	SENT_204	[p18l1429t1829r1609b1902],
30	medication	NN	O	medication	prep_with	28	SENT_204	[p18l1666t1829r2141b1901],
31	.	.	O	.	_	0	SENT_204	[p18l1666t1829r2141b1901],

1	Intrinsic	JJ	O	intrinsic	amod	2	SENT_205	[p18l9t1960r347b2032],
2	factors	NNS	O	factor	nsubj	3	SENT_205	[p18l399t1960r674b2032],
3	include	VBP	O	include	_	0	SENT_205	[p18l726t1960r1026b2032],
4	genetic	JJ	O	genetic	amod	5	SENT_205	[p18l1078t1960r1369b2054],
5	polymorphism	NN	O	polymorphism	dobj	3	SENT_205	[p18l1420t1960r2020b2054],
6	in	IN	O	in	_	0	SENT_205	[p18l2069t1960r2146b2031],
7	drug	NN	O	drug	nn	9	SENT_205	[p18l9t2089r193b2182],
8	metabolising	NN	O	metabolising	nn	9	SENT_205	[p18l220t2089r748b2182],
9	enzymes	NNS	O	enzyme	prep_in	3	SENT_205	[p18l775t2112r1153b2182],
10	,	,	O	,	_	0	SENT_205	[p18l775t2112r1153b2182],
11	body	NN	O	body	nn	12	SENT_205	[p18l1181t2089r1385b2182],
12	composition	NN	O	composition	prep_in	3	SENT_205	[p18l1412t2089r1917b2182],
13	(	CD	NUMBER	(	num	16	SENT_205	[p18l1946t2089r2146b2178],
14	lean	JJ	O	lean	amod	16	SENT_205	[p18l1946t2089r2146b2178],
15	body	NN	O	body	nn	16	SENT_205	[p18l7t2218r211b2311],
16	mass	NN	O	mass	dep	12	SENT_205	[p18l271t2240r496b2303],
17	,	,	O	,	_	0	SENT_205	[p18l271t2240r496b2303],
18	bodyweight	JJ	O	bodyweight	amod	19	SENT_205	[p18l558t2218r1073b2311],
19	)	NN	O	)	prep_in	3	SENT_205	[p18l558t2218r1073b2311],
20	and	CC	O	and	_	0	SENT_205	[p18l1138t2218r1283b2290],
21	age	NN	O	age	prep_in	3	SENT_205	[p18l1343t2240r1501b2311],
22	.	.	O	.	_	0	SENT_205	[p18l1343t2240r1501b2311],

1	Duloxetine	NNP	O	Duloxetine	nsubjpass	4	SENT_206	[p18l1566t2218r2020b2290],
2	is	VBZ	O	be	auxpass	4	SENT_206	[p18l2080t2218r2143b2290],
3	mainly	RB	O	mainly	advmod	4	SENT_206	[p18l9t2346r291b2439],
4	eliminated	VBN	O	eliminate	_	0	SENT_206	[p18l378t2346r810b2418],
5	via	IN	O	via	_	0	SENT_206	[p18l895t2346r1019b2418],
6	hepatic	JJ	O	hepatic	amod	7	SENT_206	[p18l1102t2346r1396b2439],
7	metabolism	NN	O	metabolism	prep_via	4	SENT_206	[p18l1483t2346r1962b2418],
8	by	IN	O	by	_	0	SENT_206	[p18l2044t2346r2146b2439],
9	CYP1A2	NN	O	cyp1a2	agent	4	SENT_206	[p18l10t2475r382b2547],
10	and	CC	O	and	_	0	SENT_206	[p18l432t2474r597b2560],
11	,	,	O	,	_	0	SENT_206	[p18l432t2474r597b2560],
12	to	TO	O	to	dep	4	SENT_206	[p18l646t2485r723b2546],
13	a	DT	O	a	det	15	SENT_206	[p18l772t2497r815b2546],
14	lesser	JJR	O	lesser	amod	15	SENT_206	[p18l859t2474r1092b2546],
15	extent	NN	O	extent	pobj	12	SENT_206	[p18l1137t2485r1406b2560],
16	,	,	O	,	_	0	SENT_206	[p18l1137t2485r1406b2560],
17	by	IN	O	by	_	0	SENT_206	[p18l1455t2474r1556b2568],
18	the	DT	O	the	det	20	SENT_206	[p18l1602t2474r1725b2546],
19	CYPZD6	NN	O	cypzd6	nn	20	SENT_206	[p18l1773t2474r2144b2547],
20	enzyme	NN	O	enzyme	agent	4	SENT_206	[p18l9t2626r346b2697],
21	.	.	O	.	_	0	SENT_206	[p18l9t2626r346b2697],

1	Both	DT	O	both	nsubj	5	SENT_207	[p18l387t2603r585b2675],
2	of	IN	O	of	_	0	SENT_207	[p18l621t2603r710b2675],
3	these	DT	O	these	det	4	SENT_207	[p18l738t2603r946b2675],
4	enzymes	NNS	O	enzyme	prep_of	1	SENT_207	[p18l983t2626r1337b2697],
5	show	VBP	O	show	_	0	SENT_207	[p18l1379t2603r1588b2675],
6	racial	JJ	O	racial	amod	7	SENT_207	[p18l1623t2603r1850b2675],
7	differences	NNS	O	difference	dobj	5	SENT_207	[p18l1887t2603r2143b2675, p18l9t2757r256b2820],
8	,	,	O	,	_	0	SENT_207	[p18l1887t2603r2143b2675, p18l9t2757r256b2820],
9	such	JJ	O	such	prep	5	SENT_207	[p18l303t2734r486b2806],
10	that	IN	O	that	complm	15	SENT_207	[p18l525t2734r678b2806],
11	1	CD	PERCENT	1	num	12	SENT_207	[p18l726t2735r846b2806],
12	%	NN	PERCENT	%	nsubj	15	SENT_207	[p18l726t2735r846b2806],
13	of	IN	O	of	_	0	SENT_207	[p18l891t2734r980b2806],
14	Asians	NNPS	MISC	Asians	prep_of	12	SENT_207	[p18l1012t2734r1287b2806],
15	(	VBP	O	(	ccomp	5	SENT_207	[p18l1333t2734r1714b2823],
16	Chinese	JJ	MISC	chinese	amod	21	SENT_207	[p18l1333t2734r1714b2823],
17	,	,	O	,	_	0	SENT_207	[p18l1333t2734r1714b2823],
18	Japanese	JJ	MISC	japanese	amod	21	SENT_207	[p18l1757t2736r2142b2827],
19	,	,	O	,	_	0	SENT_207	[p18l1757t2736r2142b2827],
20	Korean	JJ	MISC	korean	amod	21	SENT_207	[p18l11t2864r365b2952],
21	)	NN	O	)	dobj	15	SENT_207	[p18l11t2864r365b2952],
22	,	,	O	,	_	0	SENT_207	[p18l11t2864r365b2952],
23	5	CD	PERCENT	5	number	24	SENT_207	[p18l403t2863r685b2935],
24	—	CD	PERCENT	—	num	26	SENT_207	[p18l403t2863r685b2935],
25	lO	JJ	PERCENT	lo	quantmod	24	SENT_207	[p18l403t2863r685b2935],
26	%	NN	PERCENT	%	dobj	15	SENT_207	[p18l403t2863r685b2935],
27	of	IN	O	of	_	0	SENT_207	[p18l723t2863r811b2935],
28	Caucasians	NNPS	MISC	Caucasians	prep_of	26	SENT_207	[p18l838t2863r1295b2935],
29	and	CC	O	and	_	0	SENT_207	[p18l1331t2863r1475b2935],
30	O	NNP	O	O	conj_and	28	SENT_207	[p18l1508t2863r1791b2935],
31	—	CD	PERCENT	—	num	33	SENT_207	[p18l1508t2863r1791b2935],
32	l8	CD	PERCENT	l8	num	33	SENT_207	[p18l1508t2863r1791b2935],
33	%	NN	PERCENT	%	nsubj	38	SENT_207	[p18l1508t2863r1791b2935],
34	of	IN	O	of	_	0	SENT_207	[p18l1829t2863r1918b2935],
35	Africans	NNS	MISC	african	prep_of	33	SENT_207	[p18l1943t2863r2143b2934, p18l9t3013r186b3062],
36	do	VBP	O	do	aux	38	SENT_207	[p18l227t2991r324b3062],
37	not	RB	O	not	neg	38	SENT_207	[p18l361t3002r492b3062],
38	have	VB	O	have	rcmod	26	SENT_207	[p18l526t2991r717b3062],
39	the	DT	O	the	det	41	SENT_207	[p18l754t2991r877b3062],
40	CYPZD6	NN	O	cypzd6	nn	41	SENT_207	[p18l915t2991r1287b3062],
41	enzymem	NN	O	enzymem	dobj	38	SENT_207	[p18l1326t2981r1777b3083],
42	]	CD	NUMBER	]	num	44	SENT_207	[p18l1326t2981r1777b3083],
43	Chinese	JJ	MISC	chinese	amod	44	SENT_207	[p18l1818t2991r2146b3062],
44	women	NNS	O	woman	nsubj	47	SENT_207	[p18l9t3141r309b3191],
45	and	CC	O	and	_	0	SENT_207	[p18l350t3119r495b3191],
46	Africans	NNS	MISC	african	conj_and	44	SENT_207	[p18l533t3119r883b3191],
47	have	VBP	O	have	rcmod	41	SENT_207	[p18l924t3119r1115b3191],
48	lower	JJR	O	lower	amod	50	SENT_207	[p18l1155t3119r1389b3191],
49	CYP1A2	NN	O	cyp1a2	nn	50	SENT_207	[p18l1427t3119r1800b3191],
50	activity	NN	O	activity	dobj	47	SENT_207	[p18l1843t3119r2145b3212],
51	than	IN	O	than	_	0	SENT_207	[p18l9t3247r184b3318],
52	Caucasians	NNPS	MISC	Caucasians	prep_than	47	SENT_207	[p18l229t3238r822b3319],
53	.	.	O	.	_	0	SENT_207	[p18l229t3238r822b3319],

1	[	NN	O	[	nn	3	SENT_208	[p18l229t3238r822b3319],
2	18	CD	NUMBER	18	num	3	SENT_208	[p18l229t3238r822b3319],
3	]	NN	O	]	tmod	9	SENT_208	[p18l229t3238r822b3319],
4	Therefore	RB	O	therefore	advmod	3	SENT_208	[p18l871t3247r1295b3332],
5	,	,	O	,	_	0	SENT_208	[p18l871t3247r1295b3332],
6	it	PRP	O	it	nsubj	9	SENT_208	[p18l1344t3247r1400b3318],
7	is	VBZ	O	be	cop	9	SENT_208	[p18l1443t3247r1506b3318],
8	clinically	RB	O	clinically	advmod	9	SENT_208	[p18l1554t3247r1932b3340],
9	prudent	JJ	O	prudent	_	0	SENT_208	[p18l1976t3270r2143b3340, p18l10t3375r185b3447],
10	to	TO	O	to	aux	11	SENT_208	[p18l221t3386r297b3447],
11	investigate	VB	O	investigate	xcomp	9	SENT_208	[p18l337t3375r779b3469],
12	the	DT	O	the	det	13	SENT_208	[p18l818t3375r940b3447],
13	effect	NN	O	effect	dobj	11	SENT_208	[p18l980t3375r1212b3447],
14	of	IN	O	of	_	0	SENT_208	[p18l1250t3375r1338b3447],
15	race	NN	O	race	prep_of	13	SENT_208	[p18l1369t3398r1537b3447],
16	on	IN	O	on	_	0	SENT_208	[p18l1577t3398r1676b3447],
17	duloxetine	NN	O	duloxetine	nn	18	SENT_208	[p18l1716t3375r2146b3447],
18	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	11	SENT_208	[p18l8t3506r752b3599],
19	.	.	O	.	_	0	SENT_208	[p18l8t3506r752b3599],

1	Comparison	NN	O	comparison	_	0	SENT_209	[p18l133t3633r633b3727],
2	of	IN	O	of	dep	1	SENT_209	[p18l670t3633r759b3705],
3	duloxetine	NN	O	duloxetine	nn	4	SENT_209	[p18l790t3633r1220b3705],
4	pharmacokinetics	NNS	O	pharmacokinetic	pobj	2	SENT_209	[p18l1256t3633r1978b3727],
5	between	IN	O	between	dep	1	SENT_209	[p18l2016t3633r2143b3705, p19l8t36r252b97],

1	Caucasian	JJ	MISC	caucasian	amod	4	SENT_210	[p19l308t25r728b98],
2	and	CC	O	and	_	0	SENT_210	[p19l785t25r929b97],
3	Japanese	JJ	MISC	japanese	amod	4	SENT_210	[p19l984t27r1347b118],
4	subjects	NNS	O	subject	nsubj	7	SENT_210	[p19l1406t25r1729b119],
5	at	IN	O	at	_	0	SENT_210	[p19l1790t36r1860b97],
6	60mg	JJ	O	60mg	prep_at	4	SENT_210	[p19l1916t25r2145b119],
7	showed	VBD	O	show	_	0	SENT_210	[p19l12t154r321b226],
8	that	IN	O	that	complm	17	SENT_210	[p19l354t154r507b226],
9	the	DT	O	the	det	12	SENT_210	[p19l540t154r663b226],
10	mean	NN	O	mean	nn	12	SENT_210	[p19l697t177r917b226],
11	duloxetine	NN	O	duloxetine	nn	12	SENT_210	[p19l953t154r1383b226],
12	exposure	NN	O	exposure	nsubj	17	SENT_210	[p19l1418t177r1785b247],
13	in	IN	O	in	_	0	SENT_210	[p19l1820t154r1898b225],
14	J	NNP	O	J	nn	16	SENT_210	[p19l1931t156r1969b226],
15	apanese	JJ	O	apanese	amod	16	SENT_210	[p19l1974t177r2143b247, p19l9t305r188b355],
16	subjects	NNS	O	subject	prep_in	12	SENT_210	[p19l243t283r565b376],
17	was	VBD	O	be	ccomp	7	SENT_210	[p19l619t305r773b355],
18	20	CD	PERCENT	20	num	19	SENT_210	[p19l828t283r1007b355],
19	%	NN	PERCENT	%	npadvmod	20	SENT_210	[p19l828t283r1007b355],
20	higher	JJR	O	higher	advmod	17	SENT_210	[p19l1062t283r1325b376],
21	than	IN	O	than	dep	17	SENT_210	[p19l1373t283r1548b355],
22	in	IN	O	in	_	0	SENT_210	[p19l1598t283r1675b354],
23	Caucasian	JJ	MISC	caucasian	amod	24	SENT_210	[p19l1727t283r2146b355],
24	subjects	NNS	O	subject	prep_in	17	SENT_210	[p19l12t411r359b504],
25	,	,	O	,	_	0	SENT_210	[p19l12t411r359b504],
26	which	WDT	O	which	nsubjpass	28	SENT_210	[p19l397t411r645b483],
27	was	VBD	O	be	auxpass	28	SENT_210	[p19l678t433r832b483],
28	related	VBN	O	relate	rcmod	24	SENT_210	[p19l866t411r1146b483],
29	to	TO	O	to	_	0	SENT_210	[p19l1177t422r1253b483],
30	the	DT	O	the	det	35	SENT_210	[p19l1287t411r1410b483],
31	15	CD	PERCENT	15	num	32	SENT_210	[p19l1453t410r1625b483],
32	%	NN	PERCENT	%	npadvmod	33	SENT_210	[p19l1453t410r1625b483],
33	lower	JJR	O	lower	amod	35	SENT_210	[p19l1662t411r1895b483],
34	mean	NN	O	mean	nn	35	SENT_210	[p19l1926t433r2146b483],
35	bodyweight	NN	O	bodyweight	prep_to	28	SENT_210	[p19l7t540r493b634],
36	in	IN	O	in	_	0	SENT_210	[p19l539t540r617b612],
37	Japanese	JJ	MISC	japanese	amod	38	SENT_210	[p19l664t542r1027b634],
38	subjects	NNS	O	subject	prep_in	35	SENT_210	[p19l1078t530r1538b634],
39	.	.	O	.	_	0	SENT_210	[p19l1078t530r1538b634],

1	[	RB	O	[	_	0	SENT_211	[p19l1078t530r1538b634],
2	15	CD	NUMBER	15	number	3	SENT_211	[p19l1078t530r1538b634],
3	]	CD	NUMBER	]	num	5	SENT_211	[p19l1078t530r1538b634],
4	Further	JJ	O	further	amod	5	SENT_211	[p19l1590t540r1892b612],
5	comparison	NN	O	comparison	nsubj	22	SENT_211	[p19l1938t563r2143b612, p19l7t668r309b762],
6	of	IN	O	of	_	0	SENT_211	[p19l358t668r446b740],
7	duloxetine	NN	O	duloxetine	nn	9	SENT_211	[p19l488t668r918b740],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_211	[p19l965t668r1648b762],
9	parameters	NNS	O	parameter	prep_of	5	SENT_211	[p19l1696t679r2143b762],
10	across	IN	O	across	_	0	SENT_211	[p19l11t822r260b871],
11	Chinese	JJ	MISC	chinese	amod	16	SENT_211	[p19l313t799r663b884],
12	,	,	O	,	_	0	SENT_211	[p19l313t799r663b884],
13	Caucasian	JJ	MISC	caucasian	conj_and	11	SENT_211	[p19l717t799r1136b872],
14	and	CC	O	and	_	0	SENT_211	[p19l1187t799r1331b871],
15	Japanese	JJ	MISC	japanese	conj_and	11	SENT_211	[p19l1379t801r1742b892],
16	subjects	NNS	O	subject	prep_across	9	SENT_211	[p19l1795t799r2142b893],
17	,	,	O	,	_	0	SENT_211	[p19l1795t799r2142b893],
18	using	VBG	O	use	partmod	22	SENT_211	[p19l8t928r228b1021],
19	statistical	JJ	O	statistical	amod	20	SENT_211	[p19l289t928r671b1000],
20	analyses	NNS	O	analysis	dobj	18	SENT_211	[p19l730t928r1095b1021],
21	,	,	O	,	_	0	SENT_211	[p19l730t928r1095b1021],
22	revealed	VBD	O	reveal	ccomp	1	SENT_211	[p19l1155t928r1502b1000],
23	no	DT	O	no	det	25	SENT_211	[p19l1558t951r1657b1000],
24	significant	JJ	O	significant	amod	25	SENT_211	[p19l1718t928r2148b1021],
25	differences	NNS	O	difference	dobj	22	SENT_211	[p19l10t1057r460b1129],
26	across	IN	O	across	_	0	SENT_211	[p19l520t1079r770b1129],
27	the	DT	O	the	det	30	SENT_211	[p19l827t1057r949b1129],
28	three	CD	NUMBER	three	num	30	SENT_211	[p19l1004t1057r1206b1129],
29	racial	JJ	O	racial	amod	30	SENT_211	[p19l1261t1057r1487b1129],
30	groups	NNS	O	group	prep_across	22	SENT_211	[p19l1543t1079r1817b1150],
31	for	IN	O	for	_	0	SENT_211	[p19l1875t1057r1994b1129],
32	all	DT	O	all	det	35	SENT_211	[p19l2048t1057r2146b1129],
33	duloxetine	JJ	O	duloxetine	amod	35	SENT_211	[p19l10t1186r440b1258],
34	pharmacokinetic	JJ	O	pharmacokinetic	amod	35	SENT_211	[p19l479t1186r1162b1279],
35	parameters	NNS	O	parameter	prep_as	22	SENT_211	[p19l1202t1196r1649b1279],
36	(	RB	O	(	advmod	22	SENT_211	[p19l1695t1186r1806b1274],
37	as	RB	O	as	_	0	SENT_211	[p19l1695t1186r1806b1274],
38	well	RB	O	well	_	0	SENT_211	[p19l1849t1186r2022b1258],
39	as	IN	O	as	_	0	SENT_211	[p19l2065t1208r2143b1258],

1	Clin	NNP	O	Clin	nn	2	SENT_212	[p19l1204t1464r1311b1511],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_212	[p19l1337t1464r1790b1511],
3	2007	CD	DATE	2007	num	2	SENT_212	[p19l1811t1464r1958b1515],
4	;	:	O	;	_	0	SENT_212	[p19l1811t1464r1958b1515],
5	46	CD	NUMBER	46	number	6	SENT_212	[p19l1981t1464r2048b1511],
6	(	CD	NUMBER	(	dep	2	SENT_212	[p19l2071t1464r2145b1518],
7	9	CD	NUMBER	9	num	8	SENT_212	[p19l2071t1464r2145b1518],
8	)	NN	O	)	dep	6	SENT_212	[p19l2071t1464r2145b1518],

1	774	CD	NUMBER	774	num	2	SENT_213	[p19l185t1594r233b1618],
2	Tianmei	NNP	O	Tianmei	_	0	SENT_213	[p19l1790t1593r1899b1618],
3	et	FW	O	et	nn	4	SENT_213	[p19l1910t1596r1933b1618],
4	ul	FW	O	ul	dep	2	SENT_213	[p19l1944t1593r1973b1618],
5	.	.	O	.	_	0	SENT_213	[p19l1944t1593r1973b1618],

1	bodyweight	NN	O	bodyweight	_	0	SENT_214	[p19l6t1837r986b1931],
2	—	CD	NUMBER	—	num	4	SENT_214	[p19l6t1837r986b1931],
3	norma1ised	JJ	O	norma1ised	amod	4	SENT_214	[p19l6t1837r986b1931],
4	parameters	NNS	O	parameter	dep	1	SENT_214	[p19l1027t1838r1509b1931],
5	)	RB	O	)	advmod	1	SENT_214	[p19l1027t1838r1509b1931],
6	following	VBG	O	follow	_	0	SENT_214	[p19l1557t1837r1954b1931],
7	single	JJ	O	single	amod	10	SENT_214	[p19l2002t1837r2147b1909, p19l8t1966r130b2060],
8	or	CC	O	or	_	0	SENT_214	[p19l187t1989r270b2038],
9	multiple	JJ	O	multiple	amod	10	SENT_214	[p19l323t1966r664b2060],
10	dosing	NN	O	dosing	prep_following	1	SENT_214	[p19l720t1966r1014b2060],
11	,	,	O	,	_	0	SENT_214	[p19l720t1966r1014b2060],
12	except	IN	O	except	_	0	SENT_214	[p19l1073t1977r1340b2060],
13	for	IN	O	for	prepc_except_for	1	SENT_214	[p19l1394t1966r1513b2038],
14	the	DT	O	the	det	15	SENT_214	[p19l1566t1966r1689b2038],
15	tmax	NN	O	tmax	pobj	1	SENT_214	[p19l1744t1977r1933b2048],
16	.	.	O	.	_	0	SENT_214	[p19l1744t1977r1933b2048],

1	The	DT	O	the	det	2	SENT_215	[p19l1993t1966r2150b2038],
2	difference	NN	O	difference	nsubj	3	SENT_215	[p19l8t2095r422b2167],
3	noted	VBD	O	note	_	0	SENT_215	[p19l465t2095r692b2167],
4	in	IN	O	in	mark	9	SENT_215	[p19l734t2095r812b2167],
5	the	DT	O	the	det	6	SENT_215	[p19l854t2096r977b2167],
6	tmax	NN	O	tmax	nsubjpass	9	SENT_215	[p19l1020t2106r1188b2177],
7	may	MD	O	may	aux	9	SENT_215	[p19l1232t2118r1405b2189],
8	be	VB	O	be	auxpass	9	SENT_215	[p19l1447t2095r1543b2167],
9	related	VBN	O	relate	advcl	3	SENT_215	[p19l1585t2095r1865b2167],
10	to	TO	O	to	_	0	SENT_215	[p19l1907t2106r1983b2167],
11	the	DT	O	the	det	13	SENT_215	[p19l2027t2095r2150b2167],
12	nonparametric	JJ	O	nonparametric	amod	13	SENT_215	[p19l7t2224r598b2318],
13	method	NN	O	method	prep_to	9	SENT_215	[p19l627t2224r934b2296],
14	used	VBN	O	use	partmod	13	SENT_215	[p19l959t2224r1146b2296],
15	for	IN	O	for	_	0	SENT_215	[p19l1172t2224r1291b2296],
16	the	DT	O	the	det	17	SENT_215	[p19l1316t2224r1438b2296],
17	evaluation	NN	O	evaluation	prep_for	14	SENT_215	[p19l1466t2224r1892b2297],
18	of	IN	O	of	_	0	SENT_215	[p19l1919t2224r2008b2296],
19	the	DT	O	the	det	20	SENT_215	[p19l2027t2224r2150b2296],
20	tmax	NN	O	tmax	prep_of	17	SENT_215	[p19l7t2365r175b2436],
21	as	IN	O	as	mark	26	SENT_215	[p19l219t2377r297b2426],
22	the	DT	O	the	det	25	SENT_215	[p19l341t2354r464b2426],
23	median	JJ	O	median	amod	25	SENT_215	[p19l506t2354r807b2426],
24	tmax	NN	O	tmax	nn	25	SENT_215	[p19l849t2365r1017b2436],
25	Values	NNS	O	value	nsubj	26	SENT_215	[p19l1058t2354r1317b2427],
26	(	VBP	O	(	advcl	9	SENT_215	[p19l1364t2354r1442b2443],
27	6	CD	DURATION	6	num	28	SENT_215	[p19l1364t2354r1442b2443],
28	hours	NNS	NUMBER	hour	dobj	26	SENT_215	[p19l1485t2354r1743b2443],
29	)	CD	NUMBER	)	nsubj	32	SENT_215	[p19l1485t2354r1743b2443],
30	were	VBD	O	be	cop	32	SENT_215	[p19l1788t2377r1985b2427],
31	the	DT	O	the	det	32	SENT_215	[p19l2027t2354r2150b2426],
32	same	JJ	O	same	rcmod	28	SENT_215	[p19l11t2505r216b2554],
33	across	IN	O	across	_	0	SENT_215	[p19l252t2505r503b2554],
34	the	DT	O	the	det	36	SENT_215	[p19l539t2482r662b2554],
35	ethnic	JJ	O	ethnic	amod	36	SENT_215	[p19l697t2482r944b2554],
36	groups	NNS	O	group	prep_across	32	SENT_215	[p19l980t2505r1278b2576],
37	.	.	O	.	_	0	SENT_215	[p19l980t2505r1278b2576],

1	CLSS/F	NN	O	clss/f	nsubj	8	SENT_216	[p19l132t2612r411b2693],
2	was	VBD	O	be	cop	8	SENT_216	[p19l445t2634r600b2684],
3	22	CD	PERCENT	22	num	4	SENT_216	[p19l639t2612r820b2684],
4	%	NN	PERCENT	%	npadvmod	8	SENT_216	[p19l639t2612r820b2684],
5	and	CC	O	and	_	0	SENT_216	[p19l861t2611r1006b2683],
6	29	CD	PERCENT	29	num	7	SENT_216	[p19l1041t2612r1221b2685],
7	%	NN	PERCENT	%	npadvmod	8	SENT_216	[p19l1041t2612r1221b2685],
8	lower	JJR	O	lower	_	0	SENT_216	[p19l1261t2611r1495b2684],
9	in	IN	O	in	mark	25	SENT_216	[p19l1528t2611r1606b2683],
10	Chinese	JJ	MISC	chinese	amod	13	SENT_216	[p19l1641t2611r1969b2684],
11	and	CC	O	and	_	0	SENT_216	[p19l2006t2611r2151b2683],
12	Japanese	JJ	MISC	japanese	conj_and	10	SENT_216	[p19l7t2742r370b2834],
13	subjects	NNS	O	subject	nsubj	25	SENT_216	[p19l413t2740r761b2834],
14	,	,	O	,	_	0	SENT_216	[p19l413t2740r761b2834],
15	and	CC	O	and	_	0	SENT_216	[p19l806t2740r951b2812],
16	the	DT	O	the	det	17	SENT_216	[p19l988t2740r1111b2812],
17	Vssﬂ	NNP	O	Vssﬂ	nsubj	25	SENT_216	[p19l1150t2741r1373b2822],
18	:	:	O	:	_	0	SENT_216	[p19l1150t2741r1373b2822],
19	was	VBD	O	be	cop	25	SENT_216	[p19l1411t2763r1566b2813],
20	9	CD	PERCENT	9	num	21	SENT_216	[p19l1608t2741r1737b2813],
21	%	NN	PERCENT	%	npadvmod	25	SENT_216	[p19l1608t2741r1737b2813],
22	and	CC	O	and	_	0	SENT_216	[p19l1782t2740r1927b2812],
23	22	CD	PERCENT	22	num	24	SENT_216	[p19l1966t2741r2146b2813],
24	%	NN	PERCENT	%	conj_and	21	SENT_216	[p19l1966t2741r2146b2813],
25	lower	JJR	O	lower	ccomp	8	SENT_216	[p19l7t2869r241b2942],
26	in	IN	O	in	_	0	SENT_216	[p19l271t2869r349b2941],
27	Chinese	JJ	MISC	chinese	amod	30	SENT_216	[p19l381t2869r709b2942],
28	and	CC	O	and	_	0	SENT_216	[p19l743t2869r888b2941],
29	Japanese	JJ	MISC	japanese	conj_and	27	SENT_216	[p19l918t2871r1282b2963],
30	subjects	NNS	O	subject	prep_in	25	SENT_216	[p19l1317t2869r1665b2963],
31	,	,	O	,	_	0	SENT_216	[p19l1317t2869r1665b2963],
32	respectively	RB	O	respectively	advmod	25	SENT_216	[p19l1700t2869r2148b2963, p19l7t2998r106b3092],
33	,	,	O	,	_	0	SENT_216	[p19l1700t2869r2148b2963, p19l7t2998r106b3092],
34	than	IN	O	than	prep	25	SENT_216	[p19l162t2998r338b3070],
35	in	IN	O	in	pcomp	34	SENT_216	[p19l390t2998r467b3070],
36	Caucasian	JJ	LOCATION	caucasian	amod	37	SENT_216	[p19l520t2998r941b3071],
37	subjects	NNS	O	subject	pobj	35	SENT_216	[p19l996t2998r1342b3092],
38	.	.	O	.	_	0	SENT_216	[p19l996t2998r1342b3092],

1	These	DT	O	these	det	2	SENT_217	[p19l1400t2998r1643b3070],
2	differences	NNS	O	difference	nsubjpass	4	SENT_217	[p19l1696t2998r2148b3070],
3	were	VBD	O	be	auxpass	4	SENT_217	[p19l8t3150r204b3200],
4	reduced	VBN	O	reduce	_	0	SENT_217	[p19l267t3127r593b3199],
5	when	WRB	O	when	advmod	6	SENT_217	[p19l656t3127r877b3200],
6	normalised	VBN	O	normalise	advcl	4	SENT_217	[p19l940t3127r1397b3199],
7	for	IN	O	for	_	0	SENT_217	[p19l1460t3127r1579b3199],
8	bodyweight	NN	O	bodyweight	prep_for	6	SENT_217	[p19l1639t3127r2147b3221],
9	,	,	O	,	_	0	SENT_217	[p19l1639t3127r2147b3221],
10	such	JJ	O	such	advmod	6	SENT_217	[p19l11t3256r194b3328],
11	that	IN	O	that	dep	19	SENT_217	[p19l223t3256r376b3328],
12	CLSS/F	NN	O	clss/f	nsubj	19	SENT_217	[p19l405t3257r684b3338],
13	was	VBD	O	be	cop	19	SENT_217	[p19l713t3279r867b3329],
14	7	CD	PERCENT	7	num	15	SENT_217	[p19l900t3257r1029b3329],
15	%	NN	PERCENT	%	npadvmod	19	SENT_217	[p19l900t3257r1029b3329],
16	and	CC	O	and	_	0	SENT_217	[p19l1065t3256r1210b3328],
17	19	CD	PERCENT	19	num	18	SENT_217	[p19l1248t3257r1420b3330],
18	%	NN	PERCENT	%	npadvmod	19	SENT_217	[p19l1248t3257r1420b3330],
19	lower	JJR	O	lower	ccomp	10	SENT_217	[p19l1453t3256r1688b3329],
20	in	IN	O	in	_	0	SENT_217	[p19l1715t3256r1792b3328],
21	Chinese	JJ	MISC	chinese	amod	24	SENT_217	[p19l1822t3256r2151b3329],
22	and	CC	O	and	_	0	SENT_217	[p19l10t3385r154b3457],
23	Japanese	JJ	MISC	japanese	conj_and	21	SENT_217	[p19l185t3387r549b3479],
24	subjects	NNS	O	subject	prep_in	19	SENT_217	[p19l586t3385r909b3479],
25	and	CC	O	and	_	0	SENT_217	[p19l947t3385r1091b3457],
26	the	DT	O	the	det	27	SENT_217	[p19l1123t3385r1245b3457],
27	Vss/F	NN	O	vss/f	nsubj	31	SENT_217	[p19l1278t3386r1501b3467],
28	was	VBD	O	be	cop	31	SENT_217	[p19l1533t3408r1688b3458],
29	8	CD	PERCENT	8	num	30	SENT_217	[p19l1727t3386r1853b3458],
30	%	NN	PERCENT	%	npadvmod	31	SENT_217	[p19l1727t3386r1853b3458],
31	higher	JJR	O	higher	conj_and	4	SENT_217	[p19l1889t3385r2153b3479],
32	in	IN	O	in	_	0	SENT_217	[p19l7t3514r85b3586],
33	Chinese	JJ	MISC	chinese	prep_in	31	SENT_217	[p19l115t3514r442b3587],
34	and	CC	O	and	_	0	SENT_217	[p19l473t3514r618b3586],
35	11	CD	PERCENT	11	num	36	SENT_217	[p19l655t3515r827b3587],
36	%	NN	PERCENT	%	npadvmod	37	SENT_217	[p19l655t3515r827b3587],
37	lower	JJR	O	lower	conj_and	4	SENT_217	[p19l860t3515r1094b3587],
38	in	IN	O	in	_	0	SENT_217	[p19l1120t3514r1197b3586],
39	Japanese	JJ	MISC	japanese	amod	40	SENT_217	[p19l1225t3516r1589b3608],
40	subjects	NNS	O	subject	prep_in	31	SENT_217	[p19l1622t3514r1945b3608],
41	than	IN	O	than	prep	31	SENT_217	[p19l1976t3514r2151b3586],
42	in	IN	O	in	pcomp	41	SENT_217	[p19l7t3643r85b3715],
43	Caucasian	JJ	MISC	caucasian	amod	44	SENT_217	[p19l114t3643r535b3716],
44	subjects	NNS	O	subject	pobj	42	SENT_217	[p19l566t3643r912b3737],
45	.	.	O	.	_	0	SENT_217	[p19l566t3643r912b3737],

1	These	DT	O	these	det	2	SENT_218	[p19l946t3643r1189b3715],
2	results	NNS	O	result	nsubj	3	SENT_218	[p19l1217t3643r1482b3715],
3	suggest	VBP	O	suggest	_	0	SENT_218	[p19l1516t3654r1820b3737],
4	that	IN	O	that	complm	16	SENT_218	[p19l1847t3643r2001b3715],
5	the	DT	O	the	det	6	SENT_218	[p19l2027t3643r2150b3715],
6	magnitude	NN	O	magnitude	nsubj	16	SENT_218	[p20l7t24r440b118],
7	of	IN	O	of	_	0	SENT_218	[p20l466t24r555b96],
8	the	DT	O	the	det	9	SENT_218	[p20l572t24r695b96],
9	effect	NN	O	effect	prep_of	6	SENT_218	[p20l721t24r953b96],
10	of	IN	O	of	_	0	SENT_218	[p20l978t24r1066b96],
11	bodyweight	NN	O	bodyweight	prep_of	9	SENT_218	[p20l1083t24r1570b118],
12	on	IN	O	on	_	0	SENT_218	[p20l1594t47r1694b96],
13	duloxetine	NN	O	duloxetine	nn	14	SENT_218	[p20l1719t24r2150b96],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	11	SENT_218	[p20l6t153r730b247],
15	is	VBZ	O	be	cop	16	SENT_218	[p20l769t153r833b225],
16	small	JJ	O	small	ccomp	3	SENT_218	[p20l875t153r1092b225],
17	and	CC	O	and	_	0	SENT_218	[p20l1131t153r1276b225],
18	not	RB	O	not	neg	20	SENT_218	[p20l1312t164r1442b225],
19	clinically	RB	O	clinically	advmod	20	SENT_218	[p20l1478t153r1858b247],
20	meaningful	JJ	O	meaningful	ccomp	3	SENT_218	[p20l1895t176r2147b225, p20l7t282r271b376],
21	.	.	O	.	_	0	SENT_218	[p20l1895t176r2147b225, p20l7t282r271b376],

1	Subjects	NNS	O	subject	nsubjpass	3	SENT_219	[p20l134t411r475b505],
2	were	VBD	O	be	auxpass	3	SENT_219	[p20l553t434r750b484],
3	genotyped	VBN	O	genotype	_	0	SENT_219	[p20l827t412r1253b505],
4	to	TO	O	to	aux	5	SENT_219	[p20l1327t422r1404b483],
5	determine	VB	O	determine	xcomp	3	SENT_219	[p20l1481t411r1888b483],
6	their	PRP$	O	they	poss	9	SENT_219	[p20l1964t411r2152b483],
7	C	NN	O	c	nn	9	SENT_219	[p20l12t542r77b613],
8	YPZD6	NN	O	ypzd6	nn	9	SENT_219	[p20l83t540r375b612],
9	status	NN	O	status	dobj	5	SENT_219	[p20l437t551r663b612],
10	as	IN	O	as	mark	13	SENT_219	[p20l729t563r807b612],
11	duloxetine	NN	O	duloxetine	nsubjpass	13	SENT_219	[p20l872t540r1304b612],
12	is	VBZ	O	be	auxpass	13	SENT_219	[p20l1365t540r1429b612],
13	metabolised	VBN	O	metabolise	advcl	5	SENT_219	[p20l1493t540r1990b612],
14	by	IN	O	by	_	0	SENT_219	[p20l2049t540r2150b634],
15	CYPZD6	NN	O	cypzd6	agent	13	SENT_219	[p20l8t669r403b742],
16	.	.	O	.	_	0	SENT_219	[p20l8t669r403b742],

1	The	DT	O	the	det	2	SENT_220	[p20l474t669r631b741],
2	effect	NN	O	effect	nsubj	11	SENT_220	[p20l699t669r931b741],
3	of	IN	O	of	_	0	SENT_220	[p20l997t669r1086b741],
4	CYPZD6	NN	O	cypzd6	nn	5	SENT_220	[p20l1146t669r1519b742],
5	inhibition	NN	O	inhibition	prep_of	2	SENT_220	[p20l1586t669r1985b741],
6	on	IN	O	on	_	0	SENT_220	[p20l2051t692r2151b741],
7	duloxetine	NN	O	duloxetine	nn	8	SENT_220	[p20l8t798r440b870],
8	exposure	NN	O	exposure	prep_on	5	SENT_220	[p20l480t821r848b892],
9	is	VBZ	O	be	aux	11	SENT_220	[p20l888t798r952b870],
10	minor	JJ	O	minor	amod	11	SENT_220	[p20l994t798r1239b870],
11	(	NN	O	(	_	0	SENT_220	[p20l1280t798r1492b887],
12	60	CD	PERCENT	60	number	13	SENT_220	[p20l1280t798r1492b887],
13	%	NN	PERCENT	%	amod	14	SENT_220	[p20l1280t798r1492b887],
14	increase	NN	O	increase	dobj	11	SENT_220	[p20l1536t798r1871b870],
15	in	IN	O	in	_	0	SENT_220	[p20l1910t798r1988b870],
16	the	DT	O	the	det	19	SENT_220	[p20l2027t798r2150b870],
17	AUCss	NN	O	aucss	nn	19	SENT_220	[p20l7t919r430b1017],
18	)	CD	NUMBER	)	num	19	SENT_220	[p20l7t919r430b1017],
19	“	NN	O	“	prep_in	14	SENT_220	[p20l7t919r430b1017],
20	7	CD	NUMBER	7	num	21	SENT_220	[p20l7t919r430b1017],
21	]	NN	O	]	xcomp	11	SENT_220	[p20l7t919r430b1017],
22	compared	VBN	O	compare	_	0	SENT_220	[p20l488t928r892b1022],
23	with	IN	O	with	prepc_compared_with	21	SENT_220	[p20l944t928r1125b1001],
24	the	DT	O	the	det	25	SENT_220	[p20l1177t928r1300b1000],
25	effect	NN	O	effect	pobj	21	SENT_220	[p20l1355t928r1587b1000],
26	of	IN	O	of	_	0	SENT_220	[p20l1640t928r1729b1000],
27	CYP1A2	NN	O	cyp1a2	nn	28	SENT_220	[p20l1776t929r2149b1001],
28	inhibition	NN	O	inhibition	prep_of	25	SENT_220	[p20l7t1056r406b1128],
29	on	IN	O	on	_	0	SENT_220	[p20l442t1079r541b1128],
30	duloxetine	NN	O	duloxetine	nn	32	SENT_220	[p20l577t1056r1008b1128],
31	exposure	NN	O	exposure	nn	32	SENT_220	[p20l1045t1079r1413b1150],
32	(	NN	O	(	prep_on	28	SENT_220	[p20l1451t1056r1716b1145],
33	460	CD	PERCENT	460	num	36	SENT_220	[p20l1451t1056r1716b1145],
34	%	NN	PERCENT	%	nn	36	SENT_220	[p20l1451t1056r1716b1145],
35	increase	NN	O	increase	nn	36	SENT_220	[p20l1755t1056r2145b1145],
36	)	NN	O	)	dep	32	SENT_220	[p20l1755t1056r2145b1145],
37	.	.	O	.	_	0	SENT_220	[p20l1755t1056r2145b1145],

1	In	IN	O	in	_	0	SENT_221	[p20l7t1187r90b1257],
2	this	DT	O	this	det	3	SENT_221	[p20l123t1185r267b1257],
3	study	NN	O	study	prep_in	18	SENT_221	[p20l305t1185r545b1279],
4	,	,	O	,	_	0	SENT_221	[p20l305t1185r545b1279],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_221	[p20l580t1185r1264b1279],
6	comparison	NN	O	comparison	nsubjpass	18	SENT_221	[p20l1299t1185r1777b1279],
7	between	IN	O	between	_	0	SENT_221	[p20l1808t1185r2151b1257],
8	CYPZD6	NN	O	cypzd6	nn	10	SENT_221	[p20l8t1314r381b1387],
9	poor	JJ	O	poor	amod	10	SENT_221	[p20l412t1337r602b1408],
10	metabolisers	NNS	O	metaboliser	prep_between	6	SENT_221	[p20l631t1314r1147b1386],
11	and	CC	O	and	_	0	SENT_221	[p20l1182t1314r1327b1386],
12	CYPZD6	NN	O	cypzd6	nn	14	SENT_221	[p20l1358t1314r1731b1387],
13	extensive	JJ	O	extensive	amod	14	SENT_221	[p20l1764t1314r2150b1387],
14	metabolisers	NNS	O	metaboliser	conj_and	10	SENT_221	[p20l7t1443r524b1515],
15	could	MD	O	could	aux	18	SENT_221	[p20l552t1443r778b1515],
16	not	RB	O	not	neg	18	SENT_221	[p20l802t1454r932b1515],
17	be	VB	O	be	auxpass	18	SENT_221	[p20l954t1443r1050b1515],
18	evaluated	VBN	O	evaluate	_	0	SENT_221	[p20l1076t1443r1468b1516],
19	as	IN	O	as	mark	21	SENT_221	[p20l1494t1466r1572b1515],
20	there	EX	O	there	expl	21	SENT_221	[p20l1599t1443r1803b1515],
21	were	VBD	O	be	advcl	18	SENT_221	[p20l1828t1466r2025b1516],
22	no	DT	O	no	det	23	SENT_221	[p20l2050t1466r2149b1515],
23	CYPZD6	NN	O	cypzd6	iobj	21	SENT_221	[p20l8t1572r381b1645],
24	poor	JJ	O	poor	amod	25	SENT_221	[p20l410t1595r599b1666],
25	metabolisers	NNS	O	metaboliser	dep	23	SENT_221	[p20l625t1572r1164b1644],
26	.	.	O	.	_	0	SENT_221	[p20l625t1572r1164b1644],

1	Comparison	NN	O	comparison	nsubj	13	SENT_222	[p20l1198t1572r1700b1666],
2	of	IN	O	of	_	0	SENT_222	[p20l1728t1572r1817b1644],
3	duloxetine	NN	O	duloxetine	nn	4	SENT_222	[p20l1839t1572r2148b1644, p20l7t1701r159b1773],
4	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	1	SENT_222	[p20l189t1701r913b1795],
5	between	IN	O	between	_	0	SENT_222	[p20l944t1701r1287b1774],
6	CYPZD6	NN	O	cypzd6	nn	8	SENT_222	[p20l1318t1701r1691b1774],
7	intermediate	JJ	O	intermediate	amod	8	SENT_222	[p20l1723t1701r2147b1773, p20l10t1841r124b1902],
8	metabolisers	NNS	O	metaboliser	prep_between	4	SENT_222	[p20l158t1830r674b1902],
9	and	CC	O	and	_	0	SENT_222	[p20l712t1830r857b1902],
10	CYPZD6	NN	O	cypzd6	nn	12	SENT_222	[p20l890t1830r1263b1903],
11	extensive	JJ	O	extensive	amod	12	SENT_222	[p20l1299t1830r1684b1903],
12	metabolisers	NNS	O	metaboliser	prep_between	4	SENT_222	[p20l1718t1830r2147b1902, p20l8t1982r123b2031],
13	showed	VBD	O	show	_	0	SENT_222	[p20l178t1959r487b2032],
14	that	IN	O	that	complm	22	SENT_222	[p20l535t1959r689b2031],
15	duloxetine	NN	O	duloxetine	nn	16	SENT_222	[p20l738t1959r1169b2031],
16	exposure	NN	O	exposure	nsubj	22	SENT_222	[p20l1219t1982r1587b2053],
17	was	VBD	O	be	cop	22	SENT_222	[p20l1638t1982r1792b2032],
18	slightly	RB	O	slightly	advmod	19	SENT_222	[p20l1847t1959r2150b2053],
19	higher	JJR	O	higher	advmod	22	SENT_222	[p20l7t2088r270b2182],
20	(	CD	PERCENT	(	number	21	SENT_222	[p20l300t2088r548b2177],
21	16	CD	PERCENT	16	num	22	SENT_222	[p20l300t2088r548b2177],
22	%	NN	PERCENT	%	ccomp	13	SENT_222	[p20l300t2088r548b2177],
23	)	CD	NUMBER	)	dep	22	SENT_222	[p20l300t2088r548b2177],
24	in	IN	O	in	_	0	SENT_222	[p20l580t2088r658b2160],
25	CYPZD6	NN	O	cypzd6	nn	27	SENT_222	[p20l687t2088r1060b2161],
26	intermediate	JJ	O	intermediate	amod	27	SENT_222	[p20l1090t2088r1602b2160],
27	metabolisers	NNS	O	metaboliser	prep_in	23	SENT_222	[p20l1632t2088r2148b2160],
28	than	IN	O	than	advmod	22	SENT_222	[p20l7t2217r182b2289],
29	in	IN	O	in	_	0	SENT_222	[p20l219t2217r297b2288],
30	CYPZD6	NN	O	cypzd6	nn	32	SENT_222	[p20l334t2217r707b2290],
31	extensive	JJ	O	extensive	amod	32	SENT_222	[p20l746t2217r1131b2289],
32	metabolisers	NNS	O	metaboliser	prep_in	28	SENT_222	[p20l1168t2217r1707b2289],
33	.	.	O	.	_	0	SENT_222	[p20l1168t2217r1707b2289],

1	However	RB	O	however	advmod	10	SENT_223	[p20l1749t2219r2147b2302],
2	,	,	O	,	_	0	SENT_223	[p20l1749t2219r2147b2302],
3	this	DT	O	this	det	4	SENT_223	[p20l7t2345r151b2417],
4	magnitude	NN	O	magnitude	nsubj	10	SENT_223	[p20l187t2345r619b2439],
5	of	IN	O	of	_	0	SENT_223	[p20l655t2345r743b2417],
6	difference	NN	O	difference	prep_of	4	SENT_223	[p20l771t2345r1185b2417],
7	is	VBZ	O	be	cop	10	SENT_223	[p20l1219t2345r1283b2417],
8	not	RB	O	not	neg	10	SENT_223	[p20l1318t2356r1449b2417],
9	clinically	RB	O	clinically	advmod	10	SENT_223	[p20l1482t2345r1861b2439],
10	meaningful	JJ	O	meaningful	_	0	SENT_223	[p20l1895t2368r2147b2417, p20l7t2474r271b2568],
11	.	.	O	.	_	0	SENT_223	[p20l1895t2368r2147b2417, p20l7t2474r271b2568],

1	As	IN	O	as	mark	6	SENT_224	[p20l131t2604r240b2675],
2	CYP1A2	NN	O	cyp1a2	nsubj	6	SENT_224	[p20l283t2604r656b2676],
3	is	VBZ	O	be	cop	6	SENT_224	[p20l697t2603r760b2675],
4	the	DT	O	the	det	6	SENT_224	[p20l801t2603r924b2675],
5	primary	JJ	O	primary	amod	6	SENT_224	[p20l962t2603r1287b2697],
6	enzyme	NN	O	enzyme	advcl	21	SENT_224	[p20l1327t2626r1644b2697],
7	responsible	JJ	O	responsible	amod	6	SENT_224	[p20l1682t2603r2150b2697],
8	for	IN	O	for	_	0	SENT_224	[p20l8t2732r126b2804],
9	duloxetine	NN	O	duloxetine	nn	10	SENT_224	[p20l170t2732r601b2804],
10	metabolism	NN	O	metabolism	prep_for	7	SENT_224	[p20l646t2732r1146b2818],
11	,	,	O	,	_	0	SENT_224	[p20l646t2732r1146b2818],
12	the	DT	O	the	det	14	SENT_224	[p20l1193t2732r1316b2804],
13	large	JJ	O	large	amod	14	SENT_224	[p20l1361t2732r1564b2826],
14	variability	NN	O	variability	nsubj	21	SENT_224	[p20l1608t2732r2029b2826],
15	in	IN	O	in	_	0	SENT_224	[p20l2074t2732r2151b2804],
16	duloxetine	NN	O	duloxetine	nn	17	SENT_224	[p20l8t2861r440b2933],
17	exposure	NN	O	exposure	prep_in	14	SENT_224	[p20l491t2884r860b2955],
18	could	MD	O	could	aux	21	SENT_224	[p20l912t2861r1138b2933],
19	perhaps	RB	O	perhaps	advmod	21	SENT_224	[p20l1187t2861r1504b2955],
20	be	VB	O	be	cop	21	SENT_224	[p20l1556t2861r1651b2933],
21	due	JJ	O	due	_	0	SENT_224	[p20l1703t2861r1848b2933],
22	to	TO	O	to	_	0	SENT_224	[p20l1899t2872r1976b2933],
23	the	DT	O	the	det	25	SENT_224	[p20l2027t2861r2150b2933],
24	wide	JJ	O	wide	amod	25	SENT_224	[p20l8t2990r204b3063],
25	variation	NN	O	variation	prep_to	21	SENT_224	[p20l246t2990r610b3063],
26	in	IN	O	in	_	0	SENT_224	[p20l652t2990r729b3062],
27	CYP1A2	NN	O	cyp1a2	nn	28	SENT_224	[p20l771t2991r1145b3063],
28	activity	NN	O	activity	prep_in	25	SENT_224	[p20l1189t2990r1514b3084],
29	.	.	O	.	_	0	SENT_224	[p20l1189t2990r1514b3084],

1	Of	IN	O	of	_	0	SENT_225	[p20l1562t2990r1674b3063],
2	the	DT	O	the	det	3	SENT_225	[p20l1708t2990r1831b3062],
3	factors	NNS	O	factor	prep_of	15	SENT_225	[p20l1873t2990r2148b3062],
4	that	WDT	O	that	nsubj	5	SENT_225	[p20l7t3119r161b3191],
5	inﬂuence	VBP	O	inﬂuence	rcmod	3	SENT_225	[p20l194t3119r574b3191],
6	CYP1A2	NN	O	cyp1a2	nn	7	SENT_225	[p20l611t3120r984b3192],
7	activity	NN	O	activity	dobj	5	SENT_225	[p20l1022t3119r1349b3213],
8	,	,	O	,	_	0	SENT_225	[p20l1022t3119r1349b3213],
9	the	DT	O	the	det	13	SENT_225	[p20l1387t3119r1510b3191],
10	sex	NN	O	sex	nn	13	SENT_225	[p20l1549t3142r1680b3191],
11	and	CC	O	and	_	0	SENT_225	[p20l1717t3119r1862b3191],
12	smoking	NN	O	smoking	conj_and	10	SENT_225	[p20l1899t3119r2148b3191, p20l7t3248r135b3342],
13	status	NN	O	status	nsubjpass	15	SENT_225	[p20l181t3259r407b3320],
14	are	VBP	O	be	auxpass	15	SENT_225	[p20l453t3271r573b3320],
15	known	VBN	O	know	_	0	SENT_225	[p20l614t3248r893b3321],
16	to	TO	O	to	aux	18	SENT_225	[p20l933t3259r1009b3320],
17	significantly	RB	O	significantly	advmod	18	SENT_225	[p20l1055t3248r1564b3342],
18	inﬂuence	VB	O	inﬂuence	xcomp	15	SENT_225	[p20l1606t3248r1986b3320],
19	the	DT	O	the	dobj	18	SENT_225	[p20l2027t3248r2150b3320],

1	©	RB	O	©	amod	4	SENT_226	[p20l9t3532r52b3575],
2	2007	CD	DATE	2007	tmod	1	SENT_226	[p20l75t3528r207b3575],
3	Adis	NNP	PERSON	Adis	nn	4	SENT_226	[p20l230t3528r353b3575],
4	Doro	NNP	PERSON	Doro	_	0	SENT_226	[p20l377t3528r520b3575],
5	:	:	O	:	_	0	SENT_226	[p20l377t3528r520b3575],
6	Informorion	NNP	ORGANIZATION	Informorion	nn	7	SENT_226	[p20l547t3528r882b3575],
7	BV	NN	ORGANIZATION	bv	dep	4	SENT_226	[p20l908t3528r994b3575],
8	.	.	O	.	_	0	SENT_226	[p20l908t3528r994b3575],

1	All	DT	O	all	det	2	SENT_227	[p20l1019t3528r1086b3575],
2	rights	NNS	O	rights	nsubj	3	SENT_227	[p20l1111t3528r1262b3587],
3	reserved	VBN	O	reserve	_	0	SENT_227	[p20l1285t3528r1551b3575],
4	.	.	O	.	_	0	SENT_227	[p20l1285t3528r1551b3575],

1	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_228	[p21l6t99r729b193],
2	of	IN	O	of	_	0	SENT_228	[p21l781t99r869b171],
3	duloxetine	NN	O	duloxetine	prep_of	1	SENT_228	[p21l911t99r1365b184],
4	,	,	O	,	_	0	SENT_228	[p21l911t99r1365b184],
5	such	JJ	O	such	appos	3	SENT_228	[p21l1420t99r1603b171],
6	that	IN	O	that	complm	8	SENT_228	[p21l1650t99r1804b171],
7	women	NNS	O	woman	nsubj	8	SENT_228	[p21l1850t122r2151b172],
8	have	VBP	O	have	dep	1	SENT_228	[p21l7t228r198b301],
9	lower	JJR	O	lower	amod	11	SENT_228	[p21l239t228r473b301],
10	duloxetine	NN	O	duloxetine	nn	11	SENT_228	[p21l511t228r942b300],
11	CL/F	NN	O	cl/f	dobj	8	SENT_228	[p21l984t229r1198b301],
12	than	IN	O	than	_	0	SENT_228	[p21l1237t228r1412b300],
13	men	NNS	O	man	prep_than	8	SENT_228	[p21l1451t218r1735b300],
14	“	CD	NUMBER	“	number	15	SENT_228	[p21l1451t218r1735b300],
15	9	CD	NUMBER	9	num	16	SENT_228	[p21l1451t218r1735b300],
16	]	NN	O	]	dep	13	SENT_228	[p21l1451t218r1735b300],
17	and	CC	O	and	_	0	SENT_228	[p21l1781t228r1925b300],
18	nonsmokers	NNS	O	nonsmoker	conj_and	13	SENT_228	[p21l1964t251r2147b300, p21l11t357r346b429],

1	have	VB	O	have	_	0	SENT_229	[p21l397t357r589b430],
2	lower	JJR	O	lower	amod	4	SENT_229	[p21l639t357r873b430],
3	duloxetine	NN	O	duloxetine	nn	4	SENT_229	[p21l921t357r1352b429],
4	CLH	NN	O	clh	dobj	1	SENT_229	[p21l1403t358r1617b430],
5	:	:	O	:	_	0	SENT_229	[p21l1403t358r1617b430],
6	values	NNS	O	value	dep	1	SENT_229	[p21l1666t357r1924b430],
7	than	IN	O	than	_	0	SENT_229	[p21l1976t357r2151b429],
8	smokers	NNS	O	smoker	prep_than	6	SENT_229	[p21l11t477r449b559],
9	.	.	O	.	_	0	SENT_229	[p21l11t477r449b559],

1	[	NN	O	[	nsubj	8	SENT_230	[p21l11t477r449b559],
2	6	CD	NUMBER	6	number	3	SENT_230	[p21l11t477r449b559],
3	]	CD	NUMBER	]	dep	1	SENT_230	[p21l11t477r449b559],
4	Similarly	RB	O	similarly	advmod	3	SENT_230	[p21l512t487r913b581],
5	,	,	O	,	_	0	SENT_230	[p21l512t487r913b581],
6	Chinese	JJ	LOCATION	chinese	amod	7	SENT_230	[p21l974t487r1302b560],
7	women	NNS	O	woman	appos	1	SENT_230	[p21l1359t510r1660b560],
8	had	VBD	O	have	_	0	SENT_230	[p21l1716t487r1863b559],
9	lower	JJR	O	lower	amod	11	SENT_230	[p21l1919t487r2152b560],
10	CLSS/F	NN	O	clss/f	nn	11	SENT_230	[p21l8t616r287b697],
11	values	NNS	O	value	dobj	8	SENT_230	[p21l312t615r570b687],
12	than	IN	O	than	_	0	SENT_230	[p21l597t615r772b687],
13	men	NNS	O	man	prep_than	11	SENT_230	[p21l797t638r992b687],
14	.	.	O	.	_	0	SENT_230	[p21l797t638r992b687],

1	The	DT	O	the	det	2	SENT_231	[p21l1022t615r1180b687],
2	magnitude	NN	O	magnitude	nsubj	16	SENT_231	[p21l1205t615r1637b709],
3	of	IN	O	of	_	0	SENT_231	[p21l1664t615r1752b687],
4	the	DT	O	the	det	5	SENT_231	[p21l1770t615r1893b687],
5	effect	NN	O	effect	prep_of	2	SENT_231	[p21l1920t615r2152b687],
6	of	IN	O	of	_	0	SENT_231	[p21l8t744r98b816],
7	sex	NN	O	sex	prep_of	5	SENT_231	[p21l144t767r275b816],
8	on	IN	O	on	_	0	SENT_231	[p21l327t767r426b816],
9	duloxetine	NN	O	duloxetine	nn	10	SENT_231	[p21l476t744r907b816],
10	CL/F	NN	O	cl/f	prep_on	7	SENT_231	[p21l959t745r1174b817],
11	is	VBZ	O	be	cop	12	SENT_231	[p21l1223t744r1286b816],
12	small	JJ	O	small	_	0	SENT_231	[p21l1342t744r1581b829],
13	,	,	O	,	_	0	SENT_231	[p21l1342t744r1581b829],
14	and	CC	O	and	_	0	SENT_231	[p21l1637t744r1782b816],
15	there	EX	O	there	expl	16	SENT_231	[p21l1831t744r2034b816],
16	is	VBZ	O	be	conj_and	12	SENT_231	[p21l2085t744r2148b816],
17	considerable	JJ	O	considerable	acomp	16	SENT_231	[p21l8t872r525b944],
18	overlap	VBP	O	overlap	ccomp	17	SENT_231	[p21l585t872r889b966],
19	in	IN	O	in	_	0	SENT_231	[p21l948t872r1025b944],
20	the	DT	O	the	det	21	SENT_231	[p21l1083t872r1206b944],
21	distribution	NN	O	distribution	prep_in	18	SENT_231	[p21l1265t872r1737b944],
22	of	IN	O	of	_	0	SENT_231	[p21l1796t872r1885b944],
23	CL/F	NN	O	cl/f	prep_of	21	SENT_231	[p21l1936t873r2152b945],
24	between	IN	O	between	_	0	SENT_231	[p21l6t1001r349b1074],
25	the	DT	O	the	det	27	SENT_231	[p21l376t1002r499b1073],
26	two	CD	NUMBER	two	num	27	SENT_231	[p21l528t1012r678b1074],
27	populations	NNS	O	population	prep_between	23	SENT_231	[p21l707t1001r1207b1095],
28	.	.	O	.	_	0	SENT_231	[p21l707t1001r1207b1095],

1	The	DT	O	the	det	2	SENT_232	[p21l1241t1001r1398b1073],
2	effect	NN	O	effect	nsubjpass	8	SENT_232	[p21l1427t1001r1660b1073],
3	of	IN	O	of	_	0	SENT_232	[p21l1688t1001r1777b1073],
4	smoking	NN	O	smoking	prep_of	2	SENT_232	[p21l1801t1001r2149b1095],
5	could	MD	O	could	aux	8	SENT_232	[p21l8t1130r235b1202],
6	not	RB	O	not	neg	8	SENT_232	[p21l278t1141r408b1202],
7	be	VB	O	be	auxpass	8	SENT_232	[p21l449t1130r545b1202],
8	evaluated	VBN	O	evaluate	_	0	SENT_232	[p21l590t1130r983b1203],
9	in	IN	O	in	_	0	SENT_232	[p21l1026t1130r1103b1202],
10	this	DT	O	this	det	11	SENT_232	[p21l1147t1130r1291b1202],
11	study	NN	O	study	prep_in	8	SENT_232	[p21l1341t1130r1558b1224],
12	because	IN	O	because	mark	17	SENT_232	[p21l1601t1130r1925b1202],
13	only	RB	O	only	advmod	15	SENT_232	[p21l1971t1130r2150b1224],
14	two	CD	NUMBER	two	num	15	SENT_232	[p21l7t1270r158b1332],
15	subjects	NNS	O	subject	nsubj	17	SENT_232	[p21l198t1259r522b1353],
16	were	VBD	O	be	cop	17	SENT_232	[p21l560t1282r757b1332],
17	smokers	NNS	O	smoker	advcl	8	SENT_232	[p21l797t1259r1155b1331],
18	.	.	O	.	_	0	SENT_232	[p21l797t1259r1155b1331],

1	However	RB	O	however	advmod	10	SENT_233	[p21l1196t1261r1592b1345],
2	,	,	O	,	_	0	SENT_233	[p21l1196t1261r1592b1345],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_233	[p21l1631t1259r2148b1353, p21l7t1388r203b1460],
4	data	NNS	O	datum	nsubj	10	SENT_233	[p21l266t1388r436b1460],
5	from	IN	O	from	_	0	SENT_233	[p21l494t1388r692b1460],
6	mostly	RB	O	mostly	advmod	8	SENT_233	[p21l751t1388r1029b1482],
7	Caucasian	JJ	MISC	caucasian	amod	8	SENT_233	[p21l1090t1388r1510b1461],
8	subjects	NNS	O	subject	prep_from	4	SENT_233	[p21l1573t1388r1897b1482],
9	have	VBP	O	have	aux	10	SENT_233	[p21l1958t1388r2150b1461],
10	shown	VBN	O	show	_	0	SENT_233	[p21l11t1517r274b1590],
11	that	IN	O	that	complm	15	SENT_233	[p21l329t1518r483b1589],
12	duloxetine	NN	O	duloxetine	nn	13	SENT_233	[p21l538t1517r970b1589],
13	exposures	NNS	O	exposure	nsubjpass	15	SENT_233	[p21l1027t1540r1434b1611],
14	are	VBP	O	be	auxpass	15	SENT_233	[p21l1494t1540r1614b1589],
15	reduced	VBN	O	reduce	ccomp	10	SENT_233	[p21l1670t1517r1995b1589],
16	by	IN	O	by	dep	15	SENT_233	[p21l2049t1517r2150b1611],
17	about	IN	O	about	_	0	SENT_233	[p21l10t1647r235b1719],
18	one	CD	NUMBER	one	number	19	SENT_233	[p21l271t1647r646b1719],
19	—	CD	NUMBER	—	prep_about	15	SENT_233	[p21l271t1647r646b1719],
20	third	JJ	ORDINAL	third	quantmod	19	SENT_233	[p21l271t1647r646b1719],
21	in	IN	O	in	_	0	SENT_233	[p21l682t1647r760b1719],
22	smoking	NN	O	smoking	nn	23	SENT_233	[p21l799t1647r1147b1741],
23	adults	NNS	O	adult	prep_in	19	SENT_233	[p21l1187t1637r1529b1719],
24	.	.	O	.	_	0	SENT_233	[p21l1187t1637r1529b1719],

1	[	NN	O	[	_	0	SENT_234	[p21l1187t1637r1529b1719],
2	6	CD	NUMBER	6	number	3	SENT_234	[p21l1187t1637r1529b1719],
3	]	CD	NUMBER	]	dep	1	SENT_234	[p21l1187t1637r1529b1719],
4	Although	IN	O	although	mark	26	SENT_234	[p21l1570t1647r1957b1741],
5	factors	NNS	O	factor	nsubj	26	SENT_234	[p21l1993t1647r2147b1719, p21l7t1786r157b1847],
6	(	CD	NUMBER	(	amod	5	SENT_234	[p21l207t1776r379b1869],
7	e.g.	FW	O	e.g.	dep	6	SENT_234	[p21l207t1776r379b1869],
8	sex	NN	O	sex	dep	7	SENT_234	[p21l432t1798r585b1861],
9	,	,	O	,	_	0	SENT_234	[p21l432t1798r585b1861],
10	smoking	NN	O	smoking	nn	11	SENT_234	[p21l637t1775r984b1869],
11	status	NN	O	status	appos	7	SENT_234	[p21l1034t1786r1284b1860],
12	,	,	O	,	_	0	SENT_234	[p21l1034t1786r1284b1860],
13	CYPZD6	NN	O	cypzd6	nn	15	SENT_234	[p21l1338t1775r1700b1848],
14	genotype	NN	O	genotype	nn	15	SENT_234	[p21l1742t1776r2148b1869],
15	)	NN	O	)	appos	11	SENT_234	[p21l1742t1776r2148b1869],
16	that	WDT	O	that	nsubj	18	SENT_234	[p21l7t1904r161b1976],
17	are	VBP	O	be	cop	18	SENT_234	[p21l207t1927r328b1976],
18	responsible	JJ	O	responsible	rcmod	15	SENT_234	[p21l373t1904r841b1998],
19	for	IN	O	for	_	0	SENT_234	[p21l887t1904r1007b1976],
20	variation	NN	O	variation	prep_for	18	SENT_234	[p21l1051t1904r1414b1977],
21	in	IN	O	in	_	0	SENT_234	[p21l1460t1904r1538b1976],
22	CYP1A2	NN	O	cyp1a2	nn	25	SENT_234	[p21l1584t1905r1958b1977],
23	and	CC	O	and	_	0	SENT_234	[p21l2007t1904r2151b1976],
24	CYPZD6	NN	O	cypzd6	nn	25	SENT_234	[p21l8t2033r381b2106],
25	activity	NN	O	activity	prep_in	20	SENT_234	[p21l423t2033r727b2127],
26	affect	VBP	O	affect	advcl	41	SENT_234	[p21l767t2033r999b2105],
27	duloxetine	NN	O	duloxetine	nn	30	SENT_234	[p21l1036t2033r1467b2105],
28	pharmacokinet	NN	O	pharmacokinet	nn	30	SENT_234	[p21l1504t2033r2147b2127],
29	—	CD	NUMBER	—	num	30	SENT_234	[p21l1504t2033r2147b2127],
30	ics	NNS	O	ic	dobj	26	SENT_234	[p21l7t2162r141b2247],
31	,	,	O	,	_	0	SENT_234	[p21l7t2162r141b2247],
32	the	DT	O	the	det	33	SENT_234	[p21l171t2162r294b2234],
33	magnitude	NN	O	magnitude	nsubj	41	SENT_234	[p21l321t2162r753b2256],
34	of	IN	O	of	_	0	SENT_234	[p21l781t2162r870b2234],
35	the	DT	O	the	det	36	SENT_234	[p21l890t2162r1012b2234],
36	change	NN	O	change	prep_of	33	SENT_234	[p21l1041t2162r1328b2256],
37	in	IN	O	in	_	0	SENT_234	[p21l1355t2162r1433b2234],
38	duloxetine	NN	O	duloxetine	nn	39	SENT_234	[p21l1460t2162r1891b2234],
39	exposure	NN	O	exposure	prep_in	36	SENT_234	[p21l1919t2185r2147b2256, p21l11t2314r176b2363],
40	is	VBZ	O	be	cop	41	SENT_234	[p21l203t2291r266b2363],
41	small	JJ	O	small	rcmod	1	SENT_234	[p21l298t2291r515b2363],
42	relative	JJ	O	relative	advmod	41	SENT_234	[p21l540t2291r847b2364],
43	to	TO	O	to	_	0	SENT_234	[p21l874t2302r950b2363],
44	the	DT	O	the	det	46	SENT_234	[p21l977t2291r1100b2363],
45	high	JJ	O	high	amod	46	SENT_234	[p21l1125t2291r1307b2385],
46	variability	NN	O	variability	prep_to	42	SENT_234	[p21l1333t2291r1753b2385],
47	in	IN	O	in	_	0	SENT_234	[p21l1780t2291r1858b2363],
48	duloxetine	NN	O	duloxetine	nn	49	SENT_234	[p21l1885t2291r2147b2363, p21l8t2427r204b2499],
49	exposure	NN	O	exposure	prep_in	41	SENT_234	[p21l240t2450r629b2521],
50	.	.	O	.	_	0	SENT_234	[p21l240t2450r629b2521],

1	Evaluation	NN	O	evaluation	nsubj	13	SENT_235	[p21l131t2556r576b2629],
2	of	IN	O	of	_	0	SENT_235	[p21l604t2556r692b2628],
3	reported	VBN	O	report	amod	5	SENT_235	[p21l712t2556r1055b2650],
4	adverse	JJ	O	adverse	amod	5	SENT_235	[p21l1083t2556r1392b2629],
5	events	NNS	O	event	prep_of	1	SENT_235	[p21l1421t2567r1702b2641],
6	,	,	O	,	_	0	SENT_235	[p21l1421t2567r1702b2641],
7	vital	JJ	O	vital	amod	8	SENT_235	[p21l1734t2556r1914b2629],
8	signs	NNS	O	sign	conj_and	5	SENT_235	[p21l1945t2556r2148b2650],
9	and	CC	O	and	_	0	SENT_235	[p21l10t2685r154b2757],
10	clinical	JJ	O	clinical	amod	12	SENT_235	[p21l192t2685r492b2757],
11	laboratory	NN	O	laboratory	nn	12	SENT_235	[p21l530t2685r950b2779],
12	data	NNS	O	datum	conj_and	5	SENT_235	[p21l989t2685r1159b2757],
13	suggested	VBD	O	suggest	_	0	SENT_235	[p21l1199t2685r1600b2779],
14	that	IN	O	that	complm	34	SENT_235	[p21l1637t2685r1790b2757],
15	oral	JJ	O	oral	amod	16	SENT_235	[p21l1828t2685r1984b2757],
16	administration	NN	O	administration	nsubjpass	34	SENT_235	[p21l2024t2685r2147b2757, p21l7t2814r504b2886],
17	of	IN	O	of	_	0	SENT_235	[p21l554t2814r642b2886],
18	a	DT	O	a	det	20	SENT_235	[p21l687t2837r729b2886],
19	single	JJ	O	single	amod	20	SENT_235	[p21l780t2814r1019b2908],
20	dose	NN	O	dose	prep_of	16	SENT_235	[p21l1070t2815r1254b2886],
21	of	IN	O	of	_	0	SENT_235	[p21l1306t2814r1394b2886],
22	duloxetine	NN	O	duloxetine	prep_of	20	SENT_235	[p21l1437t2814r1868b2886],
23	60mg	JJ	O	60mg	amod	22	SENT_235	[p21l1920t2814r2149b2908],
24	followed	VBN	O	follow	partmod	22	SENT_235	[p21l8t2943r372b3016],
25	by	IN	O	by	_	0	SENT_235	[p21l397t2943r498b3037],
26	multiple	JJ	O	multiple	amod	28	SENT_235	[p21l526t2943r867b3037],
27	once-daily	JJ	O	once-daily	amod	28	SENT_235	[p21l895t2943r1326b3037],
28	doses	NNS	O	dose	agent	24	SENT_235	[p21l1355t2943r1578b3015],
29	of	IN	O	of	_	0	SENT_235	[p21l1609t2943r1698b3015],
30	duloxetine	NN	O	duloxetine	nn	31	SENT_235	[p21l1719t2943r2150b3015],
31	60mg	NN	O	60mg	prep_of	28	SENT_235	[p21l9t3072r239b3166],
32	was	VBD	O	be	auxpass	34	SENT_235	[p21l303t3095r458b3144],
33	well	RB	O	well	advmod	34	SENT_235	[p21l523t3072r697b3145],
34	tolerated	VBN	O	tolerate	ccomp	13	SENT_235	[p21l761t3072r1120b3144],
35	in	IN	O	in	_	0	SENT_235	[p21l1182t3072r1259b3144],
36	the	DT	O	the	det	40	SENT_235	[p21l1322t3072r1445b3144],
37	native	JJ	O	native	amod	40	SENT_235	[p21l1509t3072r1757b3145],
38	Chinese	JJ	MISC	chinese	amod	40	SENT_235	[p21l1822t3072r2150b3145],
39	healthy	JJ	O	healthy	amod	40	SENT_235	[p21l7t3201r307b3295],
40	subjects	NNS	O	subject	prep_in	34	SENT_235	[p21l358t3201r704b3295],
41	.	.	O	.	_	0	SENT_235	[p21l358t3201r704b3295],

1	There	EX	O	there	expl	2	SENT_236	[p21l755t3201r993b3273],
2	were	VBD	O	be	_	0	SENT_236	[p21l1039t3224r1236b3274],
3	no	DT	O	no	det	6	SENT_236	[p21l1282t3224r1381b3273],
4	clinically	RB	O	clinically	advmod	5	SENT_236	[p21l1429t3201r1809b3295],
5	significant	JJ	O	significant	amod	6	SENT_236	[p21l1859t3201r2147b3295, p21l8t3341r178b3402],
6	observations	NNS	O	observation	nsubj	2	SENT_236	[p21l221t3330r737b3403],
7	relating	VBG	O	relate	partmod	6	SENT_236	[p21l782t3330r1094b3424],
8	to	TO	O	to	_	0	SENT_236	[p21l1139t3341r1215b3402],
9	safety	NN	O	safety	prep_to	7	SENT_236	[p21l1264t3330r1503b3424],
10	or	CC	O	or	_	0	SENT_236	[p21l1549t3353r1633b3402],
11	tolerability	NN	O	tolerability	prep_to	7	SENT_236	[p21l1675t3330r2145b3424],
12	.	.	O	.	_	0	SENT_236	[p21l1675t3330r2145b3424],

1	The	DT	O	the	det	5	SENT_237	[p21l7t3459r165b3531],
2	tolerability	NN	O	tolerability	nn	5	SENT_237	[p21l191t3459r640b3553],
3	and	CC	O	and	_	0	SENT_237	[p21l669t3459r814b3531],
4	safety	NN	O	safety	conj_and	2	SENT_237	[p21l843t3459r1082b3553],
5	observations	NNS	O	observation	nsubj	9	SENT_237	[p21l1110t3459r1626b3532],
6	in	IN	O	in	_	0	SENT_237	[p21l1654t3459r1732b3531],
7	this	DT	O	this	det	8	SENT_237	[p21l1757t3459r1901b3531],
8	study	NN	O	study	prep_in	5	SENT_237	[p21l1934t3459r2150b3553],
9	appear	VBP	O	appear	_	0	SENT_237	[p21l10t3611r281b3682],
10	to	TO	O	to	aux	12	SENT_237	[p21l307t3599r383b3660],
11	be	VB	O	be	cop	12	SENT_237	[p21l411t3588r506b3660],
12	consistent	JJ	O	consistent	xcomp	9	SENT_237	[p21l535t3588r945b3660],
13	with	IN	O	with	_	0	SENT_237	[p21l972t3588r1152b3661],
14	previous	JJ	O	previous	amod	15	SENT_237	[p21l1178t3588r1529b3682],
15	data	NNS	O	datum	prep_with	12	SENT_237	[p21l1561t3588r1730b3660],
16	on	IN	O	on	_	0	SENT_237	[p21l1758t3611r1857b3660],
17	duloxetine	NN	O	duloxetine	prep_on	12	SENT_237	[p21l1885t3588r2147b3660, p21l8t3708r340b3788],
18	.	.	O	.	_	0	SENT_237	[p21l1885t3588r2147b3660, p21l8t3708r340b3788],

1	[	NN	O	[	_	0	SENT_238	[p21l1885t3588r2147b3660, p21l8t3708r340b3788],
2	17	CD	NUMBER	17	num	3	SENT_238	[p21l1885t3588r2147b3660, p21l8t3708r340b3788],
3	]	NN	O	]	dep	1	SENT_238	[p21l1885t3588r2147b3660, p21l8t3708r340b3788],

1	Conclusions	NNS	O	conclusion	_	0	SENT_239	[p22l132t170r733b250],

1	The	DT	O	the	det	2	SENT_240	[p22l131t417r288b489],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	18	SENT_240	[p22l336t417r1060b511],
3	of	IN	O	of	_	0	SENT_240	[p22l1112t417r1201b489],
4	duloxetine	NN	O	duloxetine	prep_of	2	SENT_240	[p22l1243t417r1674b489],
5	in	IN	O	in	_	0	SENT_240	[p22l1724t417r1801b489],
6	healthy	JJ	O	healthy	amod	8	SENT_240	[p22l1849t417r2150b511],
7	Chinese	JJ	MISC	chinese	amod	8	SENT_240	[p22l8t546r336b619],
8	subjects	NNS	O	subject	prep_in	4	SENT_240	[p22l380t546r703b640],
9	during	IN	O	during	_	0	SENT_240	[p22l746t546r1011b640],
10	a	DT	O	a	det	16	SENT_240	[p22l1054t569r1096b618],
11	60mg	JJ	O	60mg	amod	16	SENT_240	[p22l1136t546r1365b640],
12	once	RB	DATE	once	advmod	13	SENT_240	[p22l1407t546r1838b640],
13	—	RB	O	—	amod	16	SENT_240	[p22l1407t546r1838b640],
14	daily	JJ	SET	daily	amod	16	SENT_240	[p22l1407t546r1838b640],
15	dosing	NN	O	dosing	nn	16	SENT_240	[p22l1879t546r2149b640],
16	regimen	NNS	O	regimen	prep_during	8	SENT_240	[p22l6t675r343b769],
17	are	VBP	O	be	cop	18	SENT_240	[p22l370t698r490b747],
18	consistent	JJ	O	consistent	_	0	SENT_240	[p22l517t675r927b747],
19	with	IN	O	with	_	0	SENT_240	[p22l952t675r1133b748],
20	those	DT	O	those	prep_with	18	SENT_240	[p22l1157t675r1372b747],
21	reported	VBN	O	report	partmod	20	SENT_240	[p22l1396t675r1739b769],
22	previously	RB	DATE	previously	advmod	21	SENT_240	[p22l1763t675r2147b769, p22l7t804r84b898],
23	in	IN	O	in	_	0	SENT_240	[p22l120t804r198b876],
24	healthy	JJ	O	healthy	amod	25	SENT_240	[p22l232t804r532b898],
25	subjects	NNS	O	subject	prep_in	21	SENT_240	[p22l572t804r919b898],
26	.	.	O	.	_	0	SENT_240	[p22l572t804r919b898],

1	In	IN	O	in	_	0	SENT_241	[p22l959t806r1042b876],
2	addition	NN	O	addition	prep_in	19	SENT_241	[p22l1079t804r1435b889],
3	,	,	O	,	_	0	SENT_241	[p22l1079t804r1435b889],
4	the	DT	O	the	det	7	SENT_241	[p22l1473t805r1596b876],
5	pharmacoki	NN	O	pharmacokus	nn	7	SENT_241	[p22l1631t804r2148b898],
6	—	NN	O	—	nn	7	SENT_241	[p22l1631t804r2148b898],
7	netics	NNS	O	netic	nsubj	19	SENT_241	[p22l7t933r243b1005],
8	of	IN	O	of	_	0	SENT_241	[p22l271t933r360b1005],
9	duloxetine	NN	O	duloxetine	prep_of	7	SENT_241	[p22l379t933r811b1005],
10	in	IN	O	in	_	0	SENT_241	[p22l836t933r914b1005],
11	Chinese	JJ	MISC	chinese	amod	17	SENT_241	[p22l939t933r1290b1019],
12	,	,	O	,	_	0	SENT_241	[p22l939t933r1290b1019],
13	Caucasian	JJ	MISC	caucasian	dep	16	SENT_241	[p22l1320t933r1740b1006],
14	and	CC	O	and	_	0	SENT_241	[p22l1767t933r1912b1005],
15	J	NN	O	j	conj_and	16	SENT_241	[p22l1935t935r1973b1006],
16	apanese	JJ	O	apanese	amod	17	SENT_241	[p22l1978t956r2148b1027, p22l7t1085r188b1134],
17	populations	NNS	O	population	prep_in	9	SENT_241	[p22l231t1062r708b1156],
18	are	VBP	O	be	cop	19	SENT_241	[p22l757t1085r878b1134],
19	similar	JJ	O	similar	_	0	SENT_241	[p22l925t1062r1207b1134],
20	and	CC	O	and	_	0	SENT_241	[p22l1252t1062r1397b1134],
21	do	VBP	O	do	aux	23	SENT_241	[p22l1441t1062r1539b1134],
22	not	RB	O	not	neg	23	SENT_241	[p22l1584t1073r1714b1134],
23	suggest	VB	O	suggest	conj_and	19	SENT_241	[p22l1760t1073r2065b1156],
24	a	DT	O	a	det	25	SENT_241	[p22l2110t1085r2152b1134],
25	need	NN	O	need	dobj	23	SENT_241	[p22l7t1191r200b1263],
26	for	IN	O	for	_	0	SENT_241	[p22l239t1191r358b1263],
27	a	DT	O	a	det	30	SENT_241	[p22l396t1214r438b1263],
28	dose	NN	O	dose	nn	30	SENT_241	[p22l477t1191r661b1263],
29	adjustment	NN	O	adjustment	nn	30	SENT_241	[p22l703t1191r1152b1285],
30	recommendation	NN	O	recommendation	prep_for	25	SENT_241	[p22l1188t1191r1880b1263],
31	based	VBN	O	base	_	0	SENT_241	[p22l1917t1191r2152b1263],
32	on	IN	O	on	prepc_based_on	23	SENT_241	[p22l8t1343r108b1392],
33	the	DT	O	the	det	35	SENT_241	[p22l152t1320r275b1392],
34	racial	JJ	O	racial	amod	35	SENT_241	[p22l318t1320r546b1392],
35	status	NN	O	status	pobj	23	SENT_241	[p22l594t1331r843b1392],
36	.	.	O	.	_	0	SENT_241	[p22l594t1331r843b1392],

1	The	DT	O	the	det	2	SENT_242	[p22l893t1320r1050b1392],
2	safety	NN	O	safety	_	0	SENT_242	[p22l1098t1320r1337b1414],
3	and	CC	O	and	_	0	SENT_242	[p22l1385t1320r1529b1392],
4	adverse	JJ	O	adverse	amod	6	SENT_242	[p22l1576t1320r1885b1393],
5	event	NN	O	event	nn	6	SENT_242	[p22l1931t1331r2152b1392],
6	profiles	NNS	O	profile	conj_and	2	SENT_242	[p22l6t1449r317b1543],
7	following	VBG	O	follow	dep	2	SENT_242	[p22l355t1449r752b1543],
8	oral	JJ	O	oral	amod	9	SENT_242	[p22l789t1449r945b1521],
9	administration	NN	O	administration	pobj	7	SENT_242	[p22l982t1449r1574b1521],
10	of	IN	O	of	_	0	SENT_242	[p22l1609t1449r1698b1521],
11	single	JJ	O	single	amod	17	SENT_242	[p22l1730t1449r1969b1543],
12	and	CC	O	and	_	0	SENT_242	[p22l2007t1449r2152b1521],
13	multiple	JJ	O	multiple	conj_and	11	SENT_242	[p22l7t1578r348b1672],
14	once	RB	DATE	once	advmod	16	SENT_242	[p22l390t1578r820b1672],
15	—	RB	O	—	advmod	16	SENT_242	[p22l390t1578r820b1672],
16	daily	JJ	SET	daily	amod	17	SENT_242	[p22l390t1578r820b1672],
17	dosing	NN	O	dosing	prep_of	9	SENT_242	[p22l861t1578r1132b1672],
18	of	IN	O	of	_	0	SENT_242	[p22l1174t1578r1262b1650],
19	duloxetine	NN	O	duloxetine	nn	21	SENT_242	[p22l1296t1578r1727b1650],
20	60mg	JJ	O	60mg	amod	21	SENT_242	[p22l1769t1578r1998b1672],
21	reClin	NN	O	reclin	prep_of	17	SENT_242	[p22l2038t1601r2147b1650, p22l1206t1858r1313b1905],

1	Phormocokinei	NNP	O	Phormocokinei	_	0	SENT_243	[p22l1339t1858r1793b1905],
2	2007	CD	DATE	2007	num	1	SENT_243	[p22l1814t1858r1962b1908],
3	;	:	O	;	_	0	SENT_243	[p22l1814t1858r1962b1908],
4	46	CD	NUMBER	46	number	5	SENT_243	[p22l1986t1858r2053b1905],
5	(	CD	NUMBER	(	dep	1	SENT_243	[p22l2075t1858r2149b1912],
6	9	CD	NUMBER	9	num	7	SENT_243	[p22l2075t1858r2149b1912],
7	)	NN	O	)	dep	5	SENT_243	[p22l2075t1858r2149b1912],

1	Duloxetine	NNP	O	Duloxetine	nn	2	SENT_244	[p22l184t1987r346b2012],
2	PK	NNP	O	PK	_	0	SENT_244	[p22l357t1988r401b2012],
3	in	IN	O	in	_	0	SENT_244	[p22l412t1988r440b2012],
4	Chinese	NNP	MISC	Chinese	nn	5	SENT_244	[p22l451t1987r567b2012],
5	Subjects	NNPS	O	Subjects	prep_in	2	SENT_244	[p22l579t1987r697b2021],
6	775	CD	NUMBER	775	dep	2	SENT_244	[p22l1927t1988r1975b2012],

1	ported	VBN	O	port	csubj	6	SENT_245	[p22l6t2231r268b2324],
2	in	IN	O	in	_	0	SENT_245	[p22l313t2231r391b2302],
3	this	DT	O	this	det	4	SENT_245	[p22l436t2231r580b2303],
4	study	NN	O	study	prep_in	1	SENT_245	[p22l633t2231r848b2324],
5	are	VBP	O	be	cop	6	SENT_245	[p22l898t2254r1018b2303],
6	similar	JJ	O	similar	_	0	SENT_245	[p22l1068t2231r1349b2303],
7	to	TO	O	to	_	0	SENT_245	[p22l1393t2242r1470b2303],
8	those	DT	O	those	prep_to	6	SENT_245	[p22l1517t2231r1731b2303],
9	observed	VBN	O	observe	partmod	8	SENT_245	[p22l1779t2231r2148b2303],
10	previously	RB	DATE	previously	advmod	9	SENT_245	[p22l6t2359r459b2452],
11	.	.	O	.	_	0	SENT_245	[p22l6t2359r459b2452],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_246	[p22l130t2638r1133b2737],

1	The	DT	O	the	det	2	SENT_247	[p22l130t2923r263b2984],
2	authors	NNS	O	author	nsubj	3	SENT_247	[p22l286t2923r538b2984],
3	thank	VBP	O	thank	_	0	SENT_247	[p22l560t2923r754b2984],
4	the	DT	O	the	det	5	SENT_247	[p22l773t2923r877b2984],
5	subjects	NNS	O	subject	dobj	3	SENT_247	[p22l900t2923r1175b3002],
6	for	IN	O	for	_	0	SENT_247	[p22l1198t2923r1299b2984],
7	their	PRP$	O	they	poss	8	SENT_247	[p22l1317t2923r1478b2984],
8	participation	NN	O	participation	prep_for	3	SENT_247	[p22l1495t2923r1937b3002],
9	in	IN	O	in	_	0	SENT_247	[p22l1956t2923r2023b2983],
10	the	DT	O	the	det	11	SENT_247	[p22l2043t2923r2147b2984],
11	study	NN	O	study	prep_in	8	SENT_247	[p22l10t3030r193b3109],
12	and	CC	O	and	_	0	SENT_247	[p22l235t3030r359b3092],
13	Richard	NNP	PERSON	Richard	nn	15	SENT_247	[p22l398t3030r673b3092],
14	F.	NNP	PERSON	F.	nn	15	SENT_247	[p22l712t3032r776b3092],
15	Bergstrom	NNP	PERSON	Bergstrom	prep_for	3	SENT_247	[p22l820t3032r1206b3109],
16	,	,	O	,	_	0	SENT_247	[p22l820t3032r1206b3109],
17	PhD	NNP	O	PhD	appos	15	SENT_247	[p22l1249t3030r1421b3103],
18	,	,	O	,	_	0	SENT_247	[p22l1249t3030r1421b3103],
19	and	CC	O	and	_	0	SENT_247	[p22l1466t3030r1589b3092],
20	Stephen	NNP	PERSON	Stephen	nn	21	SENT_247	[p22l1631t3030r1908b3109],
21	Wise	NNP	PERSON	Wise	appos	15	SENT_247	[p22l1947t3030r2144b3103],
22	,	,	O	,	_	0	SENT_247	[p22l1947t3030r2144b3103],
23	MD	NNP	O	MD	appos	15	SENT_247	[p22l6t3139r163b3210],
24	,	,	O	,	_	0	SENT_247	[p22l6t3139r163b3210],
25	for	IN	O	for	_	0	SENT_247	[p22l196t3138r297b3199],
26	their	PRP$	O	they	poss	28	SENT_247	[p22l324t3138r484b3199],
27	valuable	JJ	O	valuable	amod	28	SENT_247	[p22l512t3138r805b3199],
28	guidance	NN	O	guidance	prep_for	15	SENT_247	[p22l835t3138r1148b3217],
29	on	IN	O	on	_	0	SENT_247	[p22l1178t3157r1262b3199],
30	the	DT	O	the	det	32	SENT_247	[p22l1291t3138r1395b3199],
31	study	NN	O	study	nn	32	SENT_247	[p22l1427t3138r1610b3217],
32	design	NN	O	design	prep_on	28	SENT_247	[p22l1641t3138r1883b3217],
33	.	.	O	.	_	0	SENT_247	[p22l1641t3138r1883b3217],

1	This	DT	O	this	det	2	SENT_248	[p22l130t3246r282b3307],
2	study	NN	O	study	nsubjpass	4	SENT_248	[p22l308t3246r492b3325],
3	was	VBD	O	be	auxpass	4	SENT_248	[p22l515t3265r647b3307],
4	presented	VBN	O	present	_	0	SENT_248	[p22l669t3246r1004b3325],
5	in	IN	O	in	_	0	SENT_248	[p22l1026t3246r1092b3306],
6	part	NN	O	part	prep_in	4	SENT_248	[p22l1112t3255r1248b3325],
7	at	IN	O	at	_	0	SENT_248	[p22l1271t3255r1331b3307],
8	the	DT	O	the	det	10	SENT_248	[p22l1352t3246r1456b3307],
9	American	NNP	ORGANIZATION	American	nn	10	SENT_248	[p22l1478t3246r1822b3307],
10	Association	NNP	ORGANIZATION	Association	prep_at	4	SENT_248	[p22l1843t3246r2145b3307, p22l6t3355r141b3416],
11	of	IN	ORGANIZATION	of	_	0	SENT_248	[p22l188t3355r263b3416],
12	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	13	SENT_248	[p22l304t3355r841b3416],
13	Scientists	NNS	ORGANIZATION	scientist	prep_of	10	SENT_248	[p22l890t3355r1219b3416],
14	Annual	JJ	ORGANIZATION	annual	amod	10	SENT_248	[p22l1267t3355r1524b3416],
15	Meeting	VBG	ORGANIZATION	meet	partmod	10	SENT_248	[p22l1569t3355r1859b3434],
16	in	IN	O	in	_	0	SENT_248	[p22l1906t3355r1973b3415],
17	San	NNP	LOCATION	San	nn	22	SENT_248	[p22l2021t3355r2148b3416],
18	Antonio	NNP	LOCATION	Antonio	nn	22	SENT_248	[p22l6t3462r310b3535],
19	,	,	O	,	_	0	SENT_248	[p22l6t3462r310b3535],
20	TX	NNP	LOCATION	TX	appos	22	SENT_248	[p22l341t3464r475b3535],
21	,	,	O	,	_	0	SENT_248	[p22l341t3464r475b3535],
22	USA	NNP	LOCATION	USA	prep_in	15	SENT_248	[p22l507t3463r698b3535],
23	,	,	O	,	_	0	SENT_248	[p22l507t3463r698b3535],
24	October	NNP	DATE	October	tmod	15	SENT_248	[p22l732t3462r1012b3524],
25	2006	CD	DATE	2006	num	24	SENT_248	[p22l1040t3462r1228b3524],
26	.	.	O	.	_	0	SENT_248	[p22l1040t3462r1228b3524],

1	The	DT	O	the	det	2	SENT_249	[p22l1261t3462r1395b3524],
2	Work	NN	O	work	nsubjpass	4	SENT_249	[p22l1424t3462r1604b3524],
3	was	VBD	O	be	auxpass	4	SENT_249	[p22l1631t3482r1762b3524],
4	funded	VBN	O	fund	_	0	SENT_249	[p22l1793t3462r2034b3524],
5	by	IN	O	by	_	0	SENT_249	[p22l2061t3462r2147b3541],
6	Eli	NNP	PERSON	Eli	nn	7	SENT_249	[p22l6t3570r105b3630],
7	Lilly	NNP	PERSON	Lilly	agent	4	SENT_249	[p22l142t3570r310b3649],
8	and	CC	O	and	_	0	SENT_249	[p22l350t3570r472b3631],
9	Company	NNP	O	Company	agent	4	SENT_249	[p22l509t3570r864b3649],
10	.	.	O	.	_	0	SENT_249	[p22l509t3570r864b3649],

1	All	DT	O	all	nsubj	24	SENT_250	[p22l905t3570r1014b3630],
2	of	IN	O	of	_	0	SENT_250	[p22l1052t3570r1128b3631],
3	the	DT	O	the	det	4	SENT_250	[p22l1159t3570r1263b3631],
4	authors	NNS	O	author	prep_of	1	SENT_250	[p22l1302t3570r1574b3642],
5	,	,	O	,	_	0	SENT_250	[p22l1302t3570r1574b3642],
6	except	IN	O	except	_	0	SENT_250	[p22l1615t3580r1842b3649],
7	for	IN	O	for	prepc_except_for	24	SENT_250	[p22l1877t3570r1979b3631],
8	Shu	NNP	PERSON	Shu	nn	9	SENT_250	[p22l2016t3570r2147b3631],
9	Liang	NNP	PERSON	Liang	pobj	24	SENT_250	[p22l6t3679r227b3758],
10	,	,	O	,	_	0	SENT_250	[p22l6t3679r227b3758],
11	MD	NNP	O	MD	nsubj	24	SENT_250	[p22l250t3680r408b3751],
12	,	,	O	,	_	0	SENT_250	[p22l250t3680r408b3751],
13	Professor	NNP	O	Professor	appos	11	SENT_250	[p22l431t3679r762b3740],
14	of	IN	O	of	_	0	SENT_250	[p22l781t3679r856b3740],
15	Psychiatry	NNP	O	Psychiatry	nn	21	SENT_250	[p22l870t3679r1257b3758],
16	,	,	O	,	_	0	SENT_250	[p22l870t3679r1257b3758],
17	and	CC	O	and	dep	19	SENT_250	[p22l1282t3679r1405b3740],
18	Si	NNP	PERSON	Si	nn	19	SENT_250	[p22l1427t3679r1495b3740],
19	Tianmei	NNP	PERSON	Tianmei	dep	21	SENT_250	[p22l1516t3679r1824b3751],
20	,	,	O	,	_	0	SENT_250	[p22l1516t3679r1824b3751],
21	PhD	NNP	O	PhD	prep_of	13	SENT_250	[p22l1847t3679r2019b3751],
22	,	,	O	,	_	0	SENT_250	[p22l1847t3679r2019b3751],
23	are	VBP	O	be	cop	24	SENT_250	[p22l2045t3698r2147b3740],
24	employees	NNS	O	employee	_	0	SENT_250	[p23l7t21r377b100],
25	of	IN	O	of	_	0	SENT_250	[p23l426t21r501b83],
26	Eli	NNP	ORGANIZATION	Eli	nn	27	SENT_250	[p23l541t21r641b82],
27	Lilly	NNP	ORGANIZATION	Lilly	prep_of	24	SENT_250	[p23l687t21r855b100],
28	and	CC	ORGANIZATION	and	_	0	SENT_250	[p23l904t21r1027b83],
29	Company	NNP	ORGANIZATION	Company	conj_and	27	SENT_250	[p23l1073t22r1428b100],
30	.	.	O	.	_	0	SENT_250	[p23l1073t22r1428b100],

1	Dr	NNP	O	Dr	nn	2	SENT_251	[p23l1479t23r1570b82],
2	Liang	NNP	PERSON	Liang	nsubj	6	SENT_251	[p23l1614t21r1816b100],
3	was	VBD	O	be	cop	6	SENT_251	[p23l1863t41r1995b83],
4	the	DT	O	the	det	6	SENT_251	[p23l2043t21r2147b83],
5	primary	JJ	O	primary	amod	6	SENT_251	[p23l6t129r281b208],
6	investigator	NN	O	investigator	_	0	SENT_251	[p23l309t129r721b208],
7	and	CC	O	and	_	0	SENT_251	[p23l748t129r872b190],
8	Dr	NN	O	dr	nn	9	SENT_251	[p23l898t130r989b189],
9	Tianmei	NN	PERSON	tianmeus	conj_and	6	SENT_251	[p23l1015t129r1304b190],
10	was	VBD	O	be	cop	14	SENT_251	[p23l1332t148r1463b190],
11	the	DT	O	the	det	14	SENT_251	[p23l1493t129r1597b190],
12	co	NN	O	co	nn	14	SENT_251	[p23l1625t129r2149b208],
13	—	NN	O	—	nn	14	SENT_251	[p23l1625t129r2149b208],
14	investigator	NN	O	investigator	rcmod	6	SENT_251	[p23l1625t129r2149b208],
15	for	IN	O	for	_	0	SENT_251	[p23l7t238r108b299],
16	the	DT	O	the	det	17	SENT_251	[p23l143t238r247b299],
17	study	NN	O	study	prep_for	14	SENT_251	[p23l288t238r489b317],
18	.	.	O	.	_	0	SENT_251	[p23l288t238r489b317],

1	Drs	NNP	PERSON	Drs	nn	2	SENT_252	[p23l531t239r653b299],
2	Liang	NNP	PERSON	Liang	nsubj	5	SENT_252	[p23l691t238r893b317],
3	and	CC	O	and	_	0	SENT_252	[p23l933t238r1056b299],
4	Tianmei	NNP	PERSON	Tianmei	conj_and	2	SENT_252	[p23l1092t238r1381b299],
5	have	VBP	O	have	_	0	SENT_252	[p23l1418t238r1581b299],
6	no	DT	O	no	det	7	SENT_252	[p23l1618t257r1703b299],
7	conﬂicts	NNS	O	conﬂicts	dobj	5	SENT_252	[p23l1741t238r2038b299],
8	of	IN	O	of	_	0	SENT_252	[p23l2078t238r2153b299],
9	interest	NN	O	interest	prep_of	7	SENT_252	[p23l6t345r263b407],
10	that	WDT	O	that	nsubj	13	SENT_252	[p23l289t345r419b407],
11	are	VBP	O	be	cop	13	SENT_252	[p23l448t365r550b407],
12	directly	RB	O	directly	advmod	13	SENT_252	[p23l580t345r843b424],
13	relevant	JJ	O	relevant	rcmod	7	SENT_252	[p23l870t345r1153b407],
14	to	TO	O	to	_	0	SENT_252	[p23l1178t355r1244b407],
15	the	DT	O	the	det	16	SENT_252	[p23l1272t345r1376b407],
16	content	NN	O	content	prep_to	13	SENT_252	[p23l1406t355r1662b407],
17	of	IN	O	of	_	0	SENT_252	[p23l1689t345r1765b407],
18	this	DT	O	this	det	19	SENT_252	[p23l1786t345r1908b407],
19	study	NN	O	study	prep_of	16	SENT_252	[p23l1941t345r2143b424],
20	.	.	O	.	_	0	SENT_252	[p23l1941t345r2143b424],

1	References	NNS	O	reference	_	0	SENT_253	[p23l187t610r737b690],

1	1	LS	NUMBER	1	_	0	SENT_254	[p23l91t760r135b813],
2	.	.	O	.	_	0	SENT_254	[p23l91t760r135b813],

1	Hunziker	NNP	PERSON	Hunziker	nn	2	SENT_255	[p23l180t759r467b813],
2	ME	NNP	O	ME	_	0	SENT_255	[p23l485t760r616b823],
3	,	,	O	,	_	0	SENT_255	[p23l485t760r616b823],
4	Suehs	NNP	PERSON	Suehs	nn	5	SENT_255	[p23l641t759r820b813],
5	BT	NNP	O	BT	appos	2	SENT_255	[p23l842t760r955b823],
6	,	,	O	,	_	0	SENT_255	[p23l842t760r955b823],
7	Bettinger	NNP	PERSON	Bettinger	nn	8	SENT_255	[p23l978t759r1265b829],
8	TL	NNP	O	TL	appos	2	SENT_255	[p23l1283t760r1392b823],
9	,	,	O	,	_	0	SENT_255	[p23l1283t760r1392b823],
10	et	FW	O	et	nn	11	SENT_255	[p23l1416t767r1470b813],
11	al.	FW	O	al.	appos	2	SENT_255	[p23l1491t759r1558b813],
12	.	.	O	.	_	0	SENT_255	[p23l1491t759r1558b813],

1	Duloxetine	NN	O	duloxetine	nn	2	SENT_256	[p23l1582t759r1923b813],
2	hydrochloride	NN	O	hydrochloride	_	0	SENT_256	[p23l1943t759r2146b829, p23l223t854r490b907],
3	:	:	O	:	_	0	SENT_256	[p23l1943t759r2146b829, p23l223t854r490b907],
4	a	DT	O	a	det	7	SENT_256	[p23l531t870r563b907],
5	new	JJ	O	new	amod	7	SENT_256	[p23l596t870r722b907],
6	dual-acting	JJ	O	dual-acting	amod	7	SENT_256	[p23l758t854r1102b923],
7	medication	NN	O	medication	dep	2	SENT_256	[p23l1137t854r1478b907],
8	for	IN	O	for	_	0	SENT_256	[p23l1512t854r1602b907],
9	the	DT	O	the	det	10	SENT_256	[p23l1635t854r1726b907],
10	treatment	NN	O	treatment	prep_for	7	SENT_256	[p23l1761t861r2052b907],
11	of	IN	O	of	_	0	SENT_256	[p23l2086t854r2153b907],
12	major	JJ	O	major	amod	14	SENT_256	[p23l222t949r402b1019],
13	depressive	JJ	O	depressive	amod	14	SENT_256	[p23l427t949r750b1019],
14	disorder	NN	O	disorder	prep_of	10	SENT_256	[p23l776t949r1042b1003],
15	.	.	O	.	_	0	SENT_256	[p23l776t949r1042b1003],

1	Clin	NNP	O	Clin	nn	2	SENT_257	[p23l1072t949r1203b1003],
2	Ther	NNP	O	Ther	_	0	SENT_257	[p23l1228t949r1373b1003],
3	2005	CD	DATE	2005	dep	2	SENT_257	[p23l1398t949r1568b1013],
4	;	:	O	;	_	0	SENT_257	[p23l1398t949r1568b1013],
5	27	CD	NUMBER	27	number	6	SENT_257	[p23l1597t950r1668b1003],
6	(	CD	NUMBER	(	dep	3	SENT_257	[p23l1699t950r1801b1015],
7	8	CD	NUMBER	8	num	8	SENT_257	[p23l1699t950r1801b1015],
8	)	NN	O	)	dep	6	SENT_257	[p23l1699t950r1801b1015],
9	:	:	O	:	_	0	SENT_257	[p23l1699t950r1801b1015],
10	1126-43	CD	NUMBER	1126-43	dep	3	SENT_257	[p23l1839t949r2083b1003],

1	2	LS	NUMBER	2	_	0	SENT_258	[p23l85t1045r135b1099],
2	.	.	O	.	_	0	SENT_258	[p23l85t1045r135b1099],

1	Bymaster	NNP	O	Bymaster	nn	2	SENT_259	[p23l180t1046r476b1115],
2	FP	NN	O	fp	_	0	SENT_259	[p23l499t1046r600b1109],
3	,	,	O	,	_	0	SENT_259	[p23l499t1046r600b1109],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_259	[p23l628t1046r742b1099],
5	TC	NNP	O	TC	appos	2	SENT_259	[p23l768t1045r881b1109],
6	,	,	O	,	_	0	SENT_259	[p23l768t1045r881b1109],
7	Knadler	NNP	O	Knadler	nn	8	SENT_259	[p23l911t1045r1158b1099],
8	MP	NNP	O	MP	appos	2	SENT_259	[p23l1182t1046r1308b1108],
9	,	,	O	,	_	0	SENT_259	[p23l1182t1046r1308b1108],
10	et	FW	O	et	nn	11	SENT_259	[p23l1337t1053r1391b1099],
11	al.	FW	O	al.	appos	2	SENT_259	[p23l1417t1045r1485b1099],
12	.	.	O	.	_	0	SENT_259	[p23l1417t1045r1485b1099],

1	The	DT	O	the	det	5	SENT_260	[p23l1515t1045r1632b1099],
2	dual	JJ	O	dual	amod	5	SENT_260	[p23l1659t1045r1789b1099],
3	transporter	NN	O	transporter	nn	5	SENT_260	[p23l1814t1053r2149b1115],
4	inhibitor	NN	O	inhibitor	nn	5	SENT_260	[p23l223t1140r488b1193],
5	duloxetine	NN	O	duloxetine	_	0	SENT_260	[p23l510t1140r850b1193],
6	:	:	O	:	_	0	SENT_260	[p23l510t1140r850b1193],
7	a	DT	O	a	det	8	SENT_260	[p23l879t1156r911b1193],
8	review	NN	O	review	dep	5	SENT_260	[p23l931t1140r1140b1193],
9	of	IN	O	of	_	0	SENT_260	[p23l1164t1140r1231b1193],
10	its	PRP$	O	its	poss	12	SENT_260	[p23l1248t1140r1317b1193],
11	preclinical	JJ	O	preclinical	amod	12	SENT_260	[p23l1340t1140r1665b1209],
12	pharmacology	NN	O	pharmacology	prep_of	8	SENT_260	[p23l1687t1140r2145b1209],
13	,	,	O	,	_	0	SENT_260	[p23l1687t1140r2145b1209],
14	pharmacokinetic	JJ	O	pharmacokinetic	amod	15	SENT_260	[p23l222t1235r734b1305],
15	profile	NN	O	profile	conj_and	12	SENT_260	[p23l776t1235r997b1305],
16	,	,	O	,	_	0	SENT_260	[p23l776t1235r997b1305],
17	and	CC	O	and	_	0	SENT_260	[p23l1043t1235r1152b1289],
18	clinical	JJ	O	clinical	amod	19	SENT_260	[p23l1193t1235r1417b1289],
19	results	NNS	O	result	conj_and	12	SENT_260	[p23l1459t1235r1657b1289],
20	in	IN	O	in	_	0	SENT_260	[p23l1700t1235r1759b1288],
21	depression	NN	O	depression	prep_in	19	SENT_260	[p23l1800t1235r2143b1305],
22	.	.	O	.	_	0	SENT_260	[p23l1800t1235r2143b1305],

1	Curr	NNP	MISC	Curr	nn	3	SENT_261	[p23l224t1331r364b1385],
2	Pharm	NNP	MISC	Pharm	nn	3	SENT_261	[p23l387t1331r588b1385],
3	Des	NNP	MISC	Des	_	0	SENT_261	[p23l612t1332r728b1385],
4	2005	CD	DATE	2005	dep	3	SENT_261	[p23l757t1331r927b1395],
5	;	:	O	;	_	0	SENT_261	[p23l757t1331r927b1395],
6	11	CD	NUMBER	11	number	7	SENT_261	[p23l962t1331r1023b1384],
7	(	CD	NUMBER	(	dep	4	SENT_261	[p23l1058t1331r1198b1397],
8	12	CD	NUMBER	12	num	9	SENT_261	[p23l1058t1331r1198b1397],
9	)	NN	O	)	dep	7	SENT_261	[p23l1058t1331r1198b1397],
10	:	:	O	:	_	0	SENT_261	[p23l1058t1331r1198b1397],
11	1475-93	CD	NUMBER	1475-93	dep	4	SENT_261	[p23l1237t1331r1480b1386],

1	3	LS	NUMBER	3	_	0	SENT_262	[p23l85t1428r135b1481],
2	.	.	O	.	_	0	SENT_262	[p23l85t1428r135b1481],

1	Detke	NNP	O	Detke	nn	2	SENT_263	[p23l180t1427r362b1481],
2	MJ	NNP	O	MJ	_	0	SENT_263	[p23l394t1429r508b1491],
3	,	,	O	,	_	0	SENT_263	[p23l394t1429r508b1491],
4	Wiltse	NNP	PERSON	Wiltse	nn	5	SENT_263	[p23l543t1427r743b1481],
5	CG	NNP	O	CG	appos	2	SENT_263	[p23l776t1428r898b1491],
6	,	,	O	,	_	0	SENT_263	[p23l776t1428r898b1491],
7	Mallinckrodt	NNP	ORGANIZATION	Mallinckrodt	nn	8	SENT_263	[p23l932t1427r1336b1481],
8	CH	NN	O	ch	appos	2	SENT_263	[p23l1368t1428r1489b1491],
9	,	,	O	,	_	0	SENT_263	[p23l1368t1428r1489b1491],
10	et	FW	O	et	nn	11	SENT_263	[p23l1525t1435r1579b1481],
11	al.	FW	O	al.	appos	2	SENT_263	[p23l1612t1428r1679b1481],
12	.	.	O	.	_	0	SENT_263	[p23l1612t1428r1679b1481],

1	Duloxetine	NNP	O	Duloxetine	_	0	SENT_264	[p23l1715t1427r2057b1481],
2	in	IN	O	in	_	0	SENT_264	[p23l2090t1427r2148b1480],
3	the	DT	O	the	det	7	SENT_264	[p23l223t1522r314b1575],
4	acute	JJ	O	acute	amod	7	SENT_264	[p23l345t1530r504b1575],
5	and	CC	O	and	_	0	SENT_264	[p23l534t1522r643b1575],
6	long-term	JJ	O	long-term	amod	7	SENT_264	[p23l671t1522r974b1591],
7	treatment	NN	O	treatment	prep_in	1	SENT_264	[p23l1002t1530r1292b1575],
8	of	IN	O	of	_	0	SENT_264	[p23l1321t1522r1388b1575],
9	major	JJ	O	major	amod	11	SENT_264	[p23l1411t1522r1590b1591],
10	depressive	JJ	O	depressive	amod	11	SENT_264	[p23l1618t1522r1940b1591],
11	disorder	NN	O	disorder	prep_of	7	SENT_264	[p23l1970t1522r2146b1575, p23l224t1617r335b1671],
12	:	:	O	:	_	0	SENT_264	[p23l1970t1522r2146b1575, p23l224t1617r335b1671],
13	a	DT	O	a	det	15	SENT_264	[p23l366t1634r397b1671],
14	placebo	NN	O	placebo	nn	15	SENT_264	[p23l419t1617r681b1687],
15	—	NN	O	—	dep	1	SENT_264	[p23l419t1617r681b1687],
16	and	CC	O	and	_	0	SENT_264	[p23l708t1617r816b1671],
17	paroxetine-controlled	JJ	O	paroxetine-controlled	amod	18	SENT_264	[p23l838t1617r1503b1687],
18	trial	NN	O	trial	dep	1	SENT_264	[p23l1526t1617r1663b1671],
19	.	.	O	.	_	0	SENT_264	[p23l1526t1617r1663b1671],

1	Eur	NNP	MISC	Eur	nn	4	SENT_265	[p23l1690t1619r1802b1671],
2	Neuropsy	NNP	MISC	Neuropsy	nn	4	SENT_265	[p23l1823t1619r2146b1687],
3	—	NN	O	—	nn	4	SENT_265	[p23l1823t1619r2146b1687],
4	chopharmacol	NN	O	chopharmacol	_	0	SENT_265	[p23l223t1712r658b1781],
5	2004	CD	DATE	2004	dep	4	SENT_265	[p23l685t1712r855b1775],
6	;	:	O	;	_	0	SENT_265	[p23l685t1712r855b1775],
7	14	CD	NUMBER	14	number	8	SENT_265	[p23l890t1712r957b1765],
8	(	CD	NUMBER	(	dep	5	SENT_265	[p23l986t1712r1088b1778],
9	6	CD	NUMBER	6	num	10	SENT_265	[p23l986t1712r1088b1778],
10	)	NN	O	)	dep	8	SENT_265	[p23l986t1712r1088b1778],
11	:	:	O	:	_	0	SENT_265	[p23l986t1712r1088b1778],
12	457-70	CD	NUMBER	457-70	dep	5	SENT_265	[p23l1118t1712r1335b1766],

1	4	LS	NUMBER	4	_	0	SENT_266	[p23l83t1809r135b1862],
2	.	.	O	.	_	0	SENT_266	[p23l83t1809r135b1862],

1	Dmochowski	NNP	O	Dmochowski	nn	2	SENT_267	[p23l180t1809r590b1863],
2	RR	NNP	O	RR	_	0	SENT_267	[p23l630t1810r748b1872],
3	,	,	O	,	_	0	SENT_267	[p23l630t1810r748b1872],
4	Miklos	NNP	PERSON	Miklos	nn	5	SENT_267	[p23l790t1809r1006b1862],
5	JR	NNP	PERSON	JR	appos	2	SENT_267	[p23l1047t1810r1144b1872],
6	,	,	O	,	_	0	SENT_267	[p23l1047t1810r1144b1872],
7	Norton	NNP	ORGANIZATION	Norton	nn	8	SENT_267	[p23l1186t1810r1404b1862],
8	PA	NN	ORGANIZATION	pa	appos	2	SENT_267	[p23l1443t1809r1557b1872],
9	,	,	O	,	_	0	SENT_267	[p23l1443t1809r1557b1872],
10	et	FW	O	et	nn	11	SENT_267	[p23l1600t1817r1655b1862],
11	al.	FW	O	al.	appos	2	SENT_267	[p23l1695t1809r1762b1862],
12	.	.	O	.	_	0	SENT_267	[p23l1695t1809r1762b1862],

1	Duloxetine	NNP	O	Duloxetine	_	0	SENT_268	[p23l1806t1809r2147b1862],
2	versus	CC	O	versus	prep	1	SENT_268	[p23l223t1921r416b1958],
3	placebo	NN	O	placebo	dep	2	SENT_268	[p23l449t1904r687b1974],
4	for	IN	O	for	_	0	SENT_268	[p23l719t1904r809b1958],
5	the	DT	O	the	det	6	SENT_268	[p23l838t1904r931b1958],
6	treatment	NN	O	treatment	prep_for	1	SENT_268	[p23l963t1912r1254b1958],
7	of	IN	O	of	_	0	SENT_268	[p23l1285t1904r1352b1958],
8	North	JJ	LOCATION	north	amod	10	SENT_268	[p23l1377t1904r1557b1958],
9	American	JJ	LOCATION	american	amod	10	SENT_268	[p23l1588t1904r1891b1958],
10	women	NNS	O	woman	prep_of	6	SENT_268	[p23l1923t1921r2148b1958],
11	with	IN	O	with	_	0	SENT_268	[p23l223t1999r358b2052],
12	stress	NN	O	stress	nn	14	SENT_268	[p23l393t2007r558b2052],
13	urinary	JJ	O	urinary	amod	14	SENT_268	[p23l592t1999r812b2068],
14	incontinence	NN	O	incontinence	prep_with	1	SENT_268	[p23l846t1999r1254b2052],
15	.	.	O	.	_	0	SENT_268	[p23l846t1999r1254b2052],

1	J	NNP	O	J	nn	2	SENT_269	[p23l1290t2000r1318b2053],
2	Urol	NNP	O	Urol	dep	8	SENT_269	[p23l1350t1999r1490b2053],
3	2003	CD	DATE	2003	num	5	SENT_269	[p23l1523t1999r1693b2062],
4	;	:	O	;	_	0	SENT_269	[p23l1523t1999r1693b2062],
5	170	CD	NUMBER	170	dep	2	SENT_269	[p23l1736t1999r1842b2053],
6	(	NN	O	(	dep	8	SENT_269	[p23l1877t1999r1936b2065],
7	4	CD	NUMBER	4	num	6	SENT_269	[p23l1877t1999r1936b2065],
8	Pt	NN	O	pt	dep	12	SENT_269	[p23l1969t2000r2033b2052],
9	1	CD	NUMBER	1	num	10	SENT_269	[p23l2071t1999r2142b2065],
10	)	NN	O	)	dep	8	SENT_269	[p23l2071t1999r2142b2065],
11	:	:	O	:	_	0	SENT_269	[p23l2071t1999r2142b2065],
12	1259-63	CD	NUMBER	1259-63	_	0	SENT_269	[p23l230t2095r474b2150],

1	5	CD	NUMBER	5	_	0	SENT_270	[p23l85t2191r135b2245],
2	.	.	O	.	_	0	SENT_270	[p23l85t2191r135b2245],

1	Raskin	NNP	PERSON	Raskin	nn	2	SENT_271	[p23l180t2191r393b2245],
2	J	NNP	PERSON	J	_	0	SENT_271	[p23l415t2192r460b2255],
3	,	,	O	,	_	0	SENT_271	[p23l415t2192r460b2255],
4	Pritchett	NNP	PERSON	Pritchett	nn	5	SENT_271	[p23l486t2191r747b2245],
5	YL	NNP	O	YL	appos	2	SENT_271	[p23l770t2192r887b2255],
6	,	,	O	,	_	0	SENT_271	[p23l770t2192r887b2255],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_271	[p23l912t2192r1095b2261],
8	F	NN	O	f	appos	2	SENT_271	[p23l1119t2192r1176b2254],
9	,	,	O	,	_	0	SENT_271	[p23l1119t2192r1176b2254],
10	et	FW	O	et	nn	11	SENT_271	[p23l1203t2199r1257b2245],
11	al.	FW	O	al.	appos	2	SENT_271	[p23l1281t2191r1348b2245],
12	.	.	O	.	_	0	SENT_271	[p23l1281t2191r1348b2245],

1	A	DT	O	a	det	6	SENT_272	[p23l1375t2191r1429b2244],
2	double-blind	JJ	O	double-blind	amod	6	SENT_272	[p23l1453t2191r1862b2254],
3	,	,	O	,	_	0	SENT_272	[p23l1453t2191r1862b2254],
4	randomized	JJ	O	randomized	amod	6	SENT_272	[p23l1887t2191r2146b2245, p23l223t2286r350b2339],
5	multicenter	JJ	O	multicenter	amod	6	SENT_272	[p23l368t2286r719b2339],
6	trial	NN	O	trial	_	0	SENT_272	[p23l737t2286r858b2339],
7	comparing	VBG	O	compare	partmod	6	SENT_272	[p23l878t2286r1205b2355],
8	duloxetine	NN	O	duloxetine	dobj	7	SENT_272	[p23l1225t2286r1548b2339],
9	with	IN	O	with	_	0	SENT_272	[p23l1568t2286r1703b2339],
10	placebo	NN	O	placebo	prep_with	7	SENT_272	[p23l1720t2286r1959b2355],
11	in	IN	O	in	_	0	SENT_272	[p23l1978t2286r2037b2339],
12	the	DT	O	the	det	13	SENT_272	[p23l2055t2286r2147b2339],
13	management	NN	O	management	prep_in	10	SENT_272	[p23l222t2389r617b2451],
14	of	IN	O	of	_	0	SENT_272	[p23l635t2381r701b2435],
15	diabetic	JJ	O	diabetic	amod	18	SENT_272	[p23l715t2381r956b2435],
16	peripheral	JJ	O	peripheral	amod	18	SENT_272	[p23l974t2381r1286b2451],
17	neuropathic	JJ	O	neuropathic	amod	18	SENT_272	[p23l1304t2381r1666b2451],
18	pain	NN	O	pain	prep_of	13	SENT_272	[p23l1685t2381r1832b2451],
19	.	.	O	.	_	0	SENT_272	[p23l1685t2381r1832b2451],

1	Pain	NN	O	pain	_	0	SENT_273	[p23l1854t2381r1990b2435],
2	Med	VBD	O	med	partmod	1	SENT_273	[p23l2007t2381r2148b2435],
3	2005	CD	DATE	2005	dobj	2	SENT_273	[p23l224t2477r393b2541],
4	;	:	O	;	_	0	SENT_273	[p23l224t2477r393b2541],
5	6	CD	NUMBER	6	num	6	SENT_273	[p23l423t2476r457b2531],
6	(	NN	O	(	dep	1	SENT_273	[p23l486t2477r588b2543],
7	5	CD	NUMBER	5	num	8	SENT_273	[p23l486t2477r588b2543],
8	)	NN	O	)	dep	6	SENT_273	[p23l486t2477r588b2543],
9	:	:	O	:	_	0	SENT_273	[p23l486t2477r588b2543],
10	346-56	CD	NUMBER	346-56	dep	6	SENT_273	[p23l621t2476r834b2531],

1	6	CD	NUMBER	6	_	0	SENT_274	[p23l85t2573r135b2627],
2	.	.	O	.	_	0	SENT_274	[p23l85t2573r135b2627],

1	Eli	NNP	PERSON	Eli	nn	2	SENT_275	[p23l179t2573r267b2626],
2	Lilly	NNP	PERSON	Lilly	_	0	SENT_275	[p23l313t2573r461b2643],
3	and	CC	O	and	_	0	SENT_275	[p23l508t2573r616b2627],
4	Company	NNP	O	Company	conj_and	2	SENT_275	[p23l661t2574r975b2643],
5	.	.	O	.	_	0	SENT_275	[p23l661t2574r975b2643],

1	Cymbalta	NNP	LOCATION	Cymbalta	nsubj	2	SENT_276	[p23l1024t2569r1369b2643],
2	®	VBD	O	®	_	0	SENT_276	[p23l1024t2569r1369b2643],
3	(	CD	NUMBER	(	num	5	SENT_276	[p23l1418t2573r1765b2640],
4	duloxetine	NN	O	duloxetine	nn	5	SENT_276	[p23l1418t2573r1765b2640],
5	hydrochloride	NN	O	hydrochloride	dobj	2	SENT_276	[p23l1810t2573r2146b2643, p23l222t2668r364b2734],
6	)	CD	NUMBER	)	num	8	SENT_276	[p23l1810t2573r2146b2643, p23l222t2668r364b2734],
7	delayed-release	NN	O	delayed-release	nn	8	SENT_276	[p23l408t2668r885b2737],
8	capsules	NNS	O	capsule	dep	5	SENT_276	[p23l926t2668r1184b2737],
9	[	CD	NUMBER	[	num	12	SENT_276	[p23l1231t2668r1344b2733],
10	US	NNP	LOCATION	US	nn	12	SENT_276	[p23l1231t2668r1344b2733],
11	package	NN	O	package	nn	12	SENT_276	[p23l1387t2668r1639b2737],
12	insert	NN	O	insert	dep	5	SENT_276	[p23l1680t2668r1868b2731],
13	;	:	O	;	_	0	SENT_276	[p23l1680t2668r1868b2731],
14	online	JJ	O	online	amod	15	SENT_276	[p23l1912t2668r2143b2733],
15	]	NN	O	]	dep	5	SENT_276	[p23l1912t2668r2143b2733],
16	.	.	O	.	_	0	SENT_276	[p23l1912t2668r2143b2733],

1	Available	JJ	O	available	_	0	SENT_277	[p23l222t2763r521b2817],
2	from	IN	O	from	_	0	SENT_277	[p23l544t2763r694b2817],
3	URL	NN	O	url	prep_from	1	SENT_277	[p23l716t2765r884b2817],
4	:	:	O	:	_	0	SENT_277	[p23l716t2765r884b2817],
5	http://www.fda.gov/cder/foi/label/2007/	NN	O	http://www.fda.gov/cder/foi/label/2007/	nn	6	SENT_277	[p23l912t2763r2149b2833],
6	021427s009s0lls0l3lbl	NN	O	021427s009s0lls0l3lbl	dep	1	SENT_277	[p23l223t2858r1100b2927],
7	.	.	O	.	_	0	SENT_277	[p23l223t2858r1100b2927],

1	pdf	NN	O	pdf	nsubj	3	SENT_278	[p23l223t2858r1100b2927],
2	[	CD	NUMBER	[	num	1	SENT_278	[p23l1125t2858r1436b2923],
3	Accessed	VBN	O	access	_	0	SENT_278	[p23l1125t2858r1436b2923],
4	2007	CD	DATE	2007	num	5	SENT_278	[p23l1462t2858r1610b2912],
5	Jul	NNP	DATE	Jul	tmod	3	SENT_278	[p23l1638t2858r1726b2912],
6	19	CD	DATE	19	num	5	SENT_278	[p23l1759t2858r1847b2923],
7	]	CD	NUMBER	]	dep	5	SENT_278	[p23l1759t2858r1847b2923],

1	7	CD	NUMBER	7	_	0	SENT_279	[p23l84t2956r135b3008],
2	.	.	O	.	_	0	SENT_279	[p23l84t2956r135b3008],

1	Arnold	NNP	ORGANIZATION	Arnold	nn	2	SENT_280	[p23l180t2955r397b3008],
2	LM	NNP	ORGANIZATION	LM	_	0	SENT_280	[p23l414t2956r544b3018],
3	,	,	O	,	_	0	SENT_280	[p23l414t2956r544b3018],
4	Rosen	NNP	PERSON	Rosen	nn	5	SENT_280	[p23l565t2956r757b3008],
5	A	NNP	O	A	appos	2	SENT_280	[p23l774t2955r844b3018],
6	,	,	O	,	_	0	SENT_280	[p23l774t2955r844b3018],
7	Pritchett	NNP	PERSON	Pritchett	nn	8	SENT_280	[p23l865t2955r1126b3008],
8	YL	NNP	O	YL	appos	2	SENT_280	[p23l1143t2956r1260b3018],
9	,	,	O	,	_	0	SENT_280	[p23l1143t2956r1260b3018],
10	et	FW	O	et	nn	11	SENT_280	[p23l1281t2963r1336b3008],
11	al.	FW	O	al.	appos	2	SENT_280	[p23l1354t2955r1421b3008],
12	.	.	O	.	_	0	SENT_280	[p23l1354t2955r1421b3008],

1	A	DT	O	a	det	9	SENT_281	[p23l1442t2955r1496b3008],
2	randomized	VBN	O	randomize	amod	9	SENT_281	[p23l1513t2955r1893b3018],
3	,	,	O	,	_	0	SENT_281	[p23l1513t2955r1893b3018],
4	doubleblind	NN	O	doubleblind	dep	9	SENT_281	[p23l1914t2955r2146b3008, p23l221t3050r396b3114],
5	,	,	O	,	_	0	SENT_281	[p23l1914t2955r2146b3008, p23l221t3050r396b3114],
6	placebo	NN	O	placebo	dep	9	SENT_281	[p23l418t3050r997b3120],
7	—	NN	O	—	nn	9	SENT_281	[p23l418t3050r997b3120],
8	controlled	VBN	O	control	amod	9	SENT_281	[p23l418t3050r997b3120],
9	trial	NN	O	trial	_	0	SENT_281	[p23l1016t3050r1139b3104],
10	of	IN	O	of	_	0	SENT_281	[p23l1160t3050r1226b3104],
11	duloxetine	NN	O	duloxetine	prep_of	9	SENT_281	[p23l1241t3050r1565b3104],
12	in	IN	O	in	_	0	SENT_281	[p23l1585t3050r1644b3103],
13	the	DT	O	the	det	14	SENT_281	[p23l1663t3050r1755b3104],
14	treatment	NN	O	treatment	prep_in	11	SENT_281	[p23l1776t3058r2066b3104],
15	of	IN	O	of	_	0	SENT_281	[p23l2086t3050r2153b3104],
16	women	NNS	O	woman	prep_of	14	SENT_281	[p23l223t3161r448b3198],
17	with	IN	O	with	_	0	SENT_281	[p23l482t3145r617b3198],
18	fibromyalgia	NNP	O	fibromyalgia	conj_or	18	SENT_281	[p23l650t3145r1049b3214],
19	with	IN	O	with	_	0	SENT_281	[p23l1081t3145r1216b3198],
20	or	CC	O	or	_	0	SENT_281	[p23l1250t3161r1312b3198],
21	without	IN	O	without	_	0	SENT_281	[p23l1345t3145r1580b3198],
22	major	JJ	O	major	amod	24	SENT_281	[p23l1612t3145r1792b3214],
23	depressive	JJ	O	depressive	amod	24	SENT_281	[p23l1824t3145r2147b3214],
24	disorder	NN	O	disorder	prep_with	18	SENT_281	[p23l224t3241r489b3296],
25	.	.	O	.	_	0	SENT_281	[p23l224t3241r489b3296],

1	Pain	NN	O	pain	_	0	SENT_282	[p23l518t3241r654b3296],
2	2005	CD	DATE	2005	dep	1	SENT_282	[p23l680t3241r850b3306],
3	;	:	O	;	_	0	SENT_282	[p23l680t3241r850b3306],
4	119	CD	NUMBER	119	number	5	SENT_282	[p23l886t3242r991b3296],
5	(	CD	NUMBER	(	dep	2	SENT_282	[p23l1020t3242r1186b3308],
6	1-3	CD	NUMBER	1-3	num	7	SENT_282	[p23l1020t3242r1186b3308],
7	)	NN	O	)	dep	5	SENT_282	[p23l1020t3242r1186b3308],
8	:	:	O	:	_	0	SENT_282	[p23l1020t3242r1186b3308],
9	5-15	CD	NUMBER	5-15	dep	2	SENT_282	[p23l1218t3241r1353b3296],

1	©	RB	O	©	advmod	2	SENT_283	[p23l8t3499r51b3543],
2	2007	CD	DATE	2007	_	0	SENT_283	[p23l74t3494r206b3543],
3	Adis	NNP	PERSON	Adis	nn	5	SENT_283	[p23l229t3495r351b3543],
4	Doro	NNP	PERSON	Doro	nn	5	SENT_283	[p23l376t3495r519b3543],
5	Information	NNP	O	Information	dep	2	SENT_283	[p23l545t3495r879b3543],
6	BV	NN	O	bv	dep	5	SENT_283	[p23l906t3495r992b3542],
7	.	.	O	.	_	0	SENT_283	[p23l906t3495r992b3542],

1	All	DT	O	all	det	2	SENT_284	[p23l1017t3495r1083b3542],
2	rights	NNS	O	rights	nsubj	3	SENT_284	[p23l1109t3495r1259b3555],
3	reserved	VBN	O	reserve	_	0	SENT_284	[p23l1282t3495r1549b3543],
4	.	.	O	.	_	0	SENT_284	[p23l1282t3495r1549b3543],

1	8	CD	NUMBER	8	_	0	SENT_285	[p23l87t3584r136b3637],
2	.	.	O	.	_	0	SENT_285	[p23l87t3584r136b3637],

1	Lantz	NNP	PERSON	Lantz	nn	2	SENT_286	[p23l181t3585r355b3637],
2	RJ	NN	PERSON	rj	_	0	SENT_286	[p23l381t3585r478b3647],
3	,	,	O	,	_	0	SENT_286	[p23l381t3585r478b3647],
4	Gillespie	NNP	PERSON	Gillespie	nn	5	SENT_286	[p23l507t3584r783b3653],
5	TA	NNP	O	TA	appos	2	SENT_286	[p23l809t3584r927b3647],
6	,	,	O	,	_	0	SENT_286	[p23l809t3584r927b3647],
7	Rash	NNP	O	Rash	nn	8	SENT_286	[p23l955t3584r1108b3637],
8	TJ	NNP	O	TJ	appos	2	SENT_286	[p23l1134t3585r1226b3647],
9	,	,	O	,	_	0	SENT_286	[p23l1134t3585r1226b3647],
10	et	FW	O	et	nn	11	SENT_286	[p23l1255t3591r1310b3637],
11	al.	FW	O	al.	appos	2	SENT_286	[p23l1336t3584r1404b3637],
12	.	.	O	.	_	0	SENT_286	[p23l1336t3584r1404b3637],

1	Metabolism	NN	O	metabolism	_	0	SENT_287	[p23l1433t3584r1818b3647],
2	,	,	O	,	_	0	SENT_287	[p23l1433t3584r1818b3647],
3	excretion	NN	O	excretion	conj_and	1	SENT_287	[p23l1847t3584r2148b3647],
4	,	,	O	,	_	0	SENT_287	[p23l1847t3584r2148b3647],
5	and	CC	O	and	_	0	SENT_287	[p23l226t3681r334b3736],
6	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	1	SENT_287	[p23l351t3681r894b3752],
7	of	IN	O	of	_	0	SENT_287	[p23l915t3681r982b3736],
8	duloxetine	NN	O	duloxetine	prep_of	6	SENT_287	[p23l995t3681r1319b3736],
9	in	IN	O	in	_	0	SENT_287	[p23l1338t3681r1395b3735],
10	healthy	JJ	O	healthy	amod	12	SENT_287	[p23l1414t3681r1639b3752],
11	human	JJ	O	human	amod	12	SENT_287	[p23l1657t3681r1867b3736],
12	subjects	NNS	O	subject	prep_in	8	SENT_287	[p23l1888t3681r2147b3752],
13	.	.	O	.	_	0	SENT_287	[p23l1888t3681r2147b3752],

1	Drug	NN	O	drug	_	0	SENT_288	[p24l224t22r380b91],
2	Metab	NNP	O	Metab	nn	3	SENT_288	[p24l406t21r601b75],
3	Dispos	NNP	O	Dispos	dep	1	SENT_288	[p24l627t20r838b91],
4	2003	CD	DATE	2003	num	3	SENT_288	[p24l866t21r1036b85],
5	;	:	O	;	_	0	SENT_288	[p24l866t21r1036b85],
6	31	CD	NUMBER	31	number	7	SENT_288	[p24l1067t21r1133b75],
7	(	CD	NUMBER	(	dep	3	SENT_288	[p24l1168t21r1270b88],
8	9	CD	NUMBER	9	num	9	SENT_288	[p24l1168t21r1270b88],
9	)	NN	O	)	dep	7	SENT_288	[p24l1168t21r1270b88],
10	:	:	O	:	_	0	SENT_288	[p24l1168t21r1270b88],
11	1142-50	CD	NUMBER	1142-50	dep	3	SENT_288	[p24l1308t20r1556b75],

1	.	.	O	.	_	0	SENT_289	[p24l127t160r136b169],

1	Kuo	NNP	O	Kuo	nn	2	SENT_290	[p24l183t117r312b169],
2	F	NN	O	f	_	0	SENT_290	[p24l356t117r413b179],
3	,	,	O	,	_	0	SENT_290	[p24l356t117r413b179],
4	Gillespie	NNP	ORGANIZATION	Gillespie	nn	5	SENT_290	[p24l461t116r737b185],
5	TA	NNP	ORGANIZATION	TA	appos	2	SENT_290	[p24l781t116r898b179],
6	,	,	O	,	_	0	SENT_290	[p24l781t116r898b179],
7	Kulanthaivel	NNP	PERSON	Kulanthaivel	nn	8	SENT_290	[p24l946t116r1342b169],
8	P	NN	PERSON	p	appos	2	SENT_290	[p24l1386t117r1443b179],
9	,	,	O	,	_	0	SENT_290	[p24l1386t117r1443b179],
10	et	FW	O	et	nn	11	SENT_290	[p24l1490t124r1545b169],
11	al.	FW	O	al.	appos	2	SENT_290	[p24l1588t116r1656b169],
12	.	.	O	.	_	0	SENT_290	[p24l1588t116r1656b169],

1	Synthesis	NN	MISC	synthesis	nn	4	SENT_291	[p24l1706t116r1996b185],
2	and	CC	O	and	_	0	SENT_291	[p24l2043t116r2152b169],
3	biological	JJ	O	biological	nn	4	SENT_291	[p24l222t213r531b284],
4	activity	NN	O	activity	_	0	SENT_291	[p24l573t213r801b284],
5	of	IN	O	of	_	0	SENT_291	[p24l841t213r908b268],
6	some	DT	O	some	det	11	SENT_291	[p24l945t230r1103b268],
7	known	JJ	O	known	amod	11	SENT_291	[p24l1142t213r1352b268],
8	and	CC	O	and	_	0	SENT_291	[p24l1393t213r1501b268],
9	putative	JJ	O	putative	amod	11	SENT_291	[p24l1539t213r1787b284],
10	duloxetine	NN	O	duloxetine	nn	11	SENT_291	[p24l1827t213r2151b268],
11	metabolites	NNS	O	metabolite	prep_of	4	SENT_291	[p24l224t309r594b363],
12	.	.	O	.	_	0	SENT_291	[p24l224t309r594b363],

1	Bioorg	NNP	ORGANIZATION	Bioorg	nn	4	SENT_292	[p24l623t309r835b379],
2	Med	NNP	ORGANIZATION	Med	nn	4	SENT_292	[p24l861t309r1002b363],
3	Chem	NNP	ORGANIZATION	Chem	nn	4	SENT_292	[p24l1027t309r1210b363],
4	Lett	NNP	ORGANIZATION	Lett	_	0	SENT_292	[p24l1234t310r1358b363],
5	2004	CD	DATE	2004	dep	4	SENT_292	[p24l1384t309r1554b373],
6	;	:	O	;	_	0	SENT_292	[p24l1384t309r1554b373],
7	14	CD	NUMBER	14	number	8	SENT_292	[p24l1590t309r1657b363],
8	(	CD	NUMBER	(	dep	4	SENT_292	[p24l1685t309r1826b376],
9	13	CD	NUMBER	13	num	10	SENT_292	[p24l1685t309r1826b376],
10	)	NN	O	)	dep	8	SENT_292	[p24l1685t309r1826b376],
11	:	:	O	:	_	0	SENT_292	[p24l1685t309r1826b376],
12	3481-6	CD	NUMBER	3481-6	num	14	SENT_292	[p24l1858t308r2073b363],
13	Skinner	NNP	O	Skinner	nn	14	SENT_292	[p24l183t406r421b460],
14	MH	NNP	O	MH	dep	4	SENT_292	[p24l454t407r594b470],
15	,	,	O	,	_	0	SENT_292	[p24l454t407r594b470],
16	Kuan	NNP	PERSON	Kuan	nn	17	SENT_292	[p24l632t407r797b460],
17	HY	NNP	PERSON	HY	appos	14	SENT_292	[p24l832t407r958b469],
18	,	,	O	,	_	0	SENT_292	[p24l832t407r958b469],
19	Pan	NNP	O	Pan	nn	20	SENT_292	[p24l995t407r1110b460],
20	A	NNP	O	A	appos	14	SENT_292	[p24l1145t407r1215b470],
21	,	,	O	,	_	0	SENT_292	[p24l1145t407r1215b470],
22	et	FW	O	et	nn	23	SENT_292	[p24l1253t414r1307b460],
23	al.	FW	O	al.	appos	14	SENT_292	[p24l1343t406r1410b460],
24	.	.	O	.	_	0	SENT_292	[p24l1343t406r1410b460],

1	Duloxetine	NNP	O	Duloxetine	nsubj	5	SENT_293	[p24l1449t406r1790b460],
2	is	VBZ	O	be	cop	5	SENT_293	[p24l1826t406r1873b460],
3	both	DT	O	both	preconj	5	SENT_293	[p24l1909t406r2046b460],
4	an	DT	O	a	det	5	SENT_293	[p24l2082t423r2152b460],
5	inhibitor	NN	O	inhibitor	_	0	SENT_293	[p24l224t503r490b558],
6	and	CC	O	and	_	0	SENT_293	[p24l521t504r630b558],
7	a	DT	O	a	det	8	SENT_293	[p24l662t520r693b558],
8	substrate	NN	O	substrate	conj_and	5	SENT_293	[p24l726t503r996b558],
9	of	IN	O	of	_	0	SENT_293	[p24l1028t503r1095b558],
10	cytochrome	NN	O	cytochrome	nn	11	SENT_293	[p24l1121t503r1484b574],
11	P4502D6	NN	O	p4502d6	prep_of	8	SENT_293	[p24l1515t503r1804b558],
12	in	IN	O	in	_	0	SENT_293	[p24l1836t503r1894b557],
13	healthy	JJ	O	healthy	amod	14	SENT_293	[p24l1925t503r2151b574],
14	volunteers	NNS	O	volunteer	prep_in	11	SENT_293	[p24l225t600r559b654],
15	.	.	O	.	_	0	SENT_293	[p24l225t600r559b654],

1	Clin	NNP	O	Clin	nn	3	SENT_294	[p24l590t600r720b654],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_294	[p24l745t600r1074b654],
3	Ther	NNP	O	Ther	_	0	SENT_294	[p24l1100t600r1245b654],
4	2003	CD	DATE	2003	dep	3	SENT_294	[p24l1270t600r1440b664],
5	;	:	O	;	_	0	SENT_294	[p24l1270t600r1440b664],
6	73	CD	NUMBER	73	number	7	SENT_294	[p24l1469t600r1540b654],
7	(	CD	NUMBER	(	dep	3	SENT_294	[p24l1571t600r1674b666],
8	3	CD	NUMBER	3	num	9	SENT_294	[p24l1571t600r1674b666],
9	)	NN	O	)	dep	7	SENT_294	[p24l1571t600r1674b666],
10	:	:	O	:	_	0	SENT_294	[p24l1571t600r1674b666],
11	170-7	CD	NUMBER	170-7	num	13	SENT_294	[p24l1711t600r1880b654],
12	Hua	NNP	O	Hua	nn	13	SENT_294	[p24l181t697r309b750],
13	TC	NNP	O	TC	dep	3	SENT_294	[p24l337t697r450b760],
14	,	,	O	,	_	0	SENT_294	[p24l337t697r450b760],
15	Pan	NNP	O	Pan	nn	16	SENT_294	[p24l481t698r596b750],
16	A	NNP	O	A	appos	13	SENT_294	[p24l625t697r695b760],
17	,	,	O	,	_	0	SENT_294	[p24l625t697r695b760],
18	Chan	NNP	O	Chan	nn	19	SENT_294	[p24l728t696r889b750],
19	C	NNP	O	C	appos	13	SENT_294	[p24l918t697r983b760],
20	,	,	O	,	_	0	SENT_294	[p24l918t697r983b760],
21	et	FW	O	et	nn	22	SENT_294	[p24l1015t705r1070b750],
22	al.	FW	O	al.	appos	13	SENT_294	[p24l1099t696r1166b750],
23	.	.	O	.	_	0	SENT_294	[p24l1099t696r1166b750],

1	Effect	NN	O	effect	_	0	SENT_295	[p24l1199t696r1388b750],
2	of	IN	O	of	_	0	SENT_295	[p24l1416t696r1483b750],
3	duloxetine	NN	O	duloxetine	prep_of	1	SENT_295	[p24l1507t696r1831b750],
4	on	IN	O	on	_	0	SENT_295	[p24l1861t713r1935b750],
5	tolter	NN	O	tolter	nn	8	SENT_295	[p24l1964t696r2149b750],
6	—	NN	O	—	nn	8	SENT_295	[p24l1964t696r2149b750],
7	odine	NN	O	odine	nn	8	SENT_295	[p24l225t792r393b845],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_295	[p24l444t792r987b861],
9	in	IN	O	in	_	0	SENT_295	[p24l1039t792r1098b845],
10	healthy	JJ	O	healthy	amod	11	SENT_295	[p24l1148t792r1373b861],
11	volunteers	NNS	O	volunteer	prep_in	1	SENT_295	[p24l1425t792r1760b845],
12	.	.	O	.	_	0	SENT_295	[p24l1425t792r1760b845],

1	Br	NN	O	br	nn	3	SENT_296	[p24l1815t793r1892b845],
2	J	NN	O	j	nn	3	SENT_296	[p24l1941t793r1969b845],
3	Clin	NN	O	clin	_	0	SENT_296	[p24l2021t792r2152b845],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_296	[p24l224t889r552b943],
5	2004	CD	DATE	2004	num	4	SENT_296	[p24l579t889r749b953],
6	;	:	O	;	_	0	SENT_296	[p24l579t889r749b953],
7	57	CD	NUMBER	57	number	8	SENT_296	[p24l779t889r850b943],
8	(	CD	NUMBER	(	dep	3	SENT_296	[p24l881t889r983b956],
9	5	CD	NUMBER	5	num	10	SENT_296	[p24l881t889r983b956],
10	)	NN	O	)	dep	8	SENT_296	[p24l881t889r983b956],
11	:	:	O	:	_	0	SENT_296	[p24l881t889r983b956],
12	652-6	CD	NUMBER	652-6	num	14	SENT_296	[p24l1015t889r1191b943],
13	Bradford	NNP	ORGANIZATION	Bradford	nn	14	SENT_296	[p24l181t986r459b1041],
14	LD	NNP	ORGANIZATION	LD	dep	3	SENT_296	[p24l484t988r602b1051],
15	,	,	O	,	_	0	SENT_296	[p24l484t988r602b1051],
16	Kirlin	NNP	O	Kirlin	nn	17	SENT_296	[p24l632t986r814b1040],
17	WG	NNP	O	WG	appos	14	SENT_296	[p24l839t987r982b1041],
18	.	.	O	.	_	0	SENT_296	[p24l839t987r982b1041],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_297	[p24l1012t986r1467b1057],
2	of	IN	O	of	_	0	SENT_297	[p24l1493t986r1560b1041],
3	CYP2D6	NN	O	cyp2d6	prep_of	1	SENT_297	[p24l1582t986r1861b1041],
4	in	IN	O	in	_	0	SENT_297	[p24l1889t986r1947b1040],
5	Black	JJ	O	black	amod	6	SENT_297	[p24l1973t986r2153b1041],
6	populations	NNS	O	population	prep_in	3	SENT_297	[p24l223t1082r599b1151],
7	:	:	O	:	_	0	SENT_297	[p24l223t1082r599b1151],
8	implications	NNS	O	implication	dep	1	SENT_297	[p24l627t1082r1006b1151],
9	for	IN	O	for	_	0	SENT_297	[p24l1030t1082r1119b1135],
10	psychopharmacology	NN	O	psychopharmacology	prep_for	8	SENT_297	[p24l1139t1082r1815b1151],
11	.	.	O	.	_	0	SENT_297	[p24l1139t1082r1815b1151],

1	Int	NN	O	int	nn	3	SENT_298	[p24l1842t1083r1928b1135],
2	J	NN	O	j	nn	3	SENT_298	[p24l1947t1083r1976b1135],
3	Neuropsychopharmcol	NN	O	neuropsychopharmcol	_	0	SENT_298	[p24l1998t1083r2149b1135, p24l223t1179r797b1250],
4	1998	CD	DATE	1998	dep	3	SENT_298	[p24l830t1179r994b1243],
5	;	:	O	;	_	0	SENT_298	[p24l830t1179r994b1243],
6	1	CD	NUMBER	1	num	7	SENT_298	[p24l1030t1179r1052b1233],
7	(	NN	O	(	dep	3	SENT_298	[p24l1087t1179r1189b1246],
8	2	CD	NUMBER	2	number	9	SENT_298	[p24l1087t1179r1189b1246],
9	)	CD	NUMBER	)	dep	7	SENT_298	[p24l1087t1179r1189b1246],
10	:	:	O	:	_	0	SENT_298	[p24l1087t1179r1189b1246],
11	173-85	CD	NUMBER	173-85	num	15	SENT_298	[p24l1227t1179r1434b1234],
12	Kitada	NNP	PERSON	Kitada	nn	15	SENT_298	[p24l183t1275r386b1328],
13	M.	NNP	PERSON	M.	nn	15	SENT_298	[p24l405t1276r488b1328],
14	Genetic	NNP	PERSON	Genetic	nn	15	SENT_298	[p24l513t1275r749b1328],
15	polymorphism	NN	O	polymorphism	dep	3	SENT_298	[p24l769t1275r1221b1344],
16	of	IN	O	of	_	0	SENT_298	[p24l1241t1275r1307b1328],
17	cytochrome	NN	O	cytochrome	nn	19	SENT_298	[p24l1323t1275r1685b1344],
18	P450	NN	O	p450	nn	19	SENT_298	[p24l1706t1275r1862b1328],
19	enzymes	NNS	O	enzyme	prep_of	15	SENT_298	[p24l1883t1291r2150b1344],
20	in	IN	O	in	_	0	SENT_298	[p24l224t1371r282b1424],
21	Asian	JJ	LOCATION	asian	amod	22	SENT_298	[p24l304t1371r482b1424],
22	populations	NNS	O	population	prep_in	19	SENT_298	[p24l503t1371r879b1440],
23	:	:	O	:	_	0	SENT_298	[p24l503t1371r879b1440],
24	focus	VB	O	focus	dep	25	SENT_298	[p24l907t1371r1070b1424],
25	on	IN	O	on	dep	3	SENT_298	[p24l1095t1388r1169b1424],
26	CYP2D6	NN	O	cyp2d6	pobj	25	SENT_298	[p24l1192t1371r1488b1425],
27	.	.	O	.	_	0	SENT_298	[p24l1192t1371r1488b1425],

1	Int	NN	O	int	nn	3	SENT_299	[p24l1514t1372r1599b1424],
2	J	NN	O	j	nn	3	SENT_299	[p24l1619t1372r1647b1425],
3	Clin	NN	O	clin	_	0	SENT_299	[p24l1670t1371r1800b1425],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_299	[p24l1822t1371r2151b1424],
5	Res	NNP	O	Res	dep	3	SENT_299	[p24l224t1470r336b1523],
6	2003	CD	DATE	2003	num	5	SENT_299	[p24l364t1469r534b1533],
7	;	:	O	;	_	0	SENT_299	[p24l364t1469r534b1533],
8	23	CD	NUMBER	23	number	9	SENT_299	[p24l564t1469r634b1523],
9	(	CD	NUMBER	(	dep	3	SENT_299	[p24l666t1469r768b1535],
10	1	CD	NUMBER	1	num	11	SENT_299	[p24l666t1469r768b1535],
11	)	NN	O	)	dep	9	SENT_299	[p24l666t1469r768b1535],
12	:	:	O	:	_	0	SENT_299	[p24l666t1469r768b1535],
13	31-5	CD	NUMBER	31-5	num	15	SENT_299	[p24l801t1468r935b1523],
14	Landi	NNP	PERSON	Landi	nn	15	SENT_299	[p24l181t1564r359b1617],
15	MT	NNP	O	MT	dep	3	SENT_299	[p24l407t1565r537b1627],
16	,	,	O	,	_	0	SENT_299	[p24l407t1565r537b1627],
17	Sinha	NNP	PERSON	Sinha	nn	18	SENT_299	[p24l590t1564r764b1617],
18	R	NNP	PERSON	R	appos	15	SENT_299	[p24l809t1565r875b1627],
19	,	,	O	,	_	0	SENT_299	[p24l809t1565r875b1627],
20	Lang	NNP	PERSON	Lang	nn	21	SENT_299	[p24l925t1565r1082b1633],
21	NP	NNP	O	NP	appos	15	SENT_299	[p24l1130t1565r1243b1627],
22	,	,	O	,	_	0	SENT_299	[p24l1130t1565r1243b1627],
23	et	FW	O	et	nn	24	SENT_299	[p24l1294t1572r1348b1617],
24	al.	FW	O	al.	appos	15	SENT_299	[p24l1396t1564r1463b1617],
25	.	.	O	.	_	0	SENT_299	[p24l1396t1564r1463b1617],

1	Human	JJ	O	human	amod	2	SENT_300	[p24l1515t1565r1741b1617],
2	cytochrome	NN	O	cytochrome	_	0	SENT_300	[p24l1789t1564r2151b1633],
3	P4501A2	NN	O	p4501a2	dep	2	SENT_300	[p24l224t1661r530b1716],
4	.	.	O	.	_	0	SENT_300	[p24l224t1661r530b1716],

1	IARC	NN	ORGANIZATION	iarc	nn	3	SENT_301	[p24l559t1661r740b1716],
2	Sci	NNP	O	Sci	nn	3	SENT_301	[p24l769t1661r863b1716],
3	Publ	NNP	O	Publ	_	0	SENT_301	[p24l889t1661r1029b1715],
4	1999	CD	DATE	1999	dep	3	SENT_301	[p24l1062t1661r1225b1725],
5	;	:	O	;	_	0	SENT_301	[p24l1062t1661r1225b1725],
6	(	CD	NUMBER	(	number	7	SENT_301	[p24l1256t1661r1436b1728],
7	148	CD	NUMBER	148	dep	3	SENT_301	[p24l1256t1661r1436b1728],
8	)	NN	O	)	dep	7	SENT_301	[p24l1256t1661r1436b1728],
9	:	:	O	:	_	0	SENT_301	[p24l1256t1661r1436b1728],
10	173-95	CD	NUMBER	173-95	num	12	SENT_301	[p24l1473t1661r1680b1716],
11	Chan	NNP	O	Chan	nn	12	SENT_301	[p24l182t1757r343b1811],
12	C	NNP	O	C	dep	3	SENT_301	[p24l370t1757r435b1821],
13	,	,	O	,	_	0	SENT_301	[p24l370t1757r435b1821],
14	Yeo	NNP	PERSON	Yeo	nn	15	SENT_301	[p24l465t1758r591b1811],
15	KP	NNP	O	KP	appos	12	SENT_301	[p24l620t1758r732b1821],
16	,	,	O	,	_	0	SENT_301	[p24l620t1758r732b1821],
17	Pan	NNP	O	Pan	nn	18	SENT_301	[p24l761t1758r875b1811],
18	AX	NNP	O	AX	appos	12	SENT_301	[p24l902t1757r1029b1821],
19	,	,	O	,	_	0	SENT_301	[p24l902t1757r1029b1821],
20	et	FW	O	et	nn	21	SENT_301	[p24l1059t1765r1113b1811],
21	al.	FW	O	al.	appos	12	SENT_301	[p24l1140t1757r1208b1811],
22	.	.	O	.	_	0	SENT_301	[p24l1140t1757r1208b1811],

1	Duloxetine	NNP	O	Duloxetine	nn	2	SENT_302	[p24l1239t1757r1580b1811],
2	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	4	SENT_302	[p24l1607t1757r2149b1827],
3	are	VBP	O	be	cop	4	SENT_302	[p24l226t1871r316b1907],
4	similar	JJ	O	similar	_	0	SENT_302	[p24l360t1854r571b1907],
5	in	IN	O	in	_	0	SENT_302	[p24l610t1854r668b1907],
6	Japanese	JJ	MISC	japanese	amod	9	SENT_302	[p24l708t1855r981b1923],
7	and	CC	O	and	_	0	SENT_302	[p24l1024t1854r1133b1907],
8	Caucasian	JJ	MISC	caucasian	amod	9	SENT_302	[p24l1173t1854r1488b1908],
9	subjects	NNS	O	subject	prep_in	4	SENT_302	[p24l1531t1854r1792b1923],
10	.	.	O	.	_	0	SENT_302	[p24l1531t1854r1792b1923],

1	Br	NN	O	br	nn	3	SENT_303	[p24l1836t1855r1913b1907],
2	J	NN	O	j	nn	3	SENT_303	[p24l1951t1855r1980b1908],
3	Clin	NN	O	clin	_	0	SENT_303	[p24l2021t1854r2152b1908],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_303	[p24l224t1951r552b2006],
5	2007	CD	DATE	2007	num	4	SENT_303	[p24l579t1952r749b2016],
6	;	:	O	;	_	0	SENT_303	[p24l579t1952r749b2016],
7	63	CD	NUMBER	63	number	8	SENT_303	[p24l779t1951r849b2006],
8	(	CD	NUMBER	(	dep	3	SENT_303	[p24l881t1952r983b2018],
9	3	CD	NUMBER	3	num	10	SENT_303	[p24l881t1952r983b2018],
10	)	NN	O	)	dep	8	SENT_303	[p24l881t1952r983b2018],
11	:	:	O	:	_	0	SENT_303	[p24l881t1952r983b2018],
12	310-4	CD	NUMBER	310-4	num	14	SENT_303	[p24l1015t1952r1191b2006],
13	Ma	NNP	O	Ma	nn	14	SENT_303	[p24l181t2048r283b2100],
14	N	NNP	O	N	dep	3	SENT_303	[p24l316t2048r386b2110],
15	,	,	O	,	_	0	SENT_303	[p24l316t2048r386b2110],
16	Zhang	NNP	PERSON	Zhang	nn	17	SENT_303	[p24l423t2047r619b2116],
17	B	NNP	PERSON	B	appos	14	SENT_303	[p24l653t2048r719b2110],
18	,	,	O	,	_	0	SENT_303	[p24l653t2048r719b2110],
19	Li	NNP	PERSON	Li	nn	20	SENT_303	[p24l756t2047r822b2100],
20	H	NNP	PERSON	H	appos	14	SENT_303	[p24l857t2048r927b2110],
21	,	,	O	,	_	0	SENT_303	[p24l857t2048r927b2110],
22	et	FW	O	et	nn	23	SENT_303	[p24l964t2055r1019b2100],
23	al.	FW	O	al.	appos	14	SENT_303	[p24l1053t2047r1121b2100],
24	.	.	O	.	_	0	SENT_303	[p24l1053t2047r1121b2100],

1	Determination	NN	O	determination	_	0	SENT_304	[p24l1159t2047r1604b2100],
2	of	IN	O	of	_	0	SENT_304	[p24l1639t2047r1706b2100],
3	duloxetine	NN	O	duloxetine	prep_of	1	SENT_304	[p24l1736t2047r2059b2100],
4	in	IN	O	in	_	0	SENT_304	[p24l2093t2047r2152b2100],
5	human	JJ	O	human	amod	6	SENT_304	[p24l223t2144r433b2199],
6	plasma	NN	O	plasma	prep_in	1	SENT_304	[p24l469t2144r688b2215],
7	via	IN	O	via	_	0	SENT_304	[p24l724t2144r817b2199],
8	LC/MS	NN	O	lc/ms	nn	11	SENT_304	[p24l853t2144r1079b2199],
9	and	CC	O	and	_	0	SENT_304	[p24l1121t2144r1231b2199],
10	subsequent	JJ	O	subsequent	nn	11	SENT_304	[p24l1269t2144r1609b2215],
11	application	NN	O	application	prep_via	1	SENT_304	[p24l1647t2144r1987b2215],
12	to	TO	O	to	_	0	SENT_304	[p24l2024t2152r2081b2199],
13	a	DT	O	a	det	15	SENT_304	[p24l2121t2161r2153b2199],
14	pharmacokinetic	JJ	O	pharmacokinetic	amod	15	SENT_304	[p24l223t2241r736b2312],
15	study	NN	O	study	prep_to	11	SENT_304	[p24l766t2241r929b2312],
16	in	IN	O	in	_	0	SENT_304	[p24l955t2241r1013b2295],
17	healthy	JJ	O	healthy	amod	19	SENT_304	[p24l1038t2241r1265b2312],
18	Chinese	JJ	MISC	chinese	amod	19	SENT_304	[p24l1292t2241r1538b2296],
19	volunteers	NNS	O	volunteer	prep_in	15	SENT_304	[p24l1565t2241r1900b2296],
20	.	.	O	.	_	0	SENT_304	[p24l1565t2241r1900b2296],

1	Clinica	NNP	PERSON	Clinica	nn	3	SENT_305	[p24l1931t2241r2153b2296],
2	Chimica	NNP	PERSON	Chimica	nn	3	SENT_305	[p24l225t2338r485b2392],
3	Acta	NNP	PERSON	Acta	_	0	SENT_305	[p24l509t2338r655b2391],
4	2007	CD	DATE	2007	num	3	SENT_305	[p24l680t2338r849b2401],
5	;	:	O	;	_	0	SENT_305	[p24l680t2338r849b2401],
6	380	CD	NUMBER	380	num	8	SENT_305	[p24l880t2338r1009b2392],
7	:	:	O	:	_	0	SENT_305	[p24l880t2338r1009b2392],
8	100-5	CD	NUMBER	100-5	dep	3	SENT_305	[p24l1046t2338r1214b2392],
9	Sharma	FW	O	sharma	dep	8	SENT_305	[p24l183t2435r417b2490],
10	A	NN	O	a	dep	8	SENT_305	[p24l446t2436r517b2500],
11	,	,	O	,	_	0	SENT_305	[p24l446t2436r517b2500],
12	Goldberg	NNP	ORGANIZATION	Goldberg	nn	13	SENT_305	[p24l552t2435r840b2506],
13	MJ	NNP	ORGANIZATION	MJ	appos	3	SENT_305	[p24l872t2436r985b2500],
14	,	,	O	,	_	0	SENT_305	[p24l872t2436r985b2500],
15	Cerimele	NNP	ORGANIZATION	Cerimele	nn	16	SENT_305	[p24l1020t2435r1301b2490],
16	BJ	NNP	ORGANIZATION	BJ	appos	3	SENT_305	[p24l1332t2436r1427b2490],
17	.	.	O	.	_	0	SENT_305	[p24l1332t2436r1427b2490],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_306	[p24l1462t2435r2009b2490],
2	and	CC	O	and	_	0	SENT_306	[p24l2043t2435r2152b2490],
3	safety	NN	O	safety	conj_and	1	SENT_306	[p24l226t2531r406b2600],
4	of	IN	O	of	_	0	SENT_306	[p24l455t2531r521b2584],
5	duloxetine	NN	O	duloxetine	prep_of	1	SENT_306	[p24l565t2531r905b2594],
6	,	,	O	,	_	0	SENT_306	[p24l565t2531r905b2594],
7	a	DT	O	a	det	10	SENT_306	[p24l957t2547r989b2584],
8	dual	JJ	O	dual	amod	10	SENT_306	[p24l1036t2531r1480b2584],
9	—	NN	O	—	nn	10	SENT_306	[p24l1036t2531r1480b2584],
10	serotonin	NN	O	serotonin	prep_of	1	SENT_306	[p24l1036t2531r1480b2584],
11	and	CC	O	and	_	0	SENT_306	[p24l1529t2531r1638b2584],
12	norepinephrine	NN	O	norepinephrine	nn	14	SENT_306	[p24l1685t2531r2151b2600],
13	reuptake	NN	O	reuptake	nn	14	SENT_306	[p24l223t2627r488b2696],
14	inhibitor	NN	O	inhibitor	conj_and	5	SENT_306	[p24l513t2627r793b2680],
15	.	.	O	.	_	0	SENT_306	[p24l513t2627r793b2680],

1	J	NNP	O	J	nn	3	SENT_307	[p24l823t2628r850b2681],
2	Clin	NNP	O	Clin	nn	3	SENT_307	[p24l877t2627r1008b2681],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_307	[p24l1032t2627r1361b2680],
4	2000	CD	DATE	2000	dep	3	SENT_307	[p24l1388t2627r1558b2690],
5	;	:	O	;	_	0	SENT_307	[p24l1388t2627r1558b2690],
6	40	CD	NUMBER	40	num	7	SENT_307	[p24l1586t2627r1661b2681],
7	(	NN	O	(	dep	3	SENT_307	[p24l1690t2627r1792b2693],
8	2	CD	NUMBER	2	number	9	SENT_307	[p24l1690t2627r1792b2693],
9	)	CD	NUMBER	)	dep	7	SENT_307	[p24l1690t2627r1792b2693],
10	:	:	O	:	_	0	SENT_307	[p24l1690t2627r1792b2693],
11	161-7	CD	NUMBER	161-7	num	13	SENT_307	[p24l1830t2627r1998b2681],
12	Bartoli	NNP	PERSON	Bartoli	nn	13	SENT_307	[p24l181t2724r393b2779],
13	A	NNP	O	A	dep	3	SENT_307	[p24l423t2725r493b2789],
14	,	,	O	,	_	0	SENT_307	[p24l423t2725r493b2789],
15	Xiaodong	NNP	LOCATION	Xiaodong	nn	16	SENT_307	[p24l524t2724r827b2795],
16	S	NNP	LOCATION	S	appos	13	SENT_307	[p24l858t2725r914b2789],
17	,	,	O	,	_	0	SENT_307	[p24l858t2725r914b2789],
18	Gatti	NNP	PERSON	Gatti	nn	19	SENT_307	[p24l946t2724r1097b2779],
19	G	NNP	PERSON	G	appos	13	SENT_307	[p24l1127t2725r1196b2789],
20	,	,	O	,	_	0	SENT_307	[p24l1127t2725r1196b2789],
21	et	FW	O	et	nn	22	SENT_307	[p24l1228t2733r1283b2779],
22	al.	FW	O	al.	appos	13	SENT_307	[p24l1312t2724r1379b2779],
23	.	.	O	.	_	0	SENT_307	[p24l1312t2724r1379b2779],

1	The	DT	O	the	det	2	SENT_308	[p24l1412t2725r1530b2779],
2	inﬂuence	NN	O	inﬂuence	nsubj	11	SENT_308	[p24l1559t2724r1844b2779],
3	of	IN	O	of	_	0	SENT_308	[p24l1874t2724r1940b2779],
4	ethnic	JJ	O	ethnic	amod	5	SENT_308	[p24l1965t2724r2150b2779],
5	factors	NNS	O	factor	prep_of	2	SENT_308	[p24l225t2820r431b2873],
6	and	CC	O	and	_	0	SENT_308	[p24l463t2820r572b2873],
7	gender	NN	O	gender	conj_and	2	SENT_308	[p24l601t2820r810b2889],
8	on	IN	O	on	_	0	SENT_308	[p24l839t2836r913b2873],
9	CYP1A2	NN	O	cyp1a2	prep_on	7	SENT_308	[p24l943t2820r1534b2873],
10	—	CD	NUMBER	—	num	9	SENT_308	[p24l943t2820r1534b2873],
11	mediated	VBN	O	mediate	_	0	SENT_308	[p24l943t2820r1534b2873],
12	drug	NN	O	drug	nn	13	SENT_308	[p24l1563t2820r1701b2889],
13	disposition	NN	O	disposition	dobj	11	SENT_308	[p24l1732t2820r2085b2889],
14	:	:	O	:	_	0	SENT_308	[p24l1732t2820r2085b2889],
15	a	DT	O	a	det	17	SENT_308	[p24l2121t2836r2153b2873],
16	comparative	JJ	O	comparative	amod	17	SENT_308	[p24l225t2917r604b2988],
17	study	NN	O	study	nsubj	23	SENT_308	[p24l641t2917r803b2988],
18	in	IN	O	in	_	0	SENT_308	[p24l838t2917r896b2971],
19	Caucasian	JJ	MISC	caucasian	amod	22	SENT_308	[p24l931t2917r1246b2972],
20	and	CC	O	and	_	0	SENT_308	[p24l1281t2917r1390b2972],
21	Chinese	JJ	MISC	chinese	conj_and	19	SENT_308	[p24l1424t2917r1670b2972],
22	subjects	NNS	O	subject	prep_in	17	SENT_308	[p24l1707t2917r1950b2988],
23	using	VBG	O	use	parataxis	11	SENT_308	[p24l1985t2917r2151b2988],
24	phenacetin	NN	O	phenacetin	dobj	23	SENT_308	[p24l223t3014r557b3085],
25	as	IN	O	as	_	0	SENT_308	[p24l586t3031r646b3069],
26	a	DT	O	a	det	28	SENT_308	[p24l677t3031r709b3069],
27	marker	NN	O	marker	nn	28	SENT_308	[p24l736t3015r954b3069],
28	substrate	NN	O	substrate	prep_as	23	SENT_308	[p24l984t3014r1269b3069],
29	.	.	O	.	_	0	SENT_308	[p24l984t3014r1269b3069],

1	T	NN	O	t	nn	3	SENT_309	[p24l1301t3016r1347b3068],
2	her	PRP$	O	she	poss	3	SENT_309	[p24l1348t3015r1447b3069],
3	Drug	NN	O	drug	_	0	SENT_309	[p24l1473t3016r1629b3085],
4	Monit	NNP	O	Monit	dep	3	SENT_309	[p24l1659t3014r1847b3069],
5	1996	CD	DATE	1996	num	4	SENT_309	[p24l1881t3014r2044b3079],
6	;	:	O	;	_	0	SENT_309	[p24l1881t3014r2044b3079],
7	18	CD	NUMBER	18	number	8	SENT_309	[p24l2084t3015r2148b3069],
8	(	CD	NUMBER	(	dep	3	SENT_309	[p24l226t3111r328b3178],
9	5	CD	NUMBER	5	num	10	SENT_309	[p24l226t3111r328b3178],
10	)	NN	O	)	dep	8	SENT_309	[p24l226t3111r328b3178],
11	:	:	O	:	_	0	SENT_309	[p24l226t3111r328b3178],
12	586-91	CD	NUMBER	586-91	num	14	SENT_309	[p24l360t3111r569b3166],
13	Eli	NNP	PERSON	Eli	nn	14	SENT_309	[p24l181t3208r269b3262],
14	Lilly	NNP	PERSON	Lilly	dep	3	SENT_309	[p24l322t3208r470b3279],
15	and	CC	O	and	_	0	SENT_309	[p24l526t3208r634b3263],
16	Company	NNP	O	Company	dep	3	SENT_309	[p24l688t3209r1001b3279],
17	.	.	O	.	_	0	SENT_309	[p24l688t3209r1001b3279],

1	Cymbalta	NNP	LOCATION	Cymbalta	_	0	SENT_310	[p24l1059t3208r1358b3279],
2	(	CD	NUMBER	(	num	4	SENT_310	[p24l1412t3208r1761b3275],
3	duloxetine	NN	O	duloxetine	nn	4	SENT_310	[p24l1412t3208r1761b3275],
4	hydrochloride	NN	O	hydrochloride	dep	1	SENT_310	[p24l1813t3208r2149b3279, p24l223t3304r366b3370],
5	)	CD	NUMBER	)	num	6	SENT_310	[p24l1813t3208r2149b3279, p24l223t3304r366b3370],
6	capsules	NNS	O	capsule	dep	4	SENT_310	[p24l407t3304r682b3373],
7	.	.	O	.	_	0	SENT_310	[p24l407t3304r682b3373],

1	Clinical	JJ	O	clinical	amod	3	SENT_311	[p24l725t3304r967b3357],
2	pharmacology	NN	O	pharmacology	nn	3	SENT_311	[p24l1005t3304r1446b3373],
3	biopharmaceutics	NNS	O	biopharmaceutic	nsubj	4	SENT_311	[p24l1484t3304r2027b3373],
4	review	VBP	O	review	_	0	SENT_311	[p24l2066t3320r2149b3357, p24l225t3400r389b3463],
5	,	,	O	,	_	0	SENT_311	[p24l2066t3320r2149b3357, p24l225t3400r389b3463],
6	part	NN	O	part	dobj	4	SENT_311	[p24l416t3408r536b3469],
7	2	CD	NUMBER	2	num	6	SENT_311	[p24l562t3400r614b3453],
8	:	:	O	:	_	0	SENT_311	[p24l562t3400r614b3453],
9	20	CD	NUMBER	20	number	10	SENT_311	[p24l645t3400r719b3454],
10	[	CD	NUMBER	[	dep	6	SENT_311	[p24l750t3400r1003b3465],
11	online	NN	O	online	prep	10	SENT_311	[p24l750t3400r1003b3465],
12	]	NN	O	]	dep	11	SENT_311	[p24l750t3400r1003b3465],
13	.	.	O	.	_	0	SENT_311	[p24l750t3400r1003b3465],

1	Available	JJ	O	available	_	0	SENT_312	[p24l1032t3400r1331b3454],
2	from	IN	O	from	_	0	SENT_312	[p24l1357t3400r1506b3453],
3	URL	NN	O	url	prep_from	1	SENT_312	[p24l1530t3401r1699b3454],
4	:	:	O	:	_	0	SENT_312	[p24l1530t3401r1699b3454],
5	http://www.fda.gov/cder/foi/nda/2004/021427_s000_Cymbalta.htm	NN	O	http://www.fda.gov/cder/foi/nda/2004/021427_s000_cymbalta.htm	dep	1	SENT_312	[p24l1729t3400r2149b3469, p24l225t3497r1921b3568],
6	[	CD	NUMBER	[	num	5	SENT_312	[p24l2017t3498r2149b3563, p24l225t3593r425b3646],
7	Accessed	VBN	O	access	partmod	5	SENT_312	[p24l2017t3498r2149b3563, p24l225t3593r425b3646],
8	2007	CD	DATE	2007	num	11	SENT_312	[p24l450t3593r599b3646],
9	Aug	NNP	DATE	Aug	nn	11	SENT_312	[p24l627t3593r758b3662],
10	9	CD	DATE	9	num	11	SENT_312	[p24l785t3593r841b3657],
11	]	NN	O	]	dep	7	SENT_312	[p24l785t3593r841b3657],

1	Correspondence	NN	O	correspondence	_	0	SENT_313	[p25l8t171r622b255],
2	:	:	O	:	_	0	SENT_313	[p25l8t171r622b255],
3	Evelyn	NNP	PERSON	Evelyn	nn	10	SENT_313	[p25l647t171r875b255],
4	D.	NNP	PERSON	D.	nn	10	SENT_313	[p25l899t174r974b232],
5	Lobo	NNP	PERSON	Lobo	nn	10	SENT_313	[p25l1001t171r1176b244],
6	,	,	O	,	_	0	SENT_313	[p25l1001t171r1176b244],
7	PhD	NNP	O	PhD	conj_and	10	SENT_313	[p25l1197t171r1376b244],
8	,	,	O	,	_	0	SENT_313	[p25l1197t171r1376b244],
9	Eli	NNP	ORGANIZATION	Eli	conj_and	10	SENT_313	[p25l1398t171r1494b232],
10	Lilly	NNP	ORGANIZATION	Lilly	dep	1	SENT_313	[p25l1514t172r1681b255],
11	and	CC	ORGANIZATION	and	_	0	SENT_313	[p25l1702t172r1837b233],
12	Company	NNP	ORGANIZATION	Company	conj_and	10	SENT_313	[p25l1859t173r2151b255, p25l7t298r119b360],
13	,	,	O	,	_	0	SENT_313	[p25l1859t173r2151b255, p25l7t298r119b360],
14	Drug	NNP	O	Drug	nn	15	SENT_313	[p25l147t279r337b360],
15	Disposition	NNP	O	Disposition	appos	1	SENT_313	[p25l363t279r801b360],
16	,	,	O	,	_	0	SENT_313	[p25l363t279r801b360],
17	Global	NNP	O	Global	appos	1	SENT_313	[p25l829t277r1069b339],
18	Pharmacokinetic	JJ	O	pharmacokinetic	dep	17	SENT_313	[p25l1096t277r1751b347],
19	/	:	O	/	punct	20	SENT_313	[p25l1096t277r1751b347],
20	Pharmacodynamic	JJ	LOCATION	pharmacodynamic	dep	18	SENT_313	[p25l1759t277r2151b339, p25l9t383r323b466],
21	/	:	O	/	punct	20	SENT_313	[p25l332t382r368b453],
22	Trial	NNP	O	Trial	nn	23	SENT_313	[p25l377t383r547b444],
23	Simulation	NNP	O	Simulation	dep	1	SENT_313	[p25l573t382r988b455],
24	,	,	O	,	_	0	SENT_313	[p25l573t382r988b455],
25	Corporate	NNP	ORGANIZATION	Corporate	nn	26	SENT_313	[p25l1015t384r1383b466],
26	Center	NNP	ORGANIZATION	Center	appos	23	SENT_313	[p25l1409t384r1670b455],
27	,	,	O	,	_	0	SENT_313	[p25l1409t384r1670b455],
28	DC	NNP	ORGANIZATION	DC	appos	23	SENT_313	[p25l1697t384r1815b445],
29	0724	CD	DATE	0724	num	28	SENT_313	[p25l1843t385r2024b455],
30	,	,	O	,	_	0	SENT_313	[p25l1843t385r2024b455],
31	Indianapolis	NNP	LOCATION	Indianapolis	appos	23	SENT_313	[p25l2050t385r2151b443, p25l9t488r407b571],
32	,	,	O	,	_	0	SENT_313	[p25l2050t385r2151b443, p25l9t488r407b571],
33	IN	IN	O	in	_	0	SENT_313	[p25l436t490r530b550],
34	46285	CD	NUMBER	46285	prep_in	23	SENT_313	[p25l555t490r780b561],
35	,	,	O	,	_	0	SENT_313	[p25l555t490r780b561],
36	USA	NNP	LOCATION	USA	appos	1	SENT_313	[p25l808t489r994b550],
37	.	.	O	.	_	0	SENT_313	[p25l808t489r994b550],

1	E-mail	NN	O	e-mail	_	0	SENT_314	[p25l8t593r261b655],
2	:	:	O	:	_	0	SENT_314	[p25l8t593r261b655],
3	loboeV@lilly.com	NNP	O	loboeV@lilly.com	dep	1	SENT_314	[p25l293t594r916b677],

1	Clin	NNP	O	Clin	nn	2	SENT_315	[p25l1207t863r1313b911],
2	Phormocokinet	NNP	O	Phormocokinet	_	0	SENT_315	[p25l1339t864r1794b911],
3	2007	CD	DATE	2007	num	2	SENT_315	[p25l1815t863r1963b914],
4	;	:	O	;	_	0	SENT_315	[p25l1815t863r1963b914],
5	46	CD	NUMBER	46	number	6	SENT_315	[p25l1986t864r2053b911],
6	(	CD	NUMBER	(	dep	2	SENT_315	[p25l2076t863r2150b917],
7	9	CD	NUMBER	9	num	8	SENT_315	[p25l2076t863r2150b917],
8	)	NN	O	)	dep	6	SENT_315	[p25l2076t863r2150b917],

